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ABSTRACT
Iodine, through thyroid hormones, is required for fetal brain development during 
pregnancy. Iodine deficiency was historically common in the UK and was eradicated, not 
by the usual practice of an iodised-salt programme, but through an adventitious increase in 
milk-iodine concentration. There is a dearth of information on iodine status and food 
sources of iodine in the UK which this thesis has endeavoured to address through a series 
of studies.
The thesis has highlighted several causes for concern: (1) The median urinary-iodine 
concentration in pregnant women in Surrey and Oxford (85.3 and 42.5 pg/L respectively) is 
indicative of iodine deficiency; (2) higher iodine status was associated with use of an 
iodine-containing supplement and the major dietary predictor of iodine status (assessed 
through a food-frequency questionnaire) was milk and dairy produce. A study of retail milk 
revealed organic milk to have an iodine concentration 42% lower than that of conventional 
milk and is thus a potential threat to iodine status; (3) in contrast to other countries 
worldwide, iodised salt availability is low in the UK and fewer than 20% of supermarket 
shoppers have iodised salt available to purchase; thus iodised salt is not likely to contribute 
to UK iodine status; (4) 15% of pregnant women in Oxford had a low free-thyroxine 
concentration which may pose a threat to the developing fetal brain and finally; (5) iodine 
deficiency, as assessed in stored-urine samples of a UK prospective cohort study was 
associated with adverse effects on neurological development; children of iodine-deficient 
women had a higher risk of low IQ at age 8 (OR 1.58, 95% Cl 1.09-2.29) and poorer 
reading accuracy scores at age 9 (OR 1.83, 95% Cl 1.22-2.74), even after adjustment for 
potential confounders.
The findings suggest that a UK public-health policy is required to minimise the adverse 
effects of iodine deficiency.
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Chapter 1 : Introduction
1. INTRODUCTION AND LITERATURE REVIEW
1.1 Overview
Iodine is a key component of the thyroid hormones thyroxine (T4) and triiodothyronine 
(T3), which are crucial for brain and neurological development, particularly during 
gestation and early life (reviewed by Zimmermann, 2009a). The World Health 
Organization (WHO) considers iodine deficiency to be “the single most important 
preventable cause of brain damage” worldwide (WHO et al, 2007). Although iodine 
deficiency is often considered to be a problem of developing countries, it is increasingly 
recognised that industrialised countries are not immune (Zimmermann, 2010). The UK has 
been considered to be iodine-sufficient over the last 50 years or so (Wenlock et al, 1982; 
Lee et al, 1994), but there is increasing evidence that this is no longer the case 
(Vanderpump g/ arZ., 2011).
The author investigated iodine status in UK women of childbearing age as an 
undergraduate (Bath e/ aZ., 2008) and this prompted interest in the risk of iodine deficiency 
in UK pregnant women and formed the basis of the thesis project proposal. This thesis 
describes an investigation of iodine status in UK pregnant women and an evaluation of its
impact on maternal thyroid function in pregnancy and child cognitive and developmental 
outcomes. The research in this thesis needs to be considered within the context of the 
importance of iodine in fetal cognitive development and the consequences of iodine 
deficiency, the dietary sources of iodine and the historical and current iodine status of the 
UK. These topics will form the basis of the literature review.
1.2 Global prevalence of iodine deficiency
Iodine deficiency is currently estimated to affect 241 million school-aged children, despite 
great improvements in global iodine nutrition since the turn of the century (Andersson g/ 
ürZ., 2012). This improvement is largely due to successful salt-iodisation programmes (see 
Section 1.5.1) and greater access to iodised salt (Andersson g/ aZ., 2012). Since the last 
estimate of global iodine deficiency in 2008, new national data have become available for 
many countries, including the UK which, at the start of this PhD programme in 2009, was
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one of the countries worldwide with no national data on iodine status (de Benoist et a l, 
2008). The UK is now regarded as mildly iodine deficient (Andersson et a l, 2012).
1.3 Role of iodine in pregnancy
1.3.1 Iodine and thyroid function during pregnancy
Iodine is a vital component of the thyroid hormones, comprising 65% of the molecular 
weight of T4 and 59% of that of T3 (Zimmermann et a l, 2008). Thyroid hormone receptors 
have a 15-fold higher affinity for T3 than T4 (Williams, 2008), thus T4 is considered a pro­
hormone that is converted to the biologically-active T3 by selenium-dependent 
iodothyronine deiodinase enzymes (Figure 1.1). T3 binds to thyroid hormone receptor 
proteins on target cells (e.g. brain cells), which then regulate protein synthesis and gene 
transcription (Vanderpas, 2006; Williams, 2008).
Thyroid hormones control a range of bodily functions, including carbohydrate and glucose 
metabolism, basal metabolic rate and thermoregulation. However, for the purposes of this 
thesis, only the effects on fetal neurological development will be considered.
Iodothyronine
Deiodinase
‘COOHCOOH
Thyroxine (T4) Triiodothyronine (T3)
Figure 1.1 Structure of the thyroid hormones 
Formation of thyroid hormones
Thyroid hormone production is under the control of the hypothalamic-pituitary axis and 
when circulating thyroid hormone levels decrease, thyroid stimulating hormone (TSH) is 
secreted to initiate increased production of thyroid hormones. Iodide is taken from the 
blood into the thyroid gland via the sodium-iodide symporter which is located on the baso- 
lateral membrane of the thyrocyte; this is an energy-dependent process that it is driven by
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sodium moving down its electro-chemical gradient in order to move iodine against its 
electrochemical gradient (reviewed by Rousset & Dunn, 2004).
Once iodide is taken into the thyroid, it moves to the apical membrane of the thyrocyte 
where it is oxidised by the enzyme thyroid peroxidase (TPO) in the presence of hydrogen 
peroxide and it is incorporated on to residues of thyroglobulin (Tg) to form mono-and 
diiodotyrosine (MIT and DIT) (Rousset & Dunn, 2004). Tg is a protein that is a thyroid- 
specific and provides a backbone for thyroid hormone synthesis; it facilitates the storage of 
iodine in the thyroid (Rousset & Dunn, 2004). T4 is produced by TPO coupling two DIT 
molecules and T3 formation is the result of coupling of a DIT and a MIT molecule. The 
iodinated thyroglobulin is degraded by proteolytic enzymes in lysosomes to release T4 and 
T3 into the circulation (Rousset & Dunn, 2004). Thyroid hormones are transported in the 
circulation both bound to proteins and as free hormones (fT4 and fT3).
Thyroid dysfunction
Pregnancy is regarded as a stressor for the thyroid gland and can induce a degree of 
dysfunction, especially in conditions of iodine deficiency (Glinoer, 2004). Thyroid 
dysfunction is typically described as degrees of hypothyroidism or hyperthyroidism, 
although the latter is less common in pregnant women and likely to be a result of 
autoimmune disease (Stagnaro-Green et a l, 2011).
Overt hyperthyroidism is defined as a low TSH level with high levels of thyroid hormone, 
whereas subclinical hyperthyroidism is defined by a low TSH level with normal levels of 
thyroid hormone; autoimmune thyroid disease can cause hyperthyroidism and is referred to 
as Graves’ disease (Stagnaro-Green et a l, 2011). The role of iodine intake on the incidence 
of hyperthyroidism is discussed in Section 1.5.3.
Hypothyroidism is classified as either subclinical (elevated TSH but with normal levels of 
thyroid hormone) or overt (elevated TSH with low concentration of T3 and T4). 
Hypothyroidism can be caused by an insufficient intake of iodine (and thus insufficient 
substrate for thyroid hormone production) but can also be a result of autoimmune thyroid 
disease (Hashimoto’s thryoiditis) (Stagnaro-Green et a l, 2011). Autoimmune thyroid
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disease is commonly due to antibodies against thyroid peroxidase (TPOAb positive) or 
thyroglobulin (TgAb positive) (Smallridge et a l, 2005).
In iodine deficiency, there is preferential production of T3 over T4 as one atom of iodine is 
spared (Glinoer, 1997; Morreale de Escobar et a l, 2004). This results in a condition called 
hypothyroxinaemia which is described by a low maternal T4 but with normal T3 and TSH 
levels and therefore individuals appear euthyroid (Morreale de Escobar et a l, 2004). The 
effects of thyroid dysfunction on fetal brain development are discussed in Section 1.4.2.
The role of thyroid in fetal brain development
Thyroid hormones are required throughout brain development, both prior to the fetus 
producing its own thyroid hormones (when they must be supplied by the mother) and 
postnatally (when they are dependent on neonatal and infant supply) (Williams, 2008). 
Before the onset of fetal thyroid function, maternal thyroid hormones are required for the 
proliferation and migration of neurones, while after fetal thyroid hormone production 
commences, fetal and maternal thyroid hormones are involved in neurogenesis, 
development of the brain cytoarchitecture (such as dendrite branches, axon growth and 
formation of synapses) and glial differentiation and migration; by contrast postnatal thyroid 
hormones supply is important for myelination of neurones (reviewed by Williams, 2008).
The fetus largely derives its T3 from maternal T4, as evidenced by the fact that infusion of 
T4, but not T3, to thyroid hormone deficient pregnant rats was able to normalise T3 levels 
in the fetal brain (Calvo et a l, 1990). Hypothyroxinaemia, rather than low maternal T3 
levels, during pregnancy is considered deleterious for fetal development (Morreale de 
Escobar et a l, 2000; Berbel & Berbel, 2010) (this will be discussed in Section 1.4.2).
Although the fetus does not secrete its own thyroid hormones until after mid-gestation, fT4 
has been detected in fetal compartments at as early as nine weeks (Calvo et a l, 2002). This 
fits with the discovery of thyroid hormone receptors in human placentae in the first 
trimester (Loubiere et a l, 2010). Maternal thyroid function in early pregnancy is vital for 
correct fetal brain development but maternal thyroid function is also crucial after the onset 
of fetal thyroid function, as evidenced by the fact that up to 40% of thyroid hormone in 
cord blood at birth is believed to be of maternal origin (Morreale de Escobar et a l, 2004).
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As the mother must supply the iodine for fetal thyroid-hormone production, an adequate 
iodine intake throughout gestation is required for fetal neurological development (Section
1.4.2) (Morreale de Escobar et a l , 2004).
Different structures of the brain develop at different stages of pregnancy and in the 
postnatal period (Rice & Barone, 2000) and there are considerable differences in the 
requirement for thyroid hormone at different times of gestation and in different brain 
regions (Rester et a l, 2004). Evidence from animal studies suggests that even transient 
periods of maternal hypothyroxinaemia adversely affect fetal brain neuronal migration 
which cannot be corrected after the onset of fetal thyroid function (Lavado-Autric et a l, 
2003; Auso et a l, 2004). There are critical windows during brain development during 
which a lack of thyroid hormone can result in permanent damage to the brain structure 
which may influence its function (Morreale de Escobar et a l, 2004; Williams, 2008).
1.3.2 Requirement for iodine during pregnancy
The thyroid can store up to 20 mg of iodine and these stores can be dravm on during 
pregnancy to maintain thyroid hormone production (Glinoer, 2007). There is now evidence 
to suggest that the placenta may also act as an iodine store, but it is not known whether it 
can be utilised by the fetus (Bums et a l, 2011b). Thus, the requirement for iodine during 
pregnancy can be met through dietary intake, but can also be supplemented by drawing on 
thyroidal stores of iodine, provided these have been maximised prior to conception (see 
below) (Smyth, 2006).
Dietary requirements
UK iodine requirements were set in 1991 (Department of Health, 1991); the adult 
requirement was set on the basis that 70 pg/day was required to prevent goitre [this was set 
as the Lower Reference Nutrient Intake (LRNI)] and the Reference Nutrient Intake (RNI) 
was set at twice that value, i.e. at 140 pg/day. Thus there is no Estimated Average 
Requirement (EAR) for iodine in the UK and the UK RNI has not been set as a value to 
meet the needs of 97.5% of the UK population (Department of Health, 1991).
Table 1.1 compares iodine requirements in the UK (Department of Health, 1991) to those 
set by other international bodies (Food and Nutrition Board Institute of Medicine, 2001;
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WHO et a l, 2007; WHO Secretariat et a l, 2007). The comparison highlights the fact that 
there is no increment in the iodine requirement for pregnancy in the UK. This is in marked 
contrast to the near-doubling of intake recommended by the WHO (WHO Secretariat et a l , 
2007). The RNI set by the WHO is based on a number of factors (see below).
The fact that the UK RNI is not higher in pregnancy has previously been questioned, 
alongside a suggestion that the UK Food Standards Agency (FSA) should review iodine 
requirements (Wynn & Wynn, 2000), but this was not done. The EURRECA (EURopean 
micronutrient RECommendations Aligned) programme has ranked iodine in the top ten 
micronutrients for which there is a high priority for requirements to be refined and aligned 
across Europe, owing to different requirements between countries (Cavelaars et a l, 2010).
Table 1.1 Iodine requirements by life stage according to different international bodies
Age
LRNI
Daily iodine requirements (pg/d)
UK  ^ USA  ^ Worldwide^ 
RNI RDA RNI*
15-18 years 70 140 150 150
19-50 years 70 140 150 150
Pregnancy - 220t 250
Lactation - 290 250
1. Department of Health (1991); 2. Institute of Medicine (2001) 3. WHO et al. (2007). *no LRNI or EAR is 
published, f  based on EAR of 160 pg/day, with CV of 20%.
Metabolic factors that influence the iodine requirement
There are a number of factors during pregnancy that result in an increase in thyroid 
stimulation leading to a higher T4 requirement (Smallridge et a l, 2005). As thyroxine 
production is dependent on an adequate iodine supply, these factors aid an understanding of 
why iodine requirements are increased in pregnancy.
The first change to occur is the increase in oestrogen levels in early pregnancy (6-10 weeks 
gestation) that results in an increase in thyroxine-binding globulin (TBG); TBG levels in 
pregnancy are 2-3 times higher than in the non-pregnant state (Glinoer, 2001; Glinoer, 
2004; Smallridge et a l, 2005; Fitzpatrick & Russell, 2010). Increased TBG alters the ratio
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of free-to-bound T4 and can therefore result in lower free thyroxine (fT4) concentrations 
that subsequently stimulate the requirement for T4 (Smallridge & Ladenson, 2001). The 
other important change in pregnancy is the increase in human chorionic gonadotrophin 
(hCG) which transiently peaks at the end of the trimester, stimulating the thyroid -  hCG 
and TSH have structural similarities (Fitzpatrick & Russell, 2010). This causes a 
suppression of TSH and a transient increase in T4 and T3 levels (thought to ensure 
adequate supply of T4 for the developing brain) (Williams, 2008). Finally, there is 
increased turnover of T4 during pregnancy due to placental deiodinase activity that 
converts maternal T4 to T3 (Glinoer, 2001; Smallridge et a l, 2005). These thyroidal 
changes in pregnancy mean that T4 production must increase by up to 50% in order to 
maintain fetal and maternal euthyroidism; thus, iodine supply must also increase to 
maintain the required T4 levels (Smallridge et a l, 2005).
The UK requirements for pregnancy are clearly outdated as a pregnant women requires 
additional iodine for three reasons: (i) her production of thyroid hormone increases by 50% 
(explained above), (ii) she needs to compensate for increased renal clearance of iodine and 
(iii) she needs to provide iodine for the fetus to use after the onset of fetal thyroid function 
(Delange, 2007; Zimmermann, 2009a). The WHO requirement of 250 pg iodine per day in 
pregnancy was derived as follows: to the adult requirement of 150 pg/day for non-pregnant 
women were added 50-100 pg/day to account for the 50% increase in thyroxine production 
(Delange, 2007), and 50 pg/day for the amount of iodine transferred from mother to fetus 
throughout gestation (Delange, 2007).
Delange (2007) reviewed the evidence that urinary loss of iodine is higher in pregnancy. 
The results are contradictory; while most studies show no difference in iodine excretion 
between pregnant and non-pregnant women, other studies found a higher loss of iodine in 
pregnancy. The iodine requirement for pregnancy has not been adjusted on the basis of 
additional iodine loss, as this cannot be quantified (Delange, 2007).
The US Institute of Medicine (lOM) has also used evidence from studies that supplemented 
pregnant women with iodine to suggest the dose of iodine that prevents an increase in 
thyroid volume (suggesting that the thyroid is having to adapt to a low iodine intake) (Food 
and Nutrition Board Institute of Medicine, 2001). The lOM have set an EAR of 160 pg/day
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(by contrast, the WHO have not published an EAR for iodine) and a Recommended Daily 
Allowance (RDA) of 220 pg/day (Food and Nutrition Board Institute of Medicine, 2001).
Importance of pre-conceptual iodine
It is important that women of childbearing age meet the iodine requirement prior to 
conception to maximise thyroidal stores of iodine (Glinoer, 2004). This has been 
demonstrated in Italy, where women who used iodised salt in the two years before 
conception had a reduced risk of thyroid failure than women who began to use iodised salt 
during pregnancy (Moleti et a l, 2008), or those who commenced iodine supplements 
during pregnancy (Moleti et a l, 201 la). The consumption of iodised salt prior to pregnancy 
was associated with higher fT4 levels than those in the groups that either used iodine 
supplements or began using iodised salt during pregnancy. As this has implications for fetal 
brain development, the authors suggest that women of childbearing age should take iodine 
supplements for several months prior to the onset of pregnancy (Moleti et a l, 2011a). 
Iodine deficiency has been found in UK women of childbearing age (Bath et a l, 2008; 
Rayman et a l, 2008a), so there may be cause for concern for thyroid function in UK 
pregnant women.
1.3.3 Measurement of iodine status in pregnancy
Iodine is classified as a micronutrient for which status should be assessed by biomarkers 
rather than by dietary intake (Ovesen & Boeing, 2002). Iodine is renally excreted and, as 
over 90% of ingested iodine is eventually excreted by this route, urinary iodine 
concentration (UIC) is considered an excellent biomarker of iodine intake (Jahreis et a l , 
2001; Zimmermann, 2008b; Ristic-Medic et a l, 2009; Vejbjerg et a l, 2009a); thus UIC 
will be used for iodine status assessment in this thesis (Methods, Section 2.4). The World 
Health Organisation (WHO) recommends that population iodine status assessment is based 
on the median UIC in spot-urine samples and the WHO have published cut-offs to indicate 
iodine sufficiency in pregnant populations (Table 1.2) (WHO Secretariat et a l, 2007).
A Food Frequency Questionnaire (FFQ) can be used to supplement UIC data from 
individuals and can give information on the food sources that contribute to iodine status 
(Rasmussen et a l, 2001). A spot-urine sample is not suitable for iodine assessment in
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individuals, due to the intra-individual variation in daily urine volume and iodine intake 
(Rasmussen et al, 1999; Zimmermann, 2008b; Vejbjerg et al, 2009a), but the variation in 
urine volume can be overcome by measuring urinary creatinine concentration, particularly 
if adjusted for the age and sex of individuals (Knudsen et al, 2000) (Methods, Section
2.4.2).
Table 1.2: Classification of iodine intake in pregnancy, based on median urinary iodine 
concentration (WHO Secretariat et al, 2007).
Median urinary iodine concentration 
(Pg/L)
Category of iodine intake
<150 Insufficient
150-249 Adequate
250-499 More than adequate
>500 No added health benefit expected
There are other methods for assessing population iodine status in non-pregnant adults, 
namely newborn serum TSH, goitre rate, and serum thyroglobulin (Zimmermann, 2008b) 
but these will not be further discussed as they are not recommended for assessment of 
iodine status in pregnancy (WHO Secretariat e/ a/., 2007; Zimmermann, 2008b).
1.4 Iodine deficiency disorders
The clinical consequences of an inadequate iodine intake, through inadequate thyroid 
hormone production, are grouped under the umbrella of “iodine deficiency disorders” 
(Hetzel, 1983). The acknowledgment of a range of manifestations of iodine deficiency, 
beyond thyroid enlargement, has been pivotal in increasing the recognition of the public- 
health implications of iodine deficiency on a global scale (WHO ef <3/., 2007). The World 
Health Assembly and the World Summit for Children in 1990 (UNICEF, 1990) endorsed 
the goal of eliminating iodine deficiency disorders by the year 2000, and while this was not 
achieved, by the start of the 2U  ^ century many countries had made enormous efforts to 
monitor and improve iodine status, and ensure access to iodised salt (Delange g/ a/., 2001).
In recognition of the role of iodine in the normal development of children, the European 
Food Safety Authority has given approval for food labels to display the wording “iodine 
contributes to the normal growth of children” (European Food Safety Authority, 2010).
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1.4.1 Goitre
The most recognisable sign of iodine deficiency is the swelling of the thyroid gland, or 
goitre; it is an adaptation of the thyroid gland to a very low iodine intake, by increasing the 
iodine-trapping potential of the thyroid (Zimmermann et a l, 2008). TSH stimulates 
hypertrophy and hyperplasia of the thyroid gland, which initially grows in a diffuse and 
homogenous manner, but can progress to nodule formation with increased exposure to 
iodine deficiency. Nodular goitre is more common in older inhabitants of iodine deficient 
regions and can pose a risk for iodine-induced hyperthyroidism when excessive iodine is 
supplied (Section 1.5.3) (Zimmermann et al., 2008). In addition to a lack of dietary iodine, 
the presence of goitrogens in the diet can also increase the risk of goitre (Section 1.6.5).
Iodine intake in the UK was historically low enough to cause endemic goitre (see Section 
1.7), particularly in some regions, such as the West Country and Derbyshire. The incidence 
of goitre is less of a public-health concern in the present day as iodine intake in the UK is 
generally above the level at which goitre, certainly visible goitre, would develop. 
Nevertheless, there have been recent case reports of goitre in UK vegans and individuals 
with restricted diets (Park et a!., 2005; Gordon et a l, 2006).
1.4.2 Neurological impairment in the offspring
Thyroid hormones are involved in neuronal proliferation, migration, and myelination 
(reviewed by Williams, 2008). Different structures of the brain develop at different stages 
of pregnancy and in the postnatal period (Rice & Barone, 2000) and there are considerable 
differences in the requirement for thyroid hormone at different times of gestation and in 
different brain regions (Kester et a l, 2004). Evidence from animal studies suggests that 
even transient periods of maternal hypothyroxinaemia adversely affect fetal brain neuronal 
migration which cannot be corrected after the onset of fetal thyroid function (Lavado- 
Autric et a l, 2003; Auso et a l, 2004). There are critical windows during brain development 
where a lack of thyroid hormone can result in permanent damage to the brain structure 
which may influence its function (Morreale de Escobar et a l, 2004; Williams, 2008).
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Severe prenatal iodine deficiency in pregnancy and neurological development
Owing to the role of maternal thyroid hormone in fetal brain development, iodine 
deficiency is associated with varying degrees of brain damage (Dunn & Delange, 2001). 
Severe iodine deficiency is linked to the development of cretinism, which can be 
categorised as either neurological or hypothyroid (myxedematous) but the two types can 
present in combination (Chen & Hetzel, 2010). Neurological cretinism shows symptoms of 
hearing defects, altered gait, spasticity of lower limbs, and mental retardation; hypothyroid 
cretinism leads to symptoms of thyroid insufficiency such as hypothyroidism, delayed 
sexual maturation, dry skin and stunted growth and is associated with a less severe mental 
insufficiency than neurological cretinism (Chen & Hetzel, 2010).
Some of the most important early work on the link between iodine deficiency and cretinism 
came from Papua New Guinea in the 1960s (Pharoah et a l, 1971). Iodine supplementation 
(iodised oil injection) of women of childbearing age reduced the incidence of cretinism at 
four-year follow up compared to control women who received saline injections (5 vs. 26 
cretins); the study showed that cretinism could be prevented if women were supplemented 
with iodine prior to conception (Pharoah et a l, 1971). The effeets on motor skills were still 
significant at ages 6-12 years (Connolly et a l, 1979) and cognition and motor skills were 
better at age 15 years than those of the controls (Pharoah & Connolly, 1987). In an area of 
severe iodine deficiency in China, a lower prevalence of neurological abnormality (at 2 
years) was evident in the children of women supplemented with iodine in early rather than 
late gestation (2% v& 9%) (Cao et a l, 1994). At follow-up (age 6-7 years), psychomotor 
scores were improved in children whose mothers were supplemented with iodine early in 
pregnancy, as was hearing ability (though not significantly), compared to those whose 
mothers were supplemented late in pregnancy, and to children who received supplements at 
age 2 years (O'Donnell et a l, 2002).
The effect of severe iodine deficiency on a population has been summarised by two meta­
analysis of small studies (Bleichrodt & Bom, 1994; Qian et a l, 2005). The meta-analysis 
by Bleichrodt and Bom (1994) analysed 18 studies of homogenous populations and showed 
a large effect of iodine deficiency on cognitive outcomes in the offspring, with a difference 
of 13.5 IQ points between iodine-deficient and iodine-sufficient populations. The authors
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point out that the mean IQ of an iodine-deficient population may be skewed by small 
numbers of extreme cases (i.e. cretins) rather than suggesting all members of the population 
have a lower IQ than if they resided in an iodine-sufficient region (Bleichrodt & Bom, 
1994). Qian et al (2005) conducted a meta-analysis of 37 studies in China in regions of 
severe iodine deficiency and reached a similar conclusion to that of Bleichrodt and Bom 
(1994); IQ in iodine deficient regions was 12.45 points lower than in sufficient regions. 
These meta-analyses cannot determine if the effects are due to iodine deficiency in utereo 
or in childhood, due to their cross-sectional design (reviewed by Zimmermann, 2009a).
There are reports of areas of the UK where neurological cretinism was common in the 19* 
century, for example in Somerset where there were frequent reports of cretins bom to 
women with goitre (Fagge, 1871). “Sporadic cretinism” was the term given, by Dr Fagge, 
to cases of cretinism in the UK that were clearly myxedematous or hypothyroid (Fagge, 
1871). Today, the UK is less at risk of severe iodine deficiency that could result in 
cretinism and more at risk of the effects of mild-to-moderate iodine deficiency.
Mild-to-moderate prenatal iodine deficiency and neurological outcome
The effects of mild-to-moderate iodine deficiency on cognition are less well known than 
those of severe iodine deficiency (Zimmermann, 2007a), but it is believed that there is a 
continuum of disability relating to iodine deficieney, ranging from severe impairments in 
the offspring (associated with severe iodine deficiency) to subtle impairments of IQ and 
motor ability (i.e. associated with a less severe iodine deficiency) (Dunn & Delange, 2001).
Several studies have found altered neurological outcomes in relation to subtle or mild 
matemal thyroid function (subclinical hypothyroidism or hypothyroxinaemia) during 
pregnancy (Haddow et a l, 1999; Pop et a l, 1999; Pop et a l, 2003; Kooistra et a l, 2006; Li 
et a l, 2010). These studies were conducted in countries or regions believed to be iodine 
sufficient (the US, the Netherlands and China) (Haddow et a l, 1999; Pop et a l, 1999; Pop 
et a l, 2003) but as iodine status was not measured, this can neither be confirmed nor 
disproved. It is important to note that many countries that are classified as being iodine 
sufficient according to assessment of schoolchildren and adults, have found low iodine 
status in pregnant women (Marchioni et a l, 2008; Wong et a l, 2011).
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In the US, the IQ of children bom to women with high TSH during pregnancy was 7 points 
lower than that of the children of control, euthyroid women (Haddow et a l, 1999). 
Correspondence relating to that study suggested that the effects may have been diminished 
by the inclusion of control women with hypothyroxinaemia (Morreale de Escobar & 
Escobar del Rey, 1999). A regression analysis performed by the authors after publieation of 
the paper and that showed an effect on child IQ across the range of matemal fT4 values, 
though it was not significant (Haddow et a l, 1999).
Evidence from the Netherlands suggests that matemal hypothyroxinemia during early 
gestation is associated with reduced development at three weeks of age (Kooistra et a l, 
2006), while a more recent study in India suggests no effect of matemal UIC or thyroid 
hormone on infants’ behaviour at three-weeks of age (Menon et a l, 2011). The effects of 
hypothyroxinaemia on later child development has also been evaluated in the Netherlands, 
with associations found between hypothyroxinaemia at 12 weeks’ gestation and 
psychomotor development at ten months of age (Pop et a l, 1999) and with lower mental 
and motor skills at ages one and two years (Pop et a l, 2003); the effects in these two Dutch 
studies were only seen when hypothyroxinemia was present in the first trimester and not 
later in pregnancy, indicating the importance of early iodine intake to meet the thyroid 
needs of the fetus (Pop et a l, 2003). There is also evidence that hypothyroidism and 
hypothyroxinaemia in mothers in the 2"  ^trimester (16-20 weeks) is associated with adverse 
mental and motor scores (Li et a l, 2010) though a study in the US found no difference in 
developmental scores (mental or motor) at the age of two years between those with 
hypothyroxinaemia in the 2"  ^trimester (15-20 weeks’ gestation) (below the 3*^  ^percentile) 
and those with fT4 levels between the 10* and 90* percentile (Craig et a l, 2012).
Relatively few studies have evaluated the impact on child development of low urinary 
iodine, rather than sub-optimal thyroid function. An exception was a study of pregnant 
women in Spain, though the study was limited by small numbers (n= 86) (Costeira et a l, 
2011). Matemal hypothyroxinaemia was associated with a higher risk of psychomotor 
delay while a low UIC (<50 pg/L) in the and 3*^  ^ trimesters was associated with lower 
psychomotor and mental scores at 18 months and a lower mental score at 24 months
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(Costeira et a l, 2011). This small study suggests that iodine status is an important factor in 
neurological development in a country with mild-to-moderate levels of iodine deficiency.
In addition to the effects of iodine and thyroid hormone deficiency on cognition, mild-to- 
moderate iodine deficiency has been associated with the development of the behaviour 
disorder. Attention Deficit Hyperactivity Disorder (ADHD) (Vermiglio et a l, 2004). The 
study found that none of the offspring of 11 women in the control region tested positive for 
ADHD at age 8-10 years, while 11 of 16 offspring (68.7%) in the iodine-deficient area did 
(Vermiglio et a l, 2004). Eight women developed hypothyroxinemia in early gestation, 
seven of whom produced ADHD-positive children, suggesting that ADHD development 
was related to low T4 levels in pregnancy (Vermiglio et a l, 2004). This study is limited by 
the small sample size but is consistent with the fact ADHD risk is higher in those with 
resistance to thyroid hormones (a genetic condition) (Hauser et a l, 1993). Other research 
has failed to find an association between neonatal T4 levels and ADHD diagnosis in 
childhood (Soldin et a l, 2002) therefore more research is required on the relationship 
between iodine status in pregnancy and ADHD risk.
A possible link between iodine deficiency, subsequent hypothyroxinemia, and the risk of 
the development of autism has been suggested (Sullivan & Maberly, 2004), an idea that has 
been supported in theory by others (Roman, 2007). The effects of hypothyroxinaemia 
during early pregnancy on cerebral brain development, particularly neuronal migration, are 
similar to those observed in autistic brains (Sullivan & Maberly, 2004; Roman, 2007), but 
as much of this is speculation, the area requires further study.
Supplementation of pregnant women with iodine or T4 in areas of mild-to- 
moderate iodine deficiency
Controlled studies of iodine supplementation (with varying doses of iodine) in regions of 
mild-to-moderate iodine deficiency have included a number of outcome measures, 
including thyroid volume (Romano et a l, 1991; Pedersen et a l, 1993; Glinoer et a l, 1995), 
and thyroid hormone levels (Pedersen et a l, 1993; Glinoer et a l, 1995; Liesenkotter et a l, 
1996; Nohr et a l, 2000; Antonangeli et a l, 2002); these studies have recently been 
reviewed (Zimmermann, 2007a) but will be summarised briefly here. The dose of iodine 
ranged from 100 to 230 pg/day; though all studies showed an increase in UIC in women
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who received iodine supplements, the results were not consistent in terms of the effect on 
thyroid function. Compared to controls, women who received additional iodine during 
pregnancy did not experience an increase in thyroid volume (Romano et a l, 1991), or 
thyroid volume increased to a lesser degree (Pedersen et a l, 1993; Glinoer et a l, 1995). 
Some studies showed a benefit to matemal TSH, but not fT4, levels (Pedersen et a l, 1993; 
Glinoer et a l, 1995), while others showed no effect on either TSH or fT4 levels 
(Liesenkotter et a l, 1996; Nohr et a l, 2000; Antonangeli et a l, 2002). Thus, it appears that 
while iodine status was improved, thyroid function, particularly fT4 levels which are 
relevant for fetal brain development, were not significantly altered; Zimmermann has 
suggested that in regions of mild-to-moderate iodine deficiency, the thyroid can adapt to 
maintain matemal euthyroidism (Zimmermann, 2007a; Zimmermann, 2009b).
As these studies did not include measures of infant development, it was not until 2009 that 
the effect of iodine supplementation on child cognition could be evaluated. Two separate 
trials have supplemented pregnant women from a mildly-to-moderately iodine-deficient 
region with iodine and evaluated cognition in the offspring up to the age of 18 months 
(Berbel et a l, 2009; Velasco et a l, 2009). However, both studies have limitations and 
neither was a randomised trial so further evidence is required on the benefit of iodine 
supplementation to women in regions of mild-to-moderate iodine deficiency. Berbel et al 
(2009) supplemented women with 150 pg iodine but only evaluated cognition in 44 
selected children. Women were selected on the basis of the presence of hypothyroxinaemia 
at varying time-points in pregnancy and therefore the study provides evidence for the effect 
of low fT4 levels on infant development rather than the effect of iodine supplementation 
(reviewed by Skeaff, 2011a). The results suggest that providing iodine in early pregnancy 
(4-6 weeks’ gestation) resulted in significantly higher developmental quotient scores in the 
offspring at 18 months of age than in those of the women who received iodine supplements 
in later pregnancy (12-14 weeks’ gestation) or postnatally (during lactation), there being no 
significant difference between scores in offspring of women who received iodine in the 
latter two groups. This study thus suggests the importance of providing iodine 
supplementation in early gestation (Berbel et a l, 2009). Velasco et al (2009) supplemented 
women with 230 pg iodine per day from the trimester and measured cognition in the 
offspring of treated and control women; unfortunately neurological testing was conducted
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at significantly different ages in the offspring of treated and control women (5 and 12 
months respectively). Though the psychomotor scores were significantly higher in 
offspring bom to iodine-supplemented women than to controls, the authors say that these 
findings should be considered as preliminary due to methodological problems (Velasco et 
al, 2009).
Other research has raised questions of the benefit of iodine supplementation in pregnancy 
on cognition in the offspring following findings that the use of a supplement containing 
over 200 pg iodine per day was associated with a higher risk of raised TSH than that of a 
supplement containing less than 100 pg/day (Rebagliato et al, 2010). In a follow-up study, 
psychomotor scores were found to be lower in the offspring of women who were taking a 
daily supplement containing more than 150 pg iodine than in those taking a supplement 
containing less than 100 pg (Murcia et al, 2011). It is important to note that these two 
studies (Rebagliato et a l,  2010; Murcia et a l,  2011) were observational studies and the 
iodine was part of a multivitamin and mineral supplement so the effects may not be specific 
to iodine (Murcia et al, 2011). In fact, there was no difference in neurocognitive outcome 
when the analysis was carried out by urinary iodine concentration (Murcia et al, 2011). 
Furthermore, the relationship between iodine supplement use and underlying urinary iodine 
status is unclear as no information was given on individual iodine status prior to pregnancy.
To provide evidence on the benefit of universal screening for thyroid function in pregnancy 
[not currently recommended by the American Thyroid Association (Stagnaro-Green et a l , 
2011)], the Controlled Antenatal Thyroid Screening study (CATS) was set up in the UK 
(Lazarus et al, 2012). Women were randomised to a screening group (levothyroxine was 
given if TSH was above the 97.5th percentile, or if fT4 was below the 2.5th percentile, or 
both, n = 390) or a control group (women with thyroid dysfunction that was identified after 
birth and not treated in pregnancy, n = 404) and cognitive function was measured in the 
children at the age of 3 years (Lazarus et al,  2012). The study found no benefit of 
screening and treating thyroid function on child cognition, though, as acknowledged by the 
authors, this could have been due to the insensitivity of IQ testing at 3 years or the fact that 
the intervention, which recruited women up to 20 weeks, was too late (Brent, 2012; Lazarus 
et a l,  2012). Consideration should also be given to the possibility that as reference ranges
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to diagnose thyroid dysfunction were derived from women in the trial who had been shown 
to be iodine deficient (Pearce et al, 2010), they may have been inappropriate, resulting in 
lower numbers of women included in both study arms, thus potentially reducing statistical 
power to detect differences in IQ (Bath & Rayman, 2012).
Taken together, these studies of iodine or thyroxine supplementation in pregnancy suggest 
that although the benefits to thyroid function are unclear, particularly with respect to fI4, 
there may be benefits to child cognition, particularly if iodine is provided in early 
pregnancy. The fact the CATS study did not find a benefit of screening and treating women 
with thyroxine potentially adds weight to the argument for the importance of iodine in early 
gestation, as it appears that treating thyroid dysfunction once it has been detected in 
pregnancy is too late to be of benefit and thus meeting pregnancy iodine requirements may 
offer more protection to the developing brain.
1.5 Correction of iodine deficiency in populations
1.5.1 Universal Salt lodisation (USI)
The recommended method to correct iodine deficiency in a population is Universal Salt 
lodisation (USI) (WHO et al., 2007) and a Cochrane review concluded that iodised salt is 
effective for improving a population’s iodine status (Wu et al, 2002). USI refers to the 
lodisation of all salt for human and animal consumption, and salt is usually iodised with 
potassium iodide or iodate (Sullivan, 2010).
The goal is for over 90% of households to be using adequately iodised salt but in practice 
USI is rarely achieved and some salt, for example in processed foods, remain non-iodised 
(Zimmermann, 2010). This represents a challenge for ensuring adequate iodine nutrition, 
particularly in countries where the majority of salt intake is from processed foods (WHO & 
UNICEF, 2007). This would include the UK where only 20% of salt intake is from table 
salt (Scientific Advisory Committee on Nutrition, 2003), thus food manufacturers would 
need to be encouraged to fortify the salt they use with iodine to have a meaningful impact 
on iodine intake. The introduction of iodised salt in a population does not automatically 
improve iodine nutrition for all inhabitants as a result of variations in salt intake and the 
intake of other dietary sources of iodine (Dunn, 2001). Even in countries with good access
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to iodised salt, it is unlikely to provide sufficient iodine to meet the iodine requirements of 
pregnancy (Pearce, 2008). lodised-salt programmes need to be carefully monitored to 
ensure continued success, as evidenced by deterioration in iodine status in countries that 
experience interruptions in iodised salt supply (Zimmermann et al, 2004b).
The UK does not currently have a programme for the elimination of iodine deficiency 
through use of iodised salt. There is a degree of ignorance about this fact among health 
professionals in the UK, with some (including dietitians) assuming that salt is iodised and 
there is also false information on the NHS website that goitre was eradicated in the UK by 
an iodised salt policy (NHS Choices, 2010). A study in Cardiff found that only four of 36 
samples of salt purchased had detectable iodine concentrations, and of these four, only two 
had levels suitable for the prevention of iodine deficiency (Lazarus & Smyth, 2008). 
Without an iodised salt programme, UK iodine intake is dependent entirely on food choices 
and in view of the low popularity of rich-iodine sources (e.g. fish and milk) in some 
population groups pregnant women are vulnerable to iodine deficiency (Smyth, 2006).
1.5.2 Alternatives to Universal Salt lodisation
As an alternative to salt, other foods can be used as a vehicle for iodine fortification. As 
practised in Australia and New Zealand, where all bread has been fortified with iodine 
(through iodised salt use) since 2009 (Australia New Zealand Food Standards Code, 2009). 
Fortification of bread was chosen in preference to USI or fortification of a wider selection 
of food (e.g. biscuits) owing to reduced trade barriers, fewer technical difficulties and cost 
for the consumers [(Food Standards Australia New Zealand (FSANZ), 2008)]. A small- 
scale trial in Tasmania demonstrated the potential for fortified bread to increase the median 
UIC (Seal et a l , 2007). However, this fortification programme was not designed to meet 
the iodine requirements of pregnancy [(Food Standards Australia New Zealand (FSANZ), 
2010)] and there is evidence that it has not significantly improved iodine status in pregnant 
women in Gippsland (Rahman et a l ,2 0 \ \ )  or Tasmania (Burgess et al, 2007).
Iodine intake can also be improved in a population by indirect or unintentional lodisation 
such as exposure to iodine-fortified irrigation water (DeLong et a l,  1997) or iodine- 
enriched milk and dairy produce resulting from farming practice (Phillips, 1997). The latter 
approach has improved iodine supply to the UK population, but this is an unregulated and
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haphazard source of iodine (Phillips, 1997) and as such, is less likely to be successful for 
long-term successful eradication of iodine deficieney (see Section 1.7.1).
1.5.3 Iodine excess and risks of population iodine fortification 
programmes
Excessive iodine intake
Excessive iodine intake in a population is defined as a median UIC greater than 300 pg/L in 
adults, or 500 pg/L in pregnant women (WHO et al,  2007). Overzealous and unmonitored 
iodised salt programmes can result in progression to iodine excess in regions that were 
previously iodine deficient (Dunn, 2001). In the latest global estimate, 11 countries were 
defined as having excessive iodine intake, a higher figure than the seven found to have 
excessive intake in 2007 (Andersson et al,  2012).
Excessive iodine in a population has negative implications for thyroid status, as evidenced 
in China, where the incidence of subclinical hypothyroidism and autoimmune thryoiditis 
was higher in regions with either more-than-adequate or excessive intake of iodine, than in 
a region with mild deficiency (Teng et a l,  2006).
The Wolff-Chaikoff effect is the term given to the transient impairment of thyroid hormone 
production as a result of excessive iodine (Burgi, 2010). However, the thyroid can adapt to 
high iodine intake, preventing continued hypothyroidism, thus explaining why iodine- 
sufficient individuals are tolerant to high doses of iodine (Burgi, 2010). Nonetheless, in 
areas with history of iodine deficiency, large doses of iodine (500 pg iodine over a 28 day 
period) have been shown to affect thyroid function adversely (lower fT4 and higher TSH) 
(Chow et al, 1991). In addition, individuals with long-standing iodine deficiency may not 
be able to adapt to sudden increases in iodine intake as nodular goitre may have developed. 
Nodular goitre may contain thyrocytes that are beyond normal control mechanisms and so 
excessive thyroid hormones can be produced when the supply of iodine is suddenly 
increased (Burgi, 2010) (see below).
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Safe upper limit of iodine intake
The upper limit for iodine is an arbitrary cut-off in view of the fact that individuals may 
respond adversely to intakes above or below the suggested safe level (Burgi, 2010), 
particularly in those with longstanding iodine deficieney (described below).
The UK report on Dietary Reference Values (Department of Health, 1991) suggested 
retaining the safe upper limit of 17 pg/kg BW/day or 1 mg per day for adults that was 
proposed in 1989 by JEFCA, the Joint FAO/WHO Expert Committee on Food Additives 
(JECFA, 1989). A later review by the Expert Group on Vitamins and Minerals (EVM) 
suggested that there were insufficient data to set a safe upper limit but suggested that 0.94 
mg/day would not have adverse effects (Expert Group on Vitamins and Minerals, 2003), a 
similar conclusion to JECFA in 1989.
The Tolerable Upper Intake Level of iodine for pregnant women has been set at 600 pg/day 
according to the European Commission and 1100 pg/day according to the lOM (Food and 
Nutrition Board Institute of Medicine, 2001). A deleterious effect of high iodine intake in 
pregnancy on thyroid function has been demonstrated in Japan, a region with high iodine 
intake, where a significant negative correlation was found between UIC and fT4 and fT3 
and a positive correlation with TSH (Orito et al, 2009). Thus, it is important that pregnant 
women do not ingest excessive amounts of iodine, as the lower fT4 values may have a 
negative effect on fetal brain development (Section 1.4.2).
Risks of increasing iodine supply in a population
Increasing the iodine supply to a population is not without risks to thyroid function, 
including iodine-induced hyperthyroidism, hypothyroidism or autoimmune thyroid disease 
(reviewed by Burgi, 2010).
Iodine-induced hyperthyroidism is more common in older inhabitants in a country who 
have been exposed to long-term iodine deficiency and may have developed a multinodular 
goitre that has become autonomous of pituitary control (Burgi, 2010; Laurberg et a l,
2010). Indeed this has been the subject of concern in the UK in the past as data suggested a 
correlation between previous goitre (see Section 1.6.2), thyrotoxicosis incidence (Barker & 
Phillips, 1984), and mortality from thyrotoxicosis (Phillips et a l,  1983) though not with
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incidence of thyroid antibodies (Prentice et al,  1990). The annual peak in the diagnosis of 
thyrotoxicosis in England between January and June was suggested to be a result of high 
levels of iodine in winter milk, especially in historically iodine-deficient regions (Phillips et 
al,  1988) and led to concerns of toxic levels of iodine in UK milk (Section 1.6.2).
There is evidence that provision of iodised salt in a region transiently increases thyroid 
antibodies in children, but this increase does not persist beyond one year after salt 
lodisation (Zimmermann et al, 2003). Longer term follow up (4-5 years) of adults after salt 
lodisation found increased prevalence of antibodies to TPO and thyroglobulin in Denmark, 
even in young women (Bulow Pedersen et a l,  2011). In addition, salt lodisation in 
Denmark has been association with an increased incidence of hypothyroidism (Pedersen et 
al, 2007) and a decreased incidence of hyperthyroidism (Vejbjerg et al,  2009b), and these 
effects were not confined to older inhabitants who might have been expected to be more 
vulnerable to changes in iodine supply as a result of thyroid nodules. Furthermore the 
prescription of thyroxine in Denmark increased between 1997 and 2008, suggesting that 
salt lodisation has increased hypothyroidism, though the authors also acknowledge that the 
this could be due to increased awareness of thyroid dysfunction (Cerqueira et a l ,2 0 \ \ ) .  As 
these were observational studies, it is not clear if other causal factors may have resulted in 
alterations in thyroid dysfunction in the population (Pedersen et al,  2007).
Despite the risks outlined above, the risks of improving iodine intake in a population are ( 
considered to be relatively small and outweighed by the benefits, especially for vulnerable 
groups such as pregnant women and their offspring (Zimmermann, 2008a). On balance, it 
is important that the iodine status of a population is monitored so that iodine deficiency can 
be corrected early before many individuals develop nodular goitre. During fortification 
programmes, monitoring is vital to avoid iodine intake increasing unchecked and thus 
tipping towards iodine excess (WHO et a l , 2007).
1.6 Sources of iodine and inhibitors of iodine absorption
1.6.1 Dietary sources of iodine in the UK
The iodine content of foods is dependent on the source of the food, the soil content (see 
below), whether from sea or land and farming practice (Zimmermann, 2009a). When
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examining sources of iodine in the UK diet, it is important to consider the relative 
contribution of each food group to total iodine intake [estimated from the National Diet and 
Nutrition Survey (NDNS) for all participants (Henderson et al, 2003)], as well as the 
absolute iodine concentration of each food [value from the most recent UK Total Diet 
Study (TDS) (Rose et al,  2001)]; these factors are illustrated in Figure 1.2.
The principal source of iodine in the UK diet is dairy produce (including milk), providing 
35% and 42% of iodine for men and women respectively (Henderson et al,  2003). The 
reason that dairy produce is a concentrated source of iodine will be discussed in Section 
1.6.2. Various studies have demonstrated the relationship between measured iodine status 
and milk intake, highlighting the dependency on milk consumption in the UK (Section 
1.6.2).
Fish is a rich source of iodine, as fish are able to concentrate iodine from seawater 
(Harrison et al,  1965) but there are large variations in iodine concentration, both between 
species and within species from different sources (Harrison et al,  1965; Wenlock et al,  
1982; Lee et al,  1994). The head of the fish contains the highest level of iodine as it 
contains the thyroid gland (Harrison et al,  1965; Pandav et a l,  1999), but this is rarely 
consumed in the UK. Though fish is a concentrated iodine source, it contributes just an 
estimated 11% of iodine intake in the UK (Henderson et al,  2003) (Figure 1.2), largely 
because of low fish consumption, particularly in young women (Henderson et a l,  2002).
Although cereals and cereal products, such as bread, are good sources of iodine in some 
countries worldwide [such as the US (Pearce et a l,  2004)], this is not generally the case in 
the UK. This is because potassium iodate is not used as a dough conditioner in the UK 
(instead potassium bromate is used) and iodised salt is not used in bread making (Wenlock 
et a l,  1982). Indeed, the TDS found cereals to have an iodine concentration of up to a third 
of that of milk and dairy produce (Rose et al,  2001).The NDNS estimated that cereal and 
cereal products contribute 12% to iodine intake but of that figure, only 3% was from bread 
(Henderson et a l,  2003). The “cereal products” category included pizza, porridge made 
with milk, and pasta with cheese (NDNS, 2001); thus, the contribution that this category 
makes to iodine intake is probably skewed by the high iodine content of dairy produce 
associated with cereal intake.
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Eggs are a reasonably good source of iodine, with a concentration that is similar to that of 
milk and dairy produce in UK samples (Rose et al,  2001). The iodine concentration of 
eggs reflects the iodine content of hen feed (Franke et a l , 2009). Surprisingly, a high intake 
of eggs was associated with low iodine status in the study of UK schoolgirls (Vanderpump 
et al,  2011). The FFQ used by the study was flawed as the frequency options were vague 
and unspecific and thus the author and Professor Rayman have urged caution over the 
dietary results (Bath & Rayman, 2011); unfortunately the inverse relationship between egg 
and UIC was included in the abstract to the Vanderpump et al (2011) paper.
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Figure 1.2 Iodine concentration (squares) (Rose et al, 2001) and percentage contribution of 
different food groups to total iodine (bars) (Henderson et al, 2003).
It is worth noting that erythrosine, a red food colouring, has a high iodine content but the 
iodine bioavailability is low and it is largely excreted into the faeces (European Food 
Safety Authority, 2011). Erythrosine is used in cocktail, candied and Bigarreaux cherries, 
and to mark egg shells (European Parliament and Council Directive, 1994; The Colours in 
Food Regulations, 1995). The high iodine concentration in some foods, owing to their 
erythrosine content, (e.g. glacé cherries in fruit samples) in UK Total Diet Studies (Section 
1.8) has distorted the average iodine intake which therefore had to be recalculated without
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such foods (Wenlock et a l,  1982; Lee et al, 1994). Owing to the small number of dietary 
sources containing erythrosine and poor absorption of iodine from this food colouring, it is 
not a major contributor to UK iodine intake.
1.6.2 Milk iodine concentration in the UK
The main reason milk is a rich iodine source is due to farming practice in the UK dairy 
industry, either through mineral-supplemented cattle feed or the use of iodine-containing 
disinfectants. These two factors are briefly explained below.
Iodine supplementation of cattle
Iodine supplementation of livestock was introduced in the 1920s and 1930s in the UK, as a 
result of emerging evidence that it would improve reproduction in cattle (Phillips, 1997). 
Studies around the world have shown a spillover of iodine from feed into the milk, with 
higher milk-iodine content corresponding to a higher concentration of iodine in cattle feed 
(Franke et al,  2009; Borucki Castro et al, 2011; Norouzian, 2011).
Prior to the use of iodine in the dairy industry in the UK, the levels of iodine in milk were 
relatively low; the iodine concentration of summer-milk and winter-milk from Somerset 
was just 8 pg/L and 32 pg/L respectively (1939 MRC study cited in Broadhead et a l,  
1965a) whereas recent estimates of UK milk-iodine concentration suggest higher values 
e.g. 300 pg/L for the whole year (Food Standards Agency, 2008).
The permitted level of iodine in feed was 40 mg/kg before 1996, when the maximum 
content was lowered to 10 mg/kg [(The Feeding Stuffs Regulations, 1995; The Feeding 
Stuffs Regulations (Amendment), 1996)], which was further reduced in 2005 to 5 mg/kg 
(European Union, 2005). Interestingly, the UK abstained from the vote on the reduction to 
5 mg/kg owing to concerns that this might increase the risk of iodine deficiency in cattle 
and humans (Standing committee on the food chain and animal health, 2005). The available 
data on the iodine-content of UK milk suggests that the maximum permitted iodine content 
of cattle feed has not had a substantial impact on milk-iodine content, as the milk-iodine 
concentration has been largely unaltered since 1995 (Ministry of Agriculture Fisheries and 
Food, 1997b; Ministry of Agriculture Fisheries and Food, 1999; Ministry of Agriculture 
Fisheries and Food, 2000; Food Standards Agency, 2008) although the reasons that it has
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not had an impact are unknown. The changes in farming legislation highlight the fact that 
iodine supplied to the UK diet by this major dietary source is vulnerable to changes driven 
by policies other than health or nutrition, and underlines the importance of regular 
assessment of iodine intake in the UK.
lodophors
The use of iodophors (iodine-containing disinfectants) in dairy tankers and on cows’ teats 
increases the milk-iodine content through accidental contamination (Galton et a l,  1986; 
Aumont, 1987; Borucki Castro et al,  2010). lodophors are thought to increase the milk- 
iodine content either through absorption through the cow’s teat, with the iodine then 
spilling over into the milk (Conrad & Hemken, 1978), or via the residues on the teat that 
contaminate the milk, especially if the teats are not dried sufficiently (Galton et a l,  1984; 
Rasmussen et al,  1991). More recent work has found that automated iodophor spraying of 
cows’ teats is able to increase milk-iodine content in a similar way to manual teat 
application (Galton, 2004), suggesting that iodophors can continue to increase milk-iodine 
concentrations in the present era of automated milking. Though iodophors are approved 
disinfectants in the UK (Veterinary Laboratories Agency, 2010), anecdotal evidence 
suggests that their use may be declining in the UK dairy industry (Zimmermann, 2010).
Seasonal differences in iodine concentration in UK milk
During the winter months, grazing time is reduced and cattle are housed in bams and are 
therefore more reliant on mineral-supplement feed (Phillips et al,  1988; Phillips, 1997). 
Iodine levels in winter milk have consistently been found to be considerably higher than 
those of summer milk (Broadhead et al,  1965a; Wenlock et al,  1982; Phillips et a l,  1988; 
Lee et al, 1994; Ministry of Agriculture Fisheries and Food, 1997b; Ministry of 
Agriculture Fisheries and Food, 2000; Food Standards Agency, 2008). A further 
explanation for the lower iodine levels in summer milk may be related to the anecdotal 
evidence that iodophor disinfectants are used less in the summer, being replaced by 
disinfectants that also contain an insect repellent (required when cattle are grazing 
outdoors) (Committee on Toxicity of chemicals in food consumer products and the 
environment, 2003).
25
Chapter 1 : Introduction
In the late 1980s there were concerns that the iodine content of milk had reached levels that 
were too high and might require regulation, particularly in the winter months (Phillips et 
al., 1988). This concern led to the subsequent monitoring of iodine levels in milk by the 
Ministry of Agriculture Fisheries and Food (MAFF) (Ministry of Agriculture Fisheries and 
Food, 1997b; Ministry of Agriculture Fisheries and Food, 1999; Ministry of Agriculture 
Fisheries and Food, 2000) and subsequently by the Food Standards Agency (FSA) (Food 
Standards Agency, 2008). The Committee on Toxicity of chemicals in food, consumer 
products and the environment (COT) reviewed the levels of iodine in milk reported in the 
MAFF studies and concluded that the iodine content of UK milk, even in high milk 
consumers has no health implications (Committee on Toxicity of chemicals in food 
consumer products and the environment, 2000; Committee on Toxicity of chemicals in 
food consumer products and the environment, 2003). However, there may be some 
individuals in the UK that consume high volumes of milk in conjunction with a diet that is 
rich in other iodine sources (Figure 1.2); their intake may approach the safe-upper limit for 
iodine (Section 1.5.3), particularly in the winter when milk-iodine levels are high.
1.6.3 Environmental sources of iodine
Environmental sources of iodine can contribute to iodine intake indirectly by influencing 
the iodine content of foods. A recent study has suggested that atmospheric iodine may 
contribute to iodine status (Smyth et a l,  2011). Smyth and colleagues (2011) found a 
higher UIC in girls living in a seaweed-rich coastal region than in a coastal low-seaweed 
region or inland area, in Ireland, a region of mild-to-moderate iodine deficiency (Nawoor et 
al, 2006; Lazarus & Smyth, 2008). As the study did not measure dietary intake in the three 
regions, the differences could have been due to different diet or milk-iodine concentrations 
between regions. In reality, most people spend a considerable proportion of their day 
indoors and therefore exposure to atmospheric iodine would be low.
Seawater is a concentrated iodine source and so coastal regions tend to be rich iodine areas, 
with a decreased iodine concentration in soils further away from the coast (Johnson et a l , 
2003). The iodine content of soils depends not only on proximity to the sea but also on the 
type of soil and bedrock which it is overlying (Fuge, 2007). Peat, iron rich and clay soils 
tend to have a higher iodine content than sandy soils (Johnson et a l,  2003; Fuge, 2007).
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Living in an area with iodine-rich soils does not automatically guarantee the inhabitants 
sufficient iodine intake, as demonstrated by the occurrenee of goitre in the limestone area 
of Derbyshire (an area that would be expected to have high iodine levels in the soil) (Saikat 
et al,  2004; Fuge, 2007). Organie-rich soils, although high in iodine, do not provide an 
abundance of iodine to plants as the iodine is tightly bound in the soil and thus, not 
bioavailable; in addition soil pH affects iodine availability with acid soils having a higher 
availability of iodine than alkaline soils (Johnson et al,  2003).
1.6.4 Dietary supplements containing iodine 
Supplement formulation
Dietary supplements can make significant contributions to iodine intake but their suitability 
depends on the formulation. Kelp supplements have been analysed in both the UK (Lee et 
al,  1994) and the US (Leung et al,  2009) and the iodine content was found to be highly 
variable in both studies, with most UK kelp supplements providing more than the iodine 
content declared on the label (Lee et al,  1994). As a consequence, kelp and seaweed 
supplements are an unreliable source of iodine and are not recommended during pregnancy 
(Zimmermann & Delange, 2004).
The measured iodine content of prenatal iodine-containing supplements in the US was 
found to be 76% of the stated 150 pg dose, suggesting that manufacturers had not adjusted 
the dose to reflect the fact that only 76% of potassium iodide is iodine (Leung et al,  2011). 
This is similar to two thirds of the iodine-containing supplements in the UK that had a 
measured iodine content between 60 and 100% of the stated dose (Lee et al,  1994). The 
suggested maximum limit of iodine in supplements is 150-200pg and the iodine content 
should be between 50-100% of the EC RDA due to the potential for exceeding the safe 
upper limit (Health and Consumer Protection Directorate-General, 2006).
Recommendations for iodine supplements in pregnancy worldwide
The American Thyroid Association and the Food Standards Agency of New Zealand and 
Australia recommend that pregnant and lactating women take 150 pg of iodine per day 
(Becker et al, 2006; NHMRC, 2010). However, it has been argued that this will not meet 
the iodine requirements of all pregnant women, owing to the number of unplanned
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pregnancies and poor compliance with dietary supplement taking (Sullivan, 2007). The 
WHO recommends that women who live in countries with poor coverage of iodised salt 
(i.e. < 20% of the population) should include an iodine supplement so that total dietary 
iodine intake is 250 pg per day but in countries with adequate iodised salt coverage the 
WHO does not consider that an iodine supplement is required during pregnancy (WHO 
Secretariat et al, 2007). A review of iodine supplement use in pregnancy in European 
women has found that fewer than 50% of women take a supplement containing iodine 
(Zimmermann & Delange, 2004). There is currently no recommendation for iodine 
supplementation during pregnancy or lactation in the UK, presumably because UK 
recommendations have no additional requirement for iodine in pregnancy (Department of 
Health, 1991).
1.6.5 Goitrogens
Goitrogens are dietary or environmental factors that can cause the enlargement of the 
thyroid (Gaitan, 1990). Goitrogens in food exhibit their effects in different ways; 
thiocyanate and isothiocyanates inhibit uptake of iodine into the thyroid (or breast tissue) 
through competitive inhibition of the sodium-iodide-symporter (NIS), while flavanoids 
impair the oxidation and organification of iodine into thyroid hormones through inhibition 
of thyroid peroxidase (TPO) (Gaitan, 1990).
It is generally considered that goitrogens only exert an effect if iodine intake is low; 
otherwise they are not a concern for thyroid dysfunction (Gaitan, 1990). There may be sub­
groups of the population that have concurrent iodine deficiency and high intakes of 
goitrogens e.g. vegans (Lightowler & Davies, 1998). UK pregnant women may fall into this 
category so it is important that goitrogens are assessed when evaluating their iodine status.
Dietary goitrogens
Linamarin and lotaustralin are cyanogenic glucosides and are present in a number of foods 
including cassava, lima beans, linseed, bamboo, sweet potatoes and white clover (Gaitan, 
1990; Zimmermann, 2009a). Linamarin is first metabolised into hydrogen cyanide and then 
to thiocyanate, which competes with iodine for uptake via NIS into the thyroid. Cassava is 
a well-known goitrogen, it contains linamarin in the roots of the plant; the linamarin can be
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removed if cassava roots are correctly soaked prior to consumption and thus can reduce the 
risk of goitre development from high consumption of this staple food in many countries 
(Gaitan, 1990; Dorea, 2004; Zimmermann, 2009a). The UK diet is not rich in these dietary 
goitrogens and thus they are unlikely to be of great concern.
More prevalent goitrogens in UK diets are glucosinolates, found in the cruciferae family of 
vegetables (e.g. cabbage, broccoli and cauliflower). Glucosinolates are metabolised to 
produce thiocyanate, which has anti-thyroid effects as explained above. However, 
isothiocyanates, present in cruciferous vegetables, also result in the formation of thiourea 
compounds through the reaction with amino acids and these compounds act as antithyroid 
agents through the inhibition of thyroid hormone formation and organification of iodine 
within the thyroid (Gaitan, 1990). This suggests that thyroid function may be impaired in 
iodine-deficient individuals who consume high volumes of these foods.
Other dietary goitrogens inhibit the organification and oxidation of iodine through TPO 
inhibition, thus reducing production of thyroid hormones (Gaitan, 1990). Goitrin (thio- 
oxazolidone) precursors (progoitrin) are found in turnips and swedes (also members of the 
cruciferae vegetable family) and are potent anti-thyroid agents, inhibiting thyroid hormone 
formation (Gaitan, 1990; Vanderpas, 2006). Inactive progoitrin can be ingested directly and 
activated to produce goitrin by intestinal micro organisms (Gaitan, 1990).
Soy has gained popularity in recent years in developed countries, particularly for heart 
health and menopausal symptom relief (Doerge & Sheehan, 2002). Soy contains 
isofiavones, mainly genistein, which are thought to interfere with TPO activity (reviewed 
by Doerge & Sheehan, 2002). In the 1950s, altered thyroid function was reported in infants 
fed soy-formula and consequently the formulation was changed to inelude iodine to 
overcome the antithyroid effect of soy (reviewed in Doerge & Sheehan, 2002; Messina & 
Redmond, 2006). A review has suggested no effect of soy intake on thyroid function in 
individuals that are iodine sufficient (Messina & Redmond, 2006). No relationship was 
found between dietary soy intake and matemal thyroid function in pregnant women in 
China (Li et al,  2011), but this study was conduced in a region with adequate iodine intake. 
It is possible that individuals with low iodine intake and relatively high consumption of soy 
products may be at risk of the effects on thyroid function. This is particularly relevant for
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individuals who do not consume cows’ milk and dairy products (with high iodine 
concentration) and replace it with soy milk and produce (largely not fortified with iodine).
Environmental inhibitors of iodine uptake
Smoking is a known goitrogen as it can increase thiocyanate levels in the body, thus 
exhibiting similar effects to the dietary goitrogens listed above by inhibiting uptake of 
iodine into the thyroid or breast tissue (Vanderpas, 2006). The effects of smoking on 
thyroid function are conflicting with evidence from the US that the incidence of 
hypothyroxinaemia was higher in heavy smokers (Vanderver et al,  2007), and other studies 
suggesting a lower risk of subclinical hypothyroidism in smokers than in non-smokers (Cho 
et al,  2010). The latter study was conducted in a region with excessive iodine intake and 
thus smoking may have reduced the negative effect of excess iodine on thyroid function.
Smoking has been related to increased thyroid volume, especially in regions with low 
iodine intake (Vejbjerg et al,  2008) but also in iodine-sufficient populations (Brauer et al,  
2005). Thyroid volume has been found to be higher in parous pregnant women who smoke 
(Knudsen et al,  2002). Smoking during pregnancy has been associated with lower TSH 
levels, higher T3 levels, lower cord-blood TSH levels (Shields et a l , 2009), and lower total 
and free T4 levels (Pearce et al, 2008), which may have implications for fetal brain 
development (see Section 1.4.2). Breast-milk iodine concentration has been found to be 
lower in smokers than in non-smokers (Laurberg et a l,  2004), highlighting the risk to the 
developing infant, as iodine supplied to the breast-fed infant of a smoker will be lower. It is 
clear that smoking status needs to be taken into account when evaluating thyroid function 
in pregnancy.
Perchlorate (contaminant found in groundwater) is a competitive inhibitor of NIS, as it has 
an affinity 30-times greater than iodine (Leung et a l,  2010). No effect on thyroid function 
has been demonstrated in short-term administration of varying doses of perchlorate 
(Braverman et al, 2006) or long-term occupational exposure (Leung et al, 2010). Studies 
in first-trimester pregnant women have shown that environmental exposure to perchlorate 
does not alter thyroid function in pregnancy, (Leung et a l,  2010), including in the UK 
(Pearce et al, 2010) and perchlorate exposure will not therefore be evaluated in this thesis.
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Other nutrients involved in thyroid hormone production
Thyroid hormone production is dependent on other micronutrients, including iron, 
selenium, vitamin A, and possibly zinc (reviewed by Hess, 2010). Vitamin A is linked to 
thyroid metabolism, peripheral metabolism of the thyroid hormones and uptake of iodine 
into the thyroid (reviewed by Zimmermann, 2007b; Hess, 2010). Only two trials with 
vitamin A and iodine have been conducted in school-aged children to examine the effect on 
thyroid function (Zimmermann et al,  2004a; Zimmermann et a l,  2007b); there are no data 
on the effect of vitamin A deficiency on thyroid function in pregnancy (Hess, 2010).
Thyroid peroxidase, the enzyme that catalyses incorporation of iodine into tyrosine residues 
of the protein thyroglobulin is a haem-dependent enzyme (Zimmermann & Kohrle, 2002). 
Iron deficiency can reduce the effectiveness of iodine supplementation and salt fortified 
with both iodine and iron has a greater benefit on thyroid volume and function than iodine 
alone in regions with concurrent iron and iodine deficiency (Zimmermann & Kohrle, 2002; 
Zimmermann, 2006). The importance of iron for thyroid function has implications for the 
health of the pregnant woman as iron deficiency anaemia is common in women of 
childbearing age in the UK (Henderson et al,  2003) and iron deficiency in pregnancy is 
associated with poorer thyroid function (Zimmermann et al,  2007a). It is important that 
matemal iodine status should be taken into account in any research involving iodine and 
thyroid hormones.
Selenium, through selenoproteins, is important for the protection of the thyroid gland 
(through glutathione peroxidises and thioredoxin reductases) from oxidative stress from 
excess hydrogen peroxide produced in the thyrocyte for organification of iodine, and for the 
metabolism of thyroid hormones through conversion of T4 to T3 and rT3 (through the 
iodothyronine deiodinase enzymes) (Kohrle & Gartner, 2009). There is a hierarchy of 
selenoproteins that becomes apparent in selenium deficiency and it is known that the 
deiodinase enzymes are high up in this hierarchy and are maintained even at a low selenium 
supply, whereas the glutathione peroxidase enzymes in the thyroid are more rapidly 
depleted (Schomburg & Kohrle, 2008). While the UK is known to have a relatively low 
intake of selenium that is probably inadequate to optimise glutathione peroxidase function
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(Rayman, 1997), selenium deficiency is not severe enough in the UK to affect deiodinase 
function and thus circulating levels of T4 and T3 (Rayman et a l,  2008b).
1.6.6 Food sources of iodine and goitrogens for UK pregnant women
Milk and dairy products are clearly vital for iodine intake in the UK and this is underpinned 
by correlations between the iodine concentration of milk and UIC measured in seven towns 
across the UK (Nelson et al, 1988). In addition, UIC in both the UK (Broadhead et al, 
1965b; Nelson et al,  1988) and Ireland (Nawoor et al,  2006), shows seasonal variation, 
reflecting changes in iodine concentration between summer and winter and again 
highlighting the dependency of iodine status on milk and dairy produce. This relationship 
was also seen in the UK study of schoolgirls, with a statistically lower UIC in the summer 
than the winter (76. 2 vs. 95.1 pg/L, p <0.0001); in addition responses to the FFQ showed 
that a low intake of milk was associated with a low UIC (Vanderpump et a l , 2011).
Owing to the high dependency on milk and dairy products for adequate iodine intake in the 
UK, it is clear that a decline in the use of iodine in the farming industry, as has happened 
recently in New Zealand and Australia (Thomson, 2004; Li et a l , 2006b) would potentially 
lead to a risk of iodine deficiency in the UK. One such shift in farming practice has been 
the increase in organic farming in the UK, with a 50-fold increase in organic milk sales in 
the 10 years between 1997 and 2007 (DairyCo., 2008). There is some evidence, from 
Europe, that organic milk has a lower iodine content than conventional milk (Rasmussen et 
al, 2000; Dahl et al,  2003), thus suggesting that organic dairy farming may reduce the 
contribution that milk and dairy products make to UK iodine intake. Finally, environmental 
and political factors can contribute to alterations in milk intake; for example pressure for 
the UK to meet greenhouse-gas emission targets may include the reduction of meat and 
dairy produce intake (as they contribute 40% of food-based emissions) and thus may 
further threaten iodine intake, particularly through reduced milk consumption (Millward & 
Garnett, 2010).
Given the importance of milk, dairy produce, eggs and fish for UK iodine intake (Figure 
1.2), it is hardly surprising that iodine deficiency has been demonstrated in UK vegans 
(Draper et al,  1993; Lightowler & Davies, 1998; Appleby et al,  1999), including case 
reports of goitre (Park et a l , 2005). UK vegans have been classified as moderately iodine
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deficient (median UIC 20.2 pg/L) (Lightowler & Davies, 1998) but were very close to the 
cut-off for severe deficiency [<20 pg/L, (WHO g/ a/., 2007)]. Male vegans had higher TSH 
levels than omnivores (excluding those taking kelp), suggesting a lack of dietary iodine 
(Appleby g/ a/., 1999). These studies suggest that the low iodine status in UK vegans has a 
negative impact on thyroid function. This is in contrast to recent data from the US (Leung 
et a/., 2011) that showed vegans to have a UIC (78.5 pg/L) that was lower than that of the 
general US population [median 164 pg/L (Caldwell et al,  2011)] and significantly lower 
than that of vegetarians (147 pg/L), but that thyroid function appeared to be unaffected 
(Leung g/ a/., 2011). The fact that the UIC in vegans in the US was higher than that of UK 
vegans (Lightowler & Davies, 1998) suggests that alternative dietary sources that are not 
readily available in the UK, such as iodised salt, may protect US vegans against iodine 
deficiency and subsequent effects on the thyroid.
1.7 History of Iodine Intake in the UK
Iodine deficiency used to be widespread in the UK, as evidenced by endemic goitre in some 
regions (Berry, 1901; Stocks, 1928; Murray gr a/., 1948; Hughes gr a/., 1959). The first 
estimates of a regional distribution of goitre in England were made in the early part of the 
20* Century (Berry, 1901) and in 1924, a survey of school children (total of 375,000) 
revealed levels of thyroid enlargement that were of concern and confirmed the regional 
distribution of goitre described by Berry (Stocks, 1928). The findings of thyroid 
enlargement across England prompted a recommendation by Stocks for, “prophylactic 
administration of iodine to girls in some endemic areas of England and Wales” (Stocks, 
1928), but this was not implemented on a widescale basis.
A “goitre belt” existed in England and extended from the West Country (Somerset, Dorset, 
Devon and Cornwall) through Gloucestershire and Derbyshire and into parts of Wales 
(Stocks, 1928; Phillips, 1997); goitre was also evident in Northern Ireland and parts of 
Scotland (Kelly & Snedden, 1960). The phrase, “Derbyshire neck” was frequently used 
and refers to the fact that Derbyshire was an area with endemic goitre until around the 
1930s (Saikat g/ 6z/., 2004). The regional distribution of historic goitre in the UK has been 
explored in relation to the levels of iodine in the soil, atmosphere and water in those regions 
in the late 1990s, some 70 years after the goitre belt was initially described (Stocks, 1928),
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but no direct relationship could be established (Stewart et al, 2003). This suggests that 
iodine deficiency was not only related to environmental iodine, but perhaps other dietary 
and farming factors.
Following the Second World War, the Medical Research Council (MRC) recommended the 
lodisation of salt to prevent iodine deficiency and goitre (Medical Research Goitre 
Subcommittee, 1944; Murray et a l,  1948), but no action was taken (Kelly & Snedden, 
1960; Phillips, 1997). These recommendations were based on commissioned surveys in the 
UK, through the “Goitre Sub-committee” of the MRC which found goitre rates of up to 
50% in adult women in Oxfordshire, enlarged thyroids in 43% of girls in Dorset and an 
incidence of goitre up to 23% in Scotland (Medical Research Goitre Subcommittee, 1944; 
Murray et a l, 1948). There were reports of thyroid enlargement in antenatal clinics in the 
West Country (Kelly & Snedden, 1960), highlighting the fact that women of childbearing 
age and pregnant women were exposed to iodine deficiency during these years.
As a follow up to these MRC surveys, several authors in the 1950s and 1960s attempted to 
document thyroid enlargement in certain areas of the UK (Hughes et al, 1959; Trotter et 
al,  1962; Kilpatrick et al, 1963). A study in Oxfordshire found 40% of children with 
thyroid enlargement and some children who had shown thyroid enlargement in previous 
surveys had progressed to visible goitre (Hughes et a l,  1959). Goitre in the Vale of 
Glamorgan (Wales) was higher in girls than in boys and was related to low fish 
consumption (Trotter et al, 1962). Thyroid enlargement was found to be more common in 
Sheffield than in East Lothian in Scotland (Kilpatrick et al,  1963). Thus it is clear that 
iodine deficiency was still persistent in the UK until the 1960s.
The call for more research into iodine status in the UK was raised by thyroidologists in the 
UK in the late 1980s (Hall & Lazarus, 1987); in the 1990s iodine concentration was 
measured in subjects in the follow-up to the Whickham survey (a thyroid survey in the 
1970s) and the median iodine/creatinine ratio (102 pg/g), suggested marginal iodine 
adequacy in the UK (Vanderpump et a l,  1995). In the global estimate of iodine deficiency 
in the 1990s, the UK was listed as having a zero risk of iodine deficiency (WHO et a l,  
1993). This was criticised at the time, based on evidence from dietary data suggesting that 
British women had an iodine intake below the recommendations (Wynn & Wynn, 1998).
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1.7.1 Eradication of goitre in the UK
Despite historical reports of thyroid enlargement and calls to action by the MRC, the UK 
has never introduced a formal lodisation programme to ensure optimal iodine status. 
Instead the country experienced lodisation through the adventitious increase in milk-iodine 
concentration and increased milk consumption in the UK (Phillips, 1997); the eradication 
of goitre in the UK happened for two main reasons, neither of which was Government- 
driven. Milk iodine concentration increased in the UK (see Section 1.6.2) as a result of 
iodine-fortified concentrates being given to cattle and the increased use of iodophor 
disinfectants in the dairy sector. At the same time, the Government promoted the 
consumption of milk for general health, for example through campaigns in the 1950s to 
“Drinka Pinta Milka Day” (The Dairy Council, 2004). The establishment of the Milk 
Marketing Board and school-milk schemes also caused an increase in milk consumption 
(Phillips, 1997). The combined effect of increased milk-iodine content and increased 
consumption of milk led to a three-fold increase in iodine intake between the 1950s and the 
1980s (Wenlock et al, 1982; Phillips, 1997) which was sufficient to cause a decline in the 
incidence of goitre and subsequently the population was assumed to be iodine-sufficient. A 
follow-up to a survey of adults near Newcastle (the Whickham survey) showed that thyroid 
enlargement (assessed by palpation) had declined from 23% in the 1970s to 10% in the 
same subjects at follow-up 20 years later (Vanderpump et al,  1995).
1.7.2 Was iodine deficiency truly eradicated in the UK?
Lower milk consumption in recent years (National Food Survey, 2000) has been cited 
(Vanderpump et a l ,2 0 \ \ )  as the likely reason for the decline in iodine intake in the UK, as 
noted by recent studies (Section 1.8.2). However, this explanation may be too simplistic, 
especially as consumption of other dairy products has increased in recent years (e.g. 
yoghurt) (Dairy UK, 2010). In fact, it is questionable whether iodine deficiency was truly 
eradicated in the UK; iodine intake may simply have increased sufficiently to eradicate 
visible goitre but remained at a suboptimal or mild iodine-deficiency level.
This notion can be explored by delving into the data presented in the few UK studies that 
report UIC and were carried out around the time that iodine sufficiency was assumed 
(Nelson et al, 1987; Nelson et al,  1988; Chow et al, 1991). The UIC values are suggestive
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of mild iodine deficiency, especially in the summer months when milk-iodine concentration 
is lower (Nelson et al, 1987; Nelson et al, 1988; Chow et al,  1991). For example, in a 
study that evaluated the impact of iodine supplements on thyroid function, baseline UlC 
was 49-62 pg/L (mild iodine deficiency), but the relatively low value was suggested to be a 
result of a mild winter (thus a lower reliance on mineral-supplemented feed) the previous 
year (Chow et al, 1991). In addition, goitre was prevalent in 7% of the Whickham follow- 
up survey subjects (Vanderpump et a l,  1995).
These figures suggest that iodine status has not increased to an adequate level in the UK, 
since the days of goitre and that the studies that show certain groups to be iodine deficient 
(Section 1.8.2) have revealed an underlying problem, rather than suggesting that iodine 
deficiency has re-emerged.
1.7.3 Iodine intake from UK Total Diet Studies
Though there were relatively few studies that evaluated urinary iodine status or thyroid 
volume after the 1960s, iodine intake was estimated by the Total Diet Studies in 1977-79 
(Wenlock et aï., 1982), 1985, 1991 (Lee et al., 1994), 1995 (Ministry of Agriculture 
Fisheries and Food, 1997a), and 1997 (Rose et al, 2001). These studies involved the 
laboratory analysis of representative foods and a calculation of daily iodine intake based on 
food-consumption data (Peattie et al,  1983). Table 1.3 shows that the estimated mean 
exposure was greater than the RNl for adults in all years (Department of Health, 1991). 
These studies have historically been used to suggest iodine intake is adequate in the UK 
but, as dietary estimates are not the recommended method of assessing iodine status in a 
population, an underlying iodine deficiency in the country may have been masked. The use 
of food-table iodine values to estimate exposure from dietary intake is confounded by the 
fact that the iodine content of foods varies considerably, both between similar species (e.g. 
of fish) and even within the same species reared under different conditions (i.e. because of 
farming methods), thus resulting in inaccurate estimates of iodine intake from dietary 
analysis (Rasmussen et al,  2002).
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Table 1.3 Iodine exposure from the UK Total Diet Studies (Wenlock et al, 1982; Lee et al, 1994; 
Ministry of Agriculture Fisheries and Food, 1997a; Rose et al, 2001).
Year Population average iodine exposure (pg /person/day)
1977-79 285*
1985 173*
1991 170
1995 210
1997 250
* estimation without samples including erythrosine
1.8 Iodine status in the UK since the turn of the century
1.8.1 Iodine intake in the UK from dietary data
The National Diet and Nutrition Survey (NDNS) is one of few sources of information on 
iodine intake in the UK in recent years, but as it comes from dietary rather than urinary 
analysis the data may not be very accurate (Rasmussen et a/., 2001). Nevertheless, NDNS 
data gives a means of monitoring trends in iodine intake in the UK. The mean iodine intake 
for adult (19-64 years) males and females in the 2000/01 survey (from a seven-day food 
diary estimate) was above the RNl for adults (Henderson gt a/., 2003). However, the mean 
iodine intake for women in the lowest age group (19-24 years) was 130 pg/day, falling 
short of the adult requirement and 12% had an intake of iodine below the UK LRNl (70 
pg/day) (Henderson at a/., 2003). It is notable that significantly lower intakes of iodine 
were found in the 2000/01 adult survey than in the 1986/87 survey, suggesting a possible 
fall in iodine intake (Henderson g/ a/., 2003).
The NDNS is now monitoring individuals on an annual basis, with a four-day food diary, 
instead of seven in the previous surveys (Bates g/ a/., 2011). The results for years 1 and 2 of 
this "rolling programme" suggest a further fall in iodine intake since 2000/01 (e.g. 143 v& 
161 pg/day for adult females) and an increase in the percentage with intakes below the 
LRNl (8% v& 6% for adult females) (Bates gt a/., 2011). The figures are no longer reported 
in age-group categories so it is possible that the mean is skewed by higher iodine intake in 
women of older age, as demonstrated in the 2000/01 survey (Henderson g/ a/., 2003).
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1.8.2 Data from studies using urinary iodine measures
Though there were no national data on UK iodine status until 2011 (Vanderpump et al,
2011), there were a number of small, localised studies that evaluated iodine status through 
urinary iodine assessment in women of childbearing age and pregnant women. As 
discussed (Section 1.1) the author investigated iodine status in UK women of childbearing 
age in 2007 (Bath et al,  2008) and a follow-up study (Rayman et al,  2008a) revealed mild 
iodine deficiency (median UlC 66 and 55 pg/L respectively) in the cohort when compared 
to the WHO criteria for adults (WHO et al,  2007).
Iodine deficiency has been demonstrated in a study of pregnant women from the North East 
of England (Kibirige et al,  2004), though that study is poorly described as the iodine 
concentration values are reported as pg iodine/mmol creatinine rather than conventional 
units (i.e. pg/g) and the values on the graphs which are for log-transformed data, have not 
been transformed to allow sensible interpretations. Nevertheless, the study suggests that 
40% of pregnant women in the North East of the UK have inadequate iodine status with a 
UlC between 50-100 pg/L. The Kibirige paper was published prior to recommendations 
that the median should be between 150 and 249 pg/L (WHO Secretariat et a l,  2007) and so 
the prevalence of deficiency in the cohort in the North East may have been higher than that 
reported by Kibirige et al (2004), as highlighted in the recent review of iodine deficiency 
in industrialised countries (Zimmermann, 2010). Iodine deficiency was also studied in 
pregnant women in Scotland (though only published as an abstract) and showed that 40% 
of pregnant women had an iodine intake less than half of the recommended amount for 
pregnancy and that fT4 did not show the expected increase in the first trimester, perhaps 
indicating that the women were unable to increase their thyroid hormone levels due to 
inadequate iodine intake (Barnett et al, 2002). Finally, iodine status has been reported in 
pregnant women in the CATS trial in Cardiff (Section 1.4.2) and the median UlC of 
euthyroid and hypothyroid women was indicative of iodine deficiency (98 and 117 pg/L 
respectively) when compared to WHO criteria (WHO Secretariat et al,  2007). These small- 
scale surveys raise concern; they not only suggest that UK pregnant women are not meeting 
their iodine requirement, but that women may be entering pregnancy with low thyroid- 
iodine stores, as evidenced by iodine deficiency in women of childbearing age.
38
Chapter 1 : Introduction
This concern for iodine status of UK women was heightened in 2011 when the first national 
survey of iodine status for more 60 years revealed mild iodine deficiency in UK schoolgirls 
(Vanderpump et al,  2011). UlC was measured in 737 adolescent schoolgirls (14-15 years) 
across nine regions in the UK (Vanderpump et al,  2011). The median UlC (80.1 pg/L) 
indicated mild iodine deficiency in the cohort and though Vanderpump and colleagues 
reported that severe, moderate and mild iodine deficiency were present in 1%, 16% and 
51% of participants respectively (Vanderpump et al,  2011), it was subsequently pointed 
out that this was an inaccurate way of reporting the data (as spot-urine samples cannot be 
used for diagnosis of iodine deficiency in individuals) (Skeaff, 2011b). Nevertheless, the 
results indicated that the underlying assumption that UK iodine intake is adequate is no 
longer tenable and the authors urged a comprehensive review of iodine status in the UK and 
an appropriate iodine fortification programme (Vanderpump et a l , 2 0 \ \ ) .
Using the median UlC in schoolgirls (Vanderpump et a/., 2011) and the number of school- 
aged children with an insufficient iodine intake in the UK, the country is now in the top ten 
of iodine-deficient countries worldwide (Andersson et al,  2012). The accompanying 
editorial for the Vanderpump et al (2011) study highlighted the shocking nature of a study 
that revealed iodine deficiency in a developed country such as the UK (Pearce, 2011). 
Researchers from the International Council for the Control of Iodine Deficiency Disorders 
(ICCIDD) have urged the UK to adopt a salt iodisation policy, based on success in other 
countries worldwide (van der Haar et a l,  2011).
The fact that iodine deficiency has been revealed in the UK in the present day despite the 
assumption that the problem was confined to history, mirrors the experience of other 
industrialised countries, for example the US (Caldwell et al,  2005; Hollowell & Haddow, 
2007; Caldwell et al,  2008; Perrine et al, 2010), Australia and New Zealand (Skeaff et al, 
2002; Li et a l,  2006b). All three regions have witnessed a decrease in iodine intake despite 
being considered as iodine-replete and having successfully eradicated iodine deficiency in 
the past (Zimmermann, 2011). Complacency has been regarded as the “greatest enemy in 
the war against iodine deficiency” (Dunn, 2000) and the UK Government appears to have 
fallen into this trap.
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1.9 Aims of the PhD project
There is clearly a dearth of knowledge on the iodine status of pregnant women in the UK 
and though iodine status has been measured nationally in school-aged girls, this cannot 
serve as a proxy for iodine status in pregnancy, as evidenced in other countries (Caldwell et 
al, 2008; Gowachirapant et al, 2009; Wong et al, 2011); iodine status must therefore be 
measured directly in UK pregnant women. It is not clear that the level of deficiency that has 
been demonstrated in the UK will have a negative impact on child development. To date, 
there are no data on the food sources of iodine in UK pregnant women, and while there is 
information in adults (Henderson et al,  2003), it is based on food diary analysis and not 
related to urinary iodine status. The gaps in the knowledge identified in this literature 
review have identified the following aims:
1.9.1 Overarching aim
To examine iodine status in UK pregnant women and its effects on maternal thyroid 
function and child outcome.
Specific aims
• To assess the risk of iodine deficiency in pregnant women in the South of the UK.
• To investigate the relationship between iodine status and thyroid function at 12-weeks 
gestation (a time when maternal thyroid function is critical for infant development).
• To assess the main dietary sources of iodine in UK pregnant women in order to provide 
appropriate dietetic advice to women.
• To investigate whether iodine deficiency in UK pregnant women affects child 
cognition, behaviour, and development (hearing and motor skills).
• To compare iodine concentrations in organic milk and regular milk in order to assess 
whether organic milk consumption may have an impact on UK iodine intake.
• To investigate the availability of iodised salt as an iodine source in the UK.
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1.9.2 Outline of the thesis
To meet the aims of the thesis, four studies were employed;
1. The Royal Surrey Study recruited pregnant women from the county hospital in 
Guildford.
2. The Selenium in Pregnancy Intervention (SPRINT) recruited pregnant women from the 
John Radclifle Hospital in Oxford.
3. The prospective UK study, the Avon Longitudinal Study of Parents and Children 
(ALSPAC) provided stored spot-urine samples for iodine concentration measurement.
4. A supermarket survey in the South of the UK provided milk samples and iodised salt 
data.
These studies are described in Methods (Chapter 2) but Table 1.4 shows how they were 
used to provide data for the aims outlined in 1.13.2.
Table 1.4 Studies used in the thesis to provide data for the aims of the thesis
Iodine 
status of 
UK 
pregnant 
women
Iodine and 
thyroid 
function in 
pregnancy
Iodine 
and 
cognition 
in child
Food 
sources of 
iodine in 
UK 
pregnant 
women
Iodine 
content of 
organic and 
conventional 
milk
Iodised
salt
availability
ALSPAC X X X
Royal Surrey 
Study X X
SPRINT X X
Supermarket X Xsurvey
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2. METHODS
2.1 Overview
This chapter will give an overview of the methods used for the main studies. More detailed
methods can be found within the relevant chapters for each of the studies.
2.2 Statistical testing
All statistical analyses were conducted using the Statistical Package for Social Sciences 
(SPSS) (version 17.0; SPSS, Inc., Chicago, USA).
2.2.1 Tests of normality
Data were tested for normality with the Shapiro-Wilk test. As large datasets are likely to 
fail formal normality tests (such as Shapiro-Wilk), the histograms and Q-Q plots generated 
in SPSS were inspected to evaluate whether the distribution was normal.
If variables were not normally distributed, natural logarithmic transformation was
conducted and the log-transformed variable was tested for normality; if transformation 
failed to approximate the distribution to normal, non-parametric tests were conducted on 
the untransfbrmed variables (CD Appendix).
Independent t-tests (or Mann Whitney U tests for non-parametric data) were used to 
compare two groups, and one-way ANOVA (or Kruskal Wallis for non-parametric tests) 
were used to compare more than two groups. Associations between two continuous 
measures were tested with the Pearson correlation (or Spearman Rank for non-parametric 
data). Comparisons of two categorical variables were conducted with chi-square tests.
Regression analyses (linear and logistic) were carried out to control for the effect of 
confbunders on the dependent variable (for example the effect of socio-economic factors in 
the analyses on iodine and cognitive outcomes). In order to use categorical variables with 
more than two categories in linear regression, dummy variables were created. The baseline 
category was chosen as the most common categorical level e.g. non-smokers.
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As linear regression analysis assumes that independent variables are not strongly correlated 
(multicollinearity), and that residuals are normally distributed, exhibit a straight-line 
relationship (linearity) and display a similar variance (homoscedasticity), these assumptions 
were tested for each model; multicollinearity was not considered a problem if the 
collinearity diagnostics (tolerance and VIF) were outside the critical limits (less than 0.1 for 
tolerance values and greater than 10 for VIF values).
Significance was set at p<0.05 throughout (Bonferroni correction applied for multiple 
testing where appropriate). Specific statistical testing is outlined in the appropriate chapters.
2.2.2 Effect sizes
Effect sizes were calculated throughout the chapters. It was considered especially important 
to report effect sizes for the work with the ALSPAC cohort, as large sample sizes can result 
statistical significance even when effect sizes are small (Field, 2009); thus the results may 
be significant but clinically meaningless.
The r statistic was calculated for correlations, independent t-tests and one-way ANOVA 
tests and this statistic was assessed according to the following criteria (based on the Cohen 
classification) to evaluate the effect size (Field, 2009):
r = 0.10 Small effect
r = 0.30 Medium effect
r = 0.5 Large effect
The r statistic for independent t-tests was calculated by dividing the squared t statistic by 
the sum of the squared t statistic and the degrees of freedom, and then computing the square 
root. The r statistic in one-way ANOVA was determined by taking the square root of the 
eta squared (q^) statistic (computed by dividing sum of squares between groups by the total 
sum of squares). The r statistic given in correlation analysis (Pearson’s correlation or 
Spearman Rank) was used without further calculation for effect size estimation. For non- 
parametric tests, the r statistic was calculated by dividing the z statistic (from Mann 
Whitney U tests) by the square root of the total number of observations. These r statistics 
were compared to the classification for determination of the effect size.
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2.3 Recruitment and selection of subjects
2.3.1 Royal Surrey Study
This study was planned by the author in order to evaluate iodine status in pregnant women 
at 12-weeks’ gestation in the South East of the UK. A favourable ethical opinion had 
already been granted (to Dr John Wright, a clinical endocrinologist at the Royal Surrey 
County Hospital on 8^ September 2008; Appendix 2) for a study to investigate iodine 
status in pregnant women. As this study had failed to start. Dr Wright approached the 
author giving her the opportunity to improve the study design. As originally planned, the 
study had no provision for collecting data on participants’ dietary habits nor on factors that 
might influence iodine status (such as age and use of nutritional supplements) and therefore 
these were incorporated into the revised protocol and questionnaires (Appendix 2). The 
amended study protocol was given a favourable ethical opinion by the Surrey Research 
Ethics Committee NHS and the University of Surrey Ethics Committee (Appendix 2) in 
July 2009.
Timing of the study
The study was undertaken in the summer months of 2009; recruitment commenced on the 
6^ July and was completed on the 15* September. Owing to time constraints, it was not 
possible to recruit women throughout the year and so it was considered important to 
minimise the time variation by restricting recruitment to one season. This was considered 
important as the known seasonal differences in milk iodine concentration (Introduction, 
Section 1.6.2) would likely affect UlC.
Participants
Women were recruited by the author from the ultrasound waiting room at their first 
trimester scan (around 12 weeks’ gestation), at the Royal Surrey County Hospital, 
Guildford. Women in this study were all recruited from morning clinics owing to the 
timings of clinics at the Royal Surrey County Hospital. Women were not eligible for 
inclusion if they had a history of thyroid disease or were taking thyroid medication; women 
gave informed, written consent.
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Sample collection and storage
Participants were all asked to provide a spot-urine sample at the ultrasound clinic. The 
urine specimen container was used exclusively for this study and thus the samples are 
known to be free from potential iodine contamination from the use of urine tests strips 
(Chanoine et al,  1987; Pearce et al,  2009). Samples were collected in plastic specimen 
containers with screw-top lids to prevent loss of iodine (WHO et a l , 2007). Samples were 
stored (at -80°C) at the University of Surrey until analysis.
Questionnaires
A questionnaire (designed by the author) was administered to each participant which 
collected details of participant age, smoking status, nutritional supplement use (including 
the brand name), whether vegetarian/vegan or non-consumers of fish or dairy products 
(Appendix 2). Women were also required to complete a short food frequency questionnaire 
(FFQ) designed to give detailed information only on the foods that were either iodine-rich 
or had potential goitrogenic properties. There were nine frequency options: never or less 
than once a month, 1-3 times per month, once a week, 2-3 times per week, 5-6 times per 
day, once a day, 2-3 times per day, 4-5 times per day, more than 6 times per day. The 
higher frequency options were included, as some foods (e.g. butter and water) were likely 
to be consumed more than once a day. The coding of the FFQ for examination of the 
relationship with iodine status is explained in Chapter 6.
2.3.2 SPRINT, Oxford
Selenium in Pregnancy Intervention (SPRINT) is an ongoing randomised, placebo- 
controlled trial of low-dose selenium (60 pg selenium /day as selenium-emiched yeast or 
placebo yeast) on markers of pre-eclampsia risk (principal investigator Professor Margaret 
Rayman). SPRINT was granted a favourable ethical approval by the Milton Keynes 
Research Ethics Committee on 11* December 2008. The original protocol included the 
storage of a blood and urine sample (at 12 weeks’ gestation) for future measurements, thus 
allowing the author the opportunity to use SPRINT samples for iodine and thyroid function 
analysis. The measurement of urinary iodine concentration enabled iodine status to be 
measured in another region of the UK in women who were recruited throughout the year 
and who were (in the majority) not on iodine-containing supplements; the results could be
45
Chapter 2: Methods
compared to those of women from the Royal Surrey Study. The measurement of thyroid 
function at 12 weeks’ gestation enabled the relationship between iodine status and thyroid 
function in the first trimester to be explored. An amendment for iodine and thyroid 
measurements was submitted by Professor Margaret Rayman and was accepted by 
Berkshire Research Ethics Committee on 27* July 2011.
Recruitment of subjects
Two-hundred and thirty primiparous women were recruited to the trial, at their 12-week 
ultrasound scan, by the study midwife at the John Radcliffe Hospital, Oxford. Exclusion 
criteria relevant to iodine investigation included: taking a supplement containing selenium, 
taking thyroid medication and current smokers. Women were also requested to complete a 
questionnaire that gave details on nutritional supplement use. By default, exclusion of 
women taking a multivitamin and multimineral supplement that contained selenium, meant 
that, for the most part, women were not taking an iodine-containing supplement; 
Sainsbury’s prenatal supplement contains iodine, but not selenium, and therefore a small 
percentage (2.6%, n = 6) of SPRINT women were taking an iodine-containing supplement 
at 12 weeks’ gestation. Recruitment commenced on 14* July 2009 and was completed on 
the 6* June 2011. Written consent was obtained from all participants.
Sample collection and storage
At the 12-week visit, women were screened for the study and if eligible, provided both a 
blood sample and a spot-urine sample which was stored at -80°C until analysis. Urine was 
collected in a separate specimen container for SPRINT therefore, as in the Royal Surrey 
Study, there is no fear of iodine contamination from urine test strips. One woman failed to 
produce a urine sample, and another did not give a blood sample for thyroid hormone 
measurement, leaving 228 in the study for iodine and thyroid hormone measurements.
Contribution of the author to SPRINT
The author contributed to the design of questionnaire on vitamin and mineral use 
(Appendix 2). During the two years of SPRINT recruitment, regular meetings were held 
with the study midwife, laboratory staff and investigators at the John Radcliffe Hospital, 
Oxford and the author attended all meetings. This provided an opportunity to ensure that
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samples and data were being collected appropriately. The author helped prepare the urine- 
sample shipment to the laboratory for iodine analysis at Southampton General Hospital.
2.3.3 Avon Longitudinal Study of Parents and Children: ALSPAC
To evaluate the impact of maternal iodine deficiency in pregnancy on cognitive outcomes 
in the offspring, collaboration was initiated between the author and Professor Margaret 
Rayman at the University of Surrey, and Professor Jean Golding, Dr Pauline Emmett, and 
Dr Colin Steer from the Avon Longitudinal Study of Parents and Children (ALSPAC) at 
the University of Bristol.
ALSPAC is a longitudinal study which recruited approximately 14,000 pregnant women in 
1991 and 1992 in the Avon area of the UK and has subsequently collected data on the 
development of their children. The county of Avon no longer exists but historically covered 
a region in the South-West of the UK, including the city of Bristol, and is in a part of the 
UK that historically, had a high incidence of goitre (Phillips, 1997). Among other 
biological samples, the pregnant women supplied a spot-urine sample. ALSPAC had 
unused maternal urine samples, from 12-weeks’ gestation that had been stored at -20 °C 
since collection. These samples and dataset provided an excellent opportunity to evaluate 
the relationship between maternal iodine status in pregnancy (assessed through UlC) and 
child outcome data, including cognition and behaviour.
In light of the fact that urine samples had been stored for over 20 years, the stability of 
iodine and creatinine in urine was investigated. Previous studies have shown creatinine to 
be stable when stored at refrigeration temperature (4°C) for 30 days (Spierto et a l,  1997), at 
-70°C for six months (Schultz et a l,  2000) and up to 2 % years (Parekh et al,  2007). The 
stability of UlC was also confirmed by contact with EQUIP (Ensuring the quality of 
urinary iodine procedures) (CDC iodine workshop, personal communication, August 2009). 
This confirmed that prolonged storage of urine samples in ALSPAC would not have 
affected their use for iodine assessment.
After an initial meeting in September 2009, a study proposal was submitted to the ALSPAC 
executive for permission to use the ALSPAC resource and the executive granted approval 
in October 2009. Although ALSPAC had the approval of the ALSPAC Ethics and Law
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Advisory Committee and the local NHS ethics committees, which covered additional 
analysis on samples and data, the University of Surrey Ethics Committee required an 
application for the study. The author prepared and submitted an application to the 
University of Surrey Ethics committee and a favourable opinion was granted on 8* 
February 2010 (Appendix 2).
ALSPAC methodology
ALSPAC recruitment and other methodologies have been described elsewhere (Golding et 
al,  2001) but briefly, all pregnant women living in the former Avon area in South-West 
England, with an expected delivery date between April 1991 and December 1992 were 
eligible for inclusion in ALSPAC. A total of 14,541 pregnant women enrolled, representing 
approximately 85% of eligible women; 13,988 children survived for at least 12 months.
During pregnancy, women completed a number of questionnaires providing details on a 
variety of socio-economic, emotional and personal data. Biological samples, including 
urine, were collected from the women. Outcome data on the children were collected from 
numerous sources including medical records for birth outcome data and questionnaires 
were completed by the mother for information on child development, such as child 
behaviour. From the age of seven, all children attended the ALSPAC clinic for 
assessments, including hearing, reading and IQ (Golding et al,  2001).
Selection of the current study cohort
Due to time and budget limitations, it was not possible to measure iodine status in the 
whole ALSPAC cohort and therefore a pilot study was devised. It was decided to use urine 
samples from 12-weeks’ gestation for maternal iodine status assessment, due to the 
evidence of the importance of thyroid function, and therefore iodine, at this time-point on 
infant cognition (Pop et al,  1999; Pop et al,  2003; Kooistra et al,  2006) (Introduction 
Section 1.4.2). One thousand women were selected on the basis both of availability of a 
urine sample around 12 weeks’ gestation and a measure of intelligence quotient (IQ) in the 
offspring at age 8 years. Professor Golding advised that the IQ measure at 8 years was more 
accurate than earlier measures of IQ in the ALSPAC children.
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Retrieval of urine samples
Once the decision had been made to sample women from the first trimester and the 
application had been submitted and approved by the ALSPAC executive, a list of 1000 
women from the entire ALSPAC cohort that met the inclusion criteria was prepared by an 
ALSPAC statistician (Colin Steer). ALSPAC laboratory staff subsequently retrieved the 
appropriate stored urine samples from the freezers for laboratory analysis. It was not 
possible for the author to be involved with either the selection of suitable women or the 
retrieval of the urine samples and so this was conducted as part of the agreed collaboration 
with ALSPAC.
Unfortunately, an error was made in urine sample selection by the ALSPAC laboratory 
staff that meant that samples were not from the first trimester, but in fact from the entire 
period of pregnancy (median gestational age 13 weeks, IQR 10-16 weeks). This error came 
to light almost two years after the initial sample selection and the author was not informed 
until late December 2011, by which time all of the statistical analysis had been completed 
on the entire study cohort.
Because of this error, the author completed a sub-analysis by gestational age of the urine 
samples. Women were divided into trimesters: samples up to 13 weeks gestation were 
classed as trimester 1 (n = 546), samples between weeks 14 and 26 were classed as 
trimester 2 (n = 307) and samples above 27 weeks were classed as trimester 3 (n = 147).
Possible coutamiuatiou of uriue samples
Results of laboratory analysis of the urine samples showed that some urine samples in 
ALSPAC had extremely high UlCs, much higher than the concentrations found in the 
Royal Surrey Study (Table 2.1). Although iodine intake may have fallen in the 17 years 
between ALSPAC and the Royal Surrey Study, and women were only recruited in the 
summer months in the Royal Surrey Study, the results suggested that the high values were 
not the result of iodine intake.
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Table 2.1 Comparison of UIC in ALSPAC (1991-1992) and the Royal Surrey Study (2009).
ALSPAC (1991/92)
UIC (pg/L)
Royal Surrey (2009)
Median (IQR) 96.4 (54.9-160.5) j 85.3 (39.6-145.5)
Minimum 4.2 j 3.8
Maximum 4380 1 534
Evaluation of whether high iodine values were related to medication or supplements
In order to exclude women taking thyroid medication and to investigate whether high 
urinary iodine was associated with medication use, the author prepared a list of medications 
likely to contain iodine by choosing from the complete list of medications used by 
ALSPAC women (Appendix 3). An ALSPAC researcher created three binary variables:
• use of hypothyroidism medication
• use of hyperthyroidism medication
• use of iodine-containing medication (including thyroid medications)
There was no ALSPAC code for amiodarone, indicating that it was not used by any of the 
ALSPAC women and therefore is unlikely to have been the cause of high UICs (Vejbjerg et 
al, 2009a; Zimmermann, 2009a). Medication for hypothyroidism (levothyroxine and 
thyroid hormones) was taken by three of the women in the study (0.3%); no woman was 
taking medication for hyperthyroidism. Iodine-containing medication (including 
levothyroxine and thyroid hormones) were taken by four women (0.4%). None of the 
women taking iodine medication had a UIC greater than 500pg/L, suggesting that 
medication use could not explain the very high UICs.
To explore further the cause of the high UICs, the author asked ALSPAC researchers to 
create a binary variable for use of an iodine-containing supplement (including seaweed or 
kelp). None of the women in our cohort reported use of such a supplement in pregnancy, 
eliminating this as a possible explanation for the high values.
Use of urine test strips
The fact that medications and supplements use could not explain the high iodine 
concentration values prompted the author to investigate the original ALSPAC methodology
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for the collection of urine samples. It was discovered that urine samples used by ALSPAC 
were taken as part of routine ante-natal care and revealed the possibility that some urine 
samples may have been contaminated through the use of urine test strips. Midwives were 
instructed by ALSPAC to collect urine from pregnant women in a sterile sample-container 
that had been provided for the study (and thus would be free from contamination) but if this 
was not possible, midwives were instructed to collect the clinical sample, once routine 
laboratory tests had been conducted (Professor Golding, personal communication, 
September 2010). Unfortunately there was no way to identify those urine samples that may 
have been contaminated through laboratory use.
Evidence suggests that test strips used for protein and glucose detection, can contaminate 
urine with iodine (Chanoine et al, 1987; Pearce et a l,  2009). Pearce et al (2009) identified 
iodine in the part of the test strip that tested for glucose and blood. The presence of iodine 
in the strip produces a colour change on reaction with glucose to detect glucose in the urine. 
Glucose is oxidised to gluconic acid and hydrogen peroxide by glucose oxidase; hydrogen 
peroxide then oxidises iodide (in the test strip) to free iodine and produces the colour 
change (Pearce et al,  2009).
Professor Stephen Halloran, a consultant biochemist at the Royal Surrey County Hospital, 
was involved with a UK Medical Device Alert (MDA) report on urine test strips in both 
1992 and 1998 (MDA, 1992; MDA, 1998), thus around the time of urine collection for 
ALSPAC. While the MDA did not assess the presence of iodine in test strips, the report 
does name the strips in use at the time of ALSPAC. Professor Halloran believes that Bayer 
and Roche who produced the test strips described in the literature (Chanoine et a l,  1987; 
Pearce et a l,  2009) would likely have supplied the clinics in ALSPAC and thus iodine 
contamination from those strips may account for the high values in the ALSPAC samples 
(Professor Halloran, personal communication, September 2010).
The author contacted the companies Siemens and Roche (Siemens acquired Bayer 
Diagnostics in 2006) for information on the Combur 10 test and Multistix 10 SG (urine 
strips that were listed in the MDA alerts for 1992 and 1998). Both companies reported that 
the iodine content of their test strips is unlikely to have altered since the 1990s as there has 
not been major reformulation of the test strips. Test strips were sent to the Trace Element
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Laboratory at Southampton General Hospital, where the original urine analysis was 
conducted on ALSPAC samples (Section 2.6.1). The Combur 10 test strip increased the 
iodine concentration in water to a greater degree than the Multistix 10 SG strip (318.5 vs.
63.5 pg/L when dipped for 1 second). The Siemens Multistix test strip appeared to release 
iodine from the bilirubin region of the test strip (Dr Christine Sieniawska, personal 
communication, November 2011). Based on these results, it seems likely that iodine 
released from urine test strips used in ALSPAC was the probable source of the excessively 
high readings in some of the samples.
It was decided to exclude urine samples that were potentially contaminated to avoid 
artificially high analytical results. Based on results from both the Royal Surrey Study 
(known to be free of contamination) and another study of UK pregnant women (Pearce et 
al,  2010), 500 pg/L was used as the cut-off for contamination, thus excluding 44 women 
with values above this figure; this same figure has been used as the cut-off in other studies 
of pregnant women and school-aged children (Caron et al,  1997; Burgi et al,  1999).
Exclusion o f subjects from ALSPAC
In addition to excluding the 44 women who were considered to have contaminated urine 
samples, women with inconsistent laboratory (between duplicate measures) iodine and 
creatinine measurements (as identified by the analyst at Southampton General Hospital) (n 
= 2) were excluded from the analyses as these urine samples were considered unreliable. 
Women who reported taking thyroid hormone medication (n = 3) i.e. those with known 
thyroid disease, were also excluded from the study, as is common in research on iodine and 
thyroid function during pregnancy; the final analysis was based on a total of 951 women, of 
whom 522 were in trimester one, 295 in trimester two and 134 in trimester three.
2.4 Assessment of iodine status
As the UK iodine requirements are outdated, the WHO requirements (WHO Secretariat et 
a l , 2007) were used to assess iodine status of UK pregnant women. The EAR, not the RNl 
should be used to report the prevalence of a nutrient deficiency in the population (Food and 
Nutrition Board Institute of Medicine, 2000; WHO, 2006). As the WHO does not list an 
EAR for iodine in pregnancy, an EAR was estimated by converting the pregnancy RNl of
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250 pg/day by a factor (1.4) derived for iodine by the WHO for converting the RNl of 
micronutrients to EAR values (WHO, 2006). This yielded an EAR of approximately 180 
pg/day, which the author estimates to be equivalent to a urinary iodine concentration of 110 
pg/L [on the principle that 90% of ingested iodine is excreted and the total urine volume is
1.5 litres/day (WHO Secretariat et a l, 2007)]. Thus, the EAR cut-point method (Food and 
Nutrition Board Institute of Medicine, 2000) was used to estimate the prevalence of iodine 
deficiency in UK pregnant women. The women were also described according to the WHO 
classifications of median UIC (WHO Secretariat et al,  2007) (see below).
2.4.1 Iodine concentration
The iodine status of the population of pregnant women in the Royal Surrey Study, SPRINT 
and ALSPAC was classified by the median UIC, as recommended by the WHO (WHO 
Secretariat et al, 2007). The median UIC was also compared with the suggested range 
indicative of mild-to-moderate iodine deficiency in pregnancy (Zimmermann, 2007a).
The use of iodine concentration in a spot-urine sample is not appropriate for assessment of 
iodine status of individuals (WHO et al, 2007) because of the intra-individual variability in 
both iodine intake (and therefore excretion) and urine volume. UIC was not used for the 
investigation of relationships between iodine status and cognitive outcomes nor for 
examining the relationship between iodine status and diet or maternal characteristics.
2.4.2 Individual iodine status: use of the iodine/creatinine ratio
For assessment of iodine-status in individuals, multiple 24-hour urine collections are 
required (Rasmussen et al, 1999; Vejbjerg et a l,  2009a; Zimmermann, 2009a) but are 
impractical in large-scale studies. Where only spot urine samples are available, such as in 
the studies listed above, the intra-individual variation in daily urine volume excreted can be 
reduced by measuring urinary creatinine concentration (Vejbjerg et a l,  2009a) and this can 
be further improved if the age and sex of the individual is considered (Knudsen et a l,  2000; 
Vejbjerg et al, 2009a). The age-and-sex-adjusted iodine/creatinine ratio has been proposed 
as alternative to the 24-hour urine collection (Knudsen et a l,  2000; Zimmermann, 2008b; 
Vejbjerg et a l,  2009a; Konig et a l,  2011) but this ratio has only been evaluated in adults, 
not in pregnant women. There is evidence to suggest that creatinine excretion is unaltered
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in pregnancy (Pahl et al, 2001; Mojtahedi et a l, 2002) implying that creatinine-adjnstment 
would be valid in pregnancy. The use of the age-and-sex-ac^usted ratio that is proposed by 
Knudsen et al (2000) in the pregnant women in the studies in this thesis would have 
required using an estimated figure for the total creatinine excretion per day, and might have 
introduced a possible source of error. Furthermore, the pregnant women in these studies are 
already stratified by age and sex, all being female and of limited (child-bearing) age-range. 
Unpublished research in the Netherlands has found a strong (r = 0.92) correlation between 
the simple iodine/creatinine ratio and 24-hour urinary iodine in pregnant women (Dr Huib 
Vader, personal communication, April 2011). Therefore the simple iodine/creatinine ratio 
has been used as a proxy for individual iodine status for the pregnant women in this thesis. 
It was used in the statistical analysis relating maternal iodine status to maternal 
characteristics, maternal thyroid function and child outcomes.
The author is aware of the debate regarding the use of the RNl for individual assessment 
(Beaton, 2006; Murphy et aZ., 2006), but in the absence of both a published EAR that 
relates to the WHO requirement for pregnancy, and official criteria for iodine adequacy in 
individuals, the WHO population criterion (based on the RNl) for UIC in pregnancy (WHO 
Secretariat et <2/., 2007) was used to dichotomise the iodine/creatinine ratio into adequate or 
deficient. Values above 150 pg iodine/g creatinine were considered adequate. Additional 
supplementary analyses, were performed with the “deficient” category split into “severe” 
(< 50 pg/g), and “mild-to-moderate”(50-150 pg/g) (Zimmermann, 2007a).
2.5 Supermarket survey
2.5.1 Geographical location and supermarkets sampled
A total of 77 supermarkets in 16 areas of the UK (Figure 2.1) were visited to collect 
samples for the study of organic and conventional milk-iodine concentration and data for 
the study of iodised-salt availability (see Appendix 4 for store locations). Supermarkets 
were included from 14 areas in the South of England, one in Wales (Cardiff) (Figure 2.1) 
and one in Northern Ireland (Nl) (County Antrim: Belfast).
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In each region, five supermarket chains were visited: Tesco, Asda, Sainsbury's, Morrisons, 
and Waitrose. These supermarkets were chosen as representing the m^ority of the market 
share, at 79.4% (INS Worldpanel, 2009). Sampling in Northern Ireland was restricted by 
supermarket availability, Tesco and Sainsbury’s being the only two chains with stores in 
the region. In each supermarket, organic and conventional milk was purchased (details in 
Chapter 7) and shelves were examined for availability of iodised salt (detailed method in 
Chapter 8). Milk samples were aliquoted and stored frozen (-80°C) until analysis.
For the purposes of statistical analysis, the areas were grouped into four regions: South 
West (Cornwall, Devon, Somerset, Dorset, Wiltshire and Bristol, Bath and North East 
Somerset), South East (Kent, Essex, London, Hampshire, Surrey, Sussex, Oxfordshire and 
Berkshire) Wales (Cardiff) (Figure 2.1) and Northern Ireland (County Antrim).
2.5.2 Timing of the studies
Iodine concentration in milk varies depending on the season, with lower levels in the
summer months (Introduction, Section 1.6.2). To limit this variation, the collection of 
samples was conducted from June to August. Supermarkets in each area were visited on the 
same day for milk-sample collection, to limit the potential variation due to day of purchase. 
The systematic sampling method was chosen to enable a large number of samples of each 
milk type to be collected and, as a secondary aim, to allow comparisons to be made 
between supermarket chains and regions.
2.6 Laboratory Analysis
2.6.1 Urine analysis
UIC was measured by ICP-MS as this is considered to be the “gold standard” method 
(Jooste & Strydom, 2010), and is fast and accurate with easier and safer sample preparation 
than other methods, such as Sandell-Kolthoff (Caldwell g/ a/., 2003; Macours gr aZ., 2008). 
Additionally, the limit of detection is considerably lower than that of the Sandell-Kolthoff 
method (1.2 vs. 5 pg/L) (Vanderpump g/ a/., 2011; Sieniawska g/ a/., 2012). The results 
obtained by ICP-MS are largely comparable to those from the Sandell-Kolthoff method
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(Caldwell g/ a/., 2003; Caldwell g/ a/., 2005), though there are reports that ICP-MS yields
slightly lower iodine concentrations (Macours et a l,  2008).
Royal Surrey Study
UIC was measured on a ThermoElemental X-Series ICP-MS (ThermoFisher Scientific,
Hemel Hempstead, UK) at the Trace Element Laboratory at the University of Surrey.
The samples were diluted with an alkaline diluent which was prepared by dissolving 3.32 g 
NH4H2PO4, and 1.16 g (NH4)2H2EDTA (Analar grade, Sigma-AIdrich, Dorset, UK) in 
deionised water, adding 10.0 ml ammonia solution (s.g. 0.88), and making up to 1000 ml 
with deionised water. 400 pL of each participant’s urine sample was made up to 10 ml with 
the alkaline diluent. Standard iodine solutions were prepared with potassium iodide 
solution (Analar grade, Romil Ltd, Cambridge, UK) for the construction of calibration 
curves. 400 pE of control urine was added to 400 pE of each standard in order to obtain 
matrix-matched standards. An internal standard was added to all samples: Rhodium (^^^Rh) 
and Iridium (^^ I^r) (both SPEX Certiprep Ltd, Middlesex, UK) were made up in a working 
standard solution of 1 mg/L (ppm) in 1% v/v nitric acid (Trace analysis grade, Fisher 
Scientific). This solution was made up in a ratio of 1 in 10 with the diluent. 150 pL of this 
solution was added to every tube in the analysis.
To evaluate the accuracy of the method, certified reference materials (CRM) were obtained 
through the Centre for Disease Control (CDC)’s quality-assurance programme ‘Ensuring 
the Quality of Urinary Iodine Procedures’ (EQUIP). The results are in Table 2.2.
Table 2.2 Comparison Royal Surrey Study results with certified reference materials (CRM).
CRM Mean (range) (pg/L) Value obtained in this study (pg/L)*
Number of 
measurements
U02 28.7(20.1-37.3) 27.6 (2.3) 3
U05 45.0(31.5-58.5) 47.4 (2.1) 4
U09 296.3 (251.9-340.7) 301.8(7.5) 4
m o 12.2 (8.5-15.9) 9.6 (0.8) 2
U106468 7.3 (5.1-9.5) 6.6 (NA)t 1
*Figures are mean (SD) f  SD not applicable as only one measurement performed for this CRM.
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Urinary creatinine was measured by the Jaffe rate method on AD VIA Chemistry System in 
the Biochemistry Department at The Royal Surrey County Hospital.
ALSPAC and SPRINT
Due to the high number of urine samples from the SPRINT and ALSPAC studies, it was 
not possible to use the University of Surrey laboratory for iodine analysis. Instead, these 
samples were analysed at the Trace Element Laboratory at Southampton General Hospital, 
by Dr Christine Sieniawska.
For both ALSPAC and SPRINT urine samples, iodine concentration was measured using a 
dynamic reaction cell inductively-coupled plasma (ICP) mass spectrometer (SCIEX Perkin- 
Elmer, Beaconsfield) (Sieniawska et al,  2012) and urinary creatinine was determined by 
the UniCel DxC Synchron Clinical System Analyzer by the Jaffe rate method. The SPRINT 
analysis method was a modified version of the ALSPAC method, the main difference being 
that top of the calibration curve was extended from 400 pg/L to 1269 pg/L and iodine 
concentration was reported as pmol/L instead of pg/L; values were converted to pg/L by 
multiplying by 126.9.
For both ALSPAC and SPRINT urine analyses, the accuracy of the results was verified 
using the certified reference material (CRM) Seronorm urine (Nycomed, Norway) and 
internal quality control samples (QcD and QcE).
The analysis of ALSPAC samples showed a within run precision of 2.8% RSD at 36 pg/L, 
1.9% at 120 pg/L and 2.2% at 300 pg/L. Between run precision was 2.1% RSD at 36 pg/L, 
1.6% at 120 pg/L and 3.8% at 300 pg/L. Limit of detection was 1 pg/L. The results for the 
quality-control materials are shown in Table 2.3
In the iodine analysis of SPRINT samples, the within-run precision was 2.0% at 0.28 
pmol/L, 1.3% at 0.94 pmol/L and 1.0% at 2.5 pmol/L. Between-run precision was 3.6% at 
0.28 pmol/L, 2.5% at 0.94 pmol/L and 3.3% at 2.5 pmol/L. The limit of detection was 0.01 
pmol/L. Quality control results are shown in Table 2.3
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Table 2.3 Comparison of quality control materials with ALSPAC and SPRINT results
Quality
control/CRM
Mean (range) 
(Iig/L)
Value obtained for 
ALSPAC analysis 
runs (pg/L)*
Value obtained for 
SPRINT analysis 
runs (pg/L)*
Seronorm urine i 304(270-338) 298 (14.4), n= 184 318.4 (10.1), n = 23
QcD 35.5 (33-38) 35.7 (1.2), n=  100 36.8 (1.3), n = 24
QcE 1 120(115-125) 120 (3.0),n = 93 118.0 (2.5),n = 27
* Figures are mean (SD); figures for SPRINT converted to pg/L by multiplying by 126.9
2.6.2 Thyroid function analysis
The serum samples collected in SPRINT were analysed at the Department of Biomedical 
Engineering, University of Technology, Eindhoven, The Netherlands. Measurement of
TSH, fT4 and TPO antibodies were conducted on a Modular Analytics E l70 analyser. 
Details of the laboratory method have been reported previously (Pop et al, 2003).
2.6.3 Milk analysis
Laboratory iodine analysis by LGC Ltd.
Milk sample preparation and analysis was performed at LGC Ltd., formerly the Laboratory 
of the Government Chemist, Middlesex, UK in March 2010. This method was supplied by
LGC. Milk aliquots were transported to LGC Ltd. and then stored at -18°C until analysis. 
Prior to digestion, the samples were defrosted and allowed to reach room temperature. An 
aliquot of 0.5 g was mixed with 5 ml of 5% tétraméthylammonium hydroxide (TMAH) 
solution, prepared by dissolving solid TMAH (>97% Sigma Aldrich, UK) in ultrapure 
water (>18 MG cm, Elga, UK). The vial was then placed in an oven at 90°C for 3 hours 
(Santamaria-Femadez g/ aZ., 2006). After cooling, 0.5 ml tellurium solution (1300 ng/ml 
tellurium, Romil, UK, in 1% TMAH) was added to the digested samples as an internal 
standard; samples were made up to 50 g with 1% TMAH solution.
ICP-MS determination of iodine
The digested samples were analysed for iodine concentration by inductively-coupled 
plasma mass spectrometry (ICP-MS) (Element2, ThermoFisher Scientific, Bremen, 
Germany) by external calibration using a stock standard, prepared in-house gravimetrically
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from high purity potassium iodide (+99.99%, Alfa Aesar, UK) in 5% TMAH solution. 
Subsequent dilutions were performed in 1% TMAH.
Quality Control Data
The uncertainty of the method was calculated as ±10% according to in-house United 
Kingdom Accreditation Service (UKAS) accredited methods which are in accordance with 
ISO 17025 and Eurachem/CITAC guidelines. Accuracy of the results was verified using the 
CRM BCR 063R Skimmed Milk Powder (LGC Standards, UK); [certified iodine content 
810 ± 50 ng/g (dry weight basis)]; the mean value for the CRM was 838.9 ng/g (± 23.6). 
The Coefficient of Variation for the 15 measurements of the CRM was 2.8%. Spiked 
samples of the CRM and milk samples were used to measure recovery; the means of the 
spiked recoveries were 101.5 % (±6.3) and 94.5 % (±5.0) respectively.
Role of the author in the laboratory work
The author assisted with analysis of urine samples (for iodine concentration) collected from 
the Royal Surrey Study, under the supervision of Dr Andrew Taylor and Alan Walter.
The author attended the laboratory at LGC for the six days the milk samples were being 
analysed on the ICP-MS to help with the milk sample analysis. The author was responsible 
for pippetting the digested solution into glass funnels ready to be used for ICP-MS analysis. 
The auto-sampler could not be used on the ICP-MS (due to risk of blockage with milk 
particles), necessitating the use of a shorter non-automated sampler arm; the author was 
responsible for inserting this arm into the solution for sample uptake into the ICP-MS. The 
author washed the arm for 40 seconds with 5% TMAH solution between milk samples; this 
process was repeated until all 181 milk samples (plus the CRM and spiked sample 
materials) had been analysed.
The author was required to check the values on the computer after each sample, both to 
confirm that a value had been recorded (and thus ICP-MS had successfully taken up the 
sample), and to ensure that the Relative Standard Deviation (RSD) was not increasing, 
which would have indicated that the equipment was becoming blocked by milk particles. 
The author also cleaned and soaked the glassware in the 5% TMAH solution.
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3. IODINE STATUS OF UK PREGNANT WOMEN
3.1 Introduction
Data are lacking on the iodine status of UK pregnant women and there are none on 
pregnant women in the South of the UK. Previous research has been restricted to Scotland 
(n = 433) (Barnett gf a/., 2002), the UK North-East (n = 227) (Kibirige a/ a/., 2004) or 
Cardiff (n = 757) (Pearce et al,  2010). These are not good studies of iodine status in UK 
pregnant women:- one has only been published as an abstract (Barnett et al, 2002); the 
Cardiff study (Pearce g/ <?/., 2010) reports iodine status as a secondary aim in a study on 
thyroid function according to goitrogen (percholate) exposure, and presents results for 
pregnant women who are euthyroid or hypothyroid, not for the whole group; the Kibirige et 
a/, data (2004) are not clear and contains errors (see Introduction, Section 1.8.2).
Correspondence in the Lancet by the UK and Irish representatives of ICCIDD have 
suggested that additional research should be conducted on the iodine status of UK pregnant 
women (Lazarus & Smyth, 2008). Furthermore, the investigation of the prevalence of 
iodine deficiency in pregnant women was suggested as a research priority by WHO panel
members, when publishing updated iodine requirements for pregnant women (WHO 
Secretariat g/ <3/., 2007).
3.1.1 Aims and hypotheses
This study aimed to evaluate iodine status in pregnant women in the South of England, both 
in the 1990s and at the present day, to add to the sparse and poor literature on iodine status 
of UK pregnant women.
Specific aims
# To evaluate the trend, if any, between historical (1990s) and present day iodine status in 
pregnant women.
# To evaluate the impact of various maternal characteristics on iodine status at 12 weeks' 
gestation, including maternal age, educational level, smoking status and parity.
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Post-hoc study aims
Errors made in urine sample selection by ALSPAC laboratory staff (see Methods, Section 
2.3.3) resulted in measurement of iodine status in different trimesters of pregnancy. This 
enabled comparisons of iodine status between trimesters to be made and thus a post hoc 
study aim was introduced:
• To evaluate whether iodine status differs according to trimester of pregnancy. 
Hypotheses
• UK pregnant women will be classified as having deficient iodine status, according to 
WHO criteria.
• Iodine status will be lower in pregnant women recruited in the present day than women 
in ALSPAC who were recruited in the 1990s, due to decreases in milk consumption 
over that time period.
• Non-smokers, older women and those with higher educational qualifications will have 
higher iodine status owing to different dietary-intake patterns.
3.2 Method
3.2.1 Subjects
Iodine status was evaluated in pregnant women of the ALSPAC cohort recruited in the 
1990s and in the present day by using samples from the Royal Surrey Study (2009) and 
SPRINT (2009-2011). For comparability with the Royal Surrey Pregnancy Study and 
SPRINT data sets in which urine samples were collected at 12 weeks' gestation, only data 
firom samples collected from ALSPAC women around the same time in gestation were 
analysed; there were 247 samples between 11 and 13 weeks gestation in ALSPAC.
For the purposes of investigating differences in iodine status between trimesters one, two 
and three, the results from the whole ALSPAC cohort (uncontaminated samples only: n = 
951) were used, as this provided iodine results across the whole of pregnancy (Methods, 
Section 2.3.3).
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Iodine excretion (both UIC and iodine/creatinine ratio) data were compared with the WHO 
criteria for iodine adequacy in a population of pregnant women (WHO et a l,  2007; WHO 
Secretariat et al,  2007) and the percentage below the EAR was reported (Methods, Section 
2.4); the median values for iodine concentration were also compared with the suggested 
value for mild-to-moderate iodine deficiency in pregnant women (Zimmermann, 2007a).
For the purposes of investigating the relationship between maternal characteristics and 
iodine excretion, the iodine/creatinine ratio was used as a proxy for iodine status (Methods, 
Section 2.4.2); comparisons were not made with raw iodine concentration, given the high 
intra-individual variation in volume of urine excreted which renders this measure unreliable 
for individual assessment (Vejbjerg et al,  2009a; Zimmermann, 2009a).
3.2.2 Iodine status in different trimesters of pregnancy
As outlined in the Methods chapter (Section 2.3.3), urine samples were inadvertently 
included in the ALSPAC sample from the full range of gestational ages. This unexpectedly 
provided an opportunity to evaluate the difference in iodine excretion and status as 
pregnancy progressed. Urinary iodine/creatinine results were grouped using the gestational 
age (supplied by ALSPAC statisticians to the author) into trimester one (less than 13 
weeks’ gestation; n = 522), trimester two (weeks 14 to 26 of gestation; n = 295) or trimester 
three (more than 27 weeks gestation; n = 134) as described in the Methods, Section 2.3.3.
3.2.3 Participant characteristics that may influence iodine status 
Maternal age
The impact of maternal age on iodine status was evaluated in women from both the 
ALSPAC cohort and the Royal Surrey Study. The age of ALSPAC women was recorded at 
delivery, whereas the Royal Surrey Study recorded age at recruitment, a difference of 
approximately six months. The relationship between iodine status and maternal age was 
assessed in two ways -  with age as a continuous variable, and as a categorical variable in 
three groups: 16-24 years, 25-34 years and 35-49 years, based on the classification used in 
the UK adult National Diet and Nutrition Survey (NDNS) (Henderson et a l,  2003). 
Although the lower age bracket in NDNS was 19-24 years, this was extended to 16-24 
years in ALSPAC in order to include the small number of pregnancies at young age.
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Smoking status
The impact of smoking on iodine status was evaluated in the ALSPAC cohort and the 
Royal Surrey Study. The Royal Surrey Study recorded whether women were current 
smokers or non-smokers. In ALSPAC it was possible to investigate the relationship 
between the number of cigarettes smoked per day during pregnancy and maternal iodine 
status. Data were also available on the smoking status of the mother prior to pregnancy. 
Women in ALP SAC were grouped as “non-smoker”, “smoker pre-pregnancy” or “smoker 
during pregnancy”.
Parity
Women in ALSPAC had information on parity (parity defined as number of times that the 
woman had given birth, either a live birth or a stillbirth, but excluding miscarriages and 
abortions). The Royal Surrey Study asked if women had given birth in the last three years, 
and also the length of time since the last pregnancy (not a true definition of parity). The 
relationship between time since previous birth (less than 1, 2 or 3 years) and number of 
previous pregnancies (none, one, two or more) was explored with data from the Royal 
Surrey Study and ALSPAC, respectively.
Maternal education
Data on maternal educational qualifications was only available in the ALSPAC cohort. This 
information was collected as part of a self-completed questionnaire sent to ALSPAC 
women. Maternal education was grouped as either low (no qualifications, CSE, or 
vocational), medium (0-Level) or high (A-level or degree).
3.2.4 Statistical analysis
Mean and standard deviation (SD) are reported for the maternal age as this was normally 
distributed; median and interquartile range (IQR) are reported for variables that were not 
normally distributed (iodine concentration and iodine/creatinine ratio and the number of 
cigarettes smoked per day for smokers in the ALSPAC cohort).
Iodine concentration and the iodine-to-creatinine ratio in women from ALSPAC (12 weeks’ 
gestation), the Royal Surrey Pregnancy Study and SPRINT were not normally distributed
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(CD Appendix) and were transformed using the natural logarithm to allow parametric
testing. The iodine/creatinine ratio and creatinine concentration (g/L) in all uncontaminated 
ALSPAC urine samples (n = 951) were not normally distributed, even after log 
transformation and therefore non-parametric statistics were used for these variables when 
assessing all women in ALSPAC (for the purposes of trimester differences in iodine status).
Spearman rank correlations were used to explore relationships between two continuous 
variables when one variable was not normally distributed, otherwise Pearson correlations 
were used. Independent t-tests or one-way ANOVA were used on the log-transformed data 
to compare two groups (e.g. comparison iodine status of smokers and non-smokers) or two 
or more groups respectively (e.g. comparison of iodine status between age groups). 
Categorical data were compared using chi-squared tests. The Kruskal Wallis test was used 
to compare iodine concentration, creatinine concentration and iodine/creatinine ratio 
between the three trimesters of pregnancy and post hoc testing was conducted using Mann 
Whitney with a Bonferroni correction applied for multiple testing (significance p <0.017).
The relationship between the participant characteristics and the iodine/creatinine ratio (log
transformed), when all maternal factors were controlled for, was conducted with linear 
regression for both the Royal Surrey Study and ALSPAC.
3.3 Results
3.3.1 Participant characteristics
Participant characteristics for women in ALSPAC (11-13 weeks’ gestation) and the Royal 
Surrey Study are in Table 3.1. Women were significantly older in the Royal Surrey Study 
than in ALSPAC (mean age 32.4 v& 29.8 years, /(345) = -4.63, p <0.0001), with a 
significantly higher percentage in the older age group [34.0% v& 16.4%; Table 3.1, (2) =
17.2, p<0.0001]. This is despite the fact that the age of women in the Royal Surrey Study 
was recorded some six months earlier (at recruitment) than that of the ALSPAC women (at 
delivery). More women smoked during pregnancy in ALSPAC than in the Royal Surrey 
Study (10.7% v& 5.0% Table 3.1), but the difference was not statistically significant [%^ (1) 
— 2.74, p = 0.10].
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Table 3.1 Participant characteristics of women in ALSPAC (11-13 weeks’ gestation) and Royal
Surrey Study
1 ALSPAC Royal Surrey Study
Total number of subjects 247 100
Year of recruit 1991/92 2009
Mean (SD) age (years) 29.8 (4.7)" 32.4 (4.7)
Age range (years) < 1 6 -4 2 : 19-47
Age groupt
16-24 years 33 (13.4%) 4 (4.0%)
25-34 years ; 174(70.4%) 62 (62.0%)
35-49 years 40(16.4%)" 34 (34.0%)
Smoking statusf
Non-smoker 181 (74.8%) 95 (95.0%)
Smoked pre-pregnancy 35 (14.5%)  ^ NA
Current smoker 26(10.7%) : 5 (5.0%)
Number of cigarettes/day* 10(5-15)f : NA
Parity
0 117(48.5%) NA
1 84 (34.9%) : NA
2 or more 40(16.6%) : NA
Time since previous birth
Less than 1 year : NA 4 (9.8%)
Less than 2 years NA : 24 (58.5%)
Less than 3 years i NA 13(31.7%)
Maternal Educationf
Low 48(19.5%) I NA
Medium 84(34.1%) : NA
High 114(46.3%) NA
* based on those who smoked during pregnancy only, f  data are n (%) $ data are median (IQR). NA: data not 
available, ^significantly lower than Royal Surrey Study (p<0.0001).
3.3.2 Iodine status of women from all three studies
Descriptive statistics for the urinary iodine values for all three pregnancy studies are shown 
in Table 3.2. The iodine status of UK pregnant women from ALSPAC in the early 1990s 
falls within the classification of mild-to-moderate iodine deficiency (WHO Secretariat gr
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al,  2007; Zimmermann, 2007a) with a median UIC of 90.5 pg/L and a median 
iodine/creatinine ratio of 116.5 (Table 3.2). Women in the Royal Surrey Study were also 
classified as being mildly-to-moderately iodine deficient (WHO Secretariat et al,  2007; 
Zimmermann, 2007a), with a median UIC of 85.3 pg/L and a median iodine/creatinine ratio 
of 122.9 pg/g. The median UIC figure of SPRINT women (42.5 pg/L) classifies the cohort 
as severely iodine deficient but this improves to mildly-to-moderately deficient when using 
the creatinine-adjusted value (102.9 pg/g) (Table 3.2) (WHO Secretariat et al, 2007; 
Zimmermann, 2007a). The results are shown graphically in Figure 3.1.
Between 42 and 55% of pregnant women in the three studies had urinary iodine excretion 
below the value computed for the EAR (Methods, Section 2.4), suggesting a high 
prevalence of iodine deficiency in the cohorts.
Comparison of the three studies
There was a significant difference in iodine concentration between the three studies [F(2, 
573) = 37.6, p<0.0001] and post hoc tests revealed that SPRINT samples were lower in 
iodine than both the ALSPAC (p<0.0001) and the Royal Surrey Study samples (p<0.0001). 
The iodine/creatinine ratio also differed between the studies [F(2, 573) = 3.6, p = 0.03] but 
the post hoc test showed that only the SPRINT samples were significantly lower in 
iodine/creatinine than the ALSPAC samples (p = 0.04), and that there was no significant 
difference between the ALSPAC and the Royal Surrey Study iodine/creatinine values.
For the purposes of comparing historical iodine status to current iodine status, samples 
from women in the Royal Surrey Study who were taking an iodine-containing supplement 
(see Chapter 6 for details on iodine supplement use) were excluded fi-om the comparison 
with those from ALSPAC (in which no women took such a supplement). The 58 women in 
the Royal Surrey Study who were not taking an iodine-containing supplement had a 
significantly lower urinary iodine/creatinine ratio than ALSPAC women [median 101.5 vs.
116.5 pg/g); /(303) = 2.21, p = 0.03].
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Figure 3.1 Median UIC and iodine/creatinine ratio of pregnant women in ALSPAC, Royal Surrey 
Study and SPRINT in relation to level for adequacy in pregnancy (WHO Secretariat et al., 2007) 
[^significantly lower than ALSPAC and Royal Surrey Study iodine concentration values (p<0.0001); 
^significantly lower than ALSPAC iodine/creatinine values (p<0.0001)]
Table 3.2 Iodine status of women in ALSPAC, Royal Surrey Study and SPRINT
ALSPAC
Iodine cone. I/creatinine 
(gg/L) (gg/g)
Royal Surrey
Iodine cone. I/creatinine 
(gg/L) (gg/g)
SPRINT
Iodine cone. ' I/creatinine 
(gg/L) (gg/g)
Median 90.5 116.5 85.3 122.9 42.5 102.9
(IQR) (50.0-141.0) (77-182) (39.6-145.5) (80-164) (24.6-85.6) ! (67-167)
Min 5.7 25.5
765.6
3.8 33.6 5.5 30.5
Max 496.0 534.0 1149.6 370.5 799.0
n (%) 190 161 76 67 211 155
<150* (76.9) (65.2) (76.0) (67.0) (92.1) i (67.7)
n ( % ) 61 18 34 7 126 29
<50 (24.7) (7.3) (34.0) (7.0) (55.0) (12.7)
%
below
EAR**
60.7 47.8 64.0 42.0 84.3 55.5
* either expressed as n (%) with UIC (gg/L) or iodine/creatinine ratio gg/g below cutoffs. **EAR cutoff 
estimated to be 110 gg/L or gg/g, equivalent to 180 gg/day
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3.3.3 Iodine status in different trimesters of pregnancy
The results of urinary iodine and creatinine concentrations, and the iodine/creatinine ratio
by trimester of pregnancy, for uncontaminated urine-samples from ALSPAC, are shown in 
Table 3.3. Iodine and creatinine concentrations were lowest in second-trimester urine 
samples but there was an increase in iodine/creatinine ratio as pregnancy progressed from 
trimester 1 to trimester 3, with the lowest values in trimester 1.
Table 3.3 Differences in urinary iodine and creatinine concentration and the iodine/creatinine ratio
by trimester of pregnancy
Trimester n
Iodine
concentration
(Hg/L)*
Creatinine
concentration
(g/L)*
Iodine/creatinine
(pg/g)*
% deUcientf 
(<150 pg/g)
First 522
88.6"
(52.7-140.0)
0.80"
(0.50-1.20)
106.3"
(72.6-167.5)
69.3"
Second 295
85.5"
(44.7-146.0)
0.60''
(0.30-1.00)
133.2''
(92.5-224.8)
56.9''
Third 134
131.0'' 
(75 .4 - 196.3)
0.75"
(0.50-1.00)
175.5"
(110.8-264.7)
38.1"
*Data are median (IQR) f  Suboptimal classification based on iodine/creatinine ratio (<150 gg/g). Significant 
differences between trimesters indicated by different superscript letters (within the same column)
There was a significant difference in iodine concentration between the trimesters of 
pregnancy, (2) = 24.92, p <0.0001 and a /zoc test (Bonferroni) revealed that iodine 
concentration was significantly higher (but with small effect sizes) in trimester 3 than in 
trimester I (U = 25614.0, z = -4.78, p <0.0001, r = 0.19) and trimester 2 (U = 14487.0, z = 
- 4.44, p <0.0001, r = 0.21) but there was no significant difference between trimesters 1 and 
2. By contrast, the significant difference in creatinine concentrations between trimesters 
(2) = 29.03, p <0.0001] was due to the significantly lower creatinine concentration in 
trimester 2 urine samples than in those of trimester 1 (U = 59875.5, z = -5.30, p <0.0001, 
r = 0.19) and trimester 3 (U = 16666.5, z = -2.61, p = 0.01, r = 0.13). There was no 
difference in creatinine concentration between trimesters 1 and 3. The iodine/creatinine 
ratio also significantly differed between trimesters (2) = 58.95 p <0.0001], with the ratio 
being significantly lower in trimester 1 than in trimester 2 (U = 59670.5, z = -5.35, 
p<0.0001, r = 0.19) or trimester 3 (U = 21854.0, z = -6.70, p<0.0001, r = 0.26) and
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significantly higher in trimester 3 than trimester 2 (U = 16510.0, z = -2.74, p = 0.006, r = 
0.13). All of the significant differences had small effect sizes.
These differences in iodine and creatinine concentration by trimester, meant that there was 
a significant difference between the percentage classified as having a deficient iodine status 
(<150 pg/g) between trimesters (2) = 47.01, p<0.0001; Table 3.3].
3.3.4 Relationship between iodine status and participant characteristics 
Age
In women of around 12 weeks’ gestation (n = 247) in ALSPAC, there was a significant 
positive correlation (small effect size) between iodine/creatinine ratio and maternal age 
(years) (r = 0.17, p = 0.01), but this explained only 2.9% of the variance of iodine status in 
ALSPAC women. The youngest age group (16-24 years; n = 33) showed a tendency to a 
lower median iodine/creatinine ratio than women in the 25-34 years (n = 174) and 35-49 
year old age group (n = 40) (median 89.3 vs. 114.9 and 139.1 pg/g respectively), but this 
difference failed to reach statistical significance, F(2, 244) = 2.15, p = 0.12.
There was also a positive correlation (medium effeet size) between age (in years) and the 
iodine/creatinine ratio in women from the Royal Surrey Study (r = 0.30, p = 0.003), 
explaining 9% of the variance in iodine/creatinine ratio. Older women -  35-49 years (n = 
32) had a higher iodine/creatinine ratio (median 144.8 pg/g) than did the 25-34 year group 
(107.1 pg/g; n = 62), which was again higher than that of the 16-24 year group (104.6 pg/g; 
n = 4); the difference between the three groups was significant, F(2, 97) = 3.28, p = 0.04, 
with a medium effect size (r = 0.3). The Bonferroni post hoc test revealed that the 
differences were significant only between the 25-34 year and 35-49 year age groups (p = 
0.05). Power may have been too low to detect differences between the youngest age group 
and other age groups due to the low number of women (n = 4) in that group.
Age and creatinine excretion
Creatinine excretion is known to be lower in older women than in younger women (Barr et 
al,  2005; Haddow et al,  2007), therefore the difference in creatinine excretion may explain 
the higher iodine/creatinine ratio with advancing maternal age. The effect of age on urinary
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creatinine concentration was examined in both ALSPAC and the Royal Surrey Study. 
Although in ALSPAC, creatinine excretion was lower in the oldest age group (35-49 years; 
n = 40; median 0.65 g/L) than in the youngest age group (16-24 years; n = 33; median 1.0 
g/L), the differences were not significant (2) = 3.51, p = 0.17]. There were, however, 
significant differences between creatinine concentrations in the three age groups in the 
Royal Surrey Study (2) = 6.29, p = 0.04], with lower values in the oldest group (35-49 
years; median 0.48 g/L) than in the youngest group (16-24 years; median 1.43 g/L).
Smoking status
There was a positive correlation (small effect size) between the number of cigarettes 
smoked per day in pregnancy and iodine/creatinine ratio in ALSPAC women of around 12- 
weeks’ gestation (rg = 0.15, p = 0.02; n = 245) but it only explained 2.3% of the variance in 
iodine concentration. When analysis was restricted to smokers in pregnancy, the association 
disappeared, but this may be due to low statistical power (rg = -0.004, p = 0.98, n = 26).
There was a significant difference in iodine/creatinine ratio in ALSPAC women between 
current smokers (median 158.6 pg/g), those who smoked pre-pregnancy (median 110.9 
pg/g) and non-smokers (median 106.5 pg/g) [F(2, 239) = 3.40, p = 0.04], but the effect size 
was small (r = 0.2). The post-hoc test (Bonferroni) confirmed that the iodine/creatinine 
ratio was significantly lower in non-smokers than in those who were smoking in pregnancy 
(p = 0.04), but did not differ between non-smokers and those who smoked pre-pregnancy.
A higher proportion of smokers were classified as having adequate iodine status (53.8%) 
than non-smokers (31.5%) and than those who smoked pre-pregnancy (40.0%). Of those 
women who smoked, a higher proportion was classified as having adequate than deficient 
iodine status (16.5% vs. 7.6%; Table 3.4), and of the non-smokers, a higher proportion was 
classed with deficient rather than sufficient iodine status (79.0 vs. 67.1%); the difference 
between groups approached statistical significance [%2 (2) = 5.41, p = 0.07].
Smokers in the Royal Surrey Study (n = 5) had a lower iodine/creatinine ratio than non- 
smokers (median 96.5 v& 126.0 pg/g) but the difference was not significant [t(98) = -0.58, 
p = 0.57] and the effect size was very small (r = 0.06). The low number of smokers (n = 5) 
may have resulted in insufficient power to detect differences between the two groups.
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Table 3.4 Relationship between smoking status and category of maternal iodine status in ALSPAC
Iodine to creatinine (pg/g)
Deficient (<150 pg/g) Sufficient (>150 pg/g) p value
Maternal smoking statusf
Non-smoker 124 (79.0%)
Smoked pre-pregnancy 21(13.4%) 
Smoker during pregnancy 12 (7.6%)
57 (67.1%) 
14(16.5%) 
14(16.5%)
0.07
fData are n (%) for confounders: fp value from from cross tabulation analysis
Parity
The number of previous pregnancies (none, one or two and more) was not associated with 
iodine status (iodine/creatinine ratio) in the ALSPAC cohort, [F(2, 238) = 0.81, p = 0.45], 
with a median iodine/creatinine ratio of 104.8 pg/g for no previous pregnancies, 124.3 pg/g 
for one previous pregnancy and 130.0 pg/g for two or more previous pregnancies.
The iodine/creatinine ratio in women in the Royal Surrey Study who had not given birth in 
the last three years (median 126.0 pg/g), women with birth less than 1 year ago (median 
68.4 pg/g), less than 2 years ago (median 128.7 pg/g) and less than 3 years ago (median 
108.1 pg/g) was not significantly different [F(3, 96) = 0.26, p = 0.86].
Maternal education
The iodine/creatinine ratio in ALSPAC was higher in women classified as having high 
educational qualifications (median 119.4 pg/g; n = 114) than those with medium (median 
107.3 pg/g; n = 84) or low levels of education (median 110.7 pg/g; n = 48). These 
differences were not statistically significant [F(2, 243) = 0.66, p = 0.52).
Exploration of the relationship between the categorical iodine variable (deficient or 
sufficient, as defined by a cut-off of 150 pg/g) and the category of maternal education 
showed that women in the higher educational qualification category were more likely to 
have an adequate than a deficient iodine status (48.8% 45.0%; Table 3.5) and those in
the low educational qualification category were more likely to have a deficient than 
sufficient status (20.6% 17.4%; Table 3.5). The differences were not statistically
different [linear-by-linear trend test (1) = 0.47, p = 0.49].
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Table 3.5 Relationship between maternal education and maternal iodine status
Iodine to creatinine (pg/g)
Deficient (<150 pg/g) Sufficient (>150 pg/g) p value
Maternal educationf
Low 33 (20.6%) 15(17.4%) 0.49
Medium 55 (34.4%) 29(33.7%)
High 72 (45.0%) 42 (48.8%)
fData are n (%); fp value from linear trend test in cross tabulation analysis.
Adjusted analyses
After controlling for the effect of all participant characteristics of women in ALSPAC, the 
only significant predictors of the iodine/creatinine ratio were maternal age (P = 0.02, p =
0.03) and current smoking vj". non-smoking (P = 0.39, p = O.OI). The model only explained
3% of the variance in the iodine/creatinine ratio (Table 3.6).
The adjusted linear regression analysis for the Royal Surrey Study revealed that maternal 
age was the only significant predictor of iodine/creatinine ratio (p = 0.04, p = 0.003) but the 
model was not significant at predicting scores and the variance explained was only slightly 
higher than in the ALSPAC model, but still low at 5.5% (Table 3.6).
In ALSPAC, the risk of deficient maternal iodine status (less than 150 pg/g), was
significantly associated with smoking status (p = 0.05) (the only maternal factor that was 
significant); women who smoked during pregnancy were less likely to be classified as 
iodine-deficient than were non-smokers (OR 0.37, 95% Cl 0.16-0.87; p = 0.02). The
variance predicted by the model was very low (Nagelkerke R^= 0.06) and the model was
not significant (7) = 11.21, p = 0.13].
By contrast, age was the only independent variable significantly associated with the
iodine/creatinine ratio (adequate or deficient) in the Royal Surrey Study, when controlling 
for the effect of smoking status and time since previous birth. The odds ratio for age 
suggested that for every 1 year increase in maternal age, the risk of inadequate iodine status 
was 17% lower (OR 0.83, 95% Cl 0.74-0.94). The model was significant (5) = 11.92, p 
= 0.04] and explained 15.6% of the variance (Nagelkerke R  ^= 0.156) in iodine status.
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Table 3.6 Predictors of maternal iodine/creatinine ratio in ALSPAC and Royal Surrey Study
Predictors of iodine/creatinine ratio
Unstandardised p 
(95% Cl)*
p value
ALSPAC"
Maternal age (years) 0.02 (0.002, 0.04) 0.03
Education (low vs. high) 1 -0.12 (-0.36, 0.12) 0.33
Education (medium vs. high) -0.06 (-0.25, 0.13) 0.55
Smoking (smoker pre-pregnancy V5. non-smoker) 0.08 (-0.17, 0.32) 0.53
Smoking (current smoker non-smoker) 0.39(0.11,0.66) 0.01
Parity (one vs. none) 0.03 (-0.16,0.23) 0.74
Parity (two plus vs. none) 0.08 (-0.18, 0.33) 0.56
Royal Surrey Study'’
Maternal age (years) 0.04 (0.02, 0.07) 0.003
Smoker (current smoker vs. non-smoker) 0.009 (-0.59,0.61) 0.98
Time since birth (1 year vs. no previous birth) -0.21 (-0.88, 0.44) 0.52
Time since birth (2 years vs. no previous birth) -0.18 (-0.50, 0.13) : 0.25
Time since birth (3 years vs. no previous birth) -0.05 (-0.44, 0.34) ; 0.79
*unstandardised coefficient from linear regression analysis ^Model summary: F(7,230) = 2.18, p = 0.03;
= 0.06, adjusted R^=0.03 “Model summary: F(5,94) = 2.16, p = 0.07; R^  = 0.10, adjusted R^  =0.06
3.4 Discussion
3.4.1 Iodine status of UK pregnant women in the South of the UK
The median iodine concentration in all three studies was considerably lower than that 
recommended for pregnant women by the WHO (WHO Secretariat et al, 2007); using the 
creatinine-adjusted iodine values, all three cohorts are classified as mildly-to-moderately 
iodine deficient (Zimmermann, 2007a). The results support the hypothesis that UK 
pregnant women have inadequate iodine status and suggest iodine deficiency in pregnancy 
may be prevalent in up to 55% of UK pregnant women (according to the EAR cut-point 
method).
There may be several explanations for the finding that the median iodine concentration of 
pregnant women in SPRINT is lower than that in the ALSPAC and Royal Surrey 
Pregnancy studies. Firstly, SPRINT women were recruited on the basis that they were not 
taking a pregnancy supplement containing selenium and this, by default, resulted in a low
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number of women taking an iodine-containing supplement (Methods, Section 2.3.2); by 
contrast, 42% of participants in the Royal Surrey Study were taking an iodine-containing 
supplement and their iodine status was significantly higher than those who were not taking 
such a supplement (see Chapter 6). Nevertheless, the UIC in SPRINT was still significantly 
lower than that in samples from women not taking an iodine-containing supplement in the 
Royal Surrey Study (45.2 vs. 60.3 pg/L; n = 58, p = 0.03), though the iodine/creatinine ratio 
was similar and not significantly different (102.9 vs. 101.5 pg/g; n = 58, p = 0.41). These 
differences suggest that the dilution of the urine samples was different between the studies, 
given that the lower values were only found when urine volume was not corrected by 
creatinine concentration. Investigation revealed that SPRINT women were requested to 
attend the John Radcliffe Hospital, Oxford, with a full bladder for their 12-week scan 
(when the urine samples were taken), an instruction that was not given at the Royal Surrey 
County Hospital. This supports the idea that SPRINT women produced more dilute urine 
samples; this was confirmed by visual inspection (by the author) of SPRINT urine samples, 
which revealed some very pale, dilute samples, that seemed little different from water.
3.4.2 Trends in iodine status over the past 20 years
The median iodine concentration, and iodine/creatinine ratio, in ALSPAC urine samples at 
12 weeks’ gestation were not significantly different from those in the Royal Surrey Study. 
However, records showed that no ALSPAC woman was taking an iodine-containing 
supplement, in contrast to those women in the Royal Surrey Study. When samples from 
non-iodine-containing supplement users in the Royal Surrey Study were compared with 
those of the ALSPAC women, the iodine/creatinine ratio was significantly lower, 
suggesting that UK iodine intake has fallen since the early 1990s, supporting the original 
hypothesis. This comparison may be confounded by the fact the Royal Surrey Study was 
conducted only in the summer months where lower values may be expected due to lower 
milk-iodine levels (Phillips, 1997).
As discussed in Methods (Section 2.3.2). the SPRINT samples represent pregnant women 
that are largely not taking an iodine-containing supplement, and therefore comparison of 
samples from SPRINT women with samples from ALSPAC is arguably the most correct 
way of comparing historical iodine status with current iodine status (especially as both
75
Chapter 3: Iodine status in UK pregnant women
studies sampled women in all seasons). Based on these comparisons, the results suggest a 
fall of iodine status over the 20 years between ALSPAC and the present day.
On the other hand, if the cohort of women in Royal Surrey Study is representative of 
present-day UK pregnant women, that is, that around 40% of women take a pregnancy 
supplement containing iodine, then iodine status is similar to that of 20 years ago. Thus the 
use of multivitamin and mineral supplements in pregnancy may be compensating for any 
underlying changes in iodine status in the UK. However, it should be noted that Surrey is 
one of the most affluent areas of the UK; based on indices of multiple deprivation (IMD) 
scores Surrey was ranked as the least deprived out of 27 areas in the UK (IMD scores are 
based on seven domains, including income, employment and education) (Office of National 
Statistics, 2010) and nutritional supplement use is likely to be considerably higher there 
than in other parts of the UK (see Chapter 6, Section 6.4.1).
The suggestion that iodine intake is currently lower than 20 years ago supports both the 
original hypothesis and results of the National Diet and Nutrition Survey (NDNS) that 
found that iodine intake (from food diary analysis) had fallen between the 1986/87 and the 
2000/01 adult surveys (Henderson et a l, 2003) and that iodine intake has continued to fall 
since the 2000/01 survey (Bates et a l, 2011) (Introduction, Section 1.8.1).
3.4.3 Comparison with other UK studies
The results presented in this chapter confirm the earlier studies in the UK that showed that 
pregnant women had an insufficient iodine intake (Barnett et a l, 2002; Kibirige et a l, 
2004; Pearce et a l, 2010). First-trimester iodine status of a group of pregnant women was 
studied in Cardiff (Pearce et a l, 2010) as part of a large randomised controlled trial [the 
Controlled Antenatal Thyroid Study (CATS)] to evaluate the impact of screening and 
treatment (with thyroxine) of hypothyroidism and hypothyroxinaemia in pregnancy on 
child cognitive outcomes (Lazarus et a l, 2004). The median UI in Cardiff women was 98 
pg/L in those with thyroid dysfunction (n = 374) and 117 pg/L (n = 383) in euthyroid 
women (Pearce et a l, 2010), figures that are higher than those observed in the Royal 
Surrey Study or SPRINT. The higher figures in the Cardiff women may reflect the fact 
women were recruited throughout the year and therefore include higher values from winter
76
Chapter 3: Iodine status in UK pregnant women
urine samples, as opposed to the summer samples collected in the Royal Surrey Study. 
Alternatively, the Cardiff study reported potential iodine contamination of urine samples 
from the euthyroid women through the use of urine test strips (Pearce et a l, 2009), and 
although women with values above 500 pg/L were excluded from analysis, it is possible 
that some contaminated urine samples remained in the analysis thereby raising the median 
iodine concentration in the euthyroid sample.
Comparison with results from the study in Scotland is limited by the fact that data are only 
published as an abstract and the iodine results are not clearly reported (Barnett et a l, 2002). 
The authors state that “approximately 40% of the pregnant women from this area of the UK 
have urinary iodine excretions below those corresponding to half the recommended intake” 
(Barnett et a l, 2002). Assuming that this means that 40% of women have a UIC below 150 
pg/L, the figure from Scotland is lower than the figures from ALSPAC women (76.9%), 
the Royal Surrey Study (76.0%) and SPRINT (92.1%); the statement could relate to 
iodine/creatinine ratio (as creatinine was measured in the Scottish study), but the figures are 
still lower than those below 150 pg/g for all three studies in this chapter (65.2%, 67% and 
67.7% respectively; Table 3.2). A figure of “137±104” is also reported for the iodine levels 
in the Scottish pregnant women but it is not clear if this is concentration in pg iodine/L or 
the iodine/creatinine ratio; whichever, it is a higher figure than that of the Royal Surrey 
Study or SPRINT. These comparisons suggests that iodine status may be higher in Scotland 
than in the South of the UK, a finding that is supported by historical reports of a lower 
incidence of goitre in Scotland (Kelly & Snedden, 1960) and the recent national survey of 
UK schoolgirls that found that the three centres with the lowest probability of iodine 
deficiency were all Scottish (Dundee, Aberdeen and Glasgow) (Vanderpump et a l, 2011). 
Additionally the author has found that Scottish organic milk has a higher iodine content 
than organic milk of other UK origin (Bath et a l, 2011) which, if extrapolated to all 
Scottish milk, may protect the population from deficiency (see Chapter 7).
The study in the North East of England reported figures as pg iodine/mmoI creatinine and 
the graphs only present the log-transformed values (Kibirige et at., 2004). This makes 
comparisons to the Kibirige et al. (2004) study challenging, and although attempts were 
made to convert the reported figures to the conventional pg/g (dividing by 0.11312), this
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failed to produce sensible figures, as the calculated median was 0.97 pg/g. Instead, 
comparisons can only be made on the assumption that Kibirige and colleagues correctly 
reported the percentages below cut-offs. They stated that 40% of pregnant women in the 
North East had iodine concentrations between 50 and 100 pg/L, which compares to 30.4% 
in ALSPAC, 24% in the Royal Surrey Study and 58% in SPRINT.
Taken together, the values presented from the three studies in this chapter and the three 
published studies on iodine status in pregnant women from different parts of the UK 
(Barnett et a l, 2002; Kibirige et a l, 2004; Pearce et a l, 2010), suggest that UK pregnant 
women are not meeting the higher iodine requirements of pregnancy and are consequently 
putting the normal brain and neurological development of their children at risk.
3.4.4 Comparison with other pregnancy studies around the World
The iodine status of the two studies that describe iodine status of UK pregnant women in 
the present day (Royal Surrey Study and SPRINT) are compared with post-2007 data from 
other countries where the median iodine concentration (pg/L) in a cohort of pregnant 
women has been reported (Table 3.7). The table shows countries in descending order of 
median iodine concentration with the UK studies shown in red font.
The iodine status of UK pregnant women is higher than that of women in a recent national 
survey in New Zealand (Pettigrew-Porter et al., 2011) but lower than that in Swiss 
(Andersson et a l, 2010) and American (Perrine et a l, 2010; Caldwell et a/., 2011) pregnant 
women; the latter two countries have established iodised-salt programmes. Pregnant 
women from some regions of Australia, such as New South Wales, had a higher median 
UIC than pregnant women in the two UK studies in this chapter (Table 3.7); Australia has 
recently (2009) introduced a programme of iodine fortification (Introduction, Section 1.5.2) 
and a recommendation that pregnant women take an iodine supplement because of concerns 
over the level of deficiency in the country (Australia New Zealand Food Standards Code, 
2009; NHMRC, 2010). Comparing iodine status in UK pregnant women to that of 
Australian pregnant women suggests that the UK is in a similar, or worse situation than 
Australia, and therefore the UK government should consider taking a similar approach.
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Table 3.7 Iodine status of pregnant women in countries worldwide, in descending order of iodine 
concentration (pg/L). Countries in red text are the studies in this chapter
Country Region Year Median UI n Statusf Reference
Japan Chibaprefecture
2005-
2007 219 683 S Fuse et al. (2011)
China Unknown 2007 183.8 658 S Yan et al. (2011)
Spain Gipuzkoa 2006-2008 168 586 S
Murcia et al. 
(2010)
Switzerland National 2005-2009 162 648 S
Andersson et al. 
(2010)
America National 2001-2006 153 326 s
Perrine et al. 
(2010)
India WestBengal
2007-
2008 142.8 200 MD
Chakraboity et a l 
(2010)
Bosnia and 
Hezegovina Tulza 2007 142 300 MD
Tahirovic et al. 
(2009)
Spain Valencia 2004-2005 134 655 MD
Murcia et a l  
(2010)
America National 2005-2008 125 184 MD
Caldwell et a l 
(2011)
Poland Unknown 2010 112.6 100 MD Gietka-Czernel et a l  (2010)
Thailand Bangkok 2007-2008 108 302 MD
Gowachirapant et 
üi/. (2009)
Spain Sabadell 2004-2006 94.0 282 MD
Murcia et al. 
(2010)
Australia New South Wales 2008 87.5 139 MD
Charlton et al. 
(2010)
UK Surrey 2009 85.3§ 100 MD This study
Italy Unknown 2006-2007 83 322 MD Mian et a l  (2009)
Turkey Malayta 2007 77.4 824 MD Egri et al. (2009)
Australia Tasmania 1999-2001 75 431 MD
Stillwell et al. 
(2008)
Vietnam Ha Nam 2010 70.0$ 413 MD Fisher et a l  (2011)
Portugal Minho 2003-2005 70 192 MD
Costeira et al.
V (2009)
Elahi et a l  (2009)Pakistan Lahore 2002-2005 67 254 MD
France Paris 2006-2007 49.8§ 110 SD Euton et a l  (2011)
Australia Darwin 2005-2008
.........................
49 24
1
SD Mackerras et al. (2011)
UK Oxford 2009-2011 45.2§ 229 SD  ^ This study
New Zealand National 2005 38 170 SD Pettigrew-Porter et a l  (2011)
tS=Sufficient, MD=mildly-to- 
Zimmermann, 2007a)
moderately deficient, SD=severely 
assessed in third trimester only; ^
deficient (WHO Secretariat el a l ,  2007; 
assessed in first trimester only.
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3.4.5 Information currently available to UK pregnant women
Pregnant women, and the health professionals advising them in the early 1990s would have 
been unaware that there was a requirement for additional iodine beyond the 140 pg/d 
recommended for adults, there being no separate recommendation for UK pregnant women 
(Department of Health, 1991). It is not surprising that women in the ALSPAC study, from a 
region that was part of the old goitre belt (Phillips, 1997), have been found to be deficient 
by current WHO criteria (WHO et a l, 2007). Conversely, although there are now clear 
recommendations for increased iodine intake during pregnancy in many other countries, 
that is not the case in the UK and sadly, many health professionals, and therefore pregnant 
women, remain ignorant of the need for additional iodine during this life stage.
It is surprising that current UK guidelines for iodine in pregnancy have not been revised 
upwards in line with those of other authorities (Food and Nutrition Board Institute of 
Medicine, 2001; WHO et ah, 2007). As dietary recommendations for pregnancy are based 
on nutrient requirements, the fact that the UK iodine requirements for pregnancy are 
outdated may explain the absence of advice on iodine intake in pregnancy on government 
websites (NHS Choices, 2009c), by the British Dietetic Association (Gordon, 2009), and on 
other websites that provide dietary advice to pregnant women (BUPA, 2010; BBC, 2011).
3.4.6 Iodine status in different trimesters
The data from ALSPAC show a higher iodine concentration (pg/L) in the third trimester 
than in trimesters 1 and 2; by contrast, creatinine concentration was not significantly 
different between trimesters 1 and 3, but was significantly lower in trimester 2. The results 
also suggest that iodine status (iodine/creatinine ratio) increases as pregnancy progresses, 
with a lower number of women classified as having suboptimal iodine status in trimester 3 
than earlier in pregnancy. There may be several explanations for these findings:
1. Variation between individuals
The urine samples used to evaluate the difference in iodine excretion by trimester are not 
from the same women therefore it cannot be concluded with any degree of certainty that the 
changes in iodine excretion are a result of gestational changes.
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2  Dilution o f urine samples
It is possible that the urine samples provided at different time points during pregnancy vary 
in dilution and this may explain the differences between the raw concentration figures for 
both iodine and creatinine concentration per litre. For example, samples provided in the 
second trimester may have been collected at the same time as an ante-natal scan 
appointment where women were required to have a full bladder (as in SPRINT), and 
consequently consumed more fluids prior to providing the urine sample.
3. Methodological bias
As there is a suggestion of a circadian rhythm in iodine excretion, with higher values in 
samples hours after a meal (AIs et a l, 2000), there is a possibility that the timing of sample 
collection in the third trimester was systematically different from the timing in earlier 
pregnancy (e.g. due to different clinic times). Additionally, the spread of samples 
throughout the year is unknown, and it is possible that a higher proportion of samples in the 
third trimester were from the winter months.
4. Diet changes throughout pregnancy
As pregnancy progresses a greater quantity of iodine-rich foods may be consumed, 
particularly if, for example, morning sickness or general anxiety at the beginning of 
pregnancy altered food choices and caused a lower intake of foods that are iodine sources. 
For example, fish (owing to concerns of mercury exposure) and eggs (because of food- 
poisoning risk from undercooked eggs) carry food safety warnings (NHS Choices, 2009b).
5. Changes in iodine excretion
There may be a genuine change in metabolism and excretion of iodine during pregnancy 
that reflects renal function. For example, it is suggested that as glomerular-filtration rate 
peaks in the first trimester of pregnancy, this may cause a higher urinary excretion of iodine 
in early pregnancy (Stilwell et a l, 2008). Also, there is a suggestion that iodine is 
transferred to the fetal-placental unit in later pregnancy (Brander et a l, 2003) but again, 
this would result in a lower excretion of iodine into the urine. It has been suggested that in 
an iodine-deficient population, thyroidal stores of iodine become depleted as pregnancy 
progresses (Brander et a l, 2003) and thus the expectation would be that urinary iodine
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excretion was lower in later pregnancy. However, the mechanisms previously suggested in 
the literature for an altered iodine excretion, would cause higher levels of urinary iodine in 
earlier pregnancy and are unlikely to explain the differences seen in ALSPAC.
Although there are studies that report changes in iodine concentration (as pg /L) throughout 
pregnancy (Stilwell et a l, 2008; Andersson et a l, 2010), there are few studies that report 
iodine/creatinine ratio changes (Smyth et a l, 1997; Brander et a l, 2003; Fuse et a l, 2011). 
This may reflect the fact that the iodine/creatinine ratio is not recommended by the WHO 
for monitoring iodine status (WHO et a l, 2007). Of the studies that have assessed 
iodine/creatinine ratio, the results are conflicting, with evidence from Switzerland (iodine- 
deficient region at the time of study) (Brander et a l, 2003) and Ireland (iodine-deficient) 
(Smyth et a l, 1997) of declining iodine/creatinine ratio from trimester 1 to 3, but evidence 
from Japan (iodine-replete) (Fuse et a/., 2011) and Spain (iodine-deficient) (Sanchez-Vega 
et a l , 2008) of a higher iodine/creatinine ratio in later pregnancy samples.
The studies that have evaluated changes in iodine concentration (micrograms per litre) also 
show conflicting changes throughout gestation, with no clear pattern of whether the 
changes reflect the underlying iodine status of the population. Some evidence suggests that 
iodine concentration decreases as pregnancy advances, in both iodine deficient regions 
(Smyth et a l, 1997; Smyth, 1999; Stilwell et a l, 2008), and iodine-sufficient regions 
(Smyth, 1999; Ainy et a l, 2007); while other evidence suggests that iodine concentration is 
higher in trimester 3 than in trimester 1, in both iodine-deficient regions (Smyth, 1999), and 
iodine-sufficient regions (Kung et a l, 2000; Alvarez-Pedrerol et a l, 2009). Other studies 
have found no significant difference in iodine concentration between trimesters (Caron et 
a l, 1997; Elnagar et a l, 1998; Fumarola et a l, 2009; Andersson et al., 2010).
As investigation of changing iodine excretion during gestation in ALSPAC was a post-hoc 
aim (owing to incorrect sample selection), drawing conclusions is challenging, as much of 
the information required to explain the findings is not available. In addition, iodine 
excretion in trimesters was measured in different women, and so the study is not 
appropriate to test the hypothesis that iodine excretion alters during pregnancy.
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3.4.7 Maternal characteristics that affect iodine status 
Age
Maternal age was a significant predictor of the iodine/creatinine ratio for both ALSPAC 
and Royal Surrey pregnant women. Back-transformation of the beta values (from linear 
regression), for both ALSPAC and the Royal Surrey Study, suggests that a one-year 
increase in maternal age predicts a 1.02 -  1.04 pg/g increase in iodine/creatinine ratio; this 
is a modest and potentially clinically insignificant increase in iodine status. When iodine 
status was dichotomised into deficient and adequate, an increase in maternal age was 
associated with a lower risk (17%) of the mother being classified with a deficient iodine 
status in the women of the Royal Surrey Study. Findings from both studies suggested that 
iodine status was lower in the younger maternal age groups, and thus the hypothesis that 
older women would have a higher iodine status was supported.
The finding of a positive association between iodine status and maternal age supports data 
from other studies both in the UK (Henderson et a l, 2003; Kibirige et a l, 2004), and 
worldwide (Fuse et a l, 2011). For example, iodine intake in UK women (estimated by food 
diary analysis) was significantly higher in older women than in the two youngest age 
groups in the adult National Diet and Nutrition Survey (NDNS) (Henderson et a l, 2003). 
Estimated iodine intake was 162 pg/day in women in the 35-49 year age group, compared 
to 130 pg and 145 pg/day in the 19-24 year and 25 to 34 year groups, respectively. A lower 
urinary iodine excretion was also found in pregnant women in younger age groups in the 
study in the North East UK (although this was not statistically significant) (Kibirige et a l, 
2004). By contrast, a study of pregnant women in Portugal did not find a significant 
correlation between UIC and maternal age (Costeira et a l, 2009), but as that study did not 
correct spot UIC for creatinine, it is perhaps not surprising that no differences were found.
A potential explanation for the higher iodine/creatinine ratio in older women is that 
creatinine excretion decreases with age (due to reduced muscle mass). Indeed, ALSPAC 
and the Royal Surrey Study showed a trend to a lower creatinine excretion in older women, 
but the differences were only significant in the Royal Surrey Study; low numbers of women 
in the younger age group in the Royal Surrey limits the interpretation of these findings.
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Another explanation for the higher iodine status in older women is that that diets of older 
women differ from those of younger women i.e. a cohort effect exists such that the foods 
women were brought up on and exposed to at younger ages differs and these patterns 
persist into adulthood. As such, older women may consume a higher volume of iodine-rich 
foods, particularly of fish and milk, which may explain differences in iodine status with 
age. In support of this idea, the NDNS survey showed that older women were more likely 
to consume white and oily fish than the younger age groups and women aged 35-49 years 
had a higher average milk consumption than women aged 19-24 years (Henderson et a l, 
2002).
Smoking status in pregnancy
The results from ALSPAC and the Royal Surrey Study for the influence of smoking on 
iodine status are conflicting and do not support the original hypothesis, that smoking status 
would be associated with a lower iodine status. The ALSPAC results suggest a higher 
iodine status in those who smoked during pregnancy; the association was significant even 
after controlling for the effects of other maternal characteristics; by contrast, the Royal 
Surrey Study showed a trend for a lower iodine status in smokers than in non-smokers, 
although the differences were not significant. The analysis of the Royal Surrey Study was 
limited by the number (5%) of smokers and results should be interpreted with caution.
Vila and colleagues (2011) found a positive correlation between number of cigarettes 
smoked and UIC in Spanish pregnant women, supporting the finding in ALSPAC women 
at 12 weeks’ gestation. In the light of the ALSPAC findings, the observation that heavy 
cigarette smoking was only associated with hypothyroxinaemia in those with high UIC 
(Vanderver et a l, 2007) may in fact have been due to reverse causality, i.e. heavy cigarette 
smoking had caused the high UIC. By contrast, other studies have not found an association 
between cigarette smoking (assessed by questionnaire and urine cotinine levels) and UIC, 
although this was in a non-pregnant population (Leung et a l, 2007). It has been suggested 
that the higher iodine excretion in smokers may be due to the increased wastage of iodine 
into the urine (Vila et a l, 2011). As cigarette smoke contains a goitrogen, thiocyanate 
(Zimmermann, 2009a), this may impair iodine uptake into the thyroid and thus increase
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urinary excretion, but given the paucity of studies, and conflicting evidence that exists, the 
relationship requires further investigation.
Parity
Results presented in this chapter showed no association between the number of previous 
pregnancies and maternal iodine status; a finding that is supported by other research 
(Costeira et a l, 2009; Egri et a l, 2009; Andersson et a l, 2010). Egri et a l (2009) also 
found no significant difference in iodine status and pregnancy intervals, a similar finding to 
that of the Royal Surrey Study.
A lack of power to detect significance may provide an explanation, as to why significant 
differences were not found between numbers of previous pregnancies and pregnancy 
intervals; there was some evidence of higher status in women that had had two or three 
years since the previous pregnancy than in those with less than one year, but the numbers 
(four in the group less than one year) are too small to draw firm conclusions. Although 
parity may influence later thyroid function and volume in women (Rotondi et a l, 2000), the 
knock-on effect on urinary iodine excretion (through depletion of thyroidal stores of iodine) 
may be small and require large sample sizes to have sufficient power to detect statistical 
differences. In addition, iodine intake (and thus iodine excretion), per se, is unlikely to be 
affected by parity or pregnancy interval and this may explain the lack of difference found in 
women in ALSPAC or the Royal Surrey Study.
Maternal education
The original hypothesis, that iodine status would be higher in women with high educational 
qualifications was partially supported by ALSPAC. There was a trend (non-significant) to 
lower iodine status (iodine/creatinine ratio) in women with low educational qualifications 
than in women with higher qualifications but maternal education was not a significant 
predictor of iodine status in the adjusted analysis. There may have been insufficient 
statistical power when analysing ALSPAC of women at 12 weeks’ gestation.
It is possible that iodine status is socially confounded, with women who are more educated 
and of higher socio-economic class having a more nutrient-dense (iodine-rich) diet. For
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example, it is widely known that fish intake is dependent on socio-economic status, being 
higher in those of higher status (Henderson et a l, 2002; Hibbeln et a l, 2007), and thus 
would affect iodine intake. Other studies have shown iodine to be associated with social 
class; for example low urinary iodine in the first trimester was found to be associated with a 
lower socio-economic class in pregnant women in Portugal (Costeira et a l , 2009).
3.4.8 Limitations of the studies
There are several limitations to the studies included in this chapter. Firstly, the Royal 
Surrey Study differs from ALSPAC and SPRINT in that women were only recruited in the 
summer months and during morning clinics. By contrast, urine samples in ALSPAC and 
SPRINT were available throughout the year and the timing of the urine sample was 
random. Due to the known variation in urinary iodine excretion between seasons 
(Broadhead et a l, 1965b; Nelson et a l, 1988), and the possible influence of time of urine 
collection on UlC (Als et a l, 2000), comparisons between the studies with different 
methodologies should interpreted cautiously (Soldin, 2002).
Despite the fact that women with very high UlCs were excluded from the ALSPAC data 
analysis, on the basis that their urine samples were contaminated, it is possible that some 
contaminated samples remained in the ALSPAC analysis; that would have resulted in a 
higher median iodine concentration than the true value. Hence women in the ALSPAC 
may, in fact, be more iodine-deficient than reported and the fall in iodine intake between 
the 1990s and the present day may consequently be greater.
As discussed throughout, there are small numbers of women in some groups, particularly in 
the Royal Surrey Study -  for example the youngest age group and smokers. This is likely to 
mean reduced power for detecting differences and a degree of caution is needed with the 
interpretation of these results.
3.4.9 Further work
Given the conflicting findings of studies that have investigated the influence of trimester of 
pregnancy on iodine status, and the findings in the ALSPAC women, further work is 
required in this area. Any future study should utilise the same women to measure iodine 
status at different time-points of pregnancy. However, as pregnancy, with a duration that
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covers 75% of the year, will span seasons, the recruitment of a sufficient number of women
for such a study should be staggered throughout the year. If this staggering does not occur, 
gestational ages may reflect seasonal changes in milk supply, rather than actual changes of
iodine metabolism in later pregnancy.
Additional power is required to investigate the differences in iodine status by factors such 
as smoking, maternal education and parity. The fact that ALSPAC has shown higher iodine 
status in smokers than non-smokers requires further investigation. The assumption that 
approximately 90% of iodine intake is excreted in the urine may not be true for smokers, as 
the goitrogenic properties of cigarette smoke may mean that iodine excretion is increased.
In addition, a nationwide survey of iodine status in pregnancy is required [i.e. similar to the
study of iodine status in UK schoolgirls (Vanderpump et a l, 2011)], as at present the only 
data are from small-scale localised studies, including the three listed in this chapter. Current 
iodine status should be investigated in cohorts with higher levels of deprivation and lower 
socio-economic status, such as suburbs of large UK cities. The Royal Surrey Study and 
SPRINT were conducted in counties in the South East of the UK and the South East has a 
higher weekly income than the UK national average (T611 v& €546) (Office of National 
Statistics, 2011); within the South East, Surrey and Oxfordshire were ranked and 6* 
respectively as least deprived areas (out of a total of 27) in the UK (Office of National 
Statistics, 2010). It is likely that women recruited to the Royal Surrey Study and SPRINT 
represent a socially-biased group and the results are therefore a best-case scenario.
3.5 Conclusion
The studies presented in this chapter provide the iodine assessment of a total 1280 pregnant 
women living in the South of the UK. It appears that iodine intake, from food sources 
alone, has fallen between the early 1990s (in ALSPAC) and the present day. The fact that 
pregnant women the South of the UK are mild-to-moderately iodine deficient gives cause 
for concern and challenges the beliefs held by many that iodine levels in the UK are 
sufficient.
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4. EFFECT OF IODINE STATUS IN PREGNANCY: 
MATERNAL THYROID FUNCTION
4.1 Introduction
Iodine deficiency is often cited as the most common cause of hypothyroxinaemia in 
pregnancy (Delange, 2000; de Escobar gr a/., 2004) though this evidence is based on
relatively few studies of which few are under conditions of mild iodine deficiency. There 
are no UK data on the effect of iodine status on maternal thyroid function in early 
pregnancy, a time when an adequate thyroid supply is vital for the developing fetal brain.
4.1.1 Aims and hypotheses
The study aimed to relate maternal thyroid function to iodine status, to evaluate if iodine 
deficiency in early pregnancy has an impact on maternal thyroid hormone levels.
Specific aims
• To investigate if low iodine status (iodine/creatinine ratio) is linked with a reduction in 
fT4 levels and raised TSH levels
• To classify women as having either overt hypothyroidism or hypothyroxinaemia and
assess the relationship with iodine status
• To describe the prevalence of hypothyroxinaemia and subclinical hypothyroidism in 
UK pregnant women.
Hypotheses
• Women classified as iodine-deficient will have lower fT4 and higher TSH levels than 
women classified as iodine-sufficient.
• A diagnosis of hypothyroxinaemia will be more likely in women who are iodine- 
deficient than in women of adequate iodine status.
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4.2 M ethods
4.2.1 Study design
The relationship between iodine status and thyroid function was evaluated in pregnant 
women recruited to SPRINT at around 12 weeks’ gestation. As outlined in Chapter 3, the 
SPRINT cohort was classified as mildly-to-moderately iodine deficient when using the 
creatinine-adjusted median (102.9 pg/g) (WHO Secretariat et a l, 2007), thus allowing 
thyroid function to be determined in an iodine-deficient group. The iodine/creatinine ratio 
in the 12-week spot-urine sample was used for iodine-status assessment, and fT4, TSH and 
TPO antibodies were measured in the corresponding 12-week serum samples (Chapter 2, 
Section 2.3.2).
A small number of women reported the use of an iodine-containing supplement during 
pregnancy (n = 7). Five of these women commenced supplement use prior to 12 weeks’ 
gestation but one discontinued use before 13 weeks’ gestation; in addition two women 
started supplement use at 12 weeks’ gestation. The difference in thyroid function was
examined between women who used an iodine-containing supplement either prior to 12 
weeks’ gestation (n = 5) or around the time of urine sample collection (n = 6).
4.2.2 Reference ranges for thyroid function in pregnancy
TPO antibodies were considered to be moderately elevated if above 35 kU/L (Pop et a l, 
2003), and clearly elevated if greater than 100 kU/L (lU/ml) (Pop gf aZ., 1999; Pop gr aZ., 
2003; Negro g^  aZ., 2007).
The reference ranges used to define ''normal” thyroid function were adapted from those 
established by Mannisto et al (2011) in Finland. Reference range values (2.5* and 95* 
percentiles for TSH and 2.5* and 97.5* percentiles for fT4) were averaged fiom weeks 11, 
12 and 13 (Mannisto g/ aZ., 2011) to reflect the true range of gestational ages of women at 
their "12-week” scan in SPRINT. Thus, the reference range for TSH was 0.08-2.9 mU/L 
and for fT4, it was 13-21 pmol/L; these ranges were used for defining hyperthyroidism, 
hypothyroidism and subclinical hypothyroidism.
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Isolated hypothyroxinaemia has been defined as a fT4 level below the 5* or 10* percentile 
of normal values, with a normal TSH (Stagnaro-Green et a l, 2011); Mannisto et a l (2011) 
did not report a value for the 10* percentile therefore the author estimated the cut-off to be 
<13 pmol/L (average of the 5* and 25* percentiles rounded to a whole number to reflect 
the fact that SPRINT fT4 measurements were rounded to whole numbers). A fT4 level in 
the bottom half of normal values has been suggested to be deleterious (de Escobar et a l, 
2004; The Association for Clinical Biochemistry et a l, 2006) and so an additional low fT4 
category [values below the 50* percentile in Mannisto et a l (2011)] was also included.
Thyroid dysfunction was defined (based on the cut-offs above) as follows:
• Overt hypothyroidism: TSH > 2.9mU/L and fT4 <12 pmol/L
• Subclinical hypothyroidism: TSH >2.9 mU/L and normal fT4 (> 12 pmol/L)
• Overt hyperthyroidism: TSH<0.08 mU/L and fT4 >21 pmol/L
• Hypothyroxinaemia: fT4 <13 pmoI/L and normal TSH (>0.08 and <2.9 mU/L)
• Low jT 4 levels: fT4 <15 pmol/L and normal TSH
4.2.3 Statistical analysis
Women with elevated TPGAb (>100 kU/L) were excluded firom the examination of the 
relationship between iodine status and thyroid function, due to the reported effect of 
autoimmune thyroid disease on TSH and fT4 levels (Pearce et a l, 2008). Women with 
overt hyperthyroidism or overt hypothyroidism were also excluded from these analyses.
The iodine/creatinine ratio was not normally distributed and log-transformation allowed the 
conduction of parametric tests (Chapter 3). The iodine/creatinine ratio was also 
dichotomised into the categorical variables iodine-deficient or iodine-sufficient (<I50 or 
>150 pg/g respectively) and into three groups [severely deficient (<50 pg/g), mildly-to- 
moderately deficient (50-150 pg/g) and sufficient (>I50 pg/g)].
TSH and fT4 concentrations were also not normally distributed, even after log 
transformation, therefore median and interquartile ranges are reported and non-parametric 
tests were used. The Mann Whitney U or Kruskal Wallis tests were used to compare TSH
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and fT4 levels with the categorical iodine status and Spearman Rank correlation was used 
to examine relationships with the continuous iodine variable.
Categorical data were compared (e.g. women classified with subclinical hypothyroidism 
and the categorical iodine variable) using the chi-square test (Fisher’s Exact test reported if 
the expected frequency assumption was violated).
4.3 Results
4.3.1 Prevalence of thyroid dysfunction
One woman failed to produce a blood sample and another failed to provide a urine sample, 
leaving a total of 228 in the analysis. Fourteen women (6.1%) were classified as positive 
for TPO antibodies (>100kU/L) and one woman was classified with overt hyperthyroidism 
(0.5%) (Table 4.1), leaving 213 women in the final analysis. Subclinical hypothyroidism 
was present in 14 (6.6%) of the remaining 213 women; 32 women (15.0%) had 
hypothyroxinaemia and 122 women (57.3%) had a low fI4  level (<50* percentile).
4.3.2 Relationship between TPOAb-status and iodine or thyroid status
There was no significant difference in iodine/creatinine ratio between those classified with 
normal TPOAb status (median 103.3 pg/g), moderately elevated TPOAb (median 123.8 
pg/g) and clearly elevated TPOAb (median 91.9 pg/g), [F(2, 225) = 0.24, p = 0.79, r = 
0.05]. Iodine status was lower in TPOAb-positive (>100 kU/L) women than in TPOAb- 
negative women (median 91.9 pg/g 103.9 pg/g) but the difference was not statistically 
significant and the effect size was small [r(226) = 0.70, p = 0.49, r = 0.05].
TSH levels were significantly higher (medium effect size) in women classified as TPOAb- 
positive than in those classified as TPOAb-negative (median 3.25 v& 1.40 mU/L; U = 
553.0, z = -3.96, p <0.0001, r = 0.26). While fI4  levels were lower in TPOAb-positive 
women than in TPOAb-negative women, the difference was not statistically significant 
(median 14 v& 15 pmol/L; U = 1217.0, z = -1.20, p = 0.23, r = 0.08).
There was a significant association between TPOAb status (positive or negative based on 
100 kU/L cut-off) and subclinical hypothyroidism, with a higher prevalence in women 
classified as TPOAb-positive than as TPOAb-negative (57.1% V6". 6.5%, Fisher’s Exact
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test, p <0.0001). There was no association between TPOAb-positive status and prevalence
of hypothyroxinaemia (7.1% vj. 15.0%, Fisher’s Exact test, p = 0.70).
Table 4.1 Thyroid characteristics of the SPRINT pregnant women
Thyroid characteristic n (%)
TPOAb status
Negative 202 (88.6)
Moderately elevated (>35kU/L) ! 12(5.3)
Clearly elevated (>100 kU/L) i 14(6.1)
Overt hypothyroidism 0 (0)
Overt hyperthyroidism 1 (0.4)
Subclinical hypothyroidism 14(6.6)]:
Hypothyroxinaemia (fT4 < estimated 10* percentile)]" 32(15.0)t
Low fT4 (fT4 < 50* percentile of reference range) i 122(57.3)]:
testimated 10 percentile from values by Mannisto et al. (2011) < 13pmol/L 
]:% of remaining 213 women (hyperthyroid and with women clearly elevated TPOAb excluded)
4.3.3 Influence of iodine status on thyroid function 
Iodine status and TSH  and fT4 levels
There was a weak negative correlation between iodine/creatinine ratio and TSH levels at 12 
weeks’ gestation, but this was not statistically significant (rg = -0.07, p = 0.29). TSH levels 
were higher in women classified as iodine-deficient (n = 143) than in those classified as 
iodine-sufficient (n = 70) (median 1.5 1.2 mU/L) but the difference was not statistically
significant (U = 4450, z = -1.32, p = 0.19, r = 0.09). There was no significant difference in 
TSH levels between women classified as severely iodine deficient (n = 27), mildly-to- 
moderately iodine deficient (n = 116) or sufficient (n = 70) (2) = 2.42, p = 0.30].
There was no significant correlation between iodine/creatinine ratio and fT4 levels at 12 
weeks’ gestation (rg = 0.02, p = 0.98). fT4 levels did not differ between those women 
classified as iodine-deficient or sufficient (median 15.0 15.0; U = 4926.5, z = -0.19, p =
0.85, r = 0.01) or between women classified as severely, mildly-to-moderately deficient and 
sufficient (2) = 0.62, p = 0.74].
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Iodine status and risk of thyroid dysfunction
There was no significant difference in the iodine/creatinine ratio between those classified 
with and without subclinical hypothyroidism [Z(211) = -0.26, p = 0.80]. Iodine status did 
not differ significantly between those with and without hypothyroxinaemia [/(211) = 0.29, 
p = 0.77] or a low fT4 level [/(2I I) = -0.29, p = 0.77].
There was no association between categorical iodine status (deficient or sufficient) and 
diagnosis of subclinical hypothyroidism (Fisher’s Exact test, p = 1.00). Categorical iodine 
status was also not associated with hypothyroxinaemia (I), = 0.37, p = 0.55], or with a 
low fI4  level [% (^1), = 1.33, p = 0.25].
There was no significant relationship between subclinical hypothyroidism and iodine status 
when the iodine/creatinine ratio was divided into three groups (severely deficient, mildly- 
to-moderately deficient and sufficient), (Fisher’s Exact test, p = 0.79). Iodine status (in 
three groups) was not significantly related to the incidence of hypothyroxinaemia (2), = 
0.39, p = 0.83] or a low fI4  level [y  ^(2), = 3.33, p = 0.19].
4.3.4 Use of an iodine-containing supplement and thyroid function
Women who commenced an iodine-containing supplement prior to 12 weeks’ gestation had 
higher fT4 levels and lower TSH levels than those who did not consume such as 
supplement (Table 4.2), although the differences were not significant and the effect sizes 
were small (U = 324, z = -1.46, p = 0.14, r = 0.1 and U = 409, z = -0.82, p = 0.42, r = 0.06 
respectively). None (0%) of the women taking a supplement prior to pregnancy was 
diagnosed with hypothyroxinaemia at 12 weeks, compared to 15.4% of those who did not 
use a supplement, although the difference in classification was not significant (Fishers 
Exact test = 1.00). The percentage of women classified with low fT4 levels was higher in 
women that did not use, than in those that did use, iodine-containing supplements (Table 
4.2) and the association approached significance (Fishers Exact Test p = 0.17).
Women who were taking an iodine-containing supplement at the time of urine collection 
did not have different TSH levels than those who did not take a supplement (Table 4.2 U = 
602.5, z = -0.12, p = 0.90, r = 0.01). The fT4 levels were higher, though not statistically 
significantly, in women taking an iodine-containing supplement than in those who did not
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(U = 423.5, z = -1.35, p = 0.18, r = 0.09; Table 4.2). A higher proportion of women who 
did not take an iodine-containing supplement were classified as having both 
hypothyroxinaemia and low fT4 levels than women taking such a supplement (Table 4.2), 
though this difference was not statistically significant (Fishers Exact test and p = 0.59 and p 
= 0.41 respectively).
Table 4.2 Relationship between use o f  an iodine-containing supplement and thyroid function at 12
w eeks’ gestation
TSH
(mU/L)t
fT4 Hypothyroxinaemiaf 
(pmol/L) t n (%)
Low serum fT4]: 
n(% )
Use of iodine supplement prior to 12 weeks’ gestation
0.61 16
Yes 5 (0.20-3.2) (15-17) I 0(0) 1(20)
1.40 15
No 208 (1.00-2.00) (14-16) : 32(15.4) 121 (58.2)
Use of iodine-containing supplement at the time of urine collection (12 weeks’ gestation)
1.50 16
Yes 6 (0.22-2.92) (14.8-17.0) , 0(0) 2(33.3)
1.40 15
No 207 (1.00-2.00) (14-16). 32(15.5) 120 (58.0)
t  Values are median (IQR) $Hypothyroxinaemia defined as fT4 below 10*’ percentile (<13pmol/L); low fT4 
levels below 50* percentile (<15pmol/L) based on reference range in TPOAb-negative women (Mannisto et 
a/., 2011) values are n (% of women within supplement use with classification of hypothyroxinaemia or low
fI4  levels).
4.3.5 Statistical power
Though the author is aware that statistical power should be calculated prior to a study 
commencing, the investigation of thyroid and iodine status was a secondary aim of 
SPRINT that was not part of the original study protocol (Methods, Section 2.3.2) and as 
SPRINT was powered for an outcome relating to pre-eclampsia risk, it would not have been 
possible to ensure the study was powered for thyroid function analyses.
In view of the lack of association between incidence of hypothyroxinemia and iodine 
status, statistical power was computed [with 5% significance and with the observed number 
of iodine deficient and sufficient women (n = 70 and n = 143 respectively)]. Based on an 
assumption that 8.5% of women have hypothyroxinaemia in an iodine sufficient population 
(Henrichs g/ a/., 2010), the study only had 14.5% power to detect a 1.5-fbld increased
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prevalence of hypothyroxinemia in the iodine deficient group or 37.3% power to detect a 
two-fold increased prevalence. In fact, the study was only powered to detect a 3-fold 
increased prevalence of hypothyroxinaemia in iodine deficient women.
4.4 Discussion
4.4.1 Iodine deficiency and thyroid dysfunction 
Iodine and TPOAb status
The finding of no significant difference in iodine status (iodine/creatinine ratio) between 
women who were TPOAb-positive or TPOAb-negative in SPRINT accords with results in 
pregnant Japanese women in whom iodine status was also assessed by iodine/creatinine 
ratio (Fuse ürZ., 2011).
Iodine status and TSH and fT4 levels
Although the women in SPRINT who were classified as iodine-deficient had a higher 
serum TSH, it was not significantly different and there was no difference in fT4 levels. This 
fact, and the lack of an association between iodine status and risk of subclinical 
hypothyroidism or hypothyroxinaemia suggest that iodine status was not influencing 
thyroid function at 12 weeks’ gestation and thus the original hypothesis was not supported.
Our results have been replicated in other studies that have also failed to find significant 
associations between iodine status and thyroid function in regions that are both iodine- 
sufficient (Fister et a l, 2010; Marco et a l, 2010; Fuse et a l, 2011) and iodine-deficient 
(Sanchez-Vega gf ar/., 2008; Luton gr ar/., 2011; Raverot gr a/., 2012). By contrast, just as 
many studies did find a significant relationship between iodine status in pregnancy and 
thyroid function (Vermiglio g/ a/., 1995; Vermiglio ef aZ., 1999; Glinoer, 2001; Orito g/ aZ., 
2009; Pearce g/ aZ., 2010). In Brussels, significantly higher fF4 and lower TSH values were 
found between the top and bottom tertile of iodine concentration in urine samples from 
(iodine-deficient) pregnant women (Glinoer, 2001). Vermiglio and colleagues have also 
found lower fT4 levels and higher TSH levels in pregnant women from an iodine-deficient 
region of Italy than in women from a control region with adequate iodine status (Vermiglio 
g/ aZ., 1995; Vermiglio gZ aZ., 1999). UICs (albeit indicative of excessive iodine status) were
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correlated with TSH levels in Japan (Orito et al., 2009) and UIC was positively associated 
with fT4 in iodine-deficient women in Cardiff and Italy (Pearce et a l, 2010).
The disparity in the findings of studies that have evaluated maternal iodine status and 
maternal thyroid function may be due to differences in thyroid measurements and clinical 
cut-offs used to diagnose thyroid dysfunction. It may also be related to the limitations of a 
spot-urine sample (particularly if not corrected for creatinine concentration) to estimate 
individual iodine status, and thus risk of thyroid dysfunction (see Methods, Section 2.4.2 
for the limitation of data from spot-urine samples).
The inaccuracies and limitations of a single spot-urine sample may mean that although 
women were classified as iodine-deficient in pregnancy, their pre-pregnancy iodine status 
was adequate. This may have provided greater iodine reserves in the thyroid -  a form of 
“iodine prophylaxis” -  and protected them from thyroid failure during pregnancy (Moleti et 
a l, 2008), thus reducing associations between iodine status measured in pregnancy and 
TSH and fT4 levels (Raverot et a l, 2012). Unfortunately these suggestions cannot be 
confirmed as SPRINT did not collect data on pre-pregnancy iodine status. Another 
explanation is that the placenta may act as an iodine-store than can be drawn upon to 
maintain normal thyroid function (Burns et a l, 201 lb) and that iodine may be concentrated 
in the placenta in regions with iodine deficiency (Bums et a l, 201 la).
The timing of the measurements of iodine status and thyroid function may explain the lack 
of association in SPRINT; fT4 levels have been shown to be similar in early pregnancy 
between iodine-sufficient and iodine-deficient women but to be lower in later pregnancy 
(Vermiglio et a l, 1999). Thus, the measurement of iodine status and thyroid function at the 
same time-point (i.e. 12 weeks’ gestation in SPRINT) may limit the potential to detect 
differences in thyroid function in relation to iodine status. It is possible that there is a “lag­
time” between an inadequate iodine intake and evidence of thyroid hormone insufficiency 
that is not reflected in a measurement at 12-weeks’ gestation. Thyroidal stores of iodine are 
likely to be depleted with advancing gestation in iodine-deficient women (Glinoer, 2004; 
Zimmermann, 2009a), therefore an association may be evident if thyroid function is 
measured later in pregnancy in SPRINT women and this later measure of thyroid function
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is related to iodine status at 12-weeks’ gestation; iodine-deficient women at 12 weeks’ 
gestation may be more likely to have impaired thyroid function in later pregnancy.
4.4.2 Iodine supplements and thyroid dysfunction
The findings from SPRINT suggest that maternal thyroid function was improved in those 
taking an iodine supplement, particularly in those women starting this supplement prior to 
12 weeks’ gestation, and the incidence of hypothyroxinaemia or low fT4 levels were lower 
in those women, although all results were non-significant. The results need to be interpreted 
with caution given the low numbers of women (only five or six) that consumed iodine- 
containing supplements but the low numbers may explain the lack of significance (due to 
insufficient statistical power).
There are no studies that evaluate the impact of iodine supplementation prior to pregnancy 
and maternal thyroid function during pregnancy. However, if iodised salt use prior to 
pregnancy may be considered to be a form of supplementation; Moleti and colleagues 
(2011a) found a lower risk of thyroid failure during pregnancy in women who had used 
iodised salt for at least two years prior to pregnancy than in women who began to use 
iodine supplements during pregnancy (Moleti et a l, 201 la) or who commenced iodised salt 
use during pregnancy (Moleti et a l, 2008). Those results provide support for the validity of 
the finding in SPRINT women that use of iodine-containing supplements prior to 12 weeks’ 
improved thyroid-hormone profile.
As outlined in Introduction (Section 1.4.2), the evidence for a benefit of iodine 
supplementation during pregnancy on maternal thyroid function is mixed, with some 
studies showing a benefit on maternal TSH, but not fT4, levels (Pedersen et a l, 1993; 
Glinoer et a l, 1995), while others have shown no effect on either TSH or fT4 levels 
(Liesenkotter et a l, 1996; Nohr et a l, 2000; Antonangeli et a l, 2002). By contrast, iodine- 
containing supplements at doses of 200 pg of iodine per day (from 17 weeks’ gestation) 
appear to have a negative impact on maternal thyroid hormone function (Rebagliato et a l ,
2010) as compared with iodine-containing supplements with levels of less than 100 pg per 
day; the study by Rebagliato et al (2010) differs from others in that it was an observational 
study, rather than an intervention with iodine, and iodine was given in a multivitamin and
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mineral supplement so that the effects may not be attributable to iodine alone (Rebagliato et 
a/., 2010).
4.4.3 Defining thyroid dysfunction
As there are no definitive reference ranges for TSH and fT4 in pregnancy that are method- 
and trimester-specific (de Escobar et a l, 2004; Fitzpatrick & Russell, 2010; Stagnaro- 
Green et a l, 2011), defining hypothyroxinaemia and subclinical hypothyroidism in 
SPRINT women was challenging. Gestation-specific reference ranges are required as there 
is evidence that thyroid function (TSH and fT4 levels) is altered during the course of 
pregnancy (Haddow et a l, 2004; Soldin et a l, 2004; Lambert-Messerlian et a l, 2008; 
Bocos Terraz et a l, 2009). In addition, it is widely reported that the measurement of fT4 
levels in pregnancy is complex (Fitzpatrick & Russell, 2010; Moleti et a l, 201 la; Negro et 
al, 2011; Stagnaro-Green et a l, 2011) and this is likely to make the establishment of 
globally acceptable reference ranges difficult to obtain. Method-specific reference ranges 
are required as the use of immunoassays (as in SPRINT) have been shown to measure fT4 
inaccurately (Lee et a l, 2009) as they are complicated by changes in binding-protein 
concentrations during pregnancy and thus fT4 estimates can vary depending on the 
immunoassay used (Moleti et a l, 201 lb).
The definition for isolated hypothyroxinaemia differs according to different scientists; the 
American Thyroid Association definition is vague and unquantified, simply suggesting that 
isolated hypothyroxinaemia is a fT4 level in the bottom 5* or 10* percentile of the 
reference range (which is not defined) with a normal TSH level (Stagnaro-Green et a l, 
2011). The British Thyroid Association does not define isolated maternal 
hypothyroxinaemia, but suggests that maternal fT4 levels should be kept in the upper half 
of the normal range, although, again, no reference range is suggested for pregnant women 
(The Association for Clinical Biochemistry et a l, 2006).
Moleti et a l (2011b) have recently reviewed the differences in definitions of 
hypothyroxinaemia used by researchers across the world and concluded that if the varying 
criteria for diagnosis were used in practice, women would range from being diagnosed as 
euthyroid to overtly hypothyroid (Moleti et a l, 2011b). For example, hypothyroxinaemia 
was defined as fT4 below the 10* percentile in studies in the Netherlands (Pop et a l, 1999;
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Pop et a l, 2003; Kooistra et a l, 2006; Henrichs et a l, 2010) and Spain (Berbel et a l, 
2009); however, in those studies, normal TSH was taken to be below 2.0 mU/L in the 
studies by Pop et a l (1999;2003) and Kooistra et a l (2006), below 2.5 mU/L in the study 
by Henrichs et a l (2010) and below 4.8 mU/L in the study by Berbel et al (2009). By 
contrast, a fT4 concentration below the 2.5* percentile was the cut-off for diagnosis in 
studies in the USA (Casey et a l, 2007; Cleary-Goldman et a l, 2008), the UK (Vaidya et 
a l, 2007), Italy (Moleti et a l, 2008; Moleti et a l, 2009), and China (Shan et a l, 2009) but 
the upper limit for TSH ranged between 2.3 and 4.8 mU/L (Moleti et a l, 2011b). Another 
complication when comparing these studies is that the percentiles are often based on the 
study cohort being investigated, rather than on a “normal” reference range for an iodine- 
sufficient and TPOAb-negative cohort; the concentration used to define a low fT4 level 
ranges from 9.3 pmol/L (Cleary-Goldman et a l, 2008) to 12.4 pmol/L (Pop et a l, 2003), 
while some other studies do not report the actual fT4 concentration that represents the 
bottom percentile cut-off (Kooistra et a l, 2006) (summarised by Moleti et a l, 2011b). The 
variability in the definitions for thyroid dysfunction in pregnancy, along with a lack of 
definitive reference ranges for TSH and fT4 are likely reasons for the variation in 
management of thyroid disease in pregnancy across Europe (Vaidya et a l, 2012).
4.4.4 Selection of reference ranges
Previous attempts to calculate thyroid reference ranges in the UK have failed to account for 
the underlying iodine status of the individuals (Vaidya et a l, 2007), or their TPO antibody 
status (Cotzias et a l, 2008) and therefore those reference ranges were not used in SPRINT. 
Although pregnancy-specific reference ranges have been reported in Australia (Gilbert et 
a l , 2008), they were not used for the SPRINT analysis as Australian iodine intake is known 
to have declined (Eastman, 1999; Gunton et a l, 1999; Charlton et a l, 2010), so it cannot be 
assumed that the pregnant women used in the study by Gilbert et a l were iodine-sufficient, 
despite the fact that school-children in the same region have been shown to be iodine- 
sufficient (Li et a l, 2006a).
Trimester-specific reference ranges have been published that are based on iodine-sufficient 
women in Switzerland (Strieker et a l, 2007) but the data from Mannisto et al (2011) were 
used in preference as values are provided week-by-week during gestation and give a closer
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estimate to the 11-13 week time-frame of SPRINT, in contrast to the generic “first 
trimester” values provided by Strieker et al (2007). The data from Mannisto et al. (2011) 
were from women in Finland and thus from an iodine sufficient region (Lamberg, 1986; 
Vitti et a l, 2001; Vitti et a l, 2003; Zimmermann & Andersson, 2011). The women from 
whom reference ranges were established were recruited in the late 1980s and WHO data 
suggest that the country was iodine sufficient at that time (WHO et a l, 1993). In addition, 
although there are no urinary iodine data on pregnant women in Finland, there are data to 
suggest that thyroid volume is not significantly increased above the level of non-pregnant 
controls (Brander & Kivisaari, 1989), suggesting that iodine intakes in pregnant women in 
Finland are sufficient to suppress the increase in thyroid volume typically seen in iodine- 
deficient regions (Berghout & Wiersinga, 1998; Glinoer, 2004).
4.4.5 Incidence of thyroid dysfunction
Women taking thyroid medication were excluded from SPRINT and therefore the 
estimation of overt hypothyroidism and hyperthyroidism in this cohort was not possible. 
Based on the criteria used, none of women in SPRINT had undiagnosed overt 
hypothyroidism, though one woman (0.4%) appeared to have undiagnosed 
hyperthyroidism. Previous estimates of the prevalence of hyperthyroidism in pregnancy 
(G.2-0.4%) (Lazarus & Kokandi, 2000; Gartner, 2009), are consistent with the prevalence 
of hyperthyroidism in the SPRINT cohort. However, as estimation of thyroid function in 
SPRINT was conducted in the first half of gestation, it is possible that this one woman with 
high TSH and low fT4 levels experienced transient gestational thyrotoxicosis, rather than 
overt hyperthyroidism. Gestational Transient Thyrotoxicosis (GTT) is a non-autoimmune 
hyperthyroid state that is thought to be caused through stimulation of the thyroid gland by 
high levels of hCG during the first half of gestation, leading to hyperthyroidism that does 
not require treatment (Lazarus & Kokandi, 2000; Glinoer, 2003) (see Introduction, Section 
1.3.2 for explanation of the hCG effect on the thyroid).
Subclinical hypothyroidism was present in 6.5% of the TPOAb-negative women, a figure 
higher than the reported 2-5% prevalence in pregnant women (Fitzpatrick & Russell, 2010). 
It is often suggested that subclinical hypothyroidism is more frequent in TPOAb-positive 
women than in TPOAb-negative women (Fitzpatrick & Russell, 2010), and this is true in
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the SPRINT cohort as 57.1% (n = 8) of the 14 women positive for TPO antibodies had 
subclinical hypothyroidism. By contrast, TPOAb-positive women are not thought to have a 
higher prevalence of hypothyroxinaemia than TPOAb-negative women (Fitzpatrick & 
Russell, 2010), a suggestion that was confirmed in SPRINT. This suggests that although 
iodine status at 12 weeks was not related to the prevalence of hypothyroxinaemia in 
SPRINT, low fT4 levels may be due to iodine deficiency prior to pregnancy rather than to 
antibodies to TPO, and this has been suggested in other UK study (Lazarus et a l, 2004).
Comparing the incidence of hypothyroxinemia in SPRINT with that of other countries is 
difficult in view of the differences in definitions for hypothyroxinaemia used (Section 
4.4.4). Fifteen percent of SPRINT women (TPOAb-negative) had a fT4 level below the 10* 
percentile of normal values, and were thus considered to be hypothyroxinémie; this is a 
very similar figure to the incidence recently reported in New Zealand (although this was 
only in third trimester samples) (Pettigrew-Porter et a l, 2011). The incidence of 
hypothyroxinaemia in SPRINT is considerably higher than the 1.3 -  2.1% reported in early 
pregnancy in the USA (Casey et a l, 2007; Cleary-Goldman et a l, 2008), the 2.9% reported 
in China at 12 weeks’ gestation (Shan et a l, 2009), and the 8.5% in pregnant women in the 
Netherlands (Henrichs et a l, 2010); the USA, China and the Netherlands are considered to 
be iodine-replete regions which may explain the higher prevalence of hypothyroxinaemia in 
SPRINT. By contrast, a higher rate of hypothyroxinaemia (fT4 below 10* percentile) has 
been reported in Spain (20.6% of women at 12-14 weeks’ gestation), a region with iodine 
deficiency (Berbel et a l , 2009).
Moleti et al (2008) suggest that the prevalence of hypothyroxinaemia differs within 
regions considered to be iodine-replete or iodine-deficient according to use of iodine-rich 
dietary sources prior to pregnancy by individuals [iodised salt in the study by Moleti et al 
(2008)] and evidence also exists to suggest that prevalence of hypothyroxinaemia increases 
with advancing gestation (Vermiglio et a l, 1999; Moleti et a l, 2009; Moleti et a l, 2011b), 
thus further complicating comparisons between SPRINT and other studies.
The incidence of subclinical hypothyroidism and hypothyroxinaemia in SPRINT is higher 
than in previous estimates in UK pregnant women (Vaidya et a l, 2007). Vaidya et a l 
(2007) reported thyroid function in unselected pregnancies in Middlesbrough, and
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suggested a prevalence of overt hypothyroidism and hyperthyroidism of 1% and 0.3% 
respectively; subclinical hypothyroidism was identified in 1.5% and hypothyroxinaemia 
was diagnosed in 7.8% of the women, when using manufacturers’ reference ranges (Vaidya 
et a l, 2007). That region of the UK has previously been reported as iodine-deficient 
(Kibirige et a l, 2004) and therefore similar rates of thyroid dysfunction to ours would have 
been expected. However, Vaidya et al (2007) did not exclude TPOAb-positive women 
prior to reporting incidence rates and there were no exclusion criteria so the study included 
women with known thyroid disease (excluded in SPRINT), and the manufacturer reference 
ranges used by Vaidya et a l were based on a non-pregnant population which may help to 
explain the differences in prevalence estimates.
The prevalence of moderately elevated TPO antibodies, was similar in women in SPRINT 
(greater than 35 kU/L) and the euthyroid (iodine-deficient) women of the CATS study in 
Cardiff (greater than 32 kU/L) (11.9% vs. 11.0%) (Pearce et a l, 2010). A slightly higher 
percentage of women had some degree of elevated TPO antibodies in SPRINT (11.3%) 
than in previous research in iodine-sufficient pregnant women in America (10.7%) 
(Haddow et a l, 2004) and Japan (6.8%) (Fuse et a l, 2011). These prevalence estimates fit 
with the fact that iodine deficiency (and excess) has been reported to be a causal factor for 
the development of autoimmune thyroid disease (Prummel et a l, 2004). Higher levels of 
thyroid autoimmunity have been demonstrated in areas with moderate iodine deficiency 
than in those that are mildly deficient or sufficient, with the suggestion that prolonged 
iodine deficiency increased antibody levels over a lifetime (Laurberg et a l, 1998; Pedersen 
et a l, 2003). It is possible that low selenium status in SPRINT women may explain the 
higher prevalence of elevated TPOAb. Pregnant women in Oxford have previously been 
found to be selenium-deficient (Rayman et a l, 2003) and selenium deficiency has been 
linked with increased risk for TPOAb positivity during pregnancy (Pop & Rayman, 
unpublished data).
4.4.6 Limitations
The estimation of the prevalence of hypothyroxinaemia in the SPRINT cohort is limited by 
the inherent limitations of fI4  measurements in pregnancy (Lee et a l, 2009).
102
Chapter 4: Iodine status and thyroid function in pregnancy
SPRINT was underpowered to detect differences in fT4 and TSH levels between iodine- 
deficient and iodine-sufficient women, in view of the fact that only 70 women in the final 
analysis were classified as iodine-sufficient and this may explain the null results. The study 
was especially underpowered to examine the relationship between use of iodine-containing 
supplements and thyroid function, as fewer than 5% took such a supplement.
Women in SPRINT may not be representative of the UK pregnant population, not only 
because of their higher socio-economic status (Chapter 3, Section 3.4.9) but as participants 
in a trial; there is a known selection bias introduced when recruiting to trials and so they are 
likely to have a higher socio-economic status than the Oxfordshire region in general.
SPRINT is limited by the lack of data on total and free T3 levels, thus preventing an 
investigation of the relationship between iodine status and the T3/T4 ratio. Neither 
thyroglobulin nor thyroid volume was measured so that the effect of iodine deficiency on 
thyroid stimulation could not be explored. As there was no measurement of thyroid 
function pre-pregnancy in SPRINT, the expected 50% surge in fT4 levels (see Introduction, 
Section 1.3.2) could not be explored as in other research (Costeira et a l, 2010).
Thyroid function may be impaired by deficiencies of vitamin A (Zimmermann, 2007b; 
Hess, 2010), iron or selenium (Zimmermann & Kohrle, 2002; Hess, 2010). As it was not 
possible to control for these other nutrients in the SPRINT analysis, this may explain the 
lack of association between iodine and thyroid function. For example, women who appear 
to have an adequate iodine status may have a low iron status, which would impair thyroid 
hormone production (Zimmermann et a l, 2007a) and thus reduce the ability to detect 
differences in thyroid status in relation to iodine excretion.
4.4.7 Future work
Serum and spot-urine samples will be available from 20 and 35 weeks’ gestation in 
SPRINT and thus the link between iodine status and thyroid function can be investigated at 
later time-points in pregnancy in the same women. In addition, relationships between 
iodine status in early pregnancy and later thyroid function can be evaluated, as it is likely 
that a lag period exists and thyroid stores become depleted as pregnancy progresses.
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In the same vein, future work in this area should investigate the link between iodine status 
prior to pregnancy and thyroid function during pregnancy, as this would more likely show 
if women who enter pregnancy with low thyroid stores are at increased risk for thyroid 
failure. Future research in the UK should evaluate whether women with a high intake of 
iodine-rich foods (milk and fish) in their childbearing years have a lower risk of thyroid 
dysfunction in pregnancy [as with long-term use of iodised salt (Moleti gZ a/., 2008)].
Method-and trimester-specific reference ranges are required in pregnant women that are 
iodine deficient and TPOAb-negative. Iodine sufficiency of individuals included in such 
study should be evaluated using a range of methods, including multiple 24-hour UICs 
(Rasmussen eZ aZ., 1999; Vejbjerg gZ aZ., 2009a; Konig gZ aZ., 2011) and an estimation of a 
sufficient iodine intake from dietary sources from an appropriately designed FFQ. It should 
not be assumed that because women are living in an iodine-sufficient country, reference 
ranges derived are valid (de Escobar gZ aZ., 2004).
4.5 Conclusion
Hypothyroxinaemia was relatively prevalent in the SPRINT cohort, with 15% diagnosed
with the condition. There were no clear relationships between iodine status measured at 12 
weeks’ gestation and thyroid dysfunction as evaluated at the same time-point. However the 
limitations of the methodology are such that iodine deficiency cannot be ruled out as the 
cause of hypothyroxinaemia in this cohort.
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5. EFFECT OF IODINE STATUS IN PREGNANCY: 
OUTCOMES IN THE OFFSPRING
5.1 Introduction
Although iodine deficiency in the UK population is suggested by a few studies (Barnett gZ 
a/., 2002; Kibirige gZ  aZ., 2004; Bath g Z aZ., 2008; Rayman gZ  aZ., 2008a; Vanderpump gZ  aZ.,
2011) and by the evidence of deficiency in pregnancy presented in this thesis, there is no 
information on whether the level of iodine deficiency in the UK has a negative impact on 
the child. This is of paramount importance in terms of instigating public-health action to
erradicate UK iodine deficiency; without demonstration of an adverse outcome within the 
population, health authorities would have little or no motivation to act.
5.1.1 Aims and hypotheses
• To investigate if maternal iodine status in pregnancy may influence child outcomes in 
the UK. The primary outcome is child cognition, based on IQ at the age of 8 years (this 
outcome was used for subject selection, Methods 2.3.3).
Specific aims
• To evaluate the impact on child cognition through results for IQ at the age of 8 years, 
reading skills at the age of 9 years and school attainment up to the age of 14 years 
(including special education needs) through results of Key stage 1, 2 and 3.
• To evaluate the impact on developmental outcomes including hearing ability and motor 
development (fine and gross motor development)
• To evaluate the impact on behaviour of the child at the age of 7 years, as a proxy for 
ADHD given the previous link between iodine deficiency and behaviour disorders 
(Vermiglio gZ  aZ., 2004).
Post-hoc study aim
As described in Methods (Section 2.3.3) after statistical analysis was completed, it was 
discovered that errors made in urine sample selection by ALSPAC laboratory staff resulted 
in measurement of iodine status in samples from all three trimesters of pregnancy, rather
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than in samples of around 12 weeks gestation (as requested by the author). As a result, a
post-hoc aim was introduced:
• To explore the relationship between iodine status in pregnancy and child outcomes by 
trimester of pregnancy.
Hypotheses
• Women with low iodine status in pregnancy will have children with poorer 
developmental outcomes (for all outcomes investigated) than children born to women 
who were iodine-sufficient during pregnancy.
Post-hoc study hypothesis
• Any observed relationship between iodine status in pregnancy and child outcomes 
would be stronger during early pregnancy, based on the results a study investigating 
the timing of iodine supplementation (Berbel gZ aZ., 2009) and the importance of 
thyroid hormones in the first half of pregnancy for correct brain development in the 
fetus (Morreale de Escobar gZ üfZ., 2004).
5.2 Method
The ALSPAC study was used to evaluate the relationship between maternal iodine status in 
pregnancy and child outcome (Method, Section 2.3.3). This section briefly outlines the 
child outcome measures utilised in ALSPAC for this investigation. Detailed methods used 
in the original ALSPAC study are available elsewhere (ALSPAC, 2011).
5.2.1 Cognitive outcomes
Child IQ, school attainment (Key Stage tests), reading ability and classification of school 
special education needs were the variables used to explore the relationship between 
maternal iodine status in pregnancy and cognition. Child IQ was assessed at age 8 years 
(Golding gZ  aZ., 2001), with an abbreviated form of the Wechsler Intelligence Scale for 
Children (WISC-III) (Wechsler gZ 6/Z., 1992). The verbal, performance and total IQ scores 
were calculated using standard procedures, as previously described (Hibbeln gZ  6zZ., 2007; 
Northstone gZ aZ., 2011). At age 9 years, reading speed, accuracy and comprehension were
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assessed by trained psychologists, using the Neale Analysis of Reading Ability (NARA II) 
(Neale, 1997). Children were also asked to read real words and a “Reading Score” was 
derived as the sum of correct responses (Nunes et a l, 2003). In the UK, the school National 
Curriculum is divided into “Key Stages” by the Education Authority and attainment is 
assessed at the end of each stage with national tests (Directgov, 2011). The results of the 
Reading (overall score). Writing and Mathematics scores for Key Stage I (age 7 years) and 
of English, Mathematics and Science scores for Key Stages 2 (age II years) and 3 (age 14 
years) were obtained for the ALSPAC children.
Suboptimal cognitive outcomes were defined as the lowest 25% of scores for each measure 
of IQ, reading and Key Stages 2 and 3. As Key Stage I results are coded according to 
categorical level of attainment rather than as continuous score, suboptimal scores were 
defined as the closest to the lowest 25% (below level 2b) with 17.7%, 30.6% and 19.3% 
defined as suboptimal for Reading, Writing and Mathematics, respectively. Special 
Education Needs (SEN) were assessed through linkage of the ALSPAC children with the 
Pupil Level Annual School Census when the child was approximately 12 years old. For the 
purposes of logistic regression, SEN was defined as school action and above.
5.2.2 Developmental outcomes 
Hearing
Audiometry testing was conducted when the child was aged 7 years (Golding et a l, 2001) 
and the results of air-conduction tests (at frequencies of 1, 2 and 4 kHz) were used for the 
current study. The author used the British Society of Audiologist guidelines to set hearing 
impairment thresholds (British Society of Audiology, 2004). As there were low numbers in 
the moderate and severe categories and none in the profound hearing loss category, the 
categories were collapsed into normal and mild hearing loss and above (hearing threshold 
greater than 20dB) for the purposes of logistic regression. Four variables were created: mild 
hearing impairment in left or right ear, mild hearing impairment in at least one ear and mild 
hearing impairment in both ears (Table 5.1). In view of the low numbers of children 
classified with mild hearing loss, additional analyses were performed with the hearing 
classified as suboptimal if the air-conduction results for left and right ears were closest to 
the top quartile (Table 5.1).
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Table 5.1 Frequencies of children with hearing impairment
Hearing problem Total Number
Suboptimal defined 
as mild hearing loss 
or worse
Suboptimal defined 
as air-conduction in 
the top quartile
Right ear 831 28(3.4) 175 (21.1)
Left ear 831 36 (4.3) 217(26.1)
At least one ear 831 48 (5.8) 279 (33.6)
Both ears 831 16(1.9) 113(13.6)
Values are n (%)
Motor development
Motor development was assessed in the original ALSPAC study by questionnaires 
completed by the parents when the child was 42 months of age to give a score for fine and 
gross motor skills. Motor scores were dichotomised into suboptimal or optimal, with the 
suboptimal classification given for the bottom quartile of both fine and gross motor scores.
5.2.3 Behaviour
Behaviour was assessed through the Strengths and Difficulties Questionnaire (SDQ) 
(Goodman, 1997) when the child was 81 months of age by the mother. This questionnaire, 
given around the age that ADHD is diagnosed (American Psychiatric Association, 2000),
gives an indication of the risk of behaviour disorders and therefore ADHD.
The questionnaire gives a total behaviour score and five sub-scores for: Pro-social 
behaviour. Hyperactivity, Emotional Problems, Conduct Problems, and Peer Problems. As 
scores were skewed, scores were dichotomised and suboptimal behaviour was defined 
according to published cut-offs for each variable (Goodman, 1997), as used in previous 
research in on childhood diet and behaviour in ALSPAC (Peacock et al, 2011). As shown 
in Table 5.2, the distribution of scores meant that the number classed as having behaviour 
problems ranged from 8.3% to 22%. In an attempt to overcome this wide variation, analysis 
was repeated using scores closest to the worst 10% for individual subscales (highest 10% 
indicated poorer behaviour for all sub-scales, except pro-social scores where the lowest 
10% was classed as suboptimal) (Table 5.2), a method used in previous research on 
maternal diet and child behaviour in ALSPAC (Hibbeln gZ a/., 2007).
08
Chapter 5 : Iodine status in pregnancy and child outcomes 
Table 5.2 Children classed with behaviour problems using two classifications*
Variable Total number Suboptimal defined using cut-offs
Suboptimal 
defined as worst 
10% of scoresf
Pro-social behaviour 856 71 (8.3) 71 (8.3)
Hyperactivity 854 127 (14.9) 67 (7.8)
Emotional symptoms 856 91 (10.6) 91 (10.6)
Conduct problems 857 189 (22.1) 77 (9.0)
Peer problems 856 113(13.2) 113(13.2)
Total behaviour score 854 69 (8.1) 93 (10.6)
Values are n (%) f  closed to the highest 10% for all sub-scales except pro-social behaviour where children 
closest to the lowest 10% was classed as suboptimal.
5.2.4 Statistical analysis
Mean and standard deviations are reported for normally distributed data (confbunders and 
outcome variables) and parametric testing was conducted. Independent t-tests or one-way 
ANOVA were used to compare confbunder variables between groups of iodine status 
(iodine-deficient or sufficient or status divided into three categories). Chi square (%^ ) was 
used fbr comparisons between two categorical variables, e.g. comparing maternal education 
category with the categorical iodine/creatinine variable; linear-by-linear associations were 
used if a trend was expected with more than two levels to a categorical variable.
The relationship between maternal iodine status and risk of suboptimal child cognition 
(binary classification as optimal v.y. suboptimal development) was explored using logistic 
regression with adequate iodine status as the baseline category. The baseline category was
set as the ‘normal’ for each confbunder (e.g. birth weight above 2500g) or the most 
frequent category (e.g. consumer of alcohol during pregnancy). Additional logistic 
regression analyses were conducted using three categories of iodine status; the p value for 
trend was computed by including the iodine variable as a covariate in the analyses.
Linear regression and independent t-tests were used to investigate the relationship with the 
full range of scores fbr IQ, reading and Key Stages 2 and 3. It was not possible to conduct 
statistical analysis fbr full range of behaviour motor or hearing scores due to the clustered
distribution of scores for these variables.
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Unadjusted analyses were conducted using only the iodine/creatinine variable in the model 
and adjusted analyses were conducted with potential confbunders in the model (see below) 
for both linear and logistic regression analyses.
Categories of confounders
As cognitive development is influenced by a range of factors, a variety of potential 
confbunders was controlled for in analyses. These were mostly from self-completed 
questionnaires and included 14 categorical variables and seven continuous measures. The 
covariates in the analysis were: maternal age at delivery, mother’s parenting score [7-factor 
measure of cognitive stimulation at six months of age (detailed in Roulstone et a l, 2011)], 
HOME score [6-factor measure of the emotional and cognitive environment at six months 
of age (Caldwell & Bradley, 1979)], the family adversity index [18-factor measure of 
hardship during pregnancy (Bowen et a l, 2005)], life-event score [exposure to 41 stressful 
events during pregnancy (detailed in Cookson et a l, 2009)], and intakes of both n-3 fatty 
acids (from seafood) and iron estimated from the FFQ completed at 32 weeks’ gestation 
(Rogers & Emmett, 1998). The 14 categorical variables comprised three groups: (1) Child 
factors: gender, birth weight (< 2500g, > 2500g), preterm birth (<37 weeks, > 3 7  weeks), 
breastfeeding (none, some), ethnicity (white, non-white); (2) Maternal factors: smoking 
status (non-smoker, smoked pre-pregnancy but not at 18 weeks’ gestation, smoking at 18 
weeks’ gestation), alcohol intake (non-consumer, consumed alcohol pre-pregnancy but not 
at 18 weeks’ gestation, consumed alcohol at 18 weeks’ gestation), parity (none, one, two 
plus), maternal depression since birth (yes/no), and use of fish-oil supplements during 
pregnancy (yes/no); (3) markers of socio-economic status: maternal and paternal education 
[low (no qualifications, CSE, or vocational), medium (O level) and high (A level or 
degree)], housing status (owned/mortgaged, private rented, council rented), crowding (<1 
or > 1 person per room). Iron intake was included because of its relationship with thyroid 
function (Introduction, Section 1.6.5) (Zimmermann & Kohrle, 2002). n-3 fatty acid intake 
was included due to prior associations with IQ in ALSPAC (Hibbeln et a l, 2007).
Comparison of study sample to remainder of ALSPAC cohort
The women in the final analysis of this study and the remainder of ALSPAC were 
compared (Appendix 5); the study sample had markers of higher socio-economic status
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(maternal and paternal education, housing status, smoking and crowding), a smaller 
proportion of low-birth-weight babies, preterm births, higher proportion of breastfeeding 
and higher parenting and HOME scores than the remainder of ALSPAC women. This is 
probably accounted for by drop-out (in those in lower socio-economic groups) from 
ALSPAC (Wolke et a l, 2009), as women in this study were selected on the basis of 
outcome data when the child was age 8 years.
Statistical models
Three models were used to adjust the analysis for potential confounders:- Model 1 included 
four variables that were related to maternal iodine status (Table 5.3) (maternal education, 
crowding, stressful life-event scores, and maternal age); Model 2 included 14 additional 
confounders that were significantly related to at least one cognitive outcome in this cohort 
[gender and ethnicity of the child, breastfeeding, smoking status, mother’s parenting score, 
intake of n-3 fatty acids (from seafood) and iron estimated from the FFQ, alcohol intake, 
parity, fish-oil supplements during pregnancy, paternal education, housing status, family 
adversity during pregnancy, and HOME score]; Model 3 included three additional 
confounders that were potentially on the causal pathway (birth weight, preterm birth and 
maternal depression since birth). These three models were used in the regression analysis 
for each child outcome variable.
Colinearity
Statistical Model 3 was tested to ensure that assumption of multicollinearity between 
variables (using the primary outcome of total IQ as the dependent variable) was not 
violated; the tolerance for the iodine/creatinine ratio was 0.95 and the VIF was 1.06, below 
critical limits, suggesting there was no concern (Methods, Section 2.2).
Effect modifications
All two-way interactions between the iodine variable and confounders were tested (using 
total IQ as the dependent variable) and were null (Bonferroni correction).
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Table 5.3 Relationship between confounders and maternal iodine status
Iodine to creatinine (jiig/g)
Confounder Deficient (<150 jag/g) Sufficient (>150 jug/g) p value
Crowding in the homef
Less than one person/room 
One or more persons/room
557 (97.7%) 
13(2.3%)
335 (94.9%) 
18(5.1%)
0.02
Maternal education^
Low 111 (19.1%) 63 (17.0%)
Medium 202 (34.8%) 106(28.6%) 0.04
High 267 (49.3%) 201 (54.3%)
Age of mother (yrs)§ 29.4 (4.6) 30.3 (4.5) 0.005
Life event scores§ 3.33 (2.31) 3.89 (2.66) 0.001
tJData are n (%) for categorical confounders: fp value from % ; $p value from linear trend test in cross 
tabulation analysis. §Data are mean (SD) for the continuous confounders, p value from independent t-test.
5.2.5 Analysis by trimester
The relationship with child outcome variables that were significant (or approached
significance i.e. p<0.15) were investigated by trimester (see Methods, Section 2.3.3), using 
statistical Model 1 described above. Model 1 was chosen due to the small number of cases 
(of suboptimal classification) in each trimester and a model with more confounders would
have grossly exceeded the guide of 10 cases per parameter in the model.
5.3 Results
5.3.1 Sensitivity analysis
Sensitivity analysis was conducted to examine the influence the high UICs (i.e. those 
considered to be contaminated in the original cohort; Methods, Section 2.3.3) were having 
on the IQ results. Initially, the relationship between iodine/creatinine ratio and total IQ was 
explored using correlation, for both the whole sample of 995 women (excluding three 
women on thyroid medication and two with inconsistent laboratory results) and the final 
"uncontaminated" dataset of 951 women (Methods, Section 2.3.3.). The correlation was 
weaker and not significant when using the whole cohort compared to the "uncontaminated" 
dataset (rg = 0.05, p = 0.11 vj". rg = 0.1, p = 0.003). Logistic regression was conducted to 
examine the risk of IQ score in the bottom quartile with iodine-deficiency or sufficiency in
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pregnancy. The results (Table 5.4) suggest that the extreme UIC results were weakening 
effects to a greater degree than if they were normal outliers (Steer, personal 
communication, August 2011) and so only results for the 951 “uncontaminated” women are 
reported.
Table 5.4 Sensitivity analysis for all subjects and those considered to be uncontaminated with 
iodine using risk of IQ score being in the bottom quartile as dependent variable
Maternal iodine status: Deficient vs. Adequate
Verbal IQ Performance IQ Total IQ
OR P OR P OR P
(95% Cl) value (95% Cl) value (95% Cl) value
Unadjusted analyses
All samplesf
1.18
(0.88-1.58)
0.27
1.35
(1.00-1.82)
0.05
1.28
(0.95-1.72)
0.10
Excluding 1.36 0.06
1.59
0.003
1.42
0.01contaminated^ (0.99-1.86) (1.17-2.16) (1.05-1.94)
Adjusted analyses*
All samplesf
1.19
(0.83-1.70)
0.36
1.28
(0.89-1.83)
0.19
1.44
(0.99-2.09)
0.05
Excluding
contaminated^
1.30
(0.89-1.90)
0.18
1.44
(1.01-2.06)
0.04
1.50
(1.03-2.21)
0.04
* adjusted for confounders (Model 3). j  inconsistent laboratory results and those taking hypothyroid 
medication excluded. Unadjusted n = 995, adjusted n = 823 $ Women excluded if UIC >500pg/L as urine 
sample may have been contaminated with iodine. Unadjusted n = 951, adjusted n = 793
5.3.2 Child cognitive outcomes
A higher percentage of children born to iodine-deficient than to iodine-sufficient women 
had suboptimal cognitive outcomes (Table 5.5). For example, 28% of children born to 
iodine-deficient mothers were in the bottom quartile of total IQ, compared to 21% of those 
bom to iodine-sufficient mothers (p = 0.02; Table 5.5). The percentage classed as having 
suboptimal Key Stage 1 did not differ by maternal iodine status. A higher percentage of 
children born to iodine-deficient than to iodine-sufficient women were classed as having 
Special Educational Needs (school action or above) (11.0% 7.0%, p = 0.09; Table 5.5).
The unac^usted logistic regression analysis showed maternal iodine deficiency to be 
associated with a greater risk of a suboptimal performance for nearly all cognitive
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outcomes in the child (Table 5.6). The odds ratios (OR) were not greatly changed between 
the unadjusted model and the three adjusted models (Table 5.6), but numbers of subjects 
were lower and confidence intervals wider, thus reducing the statistical significance for an 
association. Evidence remained for associations with performance and total IQ, Key Stage 
2 Mathematics score, and there was slightly stronger evidence for effects on reading 
accuracy at age 9 when using the fully adjusted model (Table 5.6). The results for Key 
Stage 2 were stronger than Key Stage I and 3 and this may be due to greater power as a 
result of a larger number of available Key Stage 2 scores. Although suboptimal IQ was 
defined as the bottom quartile of scores, the risk of low total IQ with maternal iodine 
deficiency was greater when an IQ below 85 was used as the cut-off [OR 1.87 (95% Cl 
1.11-3.17) (adjusted model 1)], suggesting that iodine deficiency is more strongly 
associated with low-end IQ scores. Children bom to mothers who were deficient in iodine 
were more likely to be classed as having a degree of Special Education Needs than those 
bom to iodine-sufficient mothers, although the results failed to reach statistical significance 
(Table 5.6).
As would be expected, matemal and paternal education were strong predictors of almost all 
cognitive outcomes, as were breastfeeding and matemal age. Model statistics for cognitive 
outcomes are in Appendix 5 but generally the fully adjustment models were significant and 
predicted between 10 and 25% of variance in cognitive scores.
Cognitive scores as a continuous variable
Children bom to iodine-sufficient mothers had higher scores for all cognitive outcomes 
than those bom to iodine-deficient mothers (Table 5.7). This relationship was attenuated 
after controlling for potential confounders (Models 1, 2 and 3) but there was evidence for 
significantly higher scores for total IQ, Key Stage 3 English, reading accuracy and 
comprehension in all three models (Table 5.7). For example, total IQ was 2.3 points lower 
in offspring of iodine-deficient than iodine-sufficient women (Adjusted Model 3; Table 
5.7).
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Table 5.5: Percentage of children with suboptimaf outcomes by maternal iodine status (unadjusted)
Iodine status
Outcomes Age (years)
Deficient 
(<I50 pg/g)
Sufficient 
(>150 pg/g)
p value ;
IQ
Verbal 8 151/581 (26%) 76/370 (21%) 0.06
Performance 8 171/581 (29%) 77/370 (21%) 0.03
Total 8 162/581 (28%) 79/370 (21%) 0.02
Key Stage 1
Reading 7 88/496(18%) 54/308(18%) 0.94
Writing 7 167/495 (34%) 79/308 (26%) 0.02
Mathematics 7 106/496 (21%) 49/307(16%) 0.06
Key Stage 2
English 11 140/524 (27%) 75/341 (22%) 0.12
Mathematics 11 145/529 (27%) 65/340(19%) 0.005
Science 11 151/528 (29%) 76/341 (22%) 0.04
Key Stage 3
English 14 125/437 (29%) 55/280 (20%) 0.01
Mathematics 14 120/446 (27%) 60/281 (21%) 0.09
Science 14 121/446 (27%) 66/283 (23%) 0.25
Reading
Words read per minute 9 141/520 (27%) 71/329 (22%) 0.07
Accuracy 9 153/522 (29%) 62/329(19%) 0.001
Comprehension 9 153/522 (29%) 73/329 (22%) 0.02
Reading score 9 140/531 (26%) 63/332(19%) 0.01
Special Education Needs
School action and above 12 51/478(11%) 21/309 (7%) 0.07
Data are number classed as suboptimal/total in category (%) t  p value from % test comparing proportion o f
suboptimal cognitive outcomes in the iodine-deficient and iodine-sufficient classification. * Suboptimal 
outcome defined as closest to the bottom quartile for Key Stage 1 (17.7%, 30.6% and 19.3% for English,
Writing and Mathematic scores respectively) or scores in the bottom quartile for all other cognitive scores.
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Chapter 5: Iodine status in pregnancy and child outcomes
5.3.3 Child behaviour outcomes
The results in Table 5.8 show the risk of behaviour problems when suboptimal was defined 
by published cut-offs and also by the worst 10% of scores. A lower percentage of children 
was classed as suboptimal when using the worst 10% of scores for hyperactivity, conduct 
scores and total behaviour scores, resulting in higher p values and wider confidence 
intervals. This suggests that the power may have been too low to detect significant 
differences in risk of behaviour problems due to matemal iodine status in this cohort.
In the majority of sub-scales the odds ratio (OR) indicate a greater risk of behaviour 
problems in children born to women deficient in iodine than those bom to iodine-sufficient 
mothers but results were not significant. Stronger results were found for pro-social 
behaviour and the total behaviour score and p values approached significance in the fully 
adjusted model (p = 0.10 and p = 0.19 respectively using published cut-offs). Matemal 
depression since birth (OR 2.72, 95% Cl 1.44-5.14, p = 0.002) and stressful life (OR 1.21, 
95% Cl 1.06-1.37, p = 0.04) events during pregnancy were all significant predictors of poor 
total behaviour scores (using published cut-offs) in the fully adjusted model 3.
5.3.4 Developmental outcomes 
Hearing
Table 5.9 shows the results of unadjusted and adjusted (for each model) logistic regression. 
Unadjusted logistic regression showed that matemal iodine deficiency was associated with 
increased risk of suboptimal hearing in the right, left, at least one ear or both ears (using the 
highest quartile of air-conduction scores to define suboptimal), and approached significance 
for suboptimal hearing in at least one ear (OR 1.30 95% Cl 0.95-1.81; p = 0.09).
Controlling for up to 21 potential confounders did not considerably change the effect sizes 
and matemal iodine deficiency was associated with a 30% increased risk of suboptimal 
hearing in at least one ear, which was significant in the adjusted model 1 (OR 1.38 95% Cl 
1.00 -  1.90; Table 5.9) but was not significant in the fully adjusted model (OR 1.34 95% Cl 
0.94 -  1.90; p = 0.10 Table 5.9). Maternal education, breastfeeding and parity showed 
trends to associations with hearing impairment but the statistical models (1, 2 or 3) were
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Chapter 5: Iodine status in pregnancy and child outcomes
not significant for mild hearing loss or suboptimal hearing, suggesting that they were poor 
at predicting hearing scores in the cohort (Appendix 5). As the values suggesting the 
models predicted up to 22% of the variance in hearing loss, it suggests that the models 
lacked statistical power, especially in the fully adjusted Model 3 (Appendix 5).
Motor scores
Though the results for either unadjusted or adjusted analyses were not statistically 
significant, iodine deficiency was associated with an increased risk of suboptimal fine 
motor scores (OR 1.41 95% Cl 0.96-2.09; p = 0.08, Model 3). There was, however, no 
effect of matemal iodine status on gross motor scores (OR 0.98 95% Cl 0.69-1.39; p = 
0.92, adjusted Model 3). Mother’s parenting score (p = 0.04), patemal education (p =0.001) 
and postnatal depression (p = 0.001) were all significant predictors of fine motor skills. 
Gross motor skills were predicted by child gender (p = 0.01), matemal alcohol intake (p = 
0.05), preterm birth (p = 0.04) and HOME score (p = 0.04). Model 3 was significant for 
gross motor skills (Appendix 5) but only explained 8% of variance. By contrast, the model 
for fine motor skills predicted 16% of the variance (28) = 83.1, p <0.0001].
5.3.5 Effect of the degree of iodine deficiency on cognitive outcomes
A dose-response trend (Figure 5.1) was evident when the “deficient” category was sub­
divided into “severely iodine deficient” and “mildly-to-moderately iodine deficient”. There 
was an approximate difference of 6 IQ points between offspring of severely iodine deficient 
than iodine-sufficient women (Figure 5.1).
The results of logistic regression using the three iodine-status groups are in Table 5.10. 
After controlling for all 21 confounding variables (Model 3), there was evidence of a trend 
to a lower risk of suboptimal classification with increasing maternal iodine status for verbal 
and total IQ, reading accuracy and reading score and Key Stage 2 English and 
Mathematics. Mild-to-moderate iodine deficiency was associated with an increased risk of 
suboptimal development compared with adequate iodine status for performance IQ (OR 
1.49 95% Cl 1.04-2.15), total IQ (OR 1.51 95% Cl 1.02-2.23) and Key Stage 2 Maths (OR 
1.62 95% Cl 1.05-2.51) (Table 5.10).
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5.3.6 Analysis by trimester
The effect size (OR) for risk of suboptimal IQ was greater in the first trimester (Table 5.11) 
than when the trimesters were combined to give results for pregnancy in general (Table 
5.6). For example, for suboptimal total IQ, iodine deficiency in the first trimester was 
associated with an odds ratio of 1.83 (95% Cl 1.12 - 3.01) compared to 1.40 (95% Cl 1.01 - 
1.96) for the whole of pregnancy. Despite the lower number in the first-trimester analysis, 
the risk of suboptimal outcome with iodine deficiency remained significant for all measures 
of IQ, Key Stage 1 Mathematics, Key Stage 2 English and Mathematics and reading 
accuracy and comprehension (Table 5.11). Iodine deficiency in the first trimester was 
associated with a greater risk of suboptimal development (judged by OR) for IQ, reading. 
Key Stage 2 and 3 compared with iodine deficiency in the second and third trimesters and 
the low numbers of women in the second and third trimesters are the likely explanation for 
null results.
5.4 Discussion
The results support the original hypothesis that iodine deficiency would be associated with 
negative child outcomes. The post-hoc study hypothesis that iodine deficiency in early 
pregnancy would have a greater effect on these outcomes that deficiency at later time- 
points was also supporting by the study findings.
5.4.1 Cognitive development and school performance
The current study found that matemal iodine deficiency was associated with a higher risk 
of suboptimal scores for total and performance IQ at age 8, reading accuracy at age 9 and 
school performance in mathematics at age 11, even after adjusting for a range of 
confounders.
In view of these results, it may well be that it was the iodine content of seafood that 
contributed to the relationship observed between maternal seafood intake and child IQ in a 
previous ALSPAC study (Hibbeln et al., 2007), though the suggestion at the time was that 
long-chain n-3 fatty acids from fish were responsible. As n-3 fatty acids from seafood were 
included as a confounder in our analyses, it is likely that the effects of iodine on the 
developing brain are in addition to any effect of long-chain n-3 fatty acids.
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Figure 5.1: Mean (95% Cl) scores for child cognitive outcomes according to maternal iodine status (urinary 
iodine/creatinine ratio), categorised as severely and mildly-to-moderately iodine-deficient and iodine- 
sufficient. Panel A: Total IQ (age 8); B: Reading Comprehension (age 9), and C: Reading Accuracy (age 9). 
Values are unadjusted for the effect of potential confounders.
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Table 5.10 Risk of suboptimal* outcomes in offspring according to maternal iodine status, when 
deficiency is split into severe and mild-to-moderate
Iodine to creatinine classification
Severe Mild-to-Moderate vv. Trend!Sufficient! Sufficient!
OR (95% Cl) n OR (95% Cl) n Pvalue n
IQ
Verbal 2.98(1.38-6.46) 41 1.21 (0.82-1.78) 442 0.03 793
Performance 1.07 (0.48-2.43) 41 1.47(1.03-2.12) 442 0.13 793
Total 2.03 (0.92-4.49) 41 1.47(1.00-2.16) 442 0.02 793
Key Stage One
Reading 1.12(0.37-3.39) 37 0.99 (0.61-1.62) 377 0.93 671
Writing 1.66 (0.71-3.86) 37 1.59(1.07-2.37) 377 0.03 671
Mathematics 0.66 (0.21-2.13) 37 1.42 (0.90-2.24) 377 0.50 670
Key Stage Two
English 2.85 (1.25-6.47) 38 1.23 (0.80-1.87) 399 0.04 723
Mathematics 2.12(0.92-4.90) 38 1.60(1.04-2.46) 403 0.02 726
Science 1.88(0.83-4.25) 38 1.38(0.92-2.06) 403 0.06 727
Key Stage Three
English 1.84 (0.64-5.26) 30 1.43 (0.87-2.34) 332 0.11 599
Mathematics 1.68 (0.67-4.23) 30 1.32(0.85-2.05) 337 0.14 605
Science 1.53 (0.63-3.71) 30 1.23 (0.74-1.71) 337 0.37 606
Reading
Words per min 1.88 (0.80-4.39) 34 1.20 (0.80-1.80) 404 0.16 712
Accuracy 2.40 (0.98-5.83) 34 1.85 (1.21-2.82) 405 0.003 713
Comprehension 1.57(0.64-3.38) 34 1.34 (0.90-2.01) 405 0.13 713
Reading Score 2.99(1.29-6.93) 36 1.35 (0.89-2.06) 411 0.02 724
* Suboptimal outcome defined as closest to the bottom quartile for Key Stage 1 (17.7%, 30.6% and 19.3% for 
English, Writing and Mathematic scores respectively) or scores in the bottom quartile for all other cognitive 
scores. Odds ratio (OR) using sufficient matemal iodine status as the baseline group, ^results from logistic 
regression using Model 3 (21 confounder variables); p value for trend using iodine variable as a covariate
rather than a factor.
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Chapter 5: Iodine status in pregnancy and child outcomes
The fact that we found stronger evidence for an effect on performance rather than verbal IQ 
speaks to the plausibility of our findings, as non-verbal tests of intelligence measure basic 
reasoning ability rather than knowledge and vocabulary which are open to environmental 
influences (Benton, 2010). Our results also suggest a worsening trend in cognitive 
outcomes as matemal prenatal iodine deficiency increases.
England has an average reading ability similar to that of other European countries but has 
one of largest ranges in reading achievement and a high proportion of children at the low 
attainment end of the spectmm compared to other countries (Twist et a l, 2007; Bradshaw 
et a l, 2010). This variation in ability is referred to as the “long tail of underachievement” 
(House of Commons Education and Skills Committee, 2005). As this study has investigated 
the risk of being in the lower quartile of scores, our results raise the possibility that iodine 
deficiency during pregnancy may be linked to this “tail”.
The latest figures in England show that 2.8% of pupils have a statement of Special 
Educational Needs (SEN) and 17.8% have SEN but without a statement (i.e. managed at 
school level) (Department for Education, 2011). Although the results of the effect of 
matemal iodine status on SEN status were not significant, the risk of the child being 
classified as requiring school action or above tended to be greater in those bom to iodine 
deficient than iodine-sufficient mothers. The current study is likely to be underpowered to 
detect significant differences, as only 9.1% of the cohort was classed as requiring school 
action or above.
Taken together, the results for cognitive function in ALSPAC suggest that matemal iodine 
deficiency should be considered as a preventable risk factor for subtle impairments in 
cognitive ability in the UK. This may blight the life of individual children and set them on a 
trajectory for poorer school attainment, examination grades and subsequent employment 
opportunities, all of which are linked to social deprivation, crime and poor health (Rice & 
Barone, 2000). This could be easily remedied with education to pregnant women on the 
importance of iodine during pregnancy and programmes to improve UK iodine intake.
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5.4.2 Motor development
There was evidence of impaired fine motor development in ALSPAC children bom to 
women who were iodine deficient during pregnancy, although this did not reach statistical 
significance (possibly due to insufficient numbers of children in the adjusted analyses). 
There was no evidence of a relationship between iodine status and gross motor scores at 42 
months. The association with fine motor development supports other research that has 
shown both iodine and thyroid hormone deficiency in pregnancy to be associated with 
poorer motor development at 2 years (Berbel et a l, 2009; Velasco et a l, 2009; Li et a l, 
2010; Costeira et a l, 2011), up to the age 3 years (Pop et a l, 1999; Pop et a l, 2003) and at 
the age of 5 years (O'Donnell et a l, 2002). The null results for gross motor skills may be 
explained by the timing of the questionnaire in ALSPAC at 42 months; the questions for 
gross motor development may have been asked too late as some of the questioned 
milestones, such as walking and running, are reached by the earlier age of 24 months (NHS 
Choices, 2011a). The questions on fine motor development at 42 months (e.g. draw a 
circle) may have been more sensitive to the detection of the effect of iodine deficiency at 
this age. Had questions on gross motor development been put at an earlier age, differences 
between children of iodine deficient or sufficient mothers might have been apparent.
5.4.3 Hearing
Our results showed a suggestion of impaired hearing (air-conduction score in the top 
quartile) in at least one ear in the children of iodine-deficient mothers, especially if 
deficient in the first trimester. The fact that there was a stronger relationship with iodine 
deficiency in early pregnancy is consistent with research in rats that has shown thyroid 
hormone receptors in the inner ear before the onset of fetal thyroid function (Knipper et a l , 
2000). Knipper et al (2000) suggest that iodine or thyroid hormone deficiency between 
week 10 and 29 of gestation may have implications for hearing in the offspring.
While there are studies that show a relationship between iodine deficiency in children and a 
higher hearing threshold (Valeix et a l, 1992; Soriguer et a l, 2000; van den Briel et a l, 
2001; Azizi et a l, 2005), there are limited data on iodine status in pregnancy and 
subsequent hearing development in the child. A study has shown that thyroid 
autoantibodies in the third trimester are associated with hearing impairment at age 8 years
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(Wasserman et a l, 2008); TPOAb in late gestation have been suggested as a marker for low 
fT4 levels in early pregnancy (Pop et a l, 1999) (and thus potentially iodine deficiency) and 
the data from Wasserman et al (2008) support our ALSPAC findings. Other support for 
our findings can be found in a study in a severely iodine-deficient region of China that 
showed iodine supplementation study during pregnancy, rather than childhood that resulted 
in a lower percentage of children with hearing loss (O'Donnell et a l, 2010), though 
differences were not statistically significant.
5.4.4 Behaviour
For the most part, matemal iodine deficiency in pregnant women of ALSPAC was not 
associated with behaviour scores in the child, although when using defined cut-offs, iodine 
deficiency was associated with poorer pro-social behaviour, conduct problems and total 
behaviour scores, especially where iodine deficiency occurred in early pregnancy. It is 
possible that the study was underpowered to detect subtle differences in behaviour scores. 
There was no significant effect of maternal iodine deficiency on hyperactivity symptoms in 
the child, suggesting no association with ADHD development in the offspring. This finding 
is in contrast to small-scale research in Italy (Vermiglio et a l, 2004) (although that study 
followed children to the age of 10 years, compared with 7 years in ALSPAC) and with 
evidence of poor attention in neonates in the Netherlands (Kooistra et a l , 2006) (although 
the fact these children were only 3 weeks of age reduces the clinical relevance of such 
findings). Research has shown that matemal TSH in pregnancy is associated with 
behaviour problems in children up to 3 years that may indicate an ADHD tendency 
(extemalizing problems) (Ghassabian et a l, 2011). The researchers found no relationship 
with intemalizing problems (anxiety and sadness) which fits with the ALSPAC finding of 
no relationship with emotional problems.
5.4.5 Effect of the timing of iodine deficiency
As brain development occurs throughout pregnancy and early life and different stmctures 
of the brain develop at different stages of pregnancy and the postnatal period (Rice & 
Barone, 2000), it is likely that the clinical presentation in the offspring will differ according 
to the timing of iodine deficiency in the mother. Deficiency of thyroid hormone (and 
therefore possibly iodine) in late pregnancy has been associated with poorer fine-motor
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skills, vision (attention and processing) and response speeds, while deficiency in early 
pregnancy has been associated with poorer gross motor skills and visual attention and 
memory (Zoeller & Rovet, 2004; Gilbert et a l, 2011). The ALSPAC results showed a 
stronger (though not statistically significant) risk of impaired fine motor skills associated 
with iodine deficiency in the second trimester than the first, suggesting that the 
development of fine motor skills may occur later in pregnancy. The suggestion that thyroid 
hormone deficiency in early pregnancy is associated with poorer visual processing (Zoeller 
& Rovet, 2004) (which may relate to reading ability) is consistent with the stronger effect 
on reading associated with iodine deficiency in the first trimester in ALSPAC.
In agreement with our finding that the strongest association between iodine deficiency in 
pregnancy and cognitive development (IQ and Key Stage tests and reading ability) was 
found in the first trimester, other studies have shown iodine supplementation earlier in 
pregnancy (compared to late pregnancy or postnatally) to be beneficial in terms of 
neurological development and cognition (Cao et a l, 1994; Berbel et a l, 2009). In further 
support of our findings is a recent US study that did not find a significant relationship 
between hypothyroxinaemia in the second trimester and neurocognitive development in the 
offspring at 2 years (Craig et a l, 2012).
As the current study used measurements of iodine status in different trimesters in different 
women, and not longitudinal assessment in the same women, it cannot be concluded that 
the effects are restricted to the period in which iodine status was measured (i.e. when the 
urine sample was collected from the women). It is possible that a woman who is classified 
as iodine deficient in the first trimester may also have a low iodine intake later in pregnancy 
and therefore the observed stronger effects on child cognition in the first trimester may be a 
proxy for sustained iodine deficiency throughout gestation. In addition, a high percentage 
of women in the study (87%) reported some breastfeeding and the measurement of iodine 
status in pregnancy may also serve as a marker for iodine status during breastfeeding. 
Women who were iodine deficient in pregnancy may also have lower breast-milk iodine 
concentrations (Azizi & Smyth, 2009; Mulrine et a l, 2010) thus further exposing the infant 
to low iodine intake resulting in a subsequent effect on brain development. In addition, it is 
possible that a woman with low iodine status raises her child on a diet that has an habitually
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low intake of rich-iodine sources (such as fish). As iodine repletion in childhood has been 
shown to improve cognitive scores in children up to the age of 12 years (Zimmermann et 
a l, 2006; Gordon et a l, 2009), it is possible that the children of iodine deficient women in 
pregnancy were also iodine deficient; however, given the lower iodine requirements in 
childhood compared to pregnancy (WHO et a l, 2007) this is unlikely to have strongly 
influenced the findings (see Limitations, Section 5.4.7).
5.4.6 Novelty of the current study
The current sizeable study adds to the sparse literature describing the in utero effects of 
mild-to-moderate iodine deficiency. Though there are studies that link cognition in the 
offspring to mildly compromised matemal thyroid function (Haddow et a l, 1999; Pop et 
a l, 2003; Henrichs et a l, 2010; Li et a l, 2010; Costeira et a l, 2011), this is not the same as 
showing an effect of iodine status per se, as thyroid function is affected by factors other 
than iodine intake. Additionally, our study is unique in having child outcomes up to the age 
of 14 years. Although iodine deficiency has been shown in UK schoolgirls (Vanderpump et 
a l, 2011) and in pregnant women in the past decade (Barnett et a l, 2002; Kibirige et a l, 
2004; Pearce et a l, 2010), this is the first study to show that the extent of iodine deficiency 
found in the UK is associated with adverse neurodevelopmental outcomes in childhood.
5.4.7 Limitations
Our study has several limitations:
(i) confounding variables: there is a possibility of residual confounding by factors that we 
either have not measured (or not measured accurately) or not considered. For the most part, 
allowing for up to 21 variables made little difference to the overall effect sizes. As the 
dataset was limited in number (particularly in sub-analyses), it was not possible to include 
additional confounders in the statistical model, for fear of over-controlling and producing 
an unstable model. It was not possible to account for other factors that may influence child 
cognition, such as postnatal dietary factors, including iodine intake. However, as the iodine 
requirements for a child are lower than for pregnant women, it unlikely that iodine 
deficiency would have been widespread in childhood in the 1990s, particularly as milk 
intake was higher than in the present day (National Food Survey, 2000). Though maternal 
iron intake was included in the model, intake was estimated from the FFQ, a less accurate
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method than using a biological maker such as serum ferritin, which was unavailable in the 
ALSPAC cohort; this may have affected the ability to control adequately for iron intake, 
which is known to influence thyroid hormone production (Zimmermann et a l, 2007a). The 
current study did not include any data on genetic variation in the mothers and this may 
influence the effect of iodine deficiency on child cognition. For example, it has been found 
that single nucleotide polymorphisms (SNPs) in the selenium-dependent type-2 deiodinase 
gene may affect T3 availability to the fetus and thus the overall risk of reduced IQ, possibly 
explaining variation in the incidence of deficits in cognition in regions with endemic iodine 
deficiency (Guo et a l, 2004).
(ii) spot-urine sample: the use of a single spot-urine sample at one time point in pregnancy 
may not reflect dietary iodine intake during the entire pregnancy (see Introduction, Section 
1.3.3). Urinary iodine excretion does not give specific information on matemal thyroid 
function or on the potential adaptation of the matemal thyroid to low iodine intakes 
(Elnagar et a l, 1998). It also gives no estimate of placental storage of iodine (Bums et a l, 
201 lb) which may be beneficial for the fetus during development, if iodine can be utilised 
from this store.
(iii) Urinary iodine contamination: the potential iodine contamination of some urine 
samples may have masked low values; however, this possible misclassification of mothers 
as iodine-sufficient rather than deficient is likely to have weakened observed effects by 
causing results to attenuate towards the null. It is unlikely that iodine contamination is 
widespread, given that we have observed significant effects of iodine status on cognition. 
The expectation would be that results would not be significant and that there would not be a 
consistent pattem observed between maternal iodine status and a range of cognitive and 
developmental outcomes, if contamination had been widespread.
(iv) Insufficient power in the sub-analyses: The current study of 522 first-trimester, 295 
second-trimester and 134 third-trimester pregnancies does not have sufficient power to 
determine effects other than those with large effect sizes. Even for the significant results 
(e.g. first trimester IQ results), the confidence intervals are wide, making it unclear whether 
the true effect might be considerably more modest than suggested by the odds ratio.
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5.4.8 Future work
The size of the current study was constrained by funding and should be extended to include 
a greater number of ALSPAC mother-child pairs. This would increase power and precision 
to identify clinically significant effects of iodine deficiency in pregnancy on a wider range 
of cognitive and behavioural outcomes.
More data are needed to provide convincing public-health messages on the amount and 
timing of iodine intake in pregnancy that would prevent harm to the developing fetus. 
Further study should measure iodine in all available ALSPAC urine samples collected at a 
variety of gestational ages. Some mothers have urine samples available at up to five time- 
points in pregnancy and would thus give longitudinal data on the influence of iodine status 
throughout pregnancy on child outcomes and would allow identification of critical 
windows for specific outcomes of child development.
5.5 Conclusions
Though the current level of iodine deficiency in the UK is not severe enough to cause the 
reappearance of goitre, our pilot study has shown that it does seem to be sufficiently severe
to affect those most vulnerable to deficiency, i.e. pregnant women and their fetuses, notably 
by reducing IQ. A series of Lancet papers reported on the loss of child developmental 
potential, with iodine highlighted as a modifiable risk factor (Engle et a l, 2007; Grantham- 
McGregor et <3/., 2007; Walker et a/., 2007; Walker et aZ., 2011). Although the focus of 
these papers was on the effects in developing countries, the consequence of a loss of 
cognitive development in terms of educational attainment, future carers and earning 
potential, could also be true of the UK. Accordingly, there needs to be an increased focus 
on the prevention of iodine deficiency in the UK to minimise the negative effects on child 
development and on the population.
Matemal iodine deficiency in pregnancy may have been overlooked as a cause of 
developmental delay in UK children. Our results highlight both the error of not monitoring 
national iodine status and the naivety of the presumption that iodine deficiency was no 
longer a problem in the UK in view of the fact that this study is retrospective.
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6. FOOD SOURCES OF IODINE IN UK PREGNANT 
WOMEN
6.1 Introduction
6.1.1 Background
There is no recorded information on the foods that contribute to iodine status in UK 
pregnant women nor do we know the effect on their iodine status of taking one of the 
iodine-containing prenatal supplements on the UK market. A previous study in UK adults 
related the contribution of food groups to iodine intake through food diary analysis 
(Henderson gr a/., 2003), but this method has limitations, as explained in Introduction, 
(Section 1.3.3). Vanderpump and colleagues (2011) made attempts to relate participants’ 
diet to urinary iodine concentration in their study of UK schoolgirls, but their FFQ had 
design flaws that threatened the reliability of their results (Introduction, Section 1.6.1 ) 
(Bath & Rayman, 2011).
6.1.2 Aims and hypotheses
To evaluate the main food and food-supplement sources that contribute to iodine status in 
UK pregnant women.
Specific aims
# To analyse the relationship between food consumption (evaluated through an FFQ) and 
iodine status (through the iodine/creatinine ratio in a spot-urine sample) in UK pregnant 
women.
# To evaluate the impact of iodine-containing nutritional supplements on the iodine status 
of UK pregnant women in the Royal Surrey Study (few SPRINT and no ALSPAC 
women used an iodine-containing supplement rendering these studies unsuitable for
such analysis).
Hypotheses
# Milk and dairy products will be the most important sources of iodine intake
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• Iodine status will be higher in women using an iodine-containing nutritional supplement 
than in women who do not use such a supplement.
6.2 Methods
Data from the Royal Surrey Study and ALSPAC were used to estimate the main 
contributors to iodine status in UK pregnant women; both studies used a FFQ for dietary 
intake estimations.
6.2.1 Royal Surrey Study
Questionnaire and FFQ
The general questionnaire that was completed as part of the Royal Surrey Study (Methods, 
Section 2.3.1) provided data on whether the women were vegetarians or vegans, as well as 
questioning whether they avoided dairy products or fish (Appendix 2). Women were also 
required to complete a 46-item semi-quantitative food frequency questionnaire, with nine 
frequency options (Methods, Section 2.3.1). The FFQ was designed only to give detailed 
information on foods that were either iodine-rich or had goitrogenic properties (Appendix 
2). Although the FFQ was not interview-led [as is recommended for improved accuracy 
(Cade et al, 2004)], the author was present during its completion which ensured that 
women understood the items (e.g. iodised salt), and that there were no missing data.
The nine frequency options of the FFQ were recoded for analysis to five weekly fbod- 
portion categories (0, 0.5, 2, 5.5 and 10); some categories were collapsed to accommodate 
low numbers (Table 6.1). The coding system for the Royal Surrey Study was based on the 
original system successfully used by ALSPAC for FFQ analysis (Rogers & Emmett, 1998). 
Due to the low numbers of consumers of seaweed (n = 13) and iodised salt (n = 4), these 
food items were dichotomised into either ''consumer" or "non-consumer" for analyses.
The Royal Surrey Study collected detailed information on milk intake and women provided 
their estimated daily milk consumption in quarter-pint (140 ml) increments (Appendix 2). 
The milk categories were coded into four categories (the original top three categories were 
collapsed due to small numbers in each group): (1) none, (2) less than quarter of a pint 
(<140ml), (3) quarter to half a pint (140 to 280ml), (4) more than a pint (>280ml).
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Although a relatively small number of women reported not consuming milk, it was 
considered to be important to keep this category distinct.
Table 6.1 Coding system used in Royal Surrey Study for weekly food intake estimation.
Original frequency options Weekly portion frequency Weekly portions code
Never or < once/per month None 0
1-3 times per month Once a fortnight 0.5
Once a week 
2-4 times per week
One to four times per week 2
5-6 times per week 
Once per day
Five to seven times per week 5.5
2-3 times per day
4-5 times per day More than once daily 10
4-5 times per day
Estimation of weight of food groups consumed weekly
The weekly portion codes (Table 6.1) were combined with estimated fbod-portion weights 
(Food Standards Agency, 2002) to give estimated weekly intake (in grams) for each food 
item in the FFQ. The FFQ was semi-quantitative (Appendix 2); where actual weights were 
given (e.g. for cream), these were used to estimate weekly consumption of these foods. For
all other items in the FFQ, medium portion sizes were estimated using the Food Standards 
Agency Food portion guide and an average was taken for composite food groups (e.g. 
white fish) (Appendix 6).
Eggs were not recoded to estimated weights because the FFQ did not suggest an egg 
portion and, as people’s perception of egg portions are likely to differ (for example a 
portion could be considered as one or two eggs), it was considered that assuming a portion 
size would lead to inaccurate results. Analysis was conducted on weekly portion 
frequencies (none, once/fortnight, one to four times/week and more than four times/week).
In addition to the milk category (detailed above), food items were combined to give four 
categories of food: (1) Total meat and poultry (all processed meat, red meat and poultry),
(2) Total dairy products (all cream, yoghurts, butter and cheese), (3) Total seafood 
(processed fish, white fish, oily fish, shellfish and fish roe), and (4) Total goitrogens [total
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soy products (soy milk, tofu and other soy products), cruciferous vegetables 
(broccoli/kale/spring greens, cabbage, Brussel sprouts, cauliflower, tumip/swede and 
radish) and sweet potatoes]. For the purposes of analysis, weekly estimated intake of food 
groups were divided into quartiles.
Use of an iodine-containing nutritional supplement
The general questionnaire in the Royal Surrey Study provided data on the use of a
nutritional supplement, including the brand name. A shelf survey was conducted, by the 
author in November 2009, of prenatal supplements available in the UK; this information 
was used to evaluate the dose of iodine (if any) in the supplement (Table 6.2).
Table 6.2 Iodine content of prenatal supplements available in the UK in 2009.
Supplement Iodine content (pg/ dose)*
Boots Pregnancy Mum To Be Advanced 150
Boots Pregnancy Mum To Be Plus 0
Duane Reade Prenatal Supplements 0
Sainsbury’s Pregnancy Care Mum and Bump 150
Sanatogen Pronatal 0
Sanatogen Pronatal Plus 0
Seven Seas Femibion Healthy Pregnancy 150
Solgar Prenatal 75
Tesco Multivitamins and Minerals for Pregnancy 140
Tommy’s Essential Multivitamins and Minerals with Folic Acid 100
Vitabiotics Pregnacare 140
Vitabiotics Pregnacare Plus 140
* Daily dose refers to the manufacturer’s recommendation. Information correct as of December 2009. 
Statistical analysis of data from the Royal Surrey Study
As reported in Chapter 3, Section 3.2.4, the urinary iodine concentration and 
iodine/creatinine ratio values were not normally distributed and therefore median and 
interquartile ranges are reported. The iodine variables were transformed using the natural 
logarithm to allow parametric testing; a non-parametric correlation was used between the 
iodine variable and food intake because the estimated weekly weight of food items 
consumed (in grams) were not normally distributed (and transformations were not possible
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due to large numbers of zero values). Iodine/creatinine ratio (log-transformed) was 
compared between quartiles of estimated quantity of the food groups consumed (or weekly 
frequency for eggs) using one-way ANOVA (with Bonferroni post hoc test) for between- 
group effects and a General Linear Model (GLM) was used with the quartiles as a 
CO variâtes for evaluation of the trend between categories.
Multiple linear regression (using GLM in SPSS) was used to evaluate the adjusted 
relationship between the (log transformed) iodine/creatinine ratio and dietary factors, while 
controlling for maternal age and iodine supplement use. Geometric means (with their 95% 
Cl) of iodine/creatinine ratio for each category of milk intake were estimated using GLM, 
adjusted for the effect of maternal age (years), use of an iodine-containing supplement, 
frequency of egg intake and weekly intake of dairy (g), meat and poultry (g), and seafood 
(g). Geometric means were computed by back transformation of adjusted means and 95% 
Cl of the log transformed iodine/creatinine variable.
The risk of iodine deficiency (iodine/creatinine ratio < 1 5 0  pg/g) with varying dietary 
patterns could not be explored using logistic regression. This was because low numbers of 
women in the Royal Surrey Study were classified as deficient (n = 67) and therefore the 
number of cases per parameter in the model (n = 3) was considerably lower than the 
suggested optimum of 10 to 20 cases per parameter. This resulted in instability in the 
model, and the iteration history showed that the final solution could not be reached; odds 
ratios were inaccurate and unreliable, thus rendering logistic regression ineffective in the 
Royal Surrey Study (CD Appendix).
6.2.2 Food sources of iodine in ALSPAC 
Analysis of the ALSPAC FFQ
The ALSPAC FFQ was part of a self-completed questionnaire that was posted to women 
around 32 weeks’ gestation; the FFQ had previously been used to estimate a range of 
nutrient intakes (Rogers & Emmett, 1998) and for the purposes of this thesis, was used by 
the author to estimate weekly intake of food items and groups. The ALSPAC FFQ was 
more extensive than the iodine-specific FFQ used in the Royal Surrey Study and covered 
43 different food items or groups commonly consumed in the UK (ALSPAC, 2011).
139
Chapter 6: Food sources of iodine
Women were questioned as to how often "nowadays”, food items were consumed and this 
was intended to reflect diet during pregnancy (Rogers & Emmett, 1998). As the ALSPAC 
FFQ was designed to give a generic picture of diet in pregnancy rather than at a speciflc 
pregnancy time-point (Rogers & Emmett, 1998), the author decided to compare food intake 
with iodine status (iodine/creatinine ratio) in all 951 ALSPAC women, rather than to 
conduct a sub-analysis by trimester.
The FFQ had five frequency options, "Never or rarely”, "Once in two weeks”, "1-3 times 
per week”, "4-7 times per week”, or "more than once per day” and these frequencies were 
scored as weekly portions: 0, 0.5, 2, 5.5 and 10 respectively (Rogers & Emmett, 1998). The 
FFQ also asked how many pieces of bread were consumed daily with options of "Less than 
1” "1-2 pieces” "3-4 pieces” or "5 or more”; these options were converted to a daily 
estimate of bread portions: 0, 1.5, 3.5 and 6 respectively. The FFQ asked more detailed 
questions about milk consumption, assessing mothers’ milk consumption by asking about 
use of milk in (a) tea, (b) coffee, (c) on breakfast cereal, (d) as a pudding, (e) as a drink, (f) 
in a milky drink, with frequency options of "yes usually”, "yes sometimes”, "no, not at all”, 
which were scored as 1, 0.5 and 0 respectively.
As the ALSPAC FFQ was unquantified, the Food Standards Agency book of Food Portion 
Sizes (Food Standards Agency, 2002) was used by the author to estimate a medium portion 
for individual food items (e.g. carrots); for the FFQ items that included more than one food 
item (e.g. white fish or offal), an average was taken of the individual food items within the 
category and thus an average portion weight was estimated for all items in the FFQ (Table
6.3). Individual portion sizes used for these calculations are in Appendix 6.
Estimated weekly weights of each of the eight food groups were calculated by combining 
the estimated number of weekly portions with estimated portion weights. This method of 
converting the FFQ answers into portion data was based on previous work in ALSPAC 
(Rogers & Emmett, 1998). The individual foods were then combined into eight broad food 
categories, (1) Milk, (2) Dairy products and eggs, (3) Seafood, (4) Meat, meat products and 
poultry, (5) Potatoes, bread and grains, (6) Fruit and vegetables, (7) Pulses, nuts and soya, 
and (8) Sugary foods (Table 6.3).
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The weekly weights of food groups, except the pulses, nuts and soya group, were recoded 
into quartiles for the purposes of statistical analyses; intake of pulses nuts and soya was 
split into two equal groups due to the data distribution within this category. Eggs and dairy 
products were combined in the same category as the FFQ assessed frequency of egg 
consumption in combination with quiche; it was considered that there was an overlap with 
milk products. Although sugary foods would not be expected to contribute to iodine status, 
they were included as a proxy for an “unhealthy” diet in the adjusted analyses.
To be comparable with the Royal Surrey Study, daily milk intake (computed by dividing 
weekly milk intake by seven) was also recoded into the categories “None”, “Less than % 
pint”, “Va to % pint” and “More than % pint” and a goitrogen category was computed by 
combining estimated intake of cabbage, sprouts, root vegetables (e.g. turnips), and soya.
Statistical analysis for ALSPACfood sources of iodine
Values of the iodine/creatinine ratio were not normally distributed even after log 
transformation and therefore median and interquartile range (IQR) are reported and non- 
parametric tests were conducted. The Kruskal-Wallis test was used to compare the 
iodine/creatinine ratio between quartiles of estimated intake of food groups.
It was not possible to analyse relationships between food groups and iodine status using 
linear modelling as the iodine variable failed the assumption of normality for linear 
regression or general linear models. Adjusted analyses were conducted using logistic 
regression, with the binary iodine categorical variable (adequate/deficient iodine status) as 
the dependent variable. The independent factors in the model included all food groups (as 
quartiles), as well as maternal characteristics that showed trends with iodine status (from 
Chapter 3): maternal age (years), maternal education (low, medium and high) and smoking 
status in pregnancy (non-smoker/smoker); smoking status was recoded as either “smoker” 
or “non-smoker” as there were no significant differences between those who smoked prior 
to pregnancy and non-smokers (see Chapter 3).
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Table 6.3 ALSPAC average portion size for individual foods within food groups
Food group Individual foods Average Portion (g)
Milk Milk in tea and coffee 30
Milk on cereal 100
Milk in puddings 150
Milk as a drink 200
Milky drinks 260
Dairy and Eggs Butter 5
Cheese 40
Egg 100
Seafood White Fish 134
Oily Fish 110
Shellfish 74
Meat, meat products  ^ Sausages, burgers 78
and poultry Pies, pasties 145
Meat 90
Poultry 100
Offal 106
Potatoes, bread and Roast Potatoes 200
grain Boiled/Mashed/ Jacket Potatoes 170
Chips 165
Crisps 27
Rice 180
Pasta 245
Pizza 230
Oat cereals 113
Wholegrain cereals 36
Other cereals 30
Crispbread 20
White bread slice 36
Wholemeal bread slice 36
Chapattis, Naan bread 108
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Table 6.3 (continued) ALSPAC average portion size for individual foods within food groups
Food group Food Group Average Portion (g)
Fruit and Vegetables Baked Beans 135
Peas 92
Cabbage/Sprouts 92
Other green vegetables 85
Carrots 60
Root vegetables 63
Salad 46
Fruit 114
Fruit Juice 160
Pulses, nuts soya Pulses 100
Nuts 50
Tofu 80
Tahini 20
Soya meat 56
Sugary foods Pudding 141
Cakes 63
Biscuits 13
Chocolate bars 54
Chocolate 50
Sweets 40
6.3 Results
6.3.1 Effect of dietary exclusions on iodine status
None of the participants reported being a vegan, but there were five vegetarians (5%) and 
one pescatarian (excludes meat and poultry but consumes fish) (1%). Only two women 
reported avoiding dairy foods (2%), while 12 women did not eat fish (12%).
As there was only one pescatarian, this sample was excluded for the purposes of comparing 
iodine status in vegetarians and omnivores. There was no significant difference in the 
iodine/creatinine ratio of omnivores and vegetarians [median 122.9 vs. 113.2 pg/g; t(97) = -
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0.14, p = 0.88]. There was also no difference in the iodine/creatinine ratio between those 
who did or did not report consuming fish [median 122.9 vs. 123.1 pg/g ; f(98) = 0.32, p = 
0.75]. The median iodine/creatinine ratio was lower (though not statistically significantly) 
in those who avoided dairy products than in the rest (median 82.2 v& 125.8 pg/g; /'(98) = 
0.32, p = 0.90, p = 0.37 ) but results should be interpreted with caution as only two women 
reported avoiding dairy products.
6.3.2 Use of an iodine-containing supplement
Seventy-five participants (75.0%) in the Royal Surrey Study were taking a nutritional 
supplement at the time of recruitment (including single folic acid supplements); a total of 
51 (51.0%) women were taking a multivitamin or mineral supplement but only 42 women 
(42.0%) were on a prenatal vitamin and mineral formulation that contained iodine (Table 
6.2). The median content of iodine in the supplements reported by the participants of the 
Royal Surrey Study was 140 pg/tablet (range 75-150). The most popular supplement brand 
was Pregnacare (or Pregnacare plus) and was taken by 37 of the 42 women (88.0%) taking 
an iodine-containing supplement.
The iodine status of women who took an iodine-containing supplement was significantly 
higher than in those who did not take such a supplement; this relationship was 
demonstrated using both the simple iodine concentration measure [median 111.0 vs. 60.9 
pg/L; t(98) = 3.63, p<0.0001, r = 0.34] and the iodine/creatinine ratio [median 149.3 vs. 
101.5 pg/g; /(98) = 3.99, p<0.0001, r = 0.37]. This is shown graphically in Figure 6.1 which 
also shows the WHO recommended levels for a population of pregnant women (WHO et 
a l, 2007; WHO Secretariat et al., 2007).
There was a significant difference [%^ (2) = 9.47, p = 0.02] in the proportion of women 
classified as having adequate iodine status (iodine/creatinine ratio >150 pg/g) between 
those who took an iodine-containing supplement (63.6%) and those who did not (36.4%). 
Of the women who did not take an iodine-containing supplement, 79.3% were classified as 
having an inadequate iodine status.
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Figure 6.1 Iodine status of women by use of iodine-containing supplement. Hatched bars represent 
iodine concentration (pg/L), solid bars represent iodine/creatinine ratio (pg/g). a\ iodine/creatinine 
ratio significantly lower than that of women taking an iodine-containing supplement (p<0.0001). h\ 
UlC significantly lower than that of women taking an iodine-containing supplement (p<0.0001)
(analysis on log-transformed data).
None of the women in ALSPAC reported use of a specific iodine or seaweed supplement 
during pregnancy and, although 414 women (43.5%) reported taking a vitamin or mineral 
supplement during pregnancy, the actual brand or composition of this supplement was not 
known. In view of there being no separate recommendation for iodine in pregnancy in the 
UK nutrient recommendations that were published around the time of ALSPAC recruitment 
(Department of Health, 1991), it is most unlikely that any prenatal supplement available in 
the 1990s would have contained iodine.
6.3.3 Dietary influences on iodine status 
Iodised salt
Iodised salt use was not recorded in ALSPAC. Iodised salt was rarely/never used by 96% 
of women in the Royal Surrey Study, and the iodine/creatinine ratio was not significantly 
different between consumers and non-consumers [/(98) = -0.33, p = 0.75, r = 0.003].
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Seaweed
Seaweed consumption was not investigated by the ALSPAC FFQ. A high percentage (86%, 
n = 86) of participants of the Royal Surrey Study never or rarely consumed seaweed and 
only four women reported consuming seaweed more than once a week (4%). Seaweed 
consumption did not influence urinary iodine excretion [/(98) = 1.21, p = 0.23, r = 0.12].
Milk and dairy products
In Royal Surrey Study participants, the correlation between estimated quantity of dairy 
products and maternal iodine/creatinine ratio was positive, but not statistically significant 
(rs = 0.16, p = 0.11). Although iodine status was higher in quartile four of dairy intake than 
quartile one (Table 6.4), the difference between quartiles was not significant [F(3, 96) = 
0.93, p = 0.43, r = 0.17] and there was no linear trend in iodine status within the quartiles, 
[F a , 99) = 2.75, p = 0.10].
Milk showed a much stronger correlation to maternal iodine/creatinine ratio than any other 
food group (rs = 0.29, p = 0.004) and approached a medium effect size. The difference in 
iodine status between the categories of milk consumption was highly significant and had a 
medium effect size [F(3, 96) = 4.34, p = 0.007, r = 0.35]; the Bonferroni post hoc test 
showed that women who did not consume milk had a significantly lower iodine status than 
those consuming more than % pint per day (p = 0.008). There was a significant linear trend 
between categories of milk consumption and iodine status \F(l, 99) = 12.38, p = 0.01], 
suggesting that as milk consumption increased, iodine status also increased, and this is 
evident when examining the median iodine/creatinine ratios for each category of milk 
consumption (Table 6.4).
One woman reported consuming % to 1 pint of goats’ milk per day, and her 
iodine/creatinine ratio was an outlier, at 1149.6 pg/g.
When intake of dairy products, seafood, meat and poultry, maternal age, frequency of egg 
consumption and the use of an iodine-containing supplement were controlled for, the 
categories of milk volume were significantly related to iodine/creatinine ratio with a 
medium effect size [F(3, 99) = 5.19, p = 0.002, r = 0.33] and a trend was evident of
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increasing iodine/creatinine ratio with increasing daily milk consumption (Figure 6.2) when 
plotting the (back transformed) adjusted means.
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Figure 6.2 Adjusted geometric means (95% Cl) of iodine/creatinine ratio by maternal milk intake 
in participants of the Royal Surrey Study [adjusted for frequency of egg intake, maternal age (yrs), 
use of iodine-containing supplement, weekly estimated intake of dairy (g), meat and poultry (g),
and seafood (g)].
In ALSPAC, estimated weekly milk intake showed the strongest correlation of all the 
dietary eomponents in the FFQ with the urinary iodine/ereatinine ratio (r^  = 0.13, p<0.001), 
but the eorrelation was weak. Other dairy products were not significantly correlated with 
urinary iodine/creatinine ratio (rs = 0.10, p = 0.77). Iodine status was higher in quartile 4 
than in quartile 1 of dairy and egg intake (median 132.0 vs. 122.1 pg/g), but the difference 
was not significant (p = 0.12, Table 6.5).
The only food group in the ALSPAC to show a significant difference in iodine/creatinine 
ratio between quartiles was weekly milk intake [%^ (3) = 21.11 p< 0.0001, Table 6.5]. 
Women with a milk intake in quartile 1 had a significantly lower iodine/creatinine ratio 
than those in quartile 2 (U= 22892.5, z = -3.55, p <0.0001, r = 0.16), quartile 3 (U= 24090, 
z = -2.75, p = 0.006, r = 0.13), and quartile 4 (U= 21816.5, z = -4.24, p <0.0001, r = 0.19) 
(Table 6.5) (Bonferroni correction: p<0.008).
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Figure 6.3 shows the iodine status of women in ALSPAC by estimated daily milk intake 
(recoded as in the Royal Surrey Study). The values are not adjusted for the influence of 
other dietary components but the data suggest that iodine status increases with higher milk 
consumption (though the increases are not proportional between categories). These findings 
support those for milk intake in the Royal Surrey Study.
ÿ . 100-
None Less than 1/4 pint 1/4 to 1/2 pint
Maternal daily milk consumption
More than 1/2 pint
Figure 6.3 Daily maternal milk consumption in ALSPAC participants and relationship with urinary 
iodine/creatinine ratio. The median values are unadjusted for other dietary influences.
Seafood
Total seafood intake (white, oily, shellfish and fish roe) was signifieantly correlated with 
the iodine/creatinine ratio (r^  = 0.21, p = 0.03) in the samples from women in the Royal 
Surrey Study, although the effect size was small. Of the individual components of the 
seafood category, the strongest correlation with iodine status was with white fish intake (rs 
= 0.19, p = 0.06), with a slightly weaker eorrelation with oily fish (rs = 0.17, p = 0.09) and 
shellfish (rs = 0.12, p = 0.24), although all effect sizes are classified as small. 
Iodine/creatinine ratio differed significantly (medium effect size) between quartiles of total 
seafood intake [F(3, 96) = 4.85, p = 0.003, r = 0.36] and the Bonferroni post-hoc test 
showed that iodine status was signifieantly lower in quartile 1 than in quartile 3 (p = 0.04)
148
Chapter 6: Food sources of iodine
but not lower than quartile 4 (Table 6.4). There was also a significant linear trend between 
quartiles of total seafood and maternal iodine status \F(\, 99) = 6.81, p = 0.01].
In ALSPAC, white fish intake was not significantly correlated with iodine status, but there 
was a positive correlation between oily fish intake (rs = 0.08, p = 0.02), and shellfish intake 
(rs= 0.07, p = 0.02), with maternal iodine/creatinine ratio, although the effect sizes of both 
correlations were very small. When white fish, oily fish and shellfish were combined to 
give “seafood” the correlation with iodine status was positive but was still weak (rs = 0.07, 
p = 0.03). The iodine/creatinine ratio was higher in quartile 4 (median 133.4 pg/g) of total 
seafood intake compared to quartile 1 (median 119.1 pg/g) but the differences were not 
significant (p = 0.21 ; Table 6.5).
Meat and Poultry
The weekly estimated weight of total meat and poultry consumption (grams) was not 
correlated with the iodine/creatinine ratio (rs = 0.11, p = 0.27) in the Royal Surrey Study. 
The iodine/creatinine ratio did not differ between quartiles of total meat and poultry intake 
per week [F(3, 96) = 1.16, p = 0.33, r = 0.19] but the linear trend between quartiles 
approached significance [F(\, 99) = 2.53, p = 0.12].
There was no significant difference in the iodine/creatinine ratio between quartiles of meat, 
meat products and poultry intakes in ALSPAC, (3) = 2.00, p = 0.57] and no correlation 
between iodine/creatinine ratio and total meat and poultry intake (rs = -0.03, p = 0.42).
Eggs
Iodine status differed significantly with frequency of egg consumption in the participants of 
the Royal Surrey Study, [F(3, 96) = 2.79, p = 0.04, r = 0.28] and a post-hoc Bonferroni test 
revealed that iodine status was lower (and approached statistical significance) in those who 
did not consume eggs than in those consuming eggs five to seven times weekly (p = 0.06; 
Table 6.4). The linear test was highly significant \F(\, 99) = 7.45, p = 0.008], suggesting 
that as frequency of egg consumption increased, maternal iodine status also rose (Table
6.4).
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Nuts, pulses aud soya
The Royal Surrey Study analyses found no significant correlation between iodine status and 
the intake of Brazil nuts and peanuts combined (rg = -0.01, p = 0.92). Soya milk intake was 
consumed regularly by 3% of the Royal Surrey Study participants but there was no 
correlation between iodine status and intake of soya milk (rg = -0.02 p = 0.87) or with tofu 
(rg = 0.02 p = 0.84) or other soy products (rg = 0.09 p = 0.36).
In ALSPAC, pulses (rg = 0.07 p = 0.02) and soya-meat burgers (rg = 0.07 p = 0.04) were 
significantly though very weakly correlated with iodine/creatinine ratio. There was no 
significant correlation between weekly intake of nuts and iodine status (rg = -0.03 p = 0.45). 
Iodine/creatinine ratio did not differ between total intake of nuts, pulses and soya foods 
above or below the median value (123.4 vs. 122.1 pg/g, U = 111284, z = -0.41, p = 0.68).
Potatoes, bread aud graius
This food category was not evaluated in the Royal Surrey Study FFQ. In ALSPAC, oat (rg = 
0.07 p = 0.03), and wholegrain breakfast-cereal intake (rg = 0.09 p = 0.008) demonstrated a 
weak positive, but significant, correlation with maternal iodine/creatinine ratio. Boiled and 
baked potatoes also showed a weak positive correlation with iodine status (rg = 0.07 p = 
0.02). However, when combined into the category of potatoes, bread and grains, 
iodine/creatinine ratio did not differ between quartiles (Table 6.5).
Fruit aud Vegetables
Fruit and vegetable consumption was not recorded in the Royal Surrey Study. In ALSPAC, 
green vegetables (rg = 0.08 p = 0.02) and carrots (rg = 0.10 p = 0.003) showed positive 
correlations with iodine status (albeit with a small effect size). The iodine/creatinine ratio 
was significantly different between the quartiles of fruit and vegetable intake (3) = 
10.12, p = 0.02] and the post-hoc analysis (with Bonferroni correction) revealed that 
women with an intake of fruit and vegetables in the bottom quartile had a significantly 
lower iodine/creatinine ratio than women in the third quartile (U = 23608.5, z = -3.07, p = 
0.02, r = 0.14); all other post-hoc comparisons were non-significant.
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Goitrogens
Total goitrogen intake did not correlated with the urinary iodine/creatinine ratio in either 
the Royal Surrey Study (rg = -0.007, p = 0.95) or ALSPAC (rg = 0.05, p = 0.12). Iodine 
status ratio did not differ between quartiles of weekly goitrogen intake in the Royal Surrey 
Study [F(3, 96) = 0.12, p = 0.95, r = 0.06] or ALSPAC (3) = 3.66, p = 0.30].
Sugary foods
Consumption of sweets and chocolate was not recorded in the Royal Surrey Study FFQ. In 
ALSPAC, chocolate bar intake was correlated significantly (but weakly) with 
iodine/creatinine ratio (rg = 0.09 p = 0.006). There was no difference in iodine/creatinine 
ratio between quartiles of sugary food intakes (3) = 1.86, p = 0.60],
Overall dietary iuflueuces ou maternal iodine status
In the Royal Surrey Study, the adjusted analysis showed that the only factors significantly 
associated with maternal iodine/creatinine were categories of milk consumption [F(3, 99) = 
5.19, p = 0.002, r = 0.33], maternal age in years [F(l, 99) = 6.75, p = 0.01, r = 0.22], and 
use of an iodine supplement [F(l, 99) = 14.03, p <0.0001, r = 0.32]. The model explained 
29.6% of the variance in iodine/creatinine ratio (adjusted R  ^= 0.296). Milk explained 11% 
and iodine supplement use explained 10% of the variance in iodine status.
In ALSPAC, milk was the only dietary factor that showed a significant relationship with 
iodine status in the adjusted analyses. The risk of iodine deficiency (iodine/creatinine <150 
pg/g) was 46% lower in women who were in the top rather than the bottom group of milk 
intake, after adjustment for other dietary and maternal factors (OR 0.54, 95% Cl 0.36-0.81, 
Table 6.6); there was a trend for decreasing risk of deficiency with increasing milk intake 
(p = 0.02). Even after adjustment for diet, the relationship between smoking in pregnancy 
and lower risk of iodine deficiency persisted (OR 0.56, 95% Cl 0.36-0.86), as did the 
relationship with increasing maternal age, although the effect size was small (OR 0.96, 
95% Cl 0.93-0.99) (Table 6.6). The model explained only 7.2% of the variance in 
iodine/creatinine values (26) = 51.01, p = 0.002; Nagelkerke R  ^= 0.072]
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Table 6.4 lodine/creatinine ratio according to maternal diet in women of the Royal Surrey Study
(unadjusted analyses)
Food group lodine/creatinine (pg/g)* ANOVA (p value)
Daily milk intake (n)
None (n = 7) 67.8 (43.7, 100.5) 0.007
< % pint (n = 24) 107.4 (71.7, 162.2)
% to 16 pint (n = 41) 127.3 (82.4, 163.3)
More than % pint (n = 28)
Quartiles of weekly dairy intake (g)
139.3 (103.5,291.0)
Quartile One (0-340g) 113.1 (69.4,161.1) 0.43
Quartile Two (341-545g) 96.4 (74.1,258.8)
Quartile Three (546-920g) 130.9 (84.3, 171.2)
Quartile Four (921g+)
Quartiles of weekly seafood intake (g)
141.8(91.5, 165.0)
Quartile One (0-40g) 108.1 (61.1, 152.0) 0.003
Quartile Two (41-313g) 87.0(59.9, 2.1)
Quartile Three (314-467g) 145.5 (107.8, 292.5
Quartile Four (468g+) 131.0 (91.6, 162.6)
Quartiles of weekly total meat and poultry intake (g)
Quartile One (0-5 5 8g) 102.5 (71.1, 139.3) 0.33
Quartile Two (559-73 5g) 130.9 (89.2, 176.6)
Quartile Three (736-869g) 133.0 (82.5, 165.8)
Quartile Four (870g+)
Frequency of egg consumption (n)
125.7 (75.4, 240.3)
None (n = 8) 88.8 (54.0, 114.9) 0.04
Once a fortnight (n = 23) 102.5 (71.3, 159.4)
One-four times/week (n = 64) 135.6 (84.8, 179.4)
Five to seven times/week (n = 5) 
Quartiles of weekly goitrogen intake (g)
130.2 (92.4, 723.2)
Quartile One (0-270g) 120.1 (76.5, 220.5) 0.95
Quartile Two (271-445g) 126.0(84.7, 157.0)
Quartile Three (446-7 lOg) 125.7(75.3, 224.8)
Quartile Four (711+) 113.2(72.3, 175.6)
Tigures are median (IQR). Composition of each food group is listed in Section 6.2.1
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Table 6.5 Comparison of iodine status aceording to quartiles of food groups in 
ALSPAC women (unadjusted analyses)
Food group lodine/creatinine (pg/g)* K-Wf (p value)
Weekly Milk intake (g)
Quartile One (0-1883) 102.9(69.9-166.5)
Quartile Two (1884-2617) 135.8(80.3-217.2)
p< 0.0001
Quartile Three (2618-3260) 124.9(82.4-179.1)
Quartile Four (3261+) 
Weakly seafood intake (g)
130.6(88.8-211.3)
Quartile One (0-67g) 119.1 (72.5-179.9)
Quartile Two (68-257) 116.7(82.8-190.9)
0.21
Quartile Three (258-323) 126.2 (82.4-192.8)
Quartile Four (324+)
Weekly dairy and egg intake (g)
133.4(81.8-204.3)
Quartile One (0-220) 122.1 (75.3-202.1)
Quartile Two (220-280) 127.2(84.1-196.7)
0.12
Quartile Three (280-420) 113.6(74.7-179.6)
Quartile Four (420+) 132.0(89.6-188.7)
Weekly meat, meat products and poultry (g)
Quartile One (0-357) 123.3(81.3-211.3)
Quartile Two (358-477) 124.6(77.5-188.0)
0.57
Quartile Three (478-704) 124.5 (78.5-191.1)
Quartile Four (705+) 117.4 (80.8-182.9)
Weekly fruit and vegetable intake (g)
Quartile One (0-1687) 105.5 (70.4-189.3)
Quartile Two (1689-2287) 118.3 (82.4-177.1)
0.02
Quartile Three (2288-2992) 135.5 (87.3-211.3)
Quartile Four (2993+) 122.1 (83.6-193.0)
Weekly intake of potatoes and grain (g)
Quartile One (0-1964) 116.2 (75.1-179.6)
Quartile Two (1964-2489) 124.5 (78.0-211.3)
0.41
Quartile Three (2490-3022) 122.2 (82.9-186.6)
Quartile Four (3023+) 130.6 (82.3-I9I.4)
Tigures are median (IQR). Composition of each food group is described in Section 6.2.2. f  Kruskal-Wallis
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Table 6.6 Risk of iodine deficiency in ALSPAC women by dietary patterns (adjusted for
dietary and maternal factors)
lodine/creatinine <150 pg/gj 
OR (95% Cl) p value (trend)
Weekly milk intake (g)
Quartile One 1
Quartile Two 0.55 (0.37,0.81)
0.02
Quartile Three 0.68(0.46,1.01)
Quartile Four : 0.54(0.36,0.81)
Weekly dairy and egg intake (g)
Quartile One 1
Quartile Two 1.20(0.82,1.75)
0.21
Quartile Three : 1.47(0.99,2.19)
Quartile Four 1.20(0.80,1.81)
Smoker vf. non-smoker : 0.56 (0.36-0.86) 0.01
Maternal age (yrs) : 0.96 (0.93-0.99) 0.01
$ Variables included in the model: All variables in the table with: quartiles of: seafood intake, meat and 
poultry, potatoes and grain, sugary foods, pulse and soya and maternal education (low, medium, high).
6.4 Discussion
6.4.1 Dietary patterns and iodine-containing supplements 
Vegetarians and vegans
The Royal Surrey Study did not find a significant difference in iodine status between 
vegetarians and omnivores. However, as the median iodine/creatinine figure was lower in 
the vegetarian women than the omnivore women, a lack of power from small number of 
vegetarians may explain why the difference was not statistically significant. To the author’s 
knowledge, this is the first study that has evaluated the difference in iodine status between 
vegetarians and omnivores in pregnant women [previous research with this aim failed to 
recruit vegetarians (Costeira g/ a/., 2009)], and while lacto-ovo vegetarian diets, in a cross­
over experimental study design, have demonstrated a potential for low iodine intake 
(Remer g/ a/., 1999), research in adults has failed to indentily vegetarians as being at a 
higher risk of deficiency than omnivores (Draper c/ a/., 1993; Rasmussen c/ a/., 2002; 
Leung cr a/., 2011).
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Iodine-containing supplement
Influence on iodine status
The 42 women in the Royal Surrey Study who reported taking an iodine-containing 
supplement had a significantly higher iodine status than women who did not take such a 
supplement, supporting the original hypothesis. The median iodine concentration in those 
taking an iodine-containing supplement (111.0 pg/L) was closer to the adequate range 
suggested by the WHO for pregnant women (150-249 pg/L) than that in women not taking 
such a supplement (60.9 pg/L), which was close to the severe deficiency level (50 pg/L) 
(Zimmermann, 2007a). After adjusting for urinary creatinine concentration the median 
(149.3 pg/g) for women taking an iodine-containing supplement was close to the lower end 
of the range indicating iodine adequacy in pregnancy (WHO Secretariat et a l, 2007), 
suggesting that the use of such a supplement can improve iodine status in pregnancy.
The higher urinary iodine excretion in pregnant women consuming an iodine supplement is 
consistent with other research in Europe (Alvarez-Pedrerol et a l, 2009; Marco et a l, 2010) 
and New Zealand (Pettigrew-Porter et a l, 2011).
The finding that risk of suboptimal iodine status in pregnancy is lower with iodine 
supplement use supports arguments from many scientists that women should routinely be 
supplemented with iodine in countries with a risk of deficiency (Glinoer, 2004; Morreale de 
Escobar et a l, 2004; Berbel et a l, 2007; de Escobar et a l, 2007; Kung, 2007; Berbel et a l,
2009). The American Thyroid Association (ATA) and the Food Standards Agency of 
Australia and New Zealand recommend that all pregnant (and lactating) women should take 
150 pg/d of iodine (as potassium iodide) during pregnancy (Becker et a l, 2006; NHMRC,
2010). The results from the Royal Surrey Study suggest that the UK Government should 
consider giving similar advice.
Kelp supplements are not recommended during pregnancy owing to the natural variability 
of iodine concentration in kelp which means that the concentration can vary widely from 
the stated value (Lee et a l, 1994; Zimmermann & Delange, 2004; Leung et a l, 2009); none 
of the women in the Royal Surrey Study reported use of kelp supplements so their effect on 
iodine status could not be evaluated.
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Use of iodine-containing supplement in UK pregnant women
Despite the fact that 51 women in Royal Surrey Study were taking a multivitamin and 
mineral prenatal supplement, only 42 of those 51 women were taking a supplement that 
contained a dose of iodine. These findings reflect the fact that (at that time) only 67% of 
UK prenatal supplements contained iodine, though this is a higher percentage than in 
prenatal supplements in the US (51%) (Leung et a l, 2009). A higher percentage of UK 
pregnant women were taking an iodine-containing supplement than were women in the US 
NHANES 2001-2006 (20%) (Gregory et a l, 2009; Perrine et a l, 2010), Switzerland (15%) 
(Andersson et a l, 2010), Spain (40%) (Mian et a l, 2009), New Zealand (23%) (Pettigrew- 
Porter et a/., 2011) and Australia (35%) (Charlton et a l, 2010). Most UK pregnant women 
are unaware of the need for iodine and the iodine content of the supplement is unlikely to 
influence brand choice. A popular UK prenatal supplement is Pregnacare (taken by 88% of 
women using a multimineral supplement in the Royal Surrey Study), which contains 140 
pg iodine, and this may explain the higher prevalence of women taking iodine during 
pregnancy in the UK than in other countries. In addition, Surrey is an affluent area (Office 
of National Statistics, 2010) and supplement use may be higher than in other UK regions as 
there is a socio-economic bias in UK supplement use (Henderson et a l, 2002).
6.4.2 Contribution of foods to iodine status in pregnancy 
Milk
The finding that a higher intake of milk was related to a higher urinary iodine excretion 
supports the original hypothesis and is consistent with studies in pregnancy in other 
countries (Brantsaeter et a l, 2007; Mian et a l, 2009; Alvarez-Pedrerol et a l, 2010; Perrine 
et a l, 2010). In Italy, UlC was significantly higher in milk consumers than in non­
consumers, and milk was the only dietary component related to iodine status in regression 
analysis that accounted for other dietary influences (Mian et a l, 2009); Mian and 
colleagues recommended that pregnant women should consume at least 300 ml of milk per 
day to provide one third of their requirements (Mian et a l , 2009); this suggested volume is 
in line with the finding in the Royal Surrey Study that women consuming more than V2 pint 
(280 ml) per day had an iodine status that was above the cut-off for iodine adequacy in 
pregnancy, even after adjusting for other dietary and maternal factors. In ALSPAC, the
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consumption of % pint milk was associated with a lower iodine status than in the Royal 
Surrey Study; this is surprising as the Royal Surrey Study was carried out in the summer 
when milk has a lower iodine content (Nelson et a l, 1988; Phillips, 1997), whereas 
ALSPAC women were recruited all year round. The difference in findings may reflect the 
difference in the methods used to estimate milk volume intake in the two studies.
Goats* milk
The one outlier in the Royal Surrey Study was a woman who reportedly consumed a high 
volume (up to 1 pint) of goats’ milk daily which is interesting in the context of the Food 
Standards Agency (2008) report that goats’ milk had a higher iodine concentration than 
cows’ milk (Food Standards Agency, 2008). However, as only one participant reported 
using goats’ milk, further study is required to confirm that this milk type may be associated 
with a high iodine status.
Dairy products
Dairy products showed a positive association with iodine status in the Royal Surrey Study, 
although this was not sustained in the adjusted analysis. Consumption of eggs and dairy 
products was not significantly associated with iodine status in ALSPAC. It is important to 
note that this category was incomplete and possibly more inaccurate than other food groups 
for two reasons:- (i) the dairy category was only based on egg, cheese and butter intake, as 
there was no information in the ALSPAC FFQ on yoghurt or cream intake, and (ii) the 
estimation of butter intake was calculated in a different way to that of other food items, 
being based on the use of butter (rather than other fat types) for frying and spreading on 
bread; these factors may have resulted in spurious associations.
Fish
In support of the fact that white fish has been shown to have a higher iodine content than 
oily fish in both Norway (Dahl et a l, 2004) and the UK (Chapter 9, Table 9.1), the 
correlation was stronger between iodine status of the Royal Surrey Study women and 
reported intake of white fish than with other fish categories, although the relationship was 
weak. Iodine status was higher in women who had fish intake in the top two quartiles, but 
the relationship was no longer significant when adjusted for other dietary factors. By
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contrast, seafood intake was not related to iodine status in the women in ALSPAC, 
although the unadjusted analyses suggested a higher iodine status in the top than in the 
bottom quartile of seafood. The significant correlations between iodine status and oily fish 
and shellfish in ALSPAC were too small to be biologically relevant. One possible 
explanation for the lack of a strong relationship between fish intake and iodine status in 
both studies (compared to the observed relationships with milk intake, despite its lower 
iodine concentration) is the insensitivity of the FFQ (see Section 6.4.3).
Seafood intake has also failed to show associations with iodine status of pregnant women in 
Spain (Costeira et a l, 2009; Alvarez-Pedrerol et a l, 2010) and Italy (Alvarez-Pedrerol et 
a l, 2010), both assessed with an FFQ, although those studies did not correct the spot-urine 
sample for creatinine concentration. A Norwegian adult study showed that fish 
consumption was not related to iodine excretion when milk and dairy products were 
included as covariates (Brantsaeter et a l, 2010). Iodine status of adolescent girls has been 
shown to be unrelated to fish intake in both Iceland (Gunnarsdottir et al ,2010) and the UK 
(Vanderpump et a l, 2011). By contrast, in adjusted analyses, fish consumption was related 
to iodine excretion in Danish adults (Rasmussen et a l, 2002) perhaps because the FFQ 
included many questions on fish consumption (n = 25) and the authors suggest that this 
may have overestimated fish intake (Rasmussen et a l, 2001). A positive association was 
also demonstrated between fish and iodine status in the US (Leung et a l, 2007).
Meat and poultry
Meat and poultry were not associated with iodine status in either ALSPAC or the Royal 
Surrey Study, a finding that echoes results in pregnant women in Italy (Mian et a l , 2009) 
and adolescent girls in the UK (Vanderpump et a l, 2011). In contrast to the findings 
presented here, meat intake (assessed with a food diary) was positively associated with UIC 
(measured in a 24-hour urine sample) in German schoolchildren (Remer et a l, 2006).
Other food items
Although the unadjusted analysis suggested that oat and wholegrain cereals were associated 
with iodine status in women in ALSPAC, this association disappeared on adjustment and 
when cereals were combined into the broad food group of potatoes, cereals and grains. The
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unadjusted analyses are most likely confounded by milk intake as breakfast-cereal 
consumption is highly correlated with milk use.
Fruit and vegetables were associated with iodine status in ALSPAC women in the 
unadjusted analysis, most likely because they are correlated with other iodine-rich food 
sources (e.g. fish) and are a marker for a healthy, nutrient-rich diet. This suggestion is 
supported by the fact that the association disappeared when adjusted for other dietary items 
and maternal characteristics. In addition, the iodine concentration of fruit and vegetables 
measured in UK Total Diet Studies (Introduction, Section 1.6.1) is low and they are 
therefore unlikely to contribute significantly to iodine status.
Seaweed
There was no information collected in ALSPAC on seaweed use, but data from the Royal 
Surrey Study suggest that seaweed is not an important source of iodine for pregnant women 
in the UK, with 86% of participants reporting never or rarely consuming it, and only 4% 
consuming seaweed more than once per week. Perhaps unsurprisingly, given the low 
numbers of consumers, there was no difference in iodine status between those who did, or 
did not, consume seaweed.
Pregnant and lactating women and children in Australia have been advised against the 
regular consumption of brown seaweed (including kelp), and to consume no more than one 
portion per week (Food Standards Australia and New Zealand (FSANZ), 2011). This 
advice is based on the high iodine concentration in brown seaweed, and on a study that 
suggested that neonatal thyroid dysfunction was caused by daily ingestion of 500 ml of 
Bonsoy milk (a soya-milk brand with a high iodine concentrations at 25000 pg/L) by the 
mother during late gestation and lactation, and also by the maternal consumption of 
seaweed soups (Crawford et a l, 2010).
Iodised salt
In contrast to the finding in the Royal Surrey Study, that there was no difference in iodine 
status between those who did and did not use iodised table salt, pregnant women in Italy 
who used iodised salt had a significantly higher iodine status that non-users of iodised salt 
(median 94 v^ -. 75 pg/L, p = 0.02); the difference in the percentage of women reporting
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iodised salt use between the study in Italy and the Royal Surrey Study (up to 44.5% vs. 
4%), is the likely explanation for the different results. In Spain, duration of use of iodised 
salt was associated with a higher UIC (Vila et a l, 2011), thus highlighting the fact that 
iodised salt consumption can improve iodine status in pregnancy.
Iodine status was not different between consumers and non-consumers of iodised salt in 
Switzerland (Andersson et a l, 2010) or in Mexico (Garcia-Solis et a l, 2011), but in both of 
those studies the percentage of non-consumers was low (9% and 4.7%), thus statistical 
power was likely too low to detect differences between groups, as was probably the case in 
the Royal Surrey Study.
The fact that such a low percentage of pregnant women reported use of iodised salt in the 
Surrey Pregnancy study is perhaps a reflection of its poor availability in the UK, which the 
author has evaluated and discussed in Chapter 8. The finding supports earlier assertions that 
iodised salt consumption is less than 5% in the UK (Lazarus & Smyth, 2008).
Goitrogens and urinary iodine
As in the Royal Surrey Study and ALSPAC, no association was found between goitrogenic 
foods (assessed by FFQ) and iodine status in a study of pregnant women in Italy (n = 332) 
(Mian et a l, 2009). Dietary goitrogens (e.g. brassica vegetables) inhibit iodine uptake into 
the thyroid, and soy products may reduce the ability to produce thyroid hormones (through 
TPO inhibition, see Introduction, Section 1.6.5) (Zimmermann, 2009a), thus potentially 
depleting the thyroid of iodine stores; the expectation is that iodine excretion is lower in 
women who consume goitrogens, as ingested iodine is diverted to the thyroid to replenish 
iodine stores, rather than excreted through the renal route. However, it is likely that the 
quantity of potential goitrogenic foods consumed on average in the UK, and in the women 
in the Royal Surrey Study, is too low to affect iodine status. It is possible that intakes in 
high consumers of goitrogen-containing foods (such as vegans) may show a stronger 
relationship with iodine status than in the women in the Royal Surrey Study who mostly 
consumed an omnivorous diet.
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6.4.3 Limitations of a Food Frequency Questionnaire
The evaluation of the impact of diet on iodine status is limited by the inherent limitations of 
a FFQ. It is perhaps not surprising that some dietary items failed to show associations with 
iodine status given that urinary iodine excretion reflects recent (previous 24 to 48 hours) 
dietary iodine intake (Rasmussen et a l, 1999; Zimmermann, 2008b), and FFQs evaluate 
dietary intakes over a much longer time period (for example the entire pregnancy period for 
the ALSPAC FFQ). Thus consumption of foods consumed in a uniform and regular way, 
such as milk, are more likely to be reflected in the iodine concentration of a spot-urine 
sample than are other food items with infrequent and irregular consumption; it is possible 
that women who reported fish intake did not consume fish in 24-48 hours prior to the spot- 
urine sample collection, thus weakening the power to detect differences in these food 
groups. More accurate relationships between dietary patterns and iodine status may be 
established with repeated urine collections in the same women which would give a better 
estimation of her individual iodine status (Vejbjerg et a l, 2009a; Konig et a l, 2011).
Grouping of food items was used in the ALSPAC FFQ (for example eggs and quiche), 
though single items should be listed if they are of interest (Cade et a l, 2004). Despite the 
lower numbers, some associations between diet and iodine status were stronger in the 
Royal Surrey Study than in ALSPAC (e.g. for seafood). This may be due to the fact the 
Royal Surrey Study FFQ was designed specifically for iodine estimation and was semi- 
quantitative thus providing a more accurate estimation of food quantities consumed (Cade 
et a l, 2004); by contrast, estimated portion sizes were used in ALSPAC and these may 
have been considerably different from actual consumed values.
6.4.4 Future work
In view of the fact that the Royal Surrey Study only had a small number of women who 
avoided cows milk and regularly consumed soya milk, a study with a greater number of 
women consuming soya milk would increase the power to compare the effect on iodine 
status in view of both the goitrogenic property of soya and the low iodine content of soya 
milks.
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Given the high iodine content reported in goats’ milk (Food Standards Agency, 2008) and 
the fact that goats’ milk consumption in one woman in the Royal Surrey Study was 
associated with high iodine excretion, further study is required to evaluate if goats’ milk (or
sheeps’ milk) consumption is associated with altered iodine status.
Unfortunately, data were not collected on the use of organic dairy products in the Royal 
Surrey Study or ALSPAC. As iodine concentration is lower in organic milk and other
organic products (see Chapter 7), it is important to establish if women consuming organic 
products are at a greater risk of iodine deficiency; any future study that collects data on 
iodine status and diet should ascertain the use of organic milk.
6.5 Conclusions
Milk and iodine-containing nutritional supplements were the most important predictors of 
iodine status in UK pregnant women. The results suggests that Government advice to 
pregnant women for 2-3 daily portions of dairy products (including milk) and 1 -2 portions 
of fish per week would ensure a good supply of iodine and reduce the risk of iodine 
deficiency. Women should be encouraged to consume at least % pint (280ml) of milk daily 
to provide a good supply of iodine during pregnancy as the results from the Royal Surrey 
Study suggest that this significantly improved iodine status in pregnancy. Individuals with 
low intakes of iodine-rich foods should ensure an adequate iodine intake prior to pregnancy 
and, if this is not possible, an iodine supplement should be included in their diet.
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7. THREATS TO UK IODINE INTAKE: IODINE
CONCENTRATION OE ORGANIC F5. CONVENTIONAL 
MILK
A version of this chapter was published by the British Journal of Nutrition online on 7* 
July 2011 “Iodine concentration o f  organic and conventional milk: implications fo r  iodine 
intake ” (Bath et a7, 2011) and a copy is in Appendix 1.
7.1 Introduction
Milk and dairy products have played a pivotal role in the historic eradication of goitre in 
the UK (Phillips, 1997) and have subsequently been the most important sources of dietary 
iodine in this country, contributing as much as 42% of adult intake (Henderson er ür/., 
2003). Milk was shown to be an important predictor of iodine status in the pregnant women 
of the ALSPAC and Royal Surrey Studies (Chapter 3).
Although conventional milk is the usual choice, organic milk is increasing in popularity in 
the UK, because of perceived health and environmental benefits (The Soil Association, 
2010). Studies in Europe have shown conventional milk to have a higher iodine 
concentration than organic milk (Rasmussen e/ ür/., 2000; Dahl g/ a/., 2003), but no such
study has been conducted in Britain. In view of both the importance of milk to UK iodine 
intake, and targeted marketing of "health" benefits of organic milk to pregnant women and
mothers of young children (OMSCo, 2012), it is important to know the difference in iodine 
concentration between organic and conventional UK milk.
7.1.1 Aims and hypotheses
The study aimed to compare the iodine concentration in samples of organic and 
conventional milk available for purchase in the UK. In view of the regional distribution of 
iodine deficiency and goitre that was present until the 1960s, it was considered of interest 
to evaluate if the region of milk origin influenced milk-iodine concentration, as might be 
expected by the undoubted variation in soil iodine content, geology and farming practice.
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Secondary aims
• To examine differences in iodine content according to the supermarket chain and area 
in which they were purchased.
• To examine the effect of processing on milk iodine concentration.
Hypotheses
• Due to restrictions on animal feeding in organic farming, the iodine content of organic 
milk will be lower than that of conventional milk.
• Milk-iodine concentration will differ between regions of the UK due to likely variations 
in soil-iodine content and farming practice across the UK.
7.2 Methods
7.2.1 Milk collection
Milk was purchased in 16 regions of the UK (Methods, Section 2.5.1), chosen for the 
reasons explained below. In each supermarket, a sample of supermarket own-brand semi­
skimmed organic milk and own-brand semi-skimmed conventional milk were purchased. 
Aliquots (20 ml) were stored in Sterilin tubes at -80 °C at the University of Surrey until 
transport to LGC Ltd. for iodine analysis (Methods, Section 2.6.3).
Milk was deemed to be organic based on the label claim and if it had an organic 
certification symbol, such as that of The Soil Association (DEFRA, 2009). Retail milk was 
chosen, rather than farm-milk samples, as this is representative of the milk consumed by 
the public and results should thus be more relevant in terms of public-health. Furthermore, 
at the time of sample purchase, retail milk accounted for 94.6% of the market with only 
5.4% of milk accounted for by doorstop delivery (period ending April 2010) (DairyCo., 
2011).
Semi-skimmed milk was sampled as it represents the most popular milk choice in the UK 
(Henderson gf a/., 2002; DairyCo., 2011). The literature indicates that there are no 
significant differences in iodine concentration between skimmed, semi-skimmed and whole 
milk (Lee g/ a/., 1994; Ministry of Agriculture Fisheries and Food, 2000).
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Southern England was chosen for logistical reasons and because it includes areas of high 
population density such as the Home Counties and London; areas from South-West 
England were included in the survey as they represent important dairy farming regions 
(Foster et a l, 2007) as evidenced by the fact the South West has the highest milk quota 
[amount of milk a farm can sell before a levy is imposed (Rural Payments Agency, 2010)] 
of all UK regions (DairyCo., 2011) and therefore that region provides much of the milk 
consumed in the UK. An opportunity arose to source milk from Northern Ireland and two 
milk samples were purchased in Belfast.
In addition to supermarket own-brand milk, major milk brands of organic milk were 
purchased, with conventional milk alternatives where possible; three samples of each brand 
were purchased. Fewer samples of branded milk were purchased reflecting their lower UK 
market share (less than 20% of UK milk consumption at the time of study) (Dairy UK,
2010). The brands included Yeo Valley Organic milk, Rachel’s Organic milk, Calon Wen 
(Welsh Organic milk). Duchy Original Organic milk and both Country Life conventional 
and organic milk. To test the effect of processing on milk-iodine content, the ultra-heat 
treated milk brand. Moo, (organic and conventional milk) and the filtered conventional 
milk brand, Cravendale, were purchased. Brands of milk were not sampled from the 16 
areas of the UK, as the place of purchase is unlikely to influence milk-iodine content in 
view of the fact that the same specific farms are used to supply the milk for many brands; 
for example. Duchy Originals uses the “Home Farm” herd in Gloucestershire, and Country 
Life Organic uses milk from just 11 farms in the West Country (Country Life, 2010).
7.2.2 Information collected for each milk sample
The date of milk sample purchase, address of supermarket, and importantly the EU Food 
Identification Mark was recorded for each milk sample (Appendix 4). Since January 
2006, all premises which process milk and dairy products must be approved and these are 
allocated a unique EU identification mark (Food Standards Agency, 2009a). The EU 
identification mark is located on all milk labels and is a way of tracing the milk back to the 
last point of processing or packaging (Food Standards Agency, 2009a), it has three parts, 
the country of origin (UK), a site specific code (indicating the dairy) and ending with the 
letters “EC” indicating the European Commission (see Figure 7.1).
165
Chapter 7: Iodine content of organic and conventional milk
7.2.3 Determination of milk origin
The Food Standards Agency databases were searched to find the processing dairy which 
corresponded to the EU mark (Food Standards Agency, 2009a). For example, "'UK 
GS003MEO\ relates to Dairy Crest, Stonehouse.
S
Figure 7.1 Example of EU Identification mark (from Waitrose conventional milk).
The origin of milk was categorised as being from Wales, the West Country, Scotland, 
Northern Ireland, or of unknown origin. The origin was determined from the label; where 
the geographical source of the milk was stated (e.g. Milk from the West Country), this was 
assumed to be the case but otherwise, the EU Identification Mark was used to trace the milk 
to the processing dairy (Food Standards Agency, 2009a) and in conjunction with internet 
sources, the origin was determined where possible.
Waitrose state that all their organic milk is supplied from a dedicated group of West 
Country farmers (Waitrose, 2009b). All the Waitrose organic samples, and Duchy Original 
organic milk, had the EU code of SS210 (Appendix 4) which related to Coombe Farm in 
Crewkerne, Somerset, and Coombe Farm use milk that is sourced from the West Country 
(Coombe Farm, 2010). Yeo Valley milk is supplied from around 100 farmers in the South 
West (Yeo Valley, 2010) and Country Life milk is also from the West Country (Country 
Life, 2010). The organic Moo UHT milk is sourced from the South West of the UK (The 
Moo Team, Personal Communication, April 2010).
Calon Wen milk is provided through the Welsh organic milk co-operative and all milk is 
Welsh (Calon Wen, 2010). Despite the fact Rachel’s is a Welsh company, Rachel’s Milk is 
is not of Welsh origin and therefore Rachel’s milk was classified as of “unknown origin”.
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There were no conventional milk samples of Scottish origin, but eight of the 16 organic 
milk samples from Sainsbury’s had an EU identification mark indicating that the dairy was 
located in Scotland, but this was only the case for milk purchased in one-pint containers (if 
there was no stock of one-pint cartons, milk was purchased in a larger volumes). To 
confirm that the milk was of Scottish origin, telephone calls were made to the Food 
Standards Agency, and Environmental Health, Stirling Council, Scotland and an email was 
sent to Graham’s Dairy; Graham’s Dairy only supply organic milk for the Sainsbury’s one 
pint containers (Sainsbury's, 2010).
There were only two samples of milk of Northern Irish origin; these were processed at 
Pennybridge dairy (Northern Ireland) and sourced from local farms (Dale Farm, 2006).
A total of 55 samples of conventional and 65 samples of organic milk were considered to 
be of “unknown origin”. This was because specific information could not be determined 
from either the milk label or on the dairy website that could pinpoint the exact origin of the 
milk; the location of the dairy was not used as a proxy for milk origin, due to the known 
processing of milk from farms across a wide catchment area (Foster et a l, 2007).
7.2.4 Statistical analysis
UHT and filtered milk samples were excluded from the comparison of organic and 
conventional milk iodine-concentration and the regional analysis, in order to make valid 
comparisons with milk samples that had simply been pasteurised.
Organic and conventional milk-iodine concentrations were not normally distributed; data 
were therefore transformed using the natural logarithm, producing normally distributed data 
and this enabled parametric tests to be performed on the log-transformed data. Geometric 
means with their 95% Cl (computed by back transformation of log values) are reported 
along with the median and interquartile range (IQR).
Independent t tests and one-way AND VA (Bonferroni post-hoc testing) were used to 
compare groups. When the assumption of homogeneity of variances was failed (as 
determined by Levene statistic), Welch statistic is reported and Games-Howell tests were 
used for post-hoc analysis.
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7.3 Results
7.3.1 Differences in iodine concentration
Descriptive data for all pasteurised organic and conventional milk samples and 
supermarket-only organic and conventional samples are shown in Table 6.2
The iodine concentration of organic milk was significantly lower than that of the 
conventional milk (large effect size) [/(150.6) = -12.2, p<0.0001, r = 0.71; Figure 7.2]. The 
median iodine concentration of organic milk was 42.1% lower than that of conventional 
milk (Table 7.1). The difference remained when branded milk samples were excluded, so as 
to compare only the 77 supermarket own-brand organic and conventional milk samples 
[t( 124.6) = -10.75, p<0.001, r = 0.69 Table 7.1].
Own-brand organic milk was significantly lower in iodine content than own-brand 
conventional milk from Waitrose [/(22.5) = -11.2, p <0.0001, r = 0.92], Tesco [/(30) = - 
9.41, p<0.0001, r = 0.86], Morrisons [/(28) = -3.72, p = 0.001, r = 0.58] and Asda [r(28) = - 
7.43, p<0.0001, r = 0.82] and all effect sizes were considered as large. However, 
Sainsbury’s organic milk and conventional milk samples were not significantly different in 
iodine content [/(17.3) = -0.34, p = 0.74, r = 0.08]. The descriptive data is in Table 7.2
There were only two brands which had both an organic and conventional product. Country 
Life and Moo (UHT). Moo organic milk was significantly lower (large effect size) in iodine 
(geometric mean 97.6 ng/g, 95% Cl 86.6, 109.9) than the Moo 1% conventional milk 
(geometric mean 162.3 ng/g, 95% Cl 160.9, 163.8) [t(2) = -18.4, p = 0.003, r = 0.9). 
Although the iodine concentration of Country Life organic milk was lower than Country 
Life conventional milk (geometric mean 167.4 ng/g 95% Cl 129.6, 216.2 and 208.5 ng/g 
95% Cl 135.0, 322.0, respectively), the difference was not significant but the effect size 
was large [t(A) = -1.9, p = 0.14, r = 0.68]. The organic milk brands had a significantly lower 
iodine concentration than supermarket own-brand conventional milk (Table 7.3).
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Table 7.1 Descriptive data for all organic and conventional samples and all supermarket organic
and conventional samples
Iodine concentration (ng/g)
Milk Type n Median Geometric Mean
(IQR) (95% Cl)
All samples
Organic 92
144.5 
(123.5, 190.5)
152.2 
(141.7, 163.5)
Conventional 80
249.5 
(220.0, 304.0)
256.4 
(245.0, 268.3)
Supermarket own-brand
Organic 77
148.0 
(127.5, 198.5)
159.8 
(148.1, 172.5)
258.4 
(246.9, 270.6)
Conventional 77
250.0 
(223, 308.5)
o  300
& 200
Com-entioiial Oigaiik
IViilk type
Figure 7.2 Iodine concentration (ng/g) according to milk type; conventional milk is higher in iodine 
than organic milk (p < 0.001). Four of the five outliers for organic milk are Scottish samples (two 
samples have similar values so only four are visible).
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Table 7.2 Iodine coneentration (ng/g) of organic and conventional milk by supermarket chain
Iodine Concentration (ng/g)
Milk Type n
Median
(IQR)
Geometric Mean 
(95% Cl)
Waitrose
Organic 15
140.0 
(101.0, 150.0)
122.5 
(105.0, 142.8)
Conventional 15
317.0 
(290.0, 333.0)
' 309.7 
(283.3,338.6)
Tesco
Organic 16
140.5 
(125.5, 161.8)
145.3 
(131.9, 159.9)
Conventional 16
233.0 
(233.3, 258.3)
240.1 
(225.9, 255.2)
Morrisons
Organic 15
195.0 
(163.0, 229.0)
193.5
(172.4,217.2)
Conventional 15
249.0 
(213.0, 284.0)
255.1 
(228.6, 284.7)
Asda
Organic
Conventional
15
1 (119.0, 144.0) 
15 '
(248.0, 324.0)
138.6
(119.7, 160.5)
277.2
(242.2,317.4)
Sainsbury’s
Organic 16
235.0 
(165.0, 289.8)
215.7 
(178.0,261.2)
Conventional 16
221.0 
(211.0, 238.5)
222.6 
(211.0, 234.7)
7.3.2 Influence of supermarket on iodine concentration
Iodine concentration differed between the five supermarkets for both organic, [F(4, 72) = 
12.3, p<0.0001, r == 0.64] and conventional milk [F(4, 34.72) = 12.2, p<0.0001 (Welch 
statistic), r = 0.57]. The post-hoc tests showed that Waitrose conventional milk was 
significantly higher in iodine than conventional milk from Tesco (p = 0.01), Morrisons (p = 
0.03) and Sainsbury’s (p <0.001) and that Asda conventional milk was significantly higher 
in iodine than Sainsbury’s conventional milk (p <0.000). By contrast, the Sainsbury’s 
organic milk was significantly higher in iodine than that of Waitrose (p <0.0001), Tesco (p 
<0.0001) and Asda (p <0.0001) and Morrison’s organic milk was significantly higher than
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that of Waitrose (p<0.0001), Tesco (p = 0.04) and Asda (p = 0.01). Other post-hoc tests 
were non-significant.
Table 7.3 Comparison of iodine concentration of organic milk brands and supermarket own-brand
conventional milk.
Calon Wen Rachel’s Yeo valley Duchy Original
(n = 3) (n = 3) (n = 3) ^
Iodine
concentration
(ng/g)
T test, p value ^
84.0 91.6 124.2 
(48.9,144.2) (84.8,99.0) (95.6,161.4) 
[83 (75.5, 94.0)] [90 (90.0, 92.5)] [131(120.5, 132)]
7(78)=-9.4, 7(13)=-35.4, 7(78) = -6.2,
p<0.0001 p<0.0001 p<0.0001
145.0 
(134.1, 156.7) 
[144(142.5, 147)]
7(12.7) = -19.7,
p<0.0001
Figures are geometric mean (95% Cl), [median (IQR)]. Comparison of branded milk sample to supermarket
own-brand conventional milk (n = 77).
7.3.3 Analysis by area of purchase
Iodine concentration did not differ between the 16 areas of the UK in which the milk was 
purchased (Methods, Section 2.5.2) for either the organic (L(15, 61) = 0.72, p = 0.75, r = 
0.39) or the conventional milk samples (F(15, 61) = 0.98, p = 0.49, r = 0.44). When the 
areas in which milk was purchased were combined into regions of the UK (Methods, 
Section 2.5.2): South East (n=8). South West (n=6), Wales (n=l) and Northern Ireland 
(n=l), there was no significant difference in iodine concentration between the four regions 
for either organic milk [L(3, 73) = 1.09, p = 0.36, r = 0.21] or conventional milk [F(3, 73) = 
0.54, p = 0.66, r = 0.15)].
7.3.4 Analysis by known milk origin
When the milk was grouped by known geographical origin, rather than by purchase 
location, organic milk from the West Country [7(40) = -8.4, p<0.001, r == 0.80], Wales [7(5) 
= -7.9, p = 0.001, r = 0.96] and of unknown origin [7(96.4) = -11.9, p <0.0001, r = 0.77] 
was significantly lower in iodine than conventional milk of the same origin (Table 7.4). 
There was no significant difference in iodine concentration between organic and 
conventional milk from Northern Ireland [7(1.9) = -0.2, p = 0.89, r = 0.01].
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Table 7.4 Iodine concentration (ng/g) of milk samples according to their known origin.
Milk Type n Median
Geometric Mean 
(95% Cl)
West Country
Organic
Conventional
24
18
140.5 
(113, 150)
236.0 
(207.8, 264)
130.3* 
(117.4, 144.6)
239.2 
(215.5, 265.4)
Wales
Organic
Conventional
3
4
83.0 
(68, 105)
212.5 
(200.5, 242.5)
84.0* 
(48.9, 144.2)
217.6 
(184.9,256.1)
Scotland
Organic 8
287.5 
(248.8, 299)
276.5* 
(238.4, 320.7)
Conventional 0 NA NA
Northern Ireland
Organic 2
220.5 
(215, 226)
220.4
(160.5,302.7)
Conventional 2
222.0 
(215, 229)
221.9 
(148.6, 331.3)
Unknown
Organic 55
145.0 
(124, 188)
152.2*
(140.8, 164.4)
Conventional 56
275.5
(224,317)
266.6 
(252.7, 281.3)
NA: no samples. *lodine concentration significantly lower than conventional milk o f same category 
(P<0.001). ^Iodine concentration significantly higher than organic milk from the West Country (f<0.001)
and organic milk of unknown origin ( f  <0.001).
Due to the small number of samples originating from Wales and Northern Ireland, these 
regions were excluded from analysis by milk origin. Organic milk differed in iodine 
concentration according to the origin (large effect size) [F(2, 84) = 23.7 , p <0.0001, r = 
0.60]. The milk of Scottish origin was significantly higher in iodine than milk from the 
West Country (p<0.0001) and milk of unknown origin (p<0.0001) and four of the five 
outliers for organic milk were of Scottish origin (Figure 7.3). Conventional milk from the 
West Country had a lower iodine concentration than milk of unknown origin but the 
difference was not significant, (medium effect size) [7(77) = 2.0, p = 0.051, r = 0.23].
To prevent Scottish milk samples from skewing the results, statistical testing was repeated 
with Scottish milk excluded; the overall difference in iodine concentration between organic
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and conventional milk remained significant {t(lA6A) = -14.4, p<0.001, r = 0.77] but the 
difference increased to 43.1%. In addition, the difference between Sainsbury’s own-brand 
organic milk and conventional milk became significant [/(7.7) = -2.4, p = 0.05, r = 0.65].
5.75-
2 5.50-
2 5.25-
o>
O 5.00-
4.75-
W est Country Scotland Unknown
Known origin of organic milk samples
Figure 7.3 Iodine concentration according to known milk origin for organic milk samples only. 
Samples from Wales and Northern Ireland were excluded due to low numbers.
7.3.5 Influence of milk processing on milk-iodine content
Organic pasteurised milk had a significantly higher iodine concentration than organic UHT 
milk, though the effect size was small [/(93) = 2.2, p = 0.03, r = 0.22] (Table 7.5). In order 
to make valid comparisons, analysis was restricted to the 15 pasteurised samples purchased 
in the same month as the UHT samples (August) and of the same origin (West Country). 
Though the difference in iodine concentration was not significant, the medium effect size 
suggests that the analysis lacked statistical power [r(16) = 2.0, p = 0.06, r = 0.44].
The conventional milk-iodine content differed (medium effect size) between the method of 
processing (pasteurised, UHT and filtered milk) [F(2, 6.4) = 717.2, p <0.0001, r = 0.43] 
(Welch statistic). Post-hoc analysis (Games-Howell) confirmed that conventional 
pasteurised milk samples were significantly higher in iodine concentration than both 
conventional UHT milk (p<0.0001) and conventional filtered milk (p<0.0001) and that
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filtered milk was significantly higher in iodine than UHT milk (p<0.0001, Table 7.3). 
When analysis was restricted to samples collected in the same month (August), the results 
remained significant but the effect size was large [F(2, 6.2) = 606.8, p<0.0001, r = 0.51].
Table 7.5 Iodine concentration (ng/g) for milk samples according to method of processing
Milk Type n
Median
(IQR)
Geometric Mean 
(95% Cl)
Organic 0 NA NA
Filtered
Conventional 3
201
1 (199-203)
201.0
(196.1,206)
Pasteurised
Organic
Conventional
92
80
144.5
! (123.5 - 190.5)
249.5
I (220.0 - 304.0)
152.2
(141.7,163.5)
256.4 
(245.0,268.3)
UHT
Organic
Conventional
3
3
96
(94-103)
162
: (1 6 2 - 163)
97.6 
(86.6, 109.9)
162.3 
(160.9, 163.8)
7.4 Discussion
7.4.1 Iodine concentration of organic vs, conventional milk
This is the first sizeable study to evaluate differences in iodine concentration between 
organic and conventional milk. The main finding, that organic milk has a significantly 
lower iodine concentration than conventional milk, supports the original hypothesis and 
data from other (smaller) European studies (Rasmussen eî a l, 2000; Dahl et a l, 2003).
Our finding that organic milk contains significantly lower iodine concentration than 
conventional milk is extremely important from a public-health perspective. Milk is the 
largest contributor to iodine intake in the UK. The National Diet and Nutrition Survey for 
adults found that milk and milk products contributed 35% of male intake and 42% of 
female intake of iodine, and was the largest contributor of the food groups studied 
(Henderson et a l, 2003). This thesis has also shown that milk and dairy products are the 
most important sources of iodine for pregnant women (Chapter 6); pregnant women are
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therefore vulnerable to lower iodine status if they consume organic milk. Pregnant women 
and mother’s of young children are targets of organic milk marketing (OMSCo, 2012).
Considering that the iodine in milk has “saved” the UK from iodine deficiency in the past 
(Introduction, Section 1.7.1), any change in milk consumption or in milk iodine 
concentration is likely to have an impact on the iodine status of the country. The fact that 
iodine concentration in summer organic milk is over 40% lower than in conventional milk 
is likely to compromise iodine intake in those that regularly use organic milk, and organic 
dairy products. This is of particular concern when pregnant women, with higher iodine 
requirements (WHO Secretariat et a l, 2007) switch to organic milk, perceiving it to be the 
“healthy” choice, and thus less likely to meet their iodine requirements.
This lower iodine concentration in organic milk is set against a background of mild iodine 
deficiency in the UK. As discussed in the Introduction (Section 1.8.2), there are data to 
suggest that UK women of childbearing age (Bath et a l, 2008; Rayman et a l, 2008a; 
Vanderpump et a l, 2011) and UK pregnant women are iodine-deficient (Barnett et a l, 
2002; Kibirige et a l, 2004; Pearce et al., 2010). In addition. Chapter 3 shows that pregnant 
women in the South of the UK are also iodine deficient, thus the lower iodine concentration 
in the principal source of iodine in the UK is likely to exacerbate an existing problem with 
increased consumption of organic milk, particularly by vulnerable groups.
Based on the median values found in this study, a portion (a medium glass: 200 g) of 
organic milk would provide approximately 29 pg of iodine compared to the 50 pg that 
would be provided by a portion of conventional milk. Of course, the impact on iodine 
intake would be greater if other organic dairy foods, such as yoghurts, were chosen.
Trends in organic milk consumption in the UK
In the UK, as in other countries in the Western world, consumer trends show an increase in 
organic milk purchasing; sales of organic milk have increased more than 50-fold over the 
ten-year period between 1997 and 2007 (DairyCo., 2008). Despite this increase, liquid 
organic milk only accounted for 3.2% of total liquid milk sales in the UK during the period 
of this study (OMSCo, 2010b), a decline on the 5.1% reported in 2008 (OMSCo, 2008) and 
a similar to the most recent market-share figure of 3.1% for the year ending April 2011
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(DairyCo., 2011). In 2009, sales of organic food in general declined after many years of 
growth; there was a 12.9% decrease in sales compared to 2008, the recession being blamed 
for this (The Soil Association, 2010). Despite this trend, liquid organic milk sales remained 
strong in 2009 and grew by 1%, though sales of organic yoghurt fell by 7% in the same 
period (The Soil Association, 2010). The most recent data suggest that the recession and 
economic downturn may be negatively affecting organic milk sales, with a decline of 
between 4.9% and 9.9% reported for 2011 (DairyCo., 2011; The Soil Association, 2012).
Although liquid organic milk accounts for a small percentage of the total milk market, and 
recent figures suggest a decline in organic milk sales, it is possible that the individuals who 
are regular consumers are those at most risk of iodine deficiency i.e. pregnant women who 
believe they are making a healthy choice by consuming organic milk, given the promotion 
of “health benefits” by the organic sector (OMSCo, 2012). Though there are no data to 
back up the theory that pregnant women represent a large percentage of organic milk 
buyers, the fact that organic baby food sales have remained strong in the economic 
recession and have grown in 2011 (The Soil Association, 2012), may serve as a proxy 
marker that pregnant women and mothers are key purchasers of organic milk.
In 2009, OMSCo launched a million-pound advertising campaign to promote organic milk 
consumption, highlighting the low cost of going “organic with every sip” (OMSCo, 2009) 
and during 2010 and 2011, there was increased advertising and promotion of organic milk 
in the UK (OMSCo, 2010b), including high-profile television advertisements for the UK 
largest organic dairy brand, Yeo valley (Yeo Valley, 2011). With increased promotion of 
organic milk and dairy products, there is the potential for further exacerbation of iodine 
deficiency in the UK, unless consumers are made aware of the lower iodine-content of 
organic milk and appropriately supplement their diet to ensure iodine requirements are met.
Comparison with other studies
In contrast to the findings of this study, iodine levels in organic milk were not different 
from those of conventional milk in Sweden (Toledo et a l, 2002). That study sampled farm 
milk from organic herds and compared iodine values to published conventional milk values 
(Toledo et a l, 2002); however the published values are from milk sampled approximately
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three to four years prior to the organic farm samples, and are therefore not directly 
comparable, especially as the conventional milk sampling may have been conducted prior 
to the change in the EU regulation regarding the maximum permitted iodine content of feed 
that came into force during 1996 (The Feeding Stuffs Regulations (Amendment), 1996).
Dahl et al (2003) showed summer Norwegian organic milk to be 31.8% lower in iodine 
concentration than conventional milk (p = 0.006), a lower percentage than the 42.1% found 
in this study which could be explained by the smaller number of Norwegian milk samples 
(7 organic and 18 conventional in the Dahl et al. study) and different soil and farming 
practice in Norway compared to the UK.
Rasmussen et al (2000) reported that the average iodine concentration in organic milk was 
significantly lower than that of conventional milk in samples from both the winter and 
summer. The figures provided by Rasmussen et a l (2000) suggest that the iodine 
concentration was approximately 40.8% lower in organic than in conventional milk in the 
summer samples, a similar figure to the 42.1% in this UK study.
The Food Standards Agency’s (2008) survey of UK milk included a small number of 
samples of organic milk (though the FSA did not break down the milk iodine concentration 
by organic or conventional samples). However, the FSA report contained a comprehensive 
appendix, enabling independent analysis of the iodine concentration of organic and 
conventional milk samples purchased by the FSA (see Chapter 9 for details). Overall, 
organic milk was 50% lower in iodine than conventional milk and 29.4% lower in the 
summer months, a lower figure than found in this study.
Comparison o f median milk iodine concentration to that o f other UK studies
The iodine concentration of milk in the UK has been regularly monitored (Introduction, 
Section 1.6.2) owing to concerns of iodine toxicity from milk consumption. When 
compared to previous levels in UK milk (Table 7.6), the current study shows higher milk- 
iodine levels than the summer samples in the FSA 2008 report (Food Standards Agency, 
2008). The reasons for this are unclear but may be due to the earlier sampling of FSA milk 
from May to July compared to June to August for the current study. The values in this 
study are similar to those in older MAFF surveys with a summer sampling period of June to
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September (Ministry of Agriculture Fisheries and Food, 1997b; Ministry of Agriculture 
Fisheries and Food, 2000).
Table 7.6 Comparison of median iodine concentration in milk from this study, FSA and MAFF
studies
Our results
Iodine concentration (median value; pg/kg)
FSA2008f MAFF1998/99f MAFF1995/96f
Overall 206.5* 150* 200 200
Conventional 249.5 170 NA NA
Organic 144.5 120 NA NA
* Organic and conventional milk combined f  Only summer results included to make valid comparisons to this
study
Is iodine concentration in conventional milk actually too high?
There is an argument that the level of iodine in conventional milk is too high. Indeed, this is 
the main reason that MAFF, and now the FSA, have monitored iodine levels in milk since 
the 1980s (Ministry of Agriculture Fisheries and Food, 2000; Food Standards Agency, 
2008). The MAFF survey sampled milk in 1998 and 1999 (Ministry of Agriculture 
Fisheries and Food, 2000) and the results were viewed by the Committee on Toxicity of 
Chemicals in Food, Consumer Products and the Environment (COT), who calculated 
estimated exposure in relation to the JECFA (Joint Expert Committee on Food Additives) 
limit for adults and children, and concluded there was no risk to health from the levels in 
milk (Committee on Toxicity of chemicals in food consumer products and the environment, 
2000). As the FSA survey of milk in 2008 found similar iodine levels to those of the MAFF 
(2000) survey, the conclusion was that the concentration in cows’ milk were unlikely to 
pose a risk to health (Food Standards Agency, 2008). The argument that organic milk 
iodine concentrations are at a “safer” level is unlikely to be valid and, given the declining 
milk consumption in the UK over recent years (National Food Survey, 2000) and the 
emergence of iodine deficiency in the UK as already discussed, (Introduction, Section 
1.8.2). It would appear more likely that lower milk-iodine concentrations in organic milk 
would have an adverse effect on UK iodine status.
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7.4.2 Potential explanations for lower iodine in organic milk
As this study did not collect data on farming practices in the organic and conventional 
farms that supplied the milk analysed, the explanations for the observed differences in 
iodine concentration are somewhat speculative. One explanation for the lower iodine 
concentration in organic milk is because of the greater restrictions on the use of vitamin and 
mineral preparations in organic farming than in conventional farming (European Union, 
2007; European Union, 2008). Standards state that 90% of feed must be organic for 
ruminants (cows), of which 60% must be fresh or conserved forage (European Union, 
2008), thus limiting the use of concentrates and relying on soil minerals, which can be low 
in some areas. For example, areas of both Devon and Derbyshire have been reported to 
show evidence of iodine deficiency in livestock (Tame, 2008).
The addition of trace minerals is permitted in UK organic farming, including iodine, but 
the use of these vitamin and mineral preparations is not permitted routinely, their use 
depends on permission being granted by the Department for the Environment, Farming and 
Affairs (DEFRA) and the farmer must be able to justify the need (European Union, 2007; 
European Union, 2008). It has been suggested that organically-farmed livestock can exhibit 
micronutrient deficiencies, including iodine (Rosati & Aumaitre, 2004). Research in 
Norway has highlighted the fact that the content of soil and forage from organic livestock 
farms is unlikely to meet the needs of livestock and that supplements containing selenium, 
copper, colbalt, and vitamin E should be given on organic farms (Govasmark, 2005). This 
is also likely to be true for iodine, although this was not investigated in the study by 
Govasmark (2005). Research in the UK has found that conventionally produced milk had a 
15% higher vitamin A concentration than organic milk, and it is suggested that this is 
related to increased concentrate feeding in conventional farming (Ellis et a l , 2007).
Another explanation for the lower iodine concentration in organic milk is the presence of 
higher quantities of goitrogens in the diets of organically-farmed dairy livestock as 
suggested by Rasmussen et al. (2000). Nitrogen-fixing crops, such as clover, are important 
in organic farming and are used in place of artificial fertilisers (Foster et a l, 2007). Organic 
farming uses higher amounts of clover (white and red clover) than conventional farming 
methods (OMSCo, 2010a). White clover contains the cyanogenic glucosides, linamarin and
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lotaustralin (Bjamholt et a l, 2008) that exhibit goitrogenic properties (Zimmermann, 
2009a). This is likely to inhibit iodine excretion into the milk, as it blocks iodine uptake 
into the mammary gland by competing with iodine for the sodium-iodide symporter (NIS).
Red clover is a rich source of isoflavones of which genistein is the most active in red clover 
(Sabudak & Guler, 2009). As discussed previously, genistein is a goitrogen, exhibiting 
effects through the inhibition of thyroid peroxidase. As such, red clover is unlikely to 
directly prevent the excretion of iodine into the mammary gland, but could affect the 
overall thyroid hormone production of the cow and may reduce iodine excretion into the 
cows’ milk, as iodine is instead diverted to the thyroid.
Although there has been no study of the effect of clover feeding on milk-iodine 
concentration, evidence from rapeseed studies [rapeseed is also considered to be a 
goitrogen (Rasmussen et a l, 2000)] provides insight into the relationship between 
goitrogens in the diets of dairy cattle and milk-iodine concentration. A study of 32 dairy 
cattle in Germany evaluated the effect of rapeseed-based feed compared to non-rapeseed 
feed (controls) on the effect of iodine supplementation of cattle and showed that the 
rapeseed reduced the iodine concentration of the milk by up to 50% of the control value 
(Franke et a l, 2009). Giving additional iodine to the cattle given rapeseed-based feed 
increased the iodine concentration in the milk, but was unable to completely overcome the 
goitrogenic effect (Franke et a l, 2009); the authors suggested that in Germany, iodine 
supplementation should be doubled when rapeseed is in feed (Franke et a l , 2009).
lodophor disinfectants and teat dips are permitted in both organic (European Union, 2008) 
and conventional farming (Veterinary Laboratories Agency, 2010) and it is therefore 
unlikely that the difference in iodine concentration can be explained by their use.
7.4.3 Regional and supermarket differences in milk iodine
The hypothesis concerning regional differences in milk-iodine concentration was only 
partially supported. Although regional differences were found when milk was broadly 
grouped by milk origin, no difference was found by area of purchase. It was perhaps 
surprising that there was a significant difference in iodine concentration between the 
supermarket chains, but not by the area in which milk was purchased. The most logical
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explanation for not finding a difference by area is the logistics and supply chain operating 
in the dairy industry (Foster et a l, 2007). Milk is processed by a dairy, which receives milk 
bulked from many farms in the region and the milk is then packaged and distributed to the 
retail outlets; it is highly likely that the same milk is supplied to stores in neighbouring 
areas within the same supermarket chain and this is the probably explanation that iodine 
concentration did not differ between regions of milk purchase.
When milk was analysed by known origin, there was a significant difference in iodine 
concentration. It was important to collect and interpret the EU Food identification mark 
(Food Standards Agency, 2009a) in order to make sense of the regional differences, 
especially in view of the unexpected inclusion of milk of Scottish origin. Without the EU 
identification mark interpretation, it would have been unclear why there was no difference 
in iodine-content between Sainsbury’s organic and conventional milk, or why there were 
regional differences in iodine between the organic samples. As outlined in Section 7.2.2, 
Scottish milk is only used in one-pint containers and Sainsbury’s shoppers who purchase 
milk in this volume will be exposed to higher iodine concentrations from their organic milk 
than the shoppers who choose larger volumes. As most milk is purchased in four-pint 
containers, with less than 10% purchased as single pints, both at the time of the study 
(DairyCo., 2009) and based on latest figures (DairyCo., 2011), this is unlikely to make a 
substantial difference to iodine intake from UK organic milk.
Our finding that Scottish organic milk is higher in iodine than milk from other regions is in 
accordance with early work by Orr et al (1931) that showed Scottish milk to be higher in 
iodine (especially in goitre-free areas of Scotland) than milk from areas of England (cited in 
Saikat et a l, 2004). By contrast, other studies have found lower concentrations of iodine in 
Scottish milk than in English milk (Broadhead et a l, 1965a; Lee et a l, 1994). Broadhead et 
al (1965) found that milk sampled from Edinburgh had a lower iodine concentration than 
the milk sampled from Sheffield. Lee et a l (1994) found milk samples from Aberdeen and 
Glasgow to be lower in iodine than those from Devon and Berkshire.
The fact that Scottish organic milk was higher in iodine than milk from the West Country is 
interesting in that historically, goitre and cretinism, were common in the West Country 
(Phillips, 1997) but their incidence was lower in Scotland (Kelly & Snedden, 1960). The
181
Chapter 7: Iodine content of organic and conventional milk
lower goitre incidence in Scotland (a soft-water area) has been attributed to differences in 
water hardness (Kelly & Snedden, 1960), as lower iodine levels are required to prevent 
goitre when the water is soft than in areas with hard water, due to the potential goitrogenic 
properties of hard water (Kelly & Snedden, 1960). Evidence from Nepal suggests that in 
regions with similar iodine intake, goitre incidence correlates with the fluoride content and 
hardness of the water (Day & Powell-Jackson, 1972). It is possible that the goitrogenic 
properties of hard water inhibit secretion of iodine into the mammary gland, and 
consequently lower the iodine concentration of milk.
This is a very simplistic explanation for the higher milk-iodine content in Scottish milk in 
this study as differences in soil, geology and farming practice are also likely to influence 
the milk-iodine concentration. As this study did not collect details of farming methods (e.g. 
soil and feed-type), it is not possible to explain the difference in iodine concentration 
between regions. The matter is further complicated by the fact that not all the milk samples 
could be traced back to specific farm locations, and as such the “milk of unknown origin” 
category contains milk from a variety of locations in the UK.
The regional differences observed in this study appear to be driving the significant 
differences between supermarkets. For example, Waitrose organic milk was significantly 
lower in iodine than that of other supermarkets but all of the Waitrose organic samples 
were from the West Country. Similarly, the finding that Sainsbury’s organic samples were 
significantly higher in iodine appears to be driven by the fact 50% of these samples were 
from Scotland. Should two-pint cartons have been purchased throughout the study, the 
Scottish influence would have been removed and Sainsbury’s would have had a similar 
iodine concentration in their organic milk to other stores.
7.4.4 Milk processing
This study found that UHT and filtered milk had a lower iodine concentration than 
pasteurised samples, thus suggesting that additional processing lowers the iodine content of 
milk. There is little information in the literature on the effect of UHT processing of milk on 
iodine concentration and no information on the effect of filtration on iodine concentration, 
therefore this study adds novel information for these two milk processing types (although
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caution obviously needs to be exhibited when interpreting these findings as there were only 
three samples of UHT and filtered milk).
UHT milk
UK UHT milk was analysed for iodine in the MAFF survey of 1997/97 (Ministry of 
Agriculture Fisheries and Food, 1999) which found that the iodine concentration of summer 
UHT milk was similar to that of summer pasteurised milk (246 and 235 pg/kg respectively) 
(Ministry of Agriculture Fisheries and Food, 1999). Data from New Zealand suggest that 
there is no difference in iodine concentration between low fat UHT or fresh milk (mean 
0.09mg/kg for each milk type) and that there is a higher iodine-content in standard UHT 
milk than fresh milk (0.12 v& 0.09 mg/kg) (Cressey, 2003).
The fact that both organic and conventional UHT milk samples were significantly lower 
(33.6% and 35.1% respectively) in iodine concentration compared to the pasteurised 
samples is of importance to the consumer. Between 2008 and 2009, UHT milk sales 
increased by 3% in the UK (DairyCo., 2009) as it appears that consumers are switching to 
this lower-cost milk in the recession. Although growth slowed during 2010 and 2011, it is 
estimated that UHT milk accounts for 7% of UK milk sales (DairyCo., 2011). Given the 
popularity of UHT milk, it would be wise to evaluate the impact of its consumption on 
iodine status. Further study should be conducted on an increased numbers of samples, 
preferably sourced from the same region in order to make valid comparisons.
The reason UHT milk is lower in iodine than pasteurised samples can be explained by the 
effect heat processing has on milk iodine content. UHT involves heating milk to 135°C 
before packing into sterile containers that allow milk to be kept unrefrigerated until opening 
(The Dairy Council, 2010). Although the literature lacks information on the effect of UHT 
processing on iodine concentration, the effect of pasteurisation has been evaluated in 
several studies (Magee & Glennie, 1928; Wheeler et a l, 1983; Norouzian et a l, 2009; 
Norouzian, 2011). In the late 1920s, a study showed that pasteurisation reduced iodine 
concentration by 20% compared to raw milk and that boiling milk reduced iodine content 
further (average loss of 26%) (Magee & Glennie, 1928). This suggests that the loss of 
iodine was progressive as temperature and duration of heating was increased. In contrast, a
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study in Australia into the heat treatment effect on iodine concentration in milk found no 
significant effect of pasteurisation on the iodine content of raw milk (Wheeler et a l, 1983). 
More recently, pasteurised milk has been shown to be 27.2% lower in iodine than raw milk 
(Norouzian et a l, 2009). Furthermore, a study that altered potassium iodide concentration 
in cattle-feed to investigate the effect on milk iodine concentration also evaluated 
processing as a secondary aim and found that pasteurisation significantly (p<0.05) lowered 
the milk iodine concentration below that of raw milk (Norouzian, 2011).
Filtered milk
The results of the current study suggest that filtered milk has an iodine concentration 19.4% 
lower than that of pasteurised milk. This may be of public-health concern in view that 
filtered milk has experienced growth and an increased market share in recent years, with 
sales growing from 164.7 million litres in 2006 (DairyCo., 2009) to 342.3 million litres in 
April 2011 (DairyCo., 2011). The reason for filtered milk to have a lower iodine 
concentration is not obvious. Filtered milk is passed through a filtration system (micro, 
ultra and nanofiltration) designed to purify the milk by removing more bacteria, enabling 
an increased shelf life (The Dairy Council, 2010). In microfiltration (the most common 
practice), the milk is passed through a membrane which removes high-molecular weight 
molecules; the milk then becomes virtually free from bacteria; milk is then homogenised 
and pasteurised as normal. Whether iodine is removed during the filtration processes is the 
subject of further study.
7.4.5 Benefits of organic milk
It should be acknowledged that there may be other benefits of organic milk that may 
influence consumer choice. Reducing exposure to pesticides is cited as a popular reason 
that consumers purchase organic food (The Soil Association, 2010) and The President’s 
Cancer Panel (2010) in the US have recommended that individuals decrease their exposure 
to pesticides by choosing food grown without pesticide or chemical fertilisers.
There are suggestions that organic dairy consumption is associated with a lower risk of 
eczema (OR 0.64, 95% Cl 0.44-0.93) (Kummeling et a l, 2008). However, Kummeling et 
al (2008) highlight the fact that the organic dairy consumption was part of an organic diet.
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and was not isolated consumption in an otherwise conventional diet (Kummeling et a l, 
2008). This evidence should not be used to encourage consumers to use organic milk in 
isolation for a reduction of eczema risk, although the study is used to promote organic milk 
consumption by OMSCo (OMSCo, 2012).
Research in the UK has found that organic milk had higher concentrations of short-chain n- 
3 fatty acids, lower n-6: n-3 ratios, and higher polyunsaturated to monounsaturated fatty 
acid ratios (Ellis et a l , 2006). Recent work from the University of Newcastle has also 
shown favourable differences between the fatty acid of profile of organic and conventional 
milk in terms of PUT A, conjugated fatty acids and alpha-linoleic acids (Butler et a l, 2011). 
This work is backed up by data from Sweden that showed a more beneficial fatty acid 
profile in organic vs. conventional milk (Fall & Emanuelson, 2011). The UK organic milk 
supplier co-operative, OMSCo, promote these differences when discussing the health 
benefits of organic milk (OMSCo, 2012) and indeed were listed in the UK Soil Association 
response (The Soil Association, 2011) to the publication of our results (Bath et a l , 2011).
Despite these small studies suggesting a benefit to organic milk, a systematic review, 
conducted for the Food Standards Agency, on the nutritional composition of organic and 
conventional food (including milk) concluded that there were no significant differences 
between the two farming methods for eight nutrients investigated (Dangour et a l, 2009). 
Unsurprisingly, the review prompted criticism from the organic sector, with suggestions 
that the selection of studies was too stringent (Benbrook et a l , 2009) and that nutritional 
differences were not the priority for consumers of organic food (Gibbon, 2009). Whether 
the reported “health benefits” of organic milk offer any protection for the consumer 
remains to be shown (Williams, 2002) but if people are making the decision to switch to 
organic milk and dairy products solely for health reasons, the suggested health benefits 
provided by the fatty-acid profile are unlikely to outweigh the disadvantages of the lower 
iodine content, especially in view of the known difficulty of converting short-chain n-3 
fatty acids to the beneficial long-chain n-3 fatty acids required for cardiovascular benefits.
7.4.6 Limitations and potential future study
Milk samples were only collected during the summer months and therefore the findings of 
this study cannot be extrapolated to winter months. However, as conventionally reared
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cattle are more reliant on mineral-supplemented feed during the winter (Phillips et a l, 
1988; Phillips, 1997), any difference observed between organic and conventional milk in 
the summer is likely to be matched, or exceeded during the winter months. An obvious 
future study would be to confirm this theory.
Milk was largely purchased from the South of England, and while this could be considered 
a limitation, the results indicate that the region of origin was a greater influence on iodine 
concentration than area of purchase. The sampling strategy was designed to produce equal 
numbers of milk samples from each area, but, as samples were not purchased according to 
the EU identification mark, there were unequal numbers of samples by origin of the milk. 
This resulted in small numbers from some regions (e.g. Wales and Scotland) and the origin 
of the milk could not be established for many of the samples. The influence of milk origin 
on iodine concentration should be interpreted with caution and requires further 
investigation. Furthermore, retail milk was analysed, which is pooled from farms; the 
influence of region of origin is therefore likely to be masked. A future study could explore 
the regional differences in milk-iodine content by selecting milk from farms directly and 
collecting details on farming practice, soil type and geology. This is potentially important 
from a public-health perspective as there is an increasing trend towards providing “local” 
produce in supermarkets. The increasing popularity of farm shops and farmers markets also 
increases the likelihood of buying local produce, as the concern for the environment 
becomes an important determinant of consumer choice. It would therefore be useful to have 
recent data on the difference in iodine content of milk produced in different UK regions.
The comparison of iodine concentration according to milk processing was a subsidiary aim 
to this study, and consequently the study was not suitably designed to test the differences 
and was limited by the small number of filtered and UHT samples. The findings of the 
study should be considered only as hypothesis generating. The effect of processing in a 
future study should be determined by measuring iodine in raw milk and subjecting this milk 
to different processing treatments, thus overcoming variation by milk-origin.
Due to the ever-changing nature of the dairy industry, the iodine results by supermarket and 
brand are confined to the time-period in which the study was conducted. For example. 
Duchy Original no longer exists as an independent brand, but merged with Waitrose in
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Originals from Waitrose, 2009). Additionally, it is not possible to state that Sainsbury’s 
supermarket organic one-pint containers will continue to have higher iodine content, as this 
is dependent on the source of milk supplied.
7.5 Conclusions
The fact that organic milk has a lower concentration of iodine than conventional milk is a 
public-health concern. When individuals make the decision to switch to organic produce 
they often start with milk (OMSCo, 2010b), believing this to be the best choice. Individuals
who make such a choice should be aware that their iodine intake may be compromised. 
Individuals consuming organic milk, particularly pregnant women, should be aware of 
alternative food sources of iodine in order to ensure that requirements are met.
The FSA would be wise to monitor the level of iodine in milk according to farm- 
management (organic or conventional). The organic dairy industry should take the findings 
of this chapter seriously. Though organic farming restrictions may affect other trace 
mineral concentrations, the issue is likely to be most serious for iodine as milk and dairy 
products are the principal source of iodine in the UK. As the UK has no “safety-net” of an 
iodised salt programme, the lower iodine content of organic milk is likely to have more 
wide-reaching implications than in countries, such as the Netherlands or America, with 
access to iodised salt and iodine-sufficiency in the population (Caldwell et a l, 2011; 
Andersson e/ <7/., 2012).
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8. THREATS TO UK IODINE INTAKE: IODISED SALT 
AVAILABILITY
8.1 Introduction
The WHO estimates that iodised salt represents just 2% of salt that reaches households in 
the UK (the penetration rate) (WHO & UNICEF, 2007). It is reported that iodised salt 
availability is low in the UK (Lazarus & Smyth, 2008; Vanderpump g/ a/., 2011), but this is 
based on one small survey at a single location (Cardiff). Additional data on iodised salt 
availability, and cost, is therefore required to inform UK public-health policy.
8.1.1 Aims and hypothesis
• To survey the availability of iodised salt in major supermarket chains located in 
Southern England, Cardiff and Northern Ireland.
• To compare the cost of iodised salt to that of standard table salt.
Hypothesis
• Iodised salt availability will be low and the cost will be higher than that of standard 
table salt.
8.2 Method
8.2.1 Collection of data
During June, July and August 2009 the availability of iodised salt in supermarket outlets 
was assessed (Methods, Section 2.5.1). Its availability was determined through visual 
inspection of supermarket shelves by the author; the cost was recorded and compared to 
that of standard table salt. Additionally, grocery online services for each supermarket were 
searched to determine if iodised salt could be purchased online.
8.2.2 Calculation of iodised salt availability
Availability of iodised salt was calculated in two ways: (i) stores selling iodised salt as a 
percentage of the total number of stores, and (ii) percentage availability per supermarket 
chain, weighted as explained below. At the time of data collection, the five supermarket
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chains had a total market share of 79.4%; Tesco and Waitrose had the largest (31%) and 
smallest (3.9%) share of the grocery market, respectively (TNS Worldpanel, 2009) (Table
8.1). It was considered important to take account of market-share data when estimating the 
availability of iodised salt in UK supermarkets.
Weighted iodised salt availability per supermarket chain was calculated by multiplying the 
percentage of market share (TNS Worldpanel, 2009) by the percentage availability in each 
chain and a total weighted availability figure was then calculated by summing the figures 
for all five chains. For example, a supermarket with 40% availability of iodised salt and a
31% market share would have a weighted availability of 12.4%.
The Premier Foods Group (the owner of the UK brand of iodised salt, Cerebos) was
contacted for information on sales of Cerebos iodised salt in order to establish if 
availability translates into purchasing.
8.3 Results
8.3.1 Availability of iodised salt
The results of the survey are displayed in Table 8.1, which shows the availability of iodised 
salt by supermarket chain. The only brand of iodised salt available for purchase in the 
supermarkets was Cerebos (Premier Foods Group Ltd, Lincolnshire, PE 12 9EQ) (Figure
8.1). The packet states that it contains at least 11.5 mg of potassium iodate per kilogram.
Iodised salt was only available in 32 of the 77 (41.6%) supermarkets visited. Iodised salt 
was available in at least one store in all regions except Bath, Bristol and North Somerset or 
County Antrim (Northern Ireland). Figure 8.2 shows the availability by supermarket chain, 
with market-share data for each chain. Waitrose and Morrison stores had the highest 
availability of iodised salt, at 87% for both chains, Sainsbury's sold iodised salt in 40% of 
its stores, however, neither Tesco nor Asda stores sold iodised salt in any of the stores 
visited in the study (Table 8.1). The only supermarket to offer iodised salt through online 
grocery shopping was Waitrose (Waitrose, 2009a). Using market-share values and 
percentages of supermarket stores that sold iodised salt, only 19.2% of the supermarket 
share of the total grocery market is exposed to iodised salt (Table 8.1).
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Figure 8.1: Example of the brand of iodised salt found in supermarkets. Photograph taken in 
Morrisons Store, Glastonbury, Somerset (June 2009).
Cerebos market share information
The Cerebos brand has a 1% value (Symphony IRI, 2010b) and 0.6% volume share 
(Symphony IRI, 2010a) of the table-salt market, but only a 0.3% value (Symphony IRI, 
2010b) and 0.4% volume share (Symphony IRI, 2010a) of the total salt market. The value 
share is likely higher than the volume share of the market due to the price of iodised salt 
that is higher than other salt products in the market.
Table 8.1 Availability of iodised salt by supermarket chain, with a weighted availability based on
market share data
Supermarket
chain
Number of 
stores visited
Stores selling 
iodised salt (%)
Market share 
(%)
Weighted 
availability (%)
Tesco 16 0(0) 31.0 0
Asda 15 0(0) 17.2 0
Sainsbury’s 16 6 (37.5) 15.9 6.0
Morrisons 15 13 (86.7) 11.4 9.9
Waitrose 15 13 (86.7) 3.9 3.4
TOTAL 77 32 (42) 79.4 19.2
8.3.2 Cost of iodised salt
The cost of Cerebos iodised salt in the supermarkets studied was between 49 and 59 pence 
for a 400 g container, therefore costing between 122.5 -147.5 pence per kg. In comparison, 
table salt from Sainsbury’s costs just 23 pence per kg; iodised salt was between 5.3 and 6.4 
times more expensive than the standard table salt.
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Figure 8.2 Iodised salt availability according to supermarket chain in a survey of 77 supermarket 
stores (15/16 stores from each chain) between June and August 2009
8.3.3 P o s t - h o c  study: additional data on iodised salt availability
After data collection in 2009, it was brought to the attention of the author that the budget 
supermarket chain Lidl stocked iodised salt. Lidl was contacted for information and the 
buying department confirmed that all the table salt available in their stores is iodised (Lidl 
customer services, personal communication 14^*^  October 2011). This salt has a 
concentration of 20 mg/kg and the cost is comparable to that of standard table salt at 30 
pence per kilogram.
The weighted availability was therefore recalculated using a figure of 100% availability of 
iodised salt in Lidl stores and the market share percentage for Lidl [2.3% (TNS 
Worldpanel, 2009)]. The percentage availability of iodised salt increased slightly to 21.5% 
of the supermarket share of the UK grocery market.
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8.4 Discussion
8.4.1 Availability of iodised salt in relation to recommendations
The study hypothesis, that availability of iodised salt is low in the UK was supported by the 
results as fewer than 45% of the supermarkets included in the survey sold the product. The 
only brand of iodised salt in the five major supermarket chains was Cerebos, while Lidl 
stocked their own-brand iodised salt.
Based on weighted availability (Table 8.1), fewer than a quarter of supermarket shoppers 
will have iodised salt available to purchase, or will be exposed to the product when making 
salt-purchasing decisions. It is of interest, and concern, that the two supermarkets with the 
largest market share, Tesco and Asda, did not sell iodised salt in any of their stores. This 
highlights the fact that the majority of shoppers are not exposed to an iodised-salt 
alternative to standard table salt.
Where iodised salt was available in the major supermarket chains, it was up to six-times 
more expensive. The premium attached to this product may dissuade people from 
purchasing it unless the benefits of iodine are clear to them. In contrast, the only salt
available in Lidl stores is iodised and is not more expensive than standard table salt, with an 
iodine concentration that is in line with WHO recommendations (WHO g/ ar/., 2007). This 
may be because Lidl is a German company and the purchasing patterns in their UK stores 
may be based on their European outlets, where salt is iodised by mandatory or voluntary 
iodised-salt programmes.
The value share of Cerebos iodised salt in the table salt market, at 0.6%, reflects in part the 
poor availability of the product, but also indicates that even in outlets that sell the salt 
consumers are not choosing to purchase iodised salt; by contrast rock salt and sea salt are 
more popular table salt choices (Premier Foods, 2010). Contrary to popular belief, both sea 
salt and rock salt are low in iodine concentration; although the sea contains iodine at 
approximately 58 pg/L (Johnson gf a/., 2003), during normal manufacture of salt, iodine 
remains in solution due to differing rates of crystallization and iodine is therefore lost from 
the salt (Dasgupta gr üf/., 2008). Furthermore, iodine may be further lost from sea salt 
during the process of evaporation (Mannar & Dunn, 1995).
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There are historical reports that iodine was added to table salt in the UK through spraying 
salt with a solution of iodine, and that table salt was iodised to 1 part potassium iodide to 
40,000 parts of salt (Holman, 1958). Despite this, the UK has never implemented a 
programme of mandatory, or even voluntary universal salt iodisation (Phillips, 1997) and 
this fact is reflected in the poor availability of iodised salt revealed by the current study.
This current study supports the previous UK survey of salt purchased in Cardiff that 
showed only four of 36 samples had detectable iodine concentrations, and of these, only 
two had levels suitable for the prevention of iodine deficiency (Lazarus & Smyth, 2008).
8.4.2 Contribution of iodised salt to iodine intake in the UK
Cerebos iodised salt in the UK contains potassium iodate at a concentration of 11.5 mg/kg 
and thus 2 g supplies only 15% of the recommended iodine intake (23 pg). The 
concentration of iodine is therefore below the minimum of 15 mg/kg that is suggested by 
the WHO for the prevention and control of iodine deficiency in a population (WHO et a l, 
2007). By contrast, iodised salt (potassium iodide) produced by Morton Salt, a US brand, 
states that 1.5 g provides 45% of the daily iodine value, equivalent to 45 mg/kg; the iodised 
salt in the US thus provides over four times as much iodine as does Cerebos iodised salt.
In view of the fact that the majority of salt consumed in the UK is added in food 
manufacture and just 15% is provided by addition at the table and during cooking 
(Henderson et a l, 2003; NHS Choices, 2011b), use of Cerebos iodised salt is unlikely to 
protect individuals from iodine deficiency, given the low concentration of iodine per g. 
Furthermore, since 2004, there has been a large drive by UK authorities and organisations 
to reduce the use of salt (Scientific Advisory Committee on Nutrition, 2003; Food 
Standards Agency, 2009b) and this has resulted in increased efforts by individuals to 
reduce their total salt intake (Wyness et a l, 2012); thus a number of people and families no 
longer use salt at the table or in cooking, following advice from the Government (NHS 
Choices, 2011 b) and other health-related authorities e.g. the British Dietetic 
Association.(Daniels, 2009).
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8.4.3 Iodised salt and cardiovascular disease -  a conflict?
There are public-health recommendations in the UK to restrict total salt intake to less than 6 
g per day, owing to links between salt intake and high blood pressure with subsequent 
health problems such as heart disease and stroke (Scientific Advisory Committee on 
Nutrition, 2003). The UK has an average salt intake of 8.6 g, with only 26% achieving the 
recommended 6 g or less per day (National Centre for Social Research & Medical Research 
Centre, 2008). There are also variations in salt intake between sex and age group, with 
young men (19-24 years) consuming an estimated 10.7 g/d whereas older women (50-64 
years) only consume 7.0 g; the top 2.5* percentile ranges from 13.9 to 18.0 g (National 
Centre for Social Research & Medical Research Centre, 2008). If the UK were to introduce 
an iodised salt programme, such a variation in salt intake would make setting the iodine 
concentration in salt challenging; appropriate levels of iodine would need to be provided 
for the majority without overdosing those with the highest intake of salt.
There are obvious conflicts between an iodised salt programme and a salt reduction 
campaign and the public may feel the messages are confusing; on the one hand the advice is 
to restrict salt intake for health protection, while on the other hand iodised salt contains an 
important mineral for health. This was the subject of the comment by the UK charity 
CASH (Consensus Action on Salt and Health) (CASH, 2011) following the publication of 
the study showing mild iodine deficiency in UK schoolgirls (Vanderpump et a l, 2011). 
The chairman of CASH, Professor Graham McGregor, stated that the recommendation to 
use iodised salt “presents a conflict in public health” (CASH, 2011). Both CASH and the 
WHO are in agreement that iodised salt should not be used as an excuse for recommending 
increased salt intake and public health messages must be clear (WHO, 2008; CASH, 2011).
Other countries (United States and the Netherlands) with strong iodised salt programmes 
have hypothesised the impact that salt restriction may have on iodine intake (Tayie & 
Jourdan, 2010; Verkaik-Kloosterman et a l, 2010). Using data from NHANES (2001-2004) 
regression models suggest that women in the United States who restricted salt intake were 
more likely to be iodine deficient (the same was not true for men) and the authors 
recommend that alternative iodine sources should be discussed with those restricting salt 
intake (Tayie & Jourdan, 2010). When researchers highlighted the benefits of reducing salt
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intake by 3 g per day in the US in terms of stroke, CVD and mortality (Bibbins-Domingo gt 
a/., 2010), members of the American Thyroid Association responded with concerns about
the knock-on effect on iodine status, proposing that salt reduction should be achieved in 
such a way that adequate iodine intake is ensured (Soldin et al, 2010). In the Netherlands, 
the effect of different scenarios of reducing salt intake on iodine status has been examined 
with statistical modelling and the results suggest that a 50% reduction in both industry and 
domestic salt use (estimated to be the required reduction to meet salt targets), may cause 
iodine deficiency in up to 10% of the general population, rising to 35% of children up to 
the age of three years ( V erkaik-Kloosterman et al, 2010).
It is clear that based on experience in countries similar to the UK, that if an iodised salt 
programme were to be introduced by the UK Government, it would need to be in harmony 
with the existing policy of salt reduction in order to achieve both improved iodine intake 
and targets for reduced salt intake.
8.4.4 Limitations and future work
This study is not exhaustive or extensive; it only sampled retail outlets in 15 counties of
England and one region of Northern Ireland. The results are also limited to the time period 
in which the study was conducted; purchasing decisions and stock may change in retail 
outlets and consequently iodised salt may become more or less available in the future.
This study could be expanded to include a more extensive evaluation of iodised salt 
availability across the UK. A survey of a representative households in the UK could also be 
conducted to assess both use of iodised salt and the concentration of iodine in household 
salt, as recommended by the WHO for the assessment and monitoring of iodine status in a 
population (WHO g/ a/., 2007). This would then provide data on the use of iodised salt in 
the UK; according to the WHO, more than 90% of households should be using iodised salt 
in order to manage iodine deficiency effectively (WHO g/ a/., 2007).
8.5 Conclusion
Based on this retail survey, current availability of iodised salt is low in the UK and is 
unlikely to be contributing to the iodine status of the population.
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9. PRODUCTION OFAN IODINE FACT SHEET
9.1 Introduction
There is very little information about iodine in dietary or nutritional advice given to the UK 
public; in particular, as previously discussed, there is a complete lack of such information 
in advice for pregnant women (Gordon, 2009; NHS Choices, 2009c; BUPA, 2010; BBC, 
2011). The UK Department of Health information on iodine is outdated, too simplistic, and 
provides very little practical guidance on achieving an adequate iodine intake (NHS 
Choices, 201 Id). Following the UK survey that indicated mild iodine deficiency in the 
country, it was proposed that nursing staff should be more aware of potential iodine 
deficiency in young girls and should “provide appropriate dietary advice” (Boyages, 2011), 
though whether UK nursing staff would have the correct dietary knowledge is doubtful. 
There is an opportunity and a need for an “Iodine Fact Sheet” for the general public, which 
will be particularly valuable for women planning a pregnancy, or who are pregnant or 
lactating.
Although the UK Total Diet Studies (Rose g/ a/., 2001) and the Food Standards Agency 
nutrient analysis have provided data on the iodine concentration of a range of foods, these
information sources need to be combined to produce a summary of the iodine content of 
UK foods. This will allow appropriate recommendations on iodine intake to be made for 
the general public, and will help in the creation of an Iodine Fact Sheet.
9.1.1 Aims
• To estimate iodine content per portion of a range of UK foods.
# By combining data from Chapters 6, 7 and 8 with information on the iodine 
concentration in UK foods, to produce an Iodine Fact Sheet for general public use.
9.2 Method
9.2.1 Iodine content per portion estimation
In order to provide a database of the iodine content of a range of foods, the author searched 
the Food Standards Agency website archives for the Food Survey data that had measured
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iodine since the most recent Total Diet study (TDS) that had measured iodine concentration 
(in 1997) (Rose et a l, 2001). The McCance and Widdowson’s Composition of Foods (the 
UK nutrient database) was not used for iodine per portion estimation as it was considered 
outdated: the last edition (6*), published in 2002, does not included the most recent nutrient 
analyses by the FSA (Food Standards Agency, 2004a; Food Standards Agency, 2004b; 
Food Standards Agency, 2008; Food Standards Agency, 2011).
The figures from the 1997 TDS were used in this chapter for food groups that did not have 
more recent iodine figures (e.g. meat). The TDS purchases foods from 20 retail outlets 
across the UK and groups foods into 20 categories to reflect UK diet patterns (Peattie et a l , 
1983). The foods are weighted according to purchasing patterns in order to reflect the 
average diet. For example, the meat category would include more of the commonly eaten 
meats to give a sensible estimate for dietary exposure. The iodine concentration figures 
were used as reported by the TDS, and converted to iodine content per portion (Food 
Standards Agency, 2002) for use in the Food Fact sheet.
The TDS report does not provide a breakdown of values, for example for white or oily fish 
or shellfish. In order to provide information that was sufficiently detailed and practically 
useful for the public, it was considered important to split the “fish” category into fish type 
(white, oily or shellfish). The results of a UK study conducted in the early 1990s (Lee et a l, 
1994) were used to provide average values for white fish, oily fish and shellfish (Appendix 
7), as the iodine content for a range of fish species (10 samples of each fish were analysed 
for iodine concentration) was available from that study. Lee et a l (1994) reported the 
iodine concentration of either cooked or raw fish, and occasionally for both; where the 
concentration was reported for both cooked and raw fish, the ratio between cooked and raw 
values was calculated to aid the estimation of the iodine content for cooked fish, when only 
the raw value was provided (Appendix 7).
The iodine concentration of fish varies widely between species (Harrison et a l, 1965), so 
only popular fish choices were included to give an average for white fish, oily fish and 
shellfish. For example, although the report by Lee et al (1994) includes the values for red 
snapper and whiting, these were not included in the white-fish average as they are not 
commonly consumed in the UK. The white-fish category was therefore based on an average
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of cod, haddock, plaice and coley; oily fish was based on mackerel, kippers, salmon, 
sardines, trout, pilchards and herring; the average iodine concentration in shellfish was 
based on scampi, mussels, cockles and prawns. As the public is advised against counting 
tinned tuna as an oily fish (as it is a poor source of long-chain n-3 fatty acids) (NHS 
Choices, 201 Ic), tinned tuna was not included in the oily-fish category. The salmon figures 
reported by Lee et al (1994) were only for tinned salmon and therefore those values were 
supplemented with information from the recent Food Standards Agency Catch-up Survey 
that included grilled fresh salmon (Food Standards Agency, 2004a).
Food Standards Agency nutrient surveys
In 2004, the FSA analysed a range of foods for nutrient content as part of a catch-up survey 
to provide missing data in the Food Nutrient Databank (Food Standards Agency, 2004a). 
Composite samples from 32 food groups were analysed (10 samples of each food), 
including fresh salmon, sushi and vegetarian mince; the iodine values for these foods are 
included in this chapter (average of composite samples taken, see Appendix 7). A range of 
pastas was also analysed by the FSA in 2004, (Food Standards Agency, 2004b) and an 
average iodine concentration for cooked pasta was used for this chapter (see Appendix 7 for 
calculation). The most recent FSA nutrient survey, examined the iodine content of 21 
composite samples (composed of 5 - 12 sub-samples) of biscuits, buns, cakes and pastries 
(Food Standards Agency, 2011). lodine-concentration values for cakes and pastries were 
averaged (Appendix 7) to give a value for this chapter.
Food Standards Agency survey of UK-produced dairy products
In 2008, the Food Standards Agency measured the iodine concentration in a range of UK- 
produced dairy products and seaweed to estimate dietary exposure and subsequent risk of 
iodine excess in the UK (Food Standards Agency, 2008). Samples of milk, yoghurt, cheese, 
eggs and seaweed were purchased in the winter (January to March) and summer (May to 
July) of 2007 (Food Standards Agency, 2008). The report gives a mean concentration for 
each food group (e.g. eggs or yoghurt), but also provides a comprehensive and detailed 
appendix, giving the iodine concentration for each food item tested. Unlike previous food 
surveys, the figures given are not for composite samples (weighted for popularity of foods), 
but rather a mean for a food group; the mean includes a range of obscure food items and
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dairy products from less popular animals (for example sheep and ostrich). It is clear from 
the figures in the FSA appendix that some samples (e.g. ewe yoghurt and quails eggs) are
skewing the mean figure for the food group. The mean figures cannot be used as presented 
by the FSA for sensible estimations of iodine content per portion of foods consumed by the 
general public.
The author entered all food items from the FSA appendix into SPSS, including details on 
the season of collection, whether the food was conventional or organic and the animal 
origin. Data were only included if there was more than one sample; for example one ostrich 
egg was analysed by the FSA but the data were not included in the report. It was possible to 
report cows’ milk and cows’ yoghurt values by season and milk type (organic and 
conventional) but not for other animal milk or cheese due to low numbers of some food 
items. Results from the SPSS analysis are in the CD Appendix.
9.3 Results
9.3.1 Iodine per portion for use in Iodine Fact Sheet
Table 9.1 gives the estimated iodine concentration per food group. The median and
interquartile range are reported for all food groups, as the iodine concentration results were 
not normally distributed. The FSA results are reported in mg/kg, but have been converted 
to pg/g, for ease of interpretation.
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9.4 Discussion
9.4.1 Iodine content o f UK foods
Seaweed was the most concentrated food source of iodine in UK foods, with an estimated 
content per portion of 107-6750 pg iodine (Table 9.1). The Food Standards Agency (2008) 
survey presented an average iodine concentration for seaweed and also for Kombu and 
Dulse; the author has clarified the iodine concentration by species, rather than as an overall 
figure. The results (Table 9.1) show that iodine content is highly variable between species 
of seaweed, as previously reported in seaweed samples in the US (Teas et a l, 2004), and 
the estimation of iodine content in this food group is challenging.
It is known that there are large variations in fish-iodine concentration, both between species 
and within species from different sources (Harrison gr a/., 1965), which makes the 
estimation of iodine content for a generic category (such as white fish) difficult as the range 
of values is large. The iodine concentration results (Table 9.1) show that white fish sampled 
in the UK had higher iodine concentration than oily fish (1.16 v& 0.47 pg/g) and this is in 
line with values for lean and fatty fish in Norway (0.86 vs. 0.40 pg/g) (Dahl et a l, 2004). 
The UK values for fish suggest that a portion (lOOg) could provide between approximately 
30 and 75% of the adult requirement (20 and 50% of the iodine requirement for pregnancy), 
depending on the type of fish consumed.
The iodine content of UK meat and poultry is low (Table 9.1) suggesting that a portion is
likely to provide less than 10% of the adult requirement, thus perhaps explaining the lack of 
an association between meat and poultry and iodine status in pregnancy in this thesis 
(Chapter 6). It has been suggested that meat is less influenced by animal feed iodine 
concentration than milk (Franke gf a/., 2009), and thus backs up the finding of the low 
iodine content in meat and poultry.
The goats' milk concentration in the FSA (2008) report was higher than cows' milk but 
similar to the 0.7 mg/kg reported for goats' milk elsewhere in the literature (Gue'guen, 
1997 cited in Meschy 2000). A potential explanation for the differences between goats' and 
cows' milk iodine concentration is a difference in iodine requirements between the two
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animals. Goats appear to have higher iodine requirements than cattle and may be more 
sensitive to iodine deficiency (Meschy, 2000), therefore goat feed may be supplemented 
with a greater concentration of iodine to minimise the risk of iodine deficiency.
The UK Government recommends between two and three portions of dairy products daily 
during pregnancy (NHS Choices, 2009a); based on calculations in this chapter, between 
approximately 114 and 196 pg of iodine would be provided (depending on the season) if 
women consumed 200 ml of milk (cows’), a portion of cheese and a pot of yoghurt per day. 
The actual amount provided is also likely to be influenced by the method of production 
(organic or conventional farming) (see Chapter 7).
9.4.2 Justification for the Iodine Fact sheet
The Iodine Fact Sheet (Figure 9.1) was designed to be a double-sided sheet to provide 
detailed information on the importance of iodine and the food sources that can ensure an 
adequate iodine status. It is written in such a way as to be understood by those with no 
previous knowledge of iodine, aiming to be as succinct in its message as possible. A 
selection of food items from Table 9.1 (figures rounded) were included to give a guide as to 
the concentrated sources of iodine (e.g. fish) in comparison to other foods considered to be 
nutrient dense (e.g. vegetables).
Given the associations discovered between milk and iodine status (Chapter 6), it was 
considered important to highlight that population groups who avoid milk and dairy 
products are at risk of deficiency. The finding that women who were taking an iodine- 
containing supplement had an improved iodine status provided the evidence that women 
who do not consume iodine-rich foods may benefit from such a supplement. Kelp 
supplements are not suitable for pregnant women due to the high variability in iodine 
concentration (Lee et a l, 1994; Zimmermann & Delange, 2004; Leung et a l, 2009) but 
unfortunately are currently the only form in which iodine is available as a single 
supplement to UK consumers; the Iodine Fact Sheet made it clear that kelp supplements 
should be avoided for this reason. It was also considered vital to highlight the fact that 
people with thyroid disease and those with longstanding iodine deficiency may react 
adversely to sudden increases in iodine (Bulow Pedersen et a/., 2011; Moleti et a l, 201 la).
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Figure 9.1 Iodine Fact Sheet
Iodine Fact Sheet
This advice is for aduks oniy {including pregnant and breastfeeding women); it is not suitable for children.
What happens if I do not have enough Iodine?What does iodine do?
iodine is essential for the production of thyroid 
hormones which are vital for many 
body processes including metabolism 
and growth. One of the most 
important roles of the thyroid 
hormones, and therefore of iodine, is 
for development of the baby’s brain 
during pregnancy and early life.
Do we get enough iodine in th e  UK?
For many years iodine intake in the UK was thought 
to be more than adequate but recent research has 
shown mild iodine deficiency in schoolgirls and 
pregnant women. There is now concern that many 
people may not be getting enough iodine.
How much iodine do t need?
Adults 150
Pregnant women 250
Breastfeeding women 250
During pregnancy and breastfeeding
It is vital that women have good stores of iodine in 
the thyroid before becoming pregnant. Women of 
childbearing age should ensure that they meet the 
adult requirement, especially if planning a pregnancy.
During pregnancy, the amount of iodine needed 
increases. This is because the mother has to make 
sufficient thyroid hormone for transfer to the baby to 
help its brain develop correctly. She also supplies all 
the iodine that the baby needs. Iodine deficiency in 
pregnancy may have serious consequences for the 
child so it is very important that pregnant women 
m eet that higher iodine requirement.
During breastfeeding, the need for iodine remains 
high so tha t the mother can supply sufficient iodine 
in her breast milk to  m eet the requirements of the 
baby whose brain is still developing.
Consuming low levels of iodine can have negative 
consequences for thyroid hormone production. 
During pregnancy, a
deficiency of iodine in the 
mother, even if mild, can 
lead to impaired brain
development in the baby and 
this can have long-term
implications for the child in later years, such as a 
lower IQ.
A low intake of iodine over a long period of time may 
cause the thyroid gland in the neck to  increase in 
order to trap iodine; this swelling may be visible and 
is known as goitre.
W here is iodine found In th e  diet?
Iodine is found in range of foods, the richest sources 
being fish and dairy products. Although seaweed is a 
concentrated source of iodine, it can provide 
excessive amounts {particularly brown seaweed e.g. 
kelp) and therefore eating it more than once a week 
is not recommended, especially during pregnancy.
For most people, milk and dairy products are their 
main sources of 
iodine. Research has 
shown that organic 
milk has a 40% lower 
iodine-content than 
conventional milk.
Organic milk and 
dairy products can still make an important 
contribution to iodine intake but if you consume 
them, you need to be aware that they will provide 
less iodine.
In many countries, iodine is added to table salt to 
give "Iodised salt". Iodised salt is not widely available 
in the UK but can be found in some branches of 
several supermarket chains. As government 
recommendations arc to reduce salt intake for health 
reasons, you should not rely on iodised salt as a 
means of increasing your iodine intake.
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The actual amount of iodine in food varies according 
to the soil iodine-content, farming practice, fish 
species and season. For example, winter milk has 
higher levels of iodine than summer milk. This makes 
estimating iodine per portion difficult. The figures in 
the table are therefore for guidance oniy.
Conventional milk
200 SO-SO**
(cows')
Organic milk (cows') 200 30-65**
Conventional
ISO SO-100**
yoghurt (cows'
Eggs (hens') 1 egg; SOg 20
Cheese (cows']T 40 15
White fish 100 115
Oily fish 100 50
Meat 100 10
Poultry 100 10
Nuts 2S 5
Bread 1 slice: 36g 5
Cereals 30
Fruit & vegetables 1 portion; SOg 3
* Actual iodine content wilt vary * * Depending on the season, 
hi^ er value in winter tlower concentration for organic
Can I have too much iodine?
Yes; excessive iodine intake can cause thyroid 
problems. As a guide, intakes should not regularly 
exceed 600 mcg/day (less in children). If you have 
thyroid disease, or have expenenced iodine 
deficiency over many years, you should speak with 
your GP before taking additional iodine. This is 
because you may respond differently to extra iodine.
Who is at risk of iodine deficiency?
Vegans are at risk of iodine deficiency as they do not 
eat rich iodine sources (fish and dairy products). 
Vegetarians may also be at risk, especially if milk 
intake is tow. Anyone who avoids fish and/or dairy 
products (e.g. due to allergy or intolerance) could be 
at risk of iodine deficiency. Soya milk is often not 
fortified with iodine (check the label) and therefore 
will not replace the iodine in cows' milk.
What about an iodine supplement?
Most adults following a healthy, balanced diet 
containing milk, dairy products and fish, should be 
able to meet their iodine requirements.
A supplement containing iodine can help meet iodine 
needs for adults who do 
not consume sufficient 
odine-rich foods. Iodine 
n supplements should be 
n the form of 'potassium 
iodide' and should not 
exceed the daily aduit requirement of 150 meg.
Seaweed or kelp supplements should not be used as 
an iodine source. This is because the amount of 
iodine in the supplement can vary considerably from 
the value claimed on the label and can provide 
excessive quantities of iodine.
It can be difficult to  meet the higher 
recommendations for iodine during pregnancy and 
breastfeeding through diet alone, especially if you do 
not eat rich sources of iodine. Many, but not all, 
multivitamin and mineral pregnancy supplements 
contain iodine, so you need to check the label. The 
supplement should provide up to 150 meg, so the 
remainder of the requirement can be met by your 
diet. If you consume high quantities of iodine-rich 
foods during pregnancy, you may not need an iodine 
supplement; talk to a registered dietitian if you are 
uncertain.
Sumnaary
Iodine is important for the production of thyroid 
hormones. During pregnancy, it 
is essential for the correct 
development of the baby's brain.
Iodine deficiency and excessive 
intakes of iodine should be 
avoided. It is advisable to speak 
with your GP before taking 
additional iodine if you have 
thyroid disease or have a history of a low intake of 
iodine for a long period of time.
This sheet is for information only. It is not intended to replace nwdkal diagnosis or oilier dietary information you have been given, f otfouv 
advice on focds to avoid if you are pregnant. Consult a dietitian or your GP i! you are unsure about any information, if you need to see a 
dietitian, visit your GP for a referral or: www.freetancedietiLians.orE for a private dietitian. Check that your dietitian is registered at 
www.lipc-uk.org. Written by Sarah Bath. Dietitian ® University of Surrey. November 2011
206
Chapter 10 Conclusions and Future work
10. CONCLUSIONS FROM THE WORK IN THIS THESIS 
AND PROPOSALS FOR FUTURE RESEARCH
10.1 Summary of thesis findings
Despite a worldwide focus on the elimination of iodine deficiency, iodine is a largely 
overlooked nutrient in the UK and there is a dearth of information on iodine intake and 
status in the UK, which this thesis has endeavoured to address through a series of studies. 
The findings of the thesis suggest that a public-health policy is required in the UK to 
minimise the risk of iodine deficiency and its adverse effects, particularly in pregnancy.
The thesis has evaluated the iodine status of pregnant women using three cohorts, two in 
the present day (Royal Surrey Study and SPRINT) and a retrospective evaluation of iodine 
status in pregnancy 20 years ago (ALSPAC). All three cohorts revealed mild-to-moderate 
iodine deficiency in UK pregnant women. The findings suggest that iodine intake in 
pregnancy (from diet alone) has fallen in the last 20 years. Iodine status in ALSPAC was 
assessed during a time when iodine intake was considered by the UK Government to be 
adequate (Lee et al, 1994) but iodine status was insufficient compared to today’s WHO 
standard for pregnancy (WHO Secretariat g/ a/., 2007). The analysis of iodine status in the 
ALSPAC cohort may suggest that iodine deficiency was never completely eradicated in the 
UK (see Introduction, Section 1.7.2).
After establishing that UK pregnant women were not meeting their iodine requirement, the 
author went on the explore whether iodine status was linked to negative outcomes either for 
maternal thyroid function or, more importantly, in terms of cognitive and developmental 
outcomes in the offspring. Although there was no evidence from SPRINT of a link between 
maternal iodine status and thyroid function at 12 weeks’ gestation, results from ALSPAC 
suggested a considerable impact of iodine deficiency in UK pregnant women on child 
outcomes; these included a greater risk of suboptimal IQ, reading ability and school 
performance, as well as possible links with hearing and fine motor development. The 
findings from SPRINT (Chapter 4) and ALSPAC (Chapter 5) may appear to be in conflict 
as one might expect that low iodine status would be linked to a poorer thyroid-hormone 
profile, which would explain the adverse outcomes in ALSPAC. The nature of the SPRINT
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study, where iodine status and thyroid function were measured at the same time-point, and 
the limitations of the spot-urine for iodine assessment of individuals (see Introduction, 
Section 1.3.3) are the likely explanation for the null findings (see Chapter 4 limitations). 
Although there was no direct relationship between iodine status and thyroid function in 
SPRINT, 15% of women had hypothyroxinaemia and 57% had fT4 in the bottom 50^  ^
percentile suggesting that low iodine status in UK pregnant women may have an impact on 
the level of T4 available to the fetus. This would have consequences for the fetus thereby 
providing a mechanism for the association of low iodine status in ALSPAC women with 
impaired fetal brain development. Unfortunately, this mechanism could not be tested in the 
ALSPAC pilot study as thyroid function could not be measured in the same women who 
provided urine samples owing to time and budget constraints.
The author then evaluated the food sources that were associated with iodine status in UK 
pregnant women. This information is important for informing public-health policy and for 
dietetic advice to women (discussed more detail in 10.1.1), and was considered to be 
important given the adverse associations between child cognition and iodine deficiency 
revealed by the ALSPAC analysis (Chapter 5). Nutritional supplements containing iodine 
were the biggest predictor of maternal iodine status in the Royal Surrey Study and helped 
protect women from iodine deficiency (Chapter 6). Analysis of the FFQs for both the Royal 
Surrey Study and ALSPAC suggested that milk was the most important dietary predictor of 
iodine status and this supports the findings in other studies of UK adults (Nelson et a l , 
1988; Henderson et a l, 2003; Vanderpump et a l, 2011). The thesis has shown that organic 
milk has an iodine concentration over 40% lower than that of conventional milk (Chapter 
7), which is a concern given the large contribution of milk to iodine intake and the 
increasing popularity of organic milk in the UK.
The Royal Surrey Study specifically asked women if they consumed iodised salt and the 
results show that the majority never or rarely consumed it. This supports the finding 
(Chapter 8) that iodised salt availability is low in the South of the UK and that, in contrast 
to most other countries, a low percentage (fewer than 20%) of supermarket shoppers in the 
UK have iodised salt available for purchase.
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10.1.1 Dietetic implications o f findings
In the absence of official guidance, UK women of childbearing age should ensure that 
iodine requirements are met, ideally prior to conception to optimise thyroidal stores, and 
iodine deficiency should be avoided during pregnancy and lactation. A change in the 
information provided to pregnant women is required, as currently the advice does not 
mention iodine (NHS Choices, 2009c) (see Chapter 6 for discussion). Furthermore, the 
information about iodine on the NHS webpage on vitamins and minerals (NHS Choices, 
201 Id) is outdated and largely unhelpful and therefore this thesis has produced an Iodine 
Fact Sheet. The author has contacted the British Dietetic Association with a view to getting 
the Iodine Fact Sheet approved and stamped with the BDA logo, which involves a peer 
review process, but has been informed that there is no capacity for new diet sheets in the 
near future, though it may be possible to have it incorporated into the BDA Food Fact 
series at a later date.
Without the “safety net” of an iodised salt programme in the UK and the poor availability 
of iodised table salt (Chapter 8), iodine intake is entirely dependent on individual food 
choices. Thus, the information gained from this thesis (Chapters 6-8) is important for 
advancing knowledge of which groups of individuals are at risk of iodine deficiency in the 
UK. Using data from this thesis (Chapters 6 and 9), a model has been created indicating the 
risk of iodine deficiency according to individual food choices (Figure 10.1).
Vegans are an obvious group of individuals at risk of iodine deficiency but represent a 
small percentage of the UK population; based on figures from the adult NDNS fewer than 
2% of the adults surveyed were vegan (Henderson et a l, 2002), none of women in the 
Royal Surrey Study was a vegan. Vegans are a recognised at-risk group for many nutrient 
deficiencies, including iodine (Lightowler & Davies, 1998; Leung et a l, 2011) and goitre 
has previously been reported in UK vegans (Park et a l, 2005). The UK Vegan Society 
highlights the risk of iodine deficiency to members, and provides advice regarding iodine 
supplementation (Walsh, 2008). Vegetarians are protected from iodine deficiency to some 
degree by the inclusion of milk and dairy products in the diet, although the quantity will 
obviously influence risk of iodine deficiency in UK vegetarians (Figure 10.1).
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Vegans and those with 
Intolerance/allergy to fish 
and dairy products
Omnivores and regular 
consumers offish and dairy 
products
Vegetarians
Risk of iodine deficiency
Iodine concentration of 
foods
Meat & 
poultry
Nuts Eggs, milk 
& cheese
Yogurt Fish
Fruits & 
vegetables
Bread & 
cereal
Figure 10.1 Schematic to show groups of women most at risk of iodine deficiency, in relation to 
iodine concentration of food groups (iodine concentration of foods is represented to scale, using 
data from Chapter 9). Model adapted from Professor DJ Millward’s protein model (University
presentation January 2012).
In contrast to vegans and vegetarians that are recognised to require nutritional advice 
(Carton, 2011), women in the UK with habitually low intakes of iodine-rieh foods are at 
greater risk of iodine deficiency as these individuals may not set alarm bells ringing with 
health professionals. Individuals who do not consume milk and dairy products (especially if 
they also have a poor intake of fish) are an example of such a group (Figure 10.1). These 
people have a high risk of iodine deficiency as a result of missing out on a major source of 
iodine, and even if they do not completely avoid this food group, a low intake may increase 
risk of iodine deficiency (as shown in Chapter 6). In fact, nodular goitre has been reported 
in a teenage girl in the UK who did not consume red meat, milk or dairy produce (Gordon 
et a l, 2006) supporting the idea that dietary restrictions increase the risk of iodine 
deficiency.
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A substantial number of women of childbearing age and pregnant women in the UK may 
restrict intake of milk and dairy products for a number of reasons, including allergy, 
intolerance (perceived or genuine), religious and moral reasons (animal welfare). 
Compounding the problem of a “dairy-free diet” is the substantial ignorance of the iodine 
content of milk, even among health professionals such as dietitians, so that iodine is 
overlooked as an at-risk nutrient when individuals avoid dairy produce. For example, an 
article aimed at providing guidance to UK dietitians in the British Dietetic Association 
monthly publication “Dietetics Today”, highlighted the nutritional risks associated with 
dairy-free diets but did not list iodine as a nutrient found in milk and therefore failed to 
discuss the implications for iodine deficiency of avoiding dairy products (Phillips, 2011). 
This is important as it means those individuals who cut dairy produce out of their diet will 
not be given appropriate advice to ensure adequate iodine from alternative sources and thus 
will be at higher risk of iodine deficiency. Soya milk and products are often used in place 
of cows’ milk and dairy produce (and were used regularly by 3% of women in the Royal 
Surrey Study) and though dietitians advise the use of calcium-enriched soya milk (Phillips,
2011), iodine intake will be further comprised in those who replace cows’ milk by soya 
milk. This is because the major soya milk brand in the UK (Alpro Soya) is not fortified 
with iodine (shelf survey by the author), while others (e.g. SoGood and Tesco soya milk) 
list potassium iodide as an ingredient but iodine is not listed in the nutrition information, 
making estimation of iodine intake very difficult for consumers of soya milk.
It is widely reported that fish consumption is low in the UK, especially in young women [as 
evidenced from the NDNS (Bates et a l, 2011)] and this may compromise iodine intake 
(Figure 10.1). Indeed, 12% of women in the Royal Surrey Study reported not consuming 
fish (Chapter 6) and in view of the fact that this study was conducted in an affluent area 
(Office of National Statistics, 2010), low fish consumption during pregnancy may be more 
prevalent than revealed in this thesis. If fish is not consumed, adequate iodine intake will 
need to be obtained from other sources and individuals need to be made aware of these 
alternative sources.
The current healthy eating advice given to pregnant women in the UK is to consume two 
portions of fish per week and up to three portions of milk and dairy products daily (NHS
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Choices, 2009a), and while this is not iodine-specific, it would make a good contribution to 
iodine intake. However, evidence from the Southampton Women’s Study (UK) suggests 
that healthy eating advice is not always followed by those planning a pregnancy (Inskip e/ 
a/., 2009), nor by those who are pregnant (Crozier er aZ., 2009). It is suggested that women
may be unaware that some recommendations are pregnancy-specific (Crozier et al., 2009) 
and this links with the “Health Belief Model”, used in dietetics, that suggests that 
individuals initiate behaviour (and thus dietary) change based on perceived risks and 
benefits (Rosenstock, 1982). Indeed research on UK pregnant women has suggested that 
dietary messages that reinforce the benefit of healthy eating in terms of outcomes for the 
mother and baby are more likely to result in dietary change (Gardner et a l, 2012). It is clear 
that in order to increase the chances that pregnant women follow dietary advice for iodine 
in the UK, information should highlight iodine as a vital nutrient for pregnancy and explain 
why it is required. This concept was used when designing the Iodine Fact Sheet.
10.2 Originality of the research and contribution to knowledge
The novelty and contribution to knowledge of each study is summarised in Table 10.1 and 
further details can be found in the relevant chapters. In addition to the points noted in the 
table, the author corrected UIC in spot-urine samples for urinary creatinine concentration to 
improve the accuracy for individual iodine assessment (Knudsen g/ a/., 2000; Vejbjerg gr 
a/., 2009a). Though this is not a novel technique, and has been used in previous research on 
iodine in pregnancy (Thomson et a l, 2001; Soldin et a l, 2003; Kibirige et a l, 2004; Fuse 
et a l, 2011), the thesis highlights the fact that the measurement of creatinine in a developed 
country, such as the UK, may be beneficial. Currently the WHO does not recommend the 
measurement of urinary creatinine (WHO gt a/., 2007) based on the fact that creatinine 
excretion may mask iodine deficiency in a population with high levels of malnutrition. 
While this generic advice to researchers worldwide may be valid for population monitoring, 
in a developed country, the measurement of urinary creatinine may aid the exploration of 
associations between iodine status and outcomes such as diet, child cognition and thyroid 
function. Much of the current research utilises the UIC value, for example in the UK survey 
of schoolgirls (Vanderpump g/ a/., 2011), and had Vanderpump and colleagues used the 
iodine/creatinine ratio, the relationships between iodine and diet might have become more
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obvious. Had the simple iodine concentration value (pg/L) been used in place of the 
iodine/creatinine ratio in this thesis, the link between iodine status and child outcomes in 
ALSPAC, or between iodine status and dietary patterns in the Royal Surrey Study 
(Chapters 5 and 6), would largely have been undetected. Furthermore, researchers must be 
aware of any methodological bias when utilising urine samples collected for other purposes 
(e.g. as part of routine ante-natal care) that may mean urine samples are artificially dilute, 
as found in SPRINT urine samples (Chapter 3); iodine deficiency would have been 
overestimated in the SPRINT cohort if the iodine/creatinine ratio not been used.
Table 10.1 Summary o f  the novelty and contribution to knowledge o f  each study in the thesis
Study Novelty and rationale for 
investigation
Contribution to knowledge
Iodine status o f  UK  
pregnant women  
(Chapter 3)
Relationship between 
iodine status and 
thyroid function in 
pregnancy (Chapter 4)
Impact o f  iodine 
deficiency on child 
outcomes (Chapter 5)
Dietary sources o f  
iodine (Chapter 6)
Comparison o f  iodine 
content o f  organic and 
conventional milk 
(Chapter 7)
Iodised salt survey 
(Chapter 8)
Iodine Fact Sheet 
(Chapter 9)
N o data on iodine status in 
pregnancy in South o f  the U K  and 
poor data reported in other UK  
studies o f  pregnant women
N o data in the UK linking iodine 
status to thyroid function in 
pregnancy and limited data in 
regions o f  mild-to-moderate 
iodine deficiency
Lack o f  data on the impact o f  
mild-to-moderate prenatal iodine 
deficiency on offspring 
neurodevelopment and no 
evidence in the UK
N o UK data on impact o f  iodine 
supplements or diet on iodine 
status in pregnancy
First sizeable study and first study 
to evaluate difference in UK milk
N o national data on iodised salt 
availability
N o reliable information source on 
iodine for UK consumers
U K  Pregnant wom en are m ildly-to- 
moderately iodine deficient
Hypothyroxinaemia present in 
15% o f  UK  pregnant wom en
N o direct relationship between  
iodine and thyroid frmction at 12 
w eeks’ gestation
Level o f  iodine deficiency in the 
UK is associated with adverse 
outcom es for the child.
Fetal brain developm ent may be 
impaired in regions o f  mild iodine 
deficiency.
M ilk is the main dietary source o f  
iodine for UK pregnant wom en
U K  prenatal supplements increased 
urinary iodine excretion.
Organic m ilk-iodine content is 
over 40% lower than conventional 
milk
Iodised salt is poorly available in 
UK supermarkets and more 
expensive than standard table salt
Production o f  user-friendly Iodine 
Fact Sheet
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10.3 Lim itations o f the research
The limitations of various studies have been highlighted in the relevant chapters throughout 
the thesis and these will not be discussed again here. However, there are several limitations 
that may have an impact on the overall conclusions from the thesis:
(1) The approximation of individual iodine status has relied on a spot-urine sample. This 
will not have affected the description of the cohorts as iodine deficient, as spot urine 
samples are suitable for population status assessment (WHO et a l, 2007), but may have 
had an impact on the relationships between iodine status and either maternal thyroid 
function (Chapter 4), child developmental outcomes (Chapter 5) or maternal characteristics 
and diet (Chapter 3 and 6). Attempts were made to increase the accuracy of a spot-urine 
sample for individual assessment by correcting for urine volume (with creatinine 
concentration) (Methods, Section 2.4.2), but it is possible that women may have been 
misclassified as either iodine-sufficient or iodine-deficient. Any misclassification may have 
been evened out in the large sample size of ALSPAC, but not in the smaller studies of the 
Royal Surrey and SPRINT and may have contributed to the null findings for some 
relationships (e.g. maternal thyroid function). Multiple spot-urine samples (with creatinine- 
adjustment) from an individual would have improved the accuracy of individual iodine 
assessment (Andersen et a l, 2008; Konig et a l, 2011).
(2) The potential iodine contamination of urine samples in ALSPAC is an obvious 
limitation. Although attempts were made to restrict analysis to those samples believed to be 
free from contamination, it is possible that samples with a UIC that appeared to be in the 
normal range were in fact contaminated; this would be possible if the true iodine 
concentration were low prior to contamination. Thus, as described in Chapter 3, the true 
median UIC may be lower than reported and the potential contamination may have 
weakened observed relationships with child development and dietary patterns and shifted 
results towards the null (Chapter 5). Contamination of urine samples with iodine through 
the use of urine test strips is common in iodine research and has been reported in other 
studies (Caron et a l, 1997; Burgi et a l, 1999; Pearce et a l, 2010). Attempts were made, 
with the analyst at the Southampton Trace Element laboratory, to establish a “marker” in 
urine that would indicate that the sample had been contaminated (by utilising the capacity
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of ICP-MS to measure multiple elements simultaneously), but this was unsuccessful. 
Although the author has learnt to ensure that any future project has urine samples that are 
free from possible contamination, it was perhaps advantageous that the contamination in 
ALSPAC was unknown at the initial collaboration meeting, as an exceptional opportunity 
to explore cognitive outcomes with iodine status in the UK would have been missed.
(3) Current iodine status in UK women was evaluated in the affluent areas of Oxford and 
Surrey (Office of National Statistics, 2010) and thus may not be a representative survey of 
pregnant women in the UK. In addition, this thesis had limited data iodine status in women 
with dietary restrictions, for example those who exclude milk and dairy products. This 
could be considered as a limitation, but it is also possible that the findings in this thesis 
represent a best-case scenario. As iodine deficiency has been demonstrated in these affluent 
areas, iodine deficiency may be more severe and widespread amongst pregnant women 
from other, more deprived regions of the UK.
(4) The difference in iodine concentration between organic and conventional milk was only 
evaluated in the summer months due to time and budget limitations. With the benefit of 
hindsight, the author would have sampled from a smaller geographical area (given the lack 
of association between area of purchase and iodine concentration. Chapter 7) and instead 
used the funds to repeat sampling in the winter months. In addition, the use of organic milk 
by UK pregnant women remains unknown as, regrettably, there was no question on organic 
milk use in the Royal Surrey Study. The author would always ensure that any future dietary 
questionnaire or study to evaluate iodine status includes a question on the type of milk 
consumed (organic or conventional).
10.4 Future work
PhD budget constraints limited the number of urine samples that could be analysed in 
ALSPAC. Funding has now been obtained for an extension of that work for the inclusion of 
a greater number of ALSPAC mother-child pairs. The urine samples will be selected from 
the 2"  ^ and 3"^  ^ trimesters of pregnancy, in order to provide knowledge of iodine status 
throughout gestation, as the samples analysed for this thesis were predominantly from the
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C* trimester (Methods, Section 2.3.3). The funding has been provided as an extension to 
Nutrimenthe project, FP7 (funded by European Conunission).
In order to provide information on the effect of longitudinal iodine status during pregnancy 
and links with child development (Chapter 5, Section 5.4.8), a proposal has been submitted 
to the Medical Research Council (MRC) to analyse all available urine samples collected 
during pregnancy in ALSPAC. This will also increase the number of samples for cross- 
sectional analysis of the impact of iodine deficiency at various time-points in pregnancy. 
As some women have provided up to five urine samples, the accuracy of individual iodine 
status assessment will be increased by having multiple spot-urine samples in the same 
individual (Andersen et a l, 2008; Konig et a l, 2011).
The data on iodine status and thyroid function at 20 and 35 weeks’ gestation will be 
available from SPRINT once the study has been completed, enabling the association 
between iodine status and thyroid function to be explored in later trimesters. As discussed 
in Chapter 4, the relationship between iodine status in early pregnancy may be more likely 
to show a relationship with maternal thyroid function in the later stages of pregnancy, as 
intra-thyroidal stores of iodine become depleted. Data will also be available on maternal 
characteristics (e.g. age and education) and dietary patterns (via a FFQ) so the findings 
from the Royal Surrey Study and ALSPAC that related those variables to maternal iodine 
status can be confirmed in this additional cohort of UK pregnant women.
The author and Professor Margaret Rayman have been approached with a view to 
collaborating with researchers from MRC Human Nutrition Research at Cambridge who 
run the UK National Diet and Nutrition Survey (NDNS). The proposal (dependent on 
funding) is to measure iodine status in stored urine samples (24-hour urine collections) 
from the adult survey (Henderson et a l, 2003) to describe iodine status in the UK more 
comprehensively. There will also be the opportunity to link urinary iodine excretion to 
dietary intake as seven-day food diaries are available from the same subjects (Henderson et 
a l, 2003). Though these samples are not from pregnant women, it would give the 
opportunity to explore dietary patterns using the more detailed information provided by 
food diaries and the more accurate measurement of individual iodine status in a 24-hour 
urine sample (Thomson et a l, 1997; Zimmermann, 2008b; Vejbjerg et a l, 2009a).
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The most obvious next-step from the ALSPAC work is a randomised, placebo-controlled 
trial (RCT) of iodine in pregnancy and subsequent evaluation of child cognition. Based on 
our ALSPAC work. Professor Margaret Rayman and the author have been approached by 
academics (endocrinologists and epidemiologists) at the University of Birmingham, to 
collaborate on such a trial. Though trials of iodine in pregnancy are currently being 
conducted in other countries (Zimmermarm & Melse-Boonstra, 2008; Brucker-Davis & 
Hieronimus, 2010; Zhou, 2010), it is important that a trial is conducted in the UK, a 
country considered to be iodine replete without a national iodine-fortification policy. 
Additionally, personal communication from the Chair of the UK Scientific Advisory 
Conunittee on Nutrition (SACN) has indicated that the evidence in this thesis will not be 
enough to change UK health policy and therefore a RCT in the UK will be required to 
provide adequate evidence.
10.4.1 Recommendations for the UK
Iodine intake and status has not been part of the public-health agenda in the UK for some 
50 years: iodine requirements for pregnancy are outdated, population monitoring has been 
absent and advice to pregnant women has ignored the need for an adequate iodine intake. 
However, evidence of iodine deficiency in schoolgirls (Vanderpump et a l, 2011) has
prompted renewed interest and iodine was discussed in February 2012 by SACN. The 
briefing paper that was prepared in advance of the meeting includes reference to the work 
in this thesis, in particular on the availability of iodised salt and the fact organic milk is 
lower in iodine than conventional milk (Scientific Advisory Conunittee on Nutrition,
2012). The evidence that work in the thesis has made a contribution to SACN discussions is 
testimony of its importance for public health policy and understanding of UK iodine 
nutrition.
Given that this thesis has revealed that iodine deficiency in UK pregnant women is 
associated with adverse child outcomes, the Department of Health needs to address this 
issue. The first step would be to initiate monitoring (urinary iodine concentration) of iodine 
status in the UK general population and a national survey of iodine status in pregnancy is 
required. Secondly, the Department of Health needs to use the results of this thesis for 
evidence-based dietary advice so that women of childbearing age and pregnant women are
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given the best possible information {via the NHS) on how to improve their iodine intake. 
Furthermore consideration could be given to recommending an iodine supplement to 
women planning a pregnancy, and during pregnancy and lactation, as recommended in the 
US (Becker et a l, 2006) and Australia and New Zealand (NHMRC, 2010).
The Department of Health should consider an iodisation programme in the UK to improve 
iodine intake. If universal salt iodisation is not implemented, because of the strong public- 
health policy to reduce salt intake in the UK (Scientific Advisory Committee on Nutrition, 
2003), the Government could follow the methods used in Australia and New Zealand and 
recommend that food manufacturers replace any salt currently added to manufactured foods 
(such as bread) with iodised salt (Australia New Zealand Food Standards Code, 2009). 
Alternatively, milk could be used as the vehicle by which to increase iodine intake in the 
UK as it is already promoted for health, so the message would be less confusing for the 
public. As milk-iodine content is not regulated, it currently represents a haphazard source 
of iodine (Phillips, 1997). The use of iodine-supplemented feed during the sununer months 
could ensure standardised concentration of iodine in milk throughout the year, and thus 
minimise the risk of iodine deficiency (Broadhead et a l, 1965a). The dairy industry, should 
be encouraged to market milk as a good source of iodine, so that individuals and health 
professionals are made aware of the fact that milk is the major source of iodine in the UK 
diet. It would be prudent for the organic dairy industry to take seriously the deficit in iodine 
content of organic milk that this thesis has revealed in view of the importance of milk to 
iodine intake in the UK.
Any iodisation programme in the UK would need to be accompanied by a careful 
monitoring programme to ensure risks of iodine excess (Introduction, Section 1.5.3) were 
minimised and managed (Dunn, 2001; Bulow Pedersen et a l, 2011).
10.5 Concluding comments
This thesis presents an overview of iodine status in UK pregnant women and the 
implications associated with low iodine status during this life stage. The findings should be 
used as a springboard for future research on iodine in the UK and will hopefully provide an 
impetus for an iodine fortification and monitoring policy by the UK Department of Health.
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• Bath S & Rayman MP (2012) Thyroid function reference ranges should take population 
iodine status into account. NEJM. In press
1b the Editor:
Lazarus and colleagues (Feb. 9 issiie)^  administered leyodiyroxme to pregnant women who had a 
senmi tiiyrotropin level of more than tlic 97.5th percentile, a senmi fi'ce tliwoxine level below 
die 2.5th percentile, or both, to investigate the potential benefit on latei* cognitive fimction in 
theii' children. However, it is qiiestioriable whether these cutoff values were appropriate, given 
die kiimwi iodine deficiency among young women in the United Kingdom  ^and indeed in a 
siibgronp of women in the tiial.^  Had reference ranges that were derived firom iodine-snfScient 
populations'^ ’^  been used, the cutofis would have been lowci' for thyrotropin and higher for free 
tlijTOxine, thereby inci'easing die numb er of women who would have been ti eated (along with 
dieii" respective controls). (Incidentally, die units of firec th^ibxine have been inaccurately 
converted on page 494 of the article.) Since thyroid dysfunction may have been underdia^bsèd, 
the statistical pow'er to detect a significant difierence may have been reduced. Althou^ the 
authors claim that die study was adequately powered, the calculation may have been invalid, 
since it was based on a studj'^  tiiat w^  ^conducted in an iodine-sufiScient country (the United 
States), and die women in that study had morc severe thyroid dysfiuiction (a hidier serum 
thyrotropin level).^ We consider that these points are pertinent to the interpretation of the results 
of this trial.
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Iodine deficiency in UK 
schoolgirls
Mark Vanderpiimtp ard  colfeagires’ 
finding of iodîrœ defideng  in the UK 
(June 1% p 2:<Wf is a remirder that 
iodine ctefiderKj' is not confined to 
lav-income nations/ feiallels are 
otfviaos io  Australia, and New Zealand, 
where national surveys confirmed 
the re-emejgence of a problem, and 
to  the USA, where the dietary iodine 
supply has fallen to  marginal fev'ds 
in vuln&rabie groups. Vanderpump 
and colleagues recommend a  more 
comprehensive investigatksn and urge 
evidence-based prcphyiams.
In our view, preventinn sbrKifd not 
r i^ d  to  wait fof more research. Global 
experience offers credible guidance: 
salt icdisation is safe, eqimtab% 
large^ self-financing, and extreme^ 
cost effectiw.’ Medical advisory com­
mittees in industrialised countries 
often advocate dai^ supplements 
for the most susceptible groups. In 
practice, hmvwcr, supplementation 
stratèges s t r u c k  to  attain meaning­
ful coverage and require a daunting 
combination of political will, efficient 
distribution, continuous communica­
tion, and robust monitoring.^ 
Focusirg these efforts on preventive 
salt icdisation is more cost effective 
a rd  sustainable.. The Netherlands 
and Denmark, mandate iodisation 
of baker's salt and  in &vitzerland, 
ho«usd%&j salt and most salt used in 
the food industry are iodised.
Vanderpump and colleagues' 
paper illustrates a drawback of the 
prevailing paradigm th at first insists 
on hard evidence of a problem 
rather than proactive prevention 
of its emergence in the first place. 
Iodine deficiency in New Zealand 
schoolchildren at a similar severity 
to  that in the UK was stew n  to 
impair cognition.s Most developing 
nations have adapted salt iodisation 
strategies, whereas the iodine status 
in many industrialised countries 
has deteriorated. Clearly, the time 
has come to  adopt salt iodisation
worlAvide for the prevention of
iodine deficiency disorders.
W R . CG. 3r d  DPK am Baati .Mcmben of itiî 
tïêetratkin;< Cncrrf forîhü Contrd af bdine 
OcfiriEiigi- Dtejreka.MSZ islhe  BimSisc.
ffiG von der Horn;
CregoiyG^ üsümot^  CWdPHixræ,
M ËM d BZimme-marm 
fvanderiS'sph.emoîy.edu
!rl«ratB nJÊ Cni.r(diforîte Ccmtrcr -af bdin* 
D«firicnr|f Dtsan&rs. PO Bt* gicmo, Ûttawc
î  lacrus jR  Smjitih FR. et
en  behîlïî nS the Bêtirfi TT^rcidAasscniSinn 'Üï 
ledinc Sw.'Ç’ Cioap. ledne ^ tatin inî.HC 
srhodÿrb; a cross-sïiaiDcal scniy. tanort 
2 C.H;3 77; 2CO?-l2 .
3  A m !en5ori.M , d e  B e n d s a  %  D am lBTi H ll t  
DWhnge F toîhtiE deftrienr '^ in t'iimpe: 
s  cccilirKiii>3 piM c hesJîh jndtfero CensM: 
Wodd Fkatlh Organéatkm. Z@8F.
3. UNICEF. SifslainjMe «hiriratbn «f radine
deficiengr progrès since 5t«  rggo'ft'crfcl 
5atrmitfcirChiidn:n. NmYeA: United 
Natisni Chïetcn's fi.r4  2CoB.
4 Unîcro^rirnn-icrASchi.ftnil;Vi«'.Ttie 
chalienscî of iodine supFfenicntaïicrc a  putiic 
health progtamn-ff pcrspertfÆ
Brd fhiict Rcs CinF-Kbcîna'.VAah 2D1D:
24:
5 Cnndnn RC. Base-MC AIL 
Morgan (MD. (SjffnnnT tadinc 
supplementalian irrprnves. tngnfiicn in mildi, 
iodine-ëîftdefiîchiidTen. A m JCAn V;it 3 E0 3 : 
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We c o f^ T S tu la te  Mark Varderpump 
and c o lle a g u e s '  on producing t h e  f ir st  
s iz e a b le  stutfy t o  d e m o n s t r a t e  t h e  
re-emergence of icdine deficiency in 
the UK. k  corroborates t h e  findings 
of o u r  otvn smaller s t u d ie s  in women 
of c h i ld b e a r ir g  age^^ and pregnant 
women.^
Hrsvcv'er, we are concerned about 
thevalidi fy of some of the condusions 
reached from the d k t  questionnaire. 
Althooÿi Vanderpump a rd  colleagues 
state that the questionnaire was 
val idabed, thieonlyproper^'formulated 
question, with defined quantities, %^ as 
for mil& consumption-. Varderpump 
and colleagues concluded that tow 
levels of milk intake were as&nciated 
with lower icdine statos and we 
concur with those  findings. However, 
the predefined responses for ifi.ve of 
the: seven questions were unquantified 
and ambguou% allowing flawed 
c®ndusiansto be: d rawn. For example,,
w ith regard to  egg consumption^ the 
predefined responses were:
(1)1 don't eat eggs 
(2JI eat eggs a t least o rse  pe r week 
(3) I eat eggs more than once per 
week
Respon&z (2|, with the phraæ “at 
least", is man-specific and ccold ra n ^  
from “once" to  "an infinite nunAer 
of times" per weeL Either response 
{2) m  (3j could be gwen in several 
circumstances, shewing that the 
question was not sermitiv'e. Herx:e we 
urge caution over the condusion that 
icdine in take isin veraely related to  egg 
consumption, particular!^' when other 
studies widi more rigarous dietary 
methods have shown the converse.* 
Eggs are an excellent source of 
several important nutrient^ and an 
inverse assodation between egg 
consiumption and »ndi ne status shouW 
not be promulgated on flie basis of a 
fla&vW food frequency questionnaire. 
We dDchrrthilwE tm *  nn «onficSsaf intaresl
Sffirah Both, *M orgmrfT P Ray rm n 
m.rayman @*urrey.acuk
IVjtnti3ns£&fcrK«.Df*isinri Faoitlyaf Hmllmand 
M Bsicil Sdcntes, UnwrtfjiCif S.w«s, <jLiJi&sni CU37XRUK
I 'Vlm&igKimp MFJ. larorosjR Sipgrtii Pi* ct at
cfi bcteS erfShe Britfcn Tty roil Associjikiri UK 
fciSne S-iT«-3y . lëdîr® statas of UK 
5d-io:%iiii: 2 cross-seclia-ai auTi’^ -.ianiet 
2<3ÎC:377:3I»7-32.
3 &4tS.W'jÉerA.T2ÿterAR=r/naîi .MR bdine 
ststcsof :UKwcitwn nf cKldhcaing age.
J  M.mM-.a- E«rcî 2GCS; 21;: 373-83.
3  R ^ r n a n  M P  S tee tii M , W S îc t  K Tayfar A  
fo(Sn« (fcfiticîKjf in UKw'cmen o.f chid-biarrgi 
age. Proc .Wat &K E333.
4 t T^ Tar A WSlar A
Ra/nssn M P. W ine dEfiritrjqi- in pnagnsnt 
wran-fw liming in She S e e * -b s t  af A » UK. AntNafriat MM; fi&: E4%
5 FScirierT, Fonbyn H AkstyU. Eer4cm«>'cr S. 
tongitudinsl eciiriratran ofM -fi arinay 
knSrc ®:>:rotbn in sctraakliiUicn asa  
scnsitV'e, lydiatian itatas- rdcpcnûen; 
iwcarrii Icël far iodine sdafin.Am) 'Oin.M:t-3r3C4 %:f3&-dC.
In a crcss-sectional survey of UK 
sdhoclgirte aged 14-15 years,
Mark Vanderpump and ccfegues ' 
faond a median urinary iodine 
concentration (ÜIC) of 801  pgi'L A 
vale» less than 100 pgi’l  indicates iodine 
deficiency in that grocp or popolatibn.
wi'«w.ahetirca?b£nir) VolSTfi INot'cintttr i  2011
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*->'C
'Nmriëai O n V  JO 9 i d o tI0 .1 0 1 7 /S (» ( j7 1 I4 5 1 1005059
ShoH  C o m m u n ica tio h
Iodine concentration of organic and conventional milk: implications for 
iodine intake
Sarah Ç; Bath  ^Suzarme Button and Margaret P. Rayman*
Kiilritîonaî Sciences Ditision, liicu&v o f  Henth an d  MeiUcal Sciences. VniversUy o f Surrey, Ciuikiford CV2 7A7/, UK
XS'uhniiilfsJ I.'iXijseialK’r X n O — f in a l  m  iiSun receisnl 4 i l j r c h  2 0 1 J — Actejiil.fsl J.3 M ars:h20n  — f tc J  t/rsftne 5 3011}
Absbact
loc&ie is fei t^iifed for adequate thjTOsd hormone prc»ductkon, 'R'hsdt b essentLil for brain development, pansrularly tn the first Trim ester of 
pregpiancj'.MSk is the principal source of iodine in UK diets, and tvhile small studies in Europe have shown organic milk to have a lower 
iodme concentration than conventional milk, no such study has been conducted in Britain, in viewcf the increasing pcpularity cf organic 
milk in the UK, we aimed to compare the iodine ccficentration of retail organic and conventional miK: and to evaluate regional influences 
in iodine levels. Samples of organic mile (n  92) and conventional milk (k KOft, purchased from retail outlets in sateen areas of the UK 
(soutftem England. Wales and Northern Ireland), were attalj-sed for iodine using indurtiveh* coupled plasma MS. The region of origin 
of the .milk was determined from information on the lal-jel. Organic milk was 42T% lower in iodine content than conventional milk 
(median iodine concentration 144-5 r. 249-5 *tg% f’<0‘00l>. There was no difference in the iodine concentration r/f either conventional 
or organic milk by area cf pur duise, However, a Æffërence was seen in icxfae concentration of organic mslc by region cf origin f f < 01)1)1 X 
Tlie lower iodine concentration of organic milk has public-health implications, particular  ^ in view of emerging evidence cf iodine 
deficiency in UK population stib-grttups, including pregnant women. Individuals who choose organic milk should be aware that dietr 
iodine intake may be cmnprrjmlsed and should ensure adequate iodine intake from alterrtative sources.
Keywords: Iodine: Organic produce: Milk: tliiitcd Kingdom
1 (xl me is rteedcd for the prcxluction of tityroid honnone.s tint are 
vial ditrsng pregnancv- and infancy owing to titdr role in bain  
and neurological development' While .severe iodine deficiency 
can cause gross mental deficiency and infiint mortality'* ,^ tisete 
is emerging evidence titat mild-to-moderate maternal iodine 
deficiency is associated with impaired infant development. 
Including lower inieEigentx' quotient (IQ) and increased inci­
dence attention deficit hjperaclivity disorder'^. For these 
reasons, pregnant wtxtten ate vulnerable to iodine deficiency^
Tlx: icxLnc content of ftxttls is dependent on the source of the 
food, whether from sea or land, lire soil cimtent (afïècttd ly  
get)!og>vgc(3grap!y, pH and soil leaciiinglandfamiLng praciice'-'^ .
In tl>e UK, mîk and diL-y products are the most important 
source.s of dietary iodine, contributing as much as 42% of 
adult intake'll Higher mll-c-iodsne ccKicentiation and 
increased milk consumption have I teen cited as the reasons 
for the ciadictlion of endemic goitre in tlx.* UK in tfie 1960s, 
which was lalxilled as an ‘accidental ptrfjlic health triumph' 
by Phillips'^ *^ , Iodine .sufficiency has been assumed in tSte 
UK for many jvars'®’'’* and iodised .sah Is .sc:ec:elj' availaltle^'.
However, there is emerging txmcern tliat tlte iodine status 
of tlte population, particularly of young w«mc*n^”"*® and 
pregnant wontcrn® may be inadetpiaie.
Altlxmgh œnvertlional milk is tlte usual clxrice, org.mic 
milk is increasing in popularity Ivcause of perceived health 
and environmental fxmcfits''®*’. Due to the stiia organic farm- 
irg régulatktns that gov ern the use of mineral supplements in 
livestock ftvd^ *"'*'^ ,^ organic mlBc may contain lower concen­
trations of trace minerals, tliercby reducing or even reversing 
the potential fscaltl: I .benefits. Studies in Europe have sliown 
conventional milk to liave a higher iodine cfjncrentiation 
than otgansc milk^ **'*^ ,^ but no such stuc%* has been explicitly 
conduaed in Britain.
The present study therefore aimed lo compare tlie iodine 
content of organic and ccEiventiona! milk ava2af>ie for purdtase 
in tlx.* IJK. A secondary aim was to determine regional vari­
ations in milk iodux: content. Our hvpotIxt.scS were that (I)  
the icxline concentration of organic milk would be lower 
than tint of conventional milk owing to organic farming prac- 
iices and (2) mSk-iodine con central on wcxild differ Ixrtween
A W M w ia d o i t  TM .U t, tce ja re lh y L iirjrm rjiian  l a c ir tn td a
•C w rv sp cm d in g  auclinr: I'rofesm r M. P. R rprun , fax +44 1483 A4A431. cinail m.HymànBsertcya:c.tjc
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S. C liath eî at-
CÛ
regions due to likdy variaticms in «)il-itxlirte content and 
farming prartfce atToss tlie UK
Materials and methods
SampVmg
Santples o f supermarket sent: skimmed (<  2% fat ) owit brand 
conventiorail and <nvn iirand organic milk were puaitased 
front five leading .stipemEiEkets (total market sltaa; 
in Mxtcen areas (largely identifiaHe as counties) o f the UK 
(fcHirtcen of whidi were in the stjuth o f England, one in Wales 
(Cardiff, Fig. Î) and one in Northern Ireland (County Antrim)) 
in June, July and Augud 3009 Tlie areas tvere combined into 
four regions for analysis: South East (k «), South West (M 6), 
Wales in  1; Fig. t )  and Ntjrthem Irelant! (M t). In addition to 
own brand supcrrréiarket m2k, three samples of popular milk 
brands were purchased the niafority of which were organic. 
Fewer samples of branded milk were purchased reflectir% 
their Sower UK market sfiare'*^  ^ As milk iodine content is 
known to vary fw’- s e t t s s a m p l i n g  was restricted to 
one season so  that milk purchased at tlie beginning and end 
of tfse collection peritxJ would he comparable .Semi skimmed 
milk was sek-tted as it is tin.: most pipuLtr clxiice in the 
Ijj^oo) iodine concentration doi;s not differ from tliai
of skirnnred or full-fat rtiiilk***. Milk was deetiwd to be organk 
based on lise lalxrl claim and tt it had an organic certification 
symfio!, such as that of The Soil Asstx:iatk>n.
Tlie areas sampled werecbosen for logistical reasons Ixit also 
liecause the inclusion of areas in the South East alknved the 
assessment o f milk from densely populated argions, whik- the 
Stxith West is h<ah a legitai of major dairy farming**^ '*** and 
h;Ls a history of high goitm rates*** Northern Ireland and 
Wales were sampled to investigiae pcaenlial regional variations.
although sampling in Northern Ireland was restricted, as onN 
two of tlie five chosen .supermarket ch i ins operated there.
The ongin of milk was categorised as being fmm Walts, the 
West Country, Scotland, Northern Ireland or of unknown origin. 
The origin wus determined from tlie laliel: wlieie the gecgnt 
phial source cf the milk was .stated (eg . milk from tlie West 
Country), ths was assumed to be tlie case hit otherwise, the 
European Union (EU) identficalion mark was inxtd to trace 
the milk to tlie processing dairy*^* and in conjunction with 
Internet sources, the origin was determined where poss8>le.
Sample anatysh
Sample preparation and analy.sss were performed at IjCC limited, 
Teddinglon, Middlesex, UK. Sample aliquots were aored at 
—RO*C Ixfoie tx’ing transpnted to LGC lamited. .An alkjuot 
t f  05 g wa,s mixed with 5 ml of 5% tetrametiiyiammonium 
hydroxidt: (TNLAU) .solutkm, prepared Iw (Bssohing .<«>lid 
TMAH (S97%; Sigma Aldridi, GBIingiiain, Dorset, LK> in 
ultnipuie water. The dal was then placed in an oven at 9ffC 
for 3h*" .^ To each sample, 0 9  ml ( f  the irtemal standard was 
added <î30()ngr'ml tellurium in îfwTMAH; Romil, Cambridge, 
UK) and tfie samples were made up to 90g  wâh Î%T.MAH- 
sokition. The digested samples were anaîy-w:d for iodine 
concentration Iw inductively coupled plasma MS (Element2; 
TIicnitoFLslier Scientific, Bremen, Germany) by external cali 
Itratron using a stock standird, prepared in hcxise gravi- 
metrically from high purity pouissium kxkde (99 99%: Alfa 
Aesar, \WR, Lutterworth, Ldcc.'Æer.shire, l.K) in 5% TMAH 
solution. Subsetjuent dilutions were performed in f % TAI.^H 
Tfie uncertainty of tite melliod was cakailated as ±  10% 
according to in house United Kingdtan Accreditation Service 
accjedited methixls, which are in accordance with International 
Organization for Standardization 17 (t29 and Eurachem.'CIT.AC
w aes
y r
South East
Southwest
f-c» vfsrafx» Susr*? «tt 
«risyças-nissoi*: a«C»C»s*i# Ssrvt,
C 0*9^  oopTtl^  3009
Ftg. 1. Map showing Itx a reas  (stiadad) te rn  whicti mi& was sampled and  how it»  areas worn combined into ragions. Milk was p u id iascd  from supermarkets b  
(owns shown, hy Mack dots. Milk was also  purchased In County Antrim, Northern Ireland (not shown).
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(Coopération tst Internationa! TraccilM'Isty in Analytical 
Clictnislry) guidelines. H ie accuracy of the results was verified 
using tlie certified reference naateria! BCR Of>3R Stimmed 
MsB: Powder (LGC Standards): (certified iodine content 
810 ±  50ng'g (dry weight hxsis)); the mean value for Û:c 
certified reference material was 8369 (SD 176) ng/g Or Î2), a 
percentage recovery o f I05‘3%- Tlie CV for llie twelve measure­
ments o f die certified reference material was 2-1 ?!i. Tîie means 
of the spiked recoveries for tlie certified reference netterial 
and the m2k samples went tOL5 tsD 6 3 ) "if (»  6) and 943  
(sn 56)%  (»r 6) resptrclK-ely,,
StaUstica! analysis
Stati.stical analysis was done with the Statistical Package for 
Social Sciences (version 17.0; SPSS, Inc., Cb'cago, IL, USA). 
Iodine concentration was mot nomtalh- distributed in either 
organic or convcntiona! mils smiiplcs, as determined Iw the 
Shapiro-Wèk test; data were fiierefore transformed using 
the natural logarillim to a Sow parametric testing. Geometric 
niuins with their 95% Cl (computed Ity teek transformation 
of log values) are reported along with the median. Indepen­
dent t tests were used to test die difference fietween organic 
and convcntiona! mslk-icxhne concentration and one-way 
AN09IA (with Bonferroni correction for /;orf hijc analysis) 
was used for oomparistm of icxline concentration Ixrtween 
the area of purchase and tlic region of origin o f the milk 
Statistical significance vvas set at f  < 0 0 5 .
Results
Différences in iodine concentration
In total ninetv-two samples of tirganic milk and eighty* 
samples of conventional ndSk were collected. Tal>!e 1 sixivvs
sununary statistics (split liy milk type) of iodine concentration 
for all samples, supermarket own-brand, otlier brands and tiy 
known region o f origin.
An independent t  test showed litat ilie iodine txincentration 
of o.'ganic milk was significantly lower titan that o f con­
ventional milk (/'< 0  001), tfjc median value c f organic 
nûîî; being 42-1 %» lower titan tliat tjf conventional mslfc. Tlie 
difference remained when the analysis was restricied to.super­
market own Irrand milk samples (ts 154; f c O  0)1 ). Branded 
organic milk samples in  15) were significantly lower in 
iodine conctmtration tlun tlxr .supermarket own-firand «>n- 
ventional milk samples in  77, P<0601; Table 1).
Analysis by area of purchase
One-way* .ANOVA showed that lit ere was rto difference in 
iodine concentration among tite sixteen areas o f punritase of 
either supermarket ovvndtrand organic or conventional rarlk 
samples (j%=075 and 049, respectively) or among the four 
regions (>^=036 and 066, respectively), le . tlie tlirce legsons 
shown in Fig. 1 and No.rtltern Ireland.
Analysis by region of origin of f/te milk
Organic milk from the West Country*, Wales arxl o f unknown 
origin w as significantly* lower in iodine than conventional 
milk of the same origin (P<0601; Tafde 1). Due to the 
small numlxtr of samples origiratting from Wales and Northern 
Irelmd, these regions were excluded from the one-way 
ANONA for analysis Ijy milk origin. Tliough no sampling 
was earned out in Scotland, eight o f the organic milk samples 
were of Scottish origin. Tlie iodine concentration of organic 
samples ditïered liy region of origin (P<(y001; Talde 1); 
/x»7 /ifxr testing revealed tliat Scottish organic milk was
Table 1. Iodine coricentrstlontrf ofpanc and conv>cntionar milk samples and tjy (mov.Ti milk origh§ 
(Mean values, mecfians, number of sanrplcs and 95% ccofidcrce intervals)
MIk type
Iodine concentration (ng/g)
Number cf srarptes., : Median Geometric mean 95 % Cf of geoirætric mean
All sampl^ Organic 82 144-5 152 2' 141-7,163-5
Conventional 60 :£4>5 £56-4,- 245-0,2653
Supermarket two-branil Organic 77 :t4B-0 m-B" 1451,172-5
Conventional 77 £50-0 2504 2459^2706
Br Tided rrilfc Organic 15 1310 118-31 100-7,139-0
Conventional 3 I960 £08-5 1350,3220
West CourSry Orgmic 24 140-5 1303* 117-4.1440
Conventional IB £360 £39-2 215.5,2654
Wales . Organic 3 800 64-0* 459.1442
Conventional 4 £12-5 £17-6 1549,£551
.Scotland Organic 6 £87-5 276-51 238.4,320-7
(kmventtonal 6 NA NA NA
Northern Ireland Organic £ ££05 £20-4 160-5302-7
Conventbnal £ 2220 £21 9 148-6,331-3
Unknown Organic 55 1450 152-2* 140-8,1644
Converitonal 56 £755 266-6 252-7,281-3
tJA, rotajpIcïûtB.
'I te n v B lli te  otîîîrinBConsBnfrâlKîn tmsib vgiitimrilty dataienttmm mni/antinnal milk ot t tà  ta r ra  categaiy (PeO 001; tndspondBTitllesl). 
t  kkan  valuer ct W ine cmcentmîan $gTùBcantly (Ktterant Imm cowentiansl BipBrmartel oxidim nd inltk (p<0-001: tndepemlmnt ( test).
, t  llaan  VQluBsof M lrts eBre*!rtiaï®i«'a® *Biiitaa.riiy dJtarerii Iiomniganisniilkot West CDuniiy end iint;na«motiain (P<0-00l; me-msy /iiOVAposStjoctest). 
'I  Statisltea) anatyris waspartonrjBd en tog-lranifcrmBd rteta
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significantly h%l:cr in iodine titan imtii organic mi& from 
llic West Ctiuntjy (P<0'001) and organic milk o f  unkntnvn 
origin tT^OOOI). Conventional milk from tite VTest Country 
cxhïtjîied a lower iodine concentration than milk of unknown 
origin, hut the difference did not reach significance <A=fK)51 >. 
To prevent Scottish mSk samples from skewing the results, 
statistical testing was repeated with Scottish tittk cxdudtxl; 
the difference in icxline concentration between organic and 
conventional milk remained significant (fcOOOl) hut the 
difference between tite median values increased to 43-19i  
(data not shown).
Discussion
This is the first sizeable study to evaluate differences in iodine 
concentration Ixttween organic and ainventsonal milk. Tire 
main findingof the present study, tltat organic milk hxsasignifi- 
cantly lower iodine concentration than cxmventional milk, 
supports both our original hypothesis and t!xr findings of 
otlxrr, smaller studies (fewer than twenty organic samples), in 
Denmark*-'** and Norway*-'^ *, itxiinc conœmraiions of the 
Norwegian and Danish «rntixT tirganic milk samples were 31'H 
and 408*hi lower thin those of conventkmal milk, respectively, 
the latter being dose to the ♦t2-l % found in tire present study.
Milk-iodine concentration in tire UK has increased from 
the levds In (lie 1920s* ** tîirough the use of iodine- 
supplemented feeds in dairy herds to protect îüvcstock against 
deficiency**’***’. Milk is also contaminated with iodine thrcxigh 
tlie use o f icxlophor disinfectants used in saniiisalion and teat 
dipping*"**. Tlie UK Ins never introduced a formal iodisation 
programme to ensure optinal iodine status, despite goitre 
being historically endemic up until die Instead,
the cotmtty has experienced iodisation iSircxigh an adurnti- 
tious increase in milk-iodine ctxicentralion*'**. Tlie jxesent 
finding tSiat the iodine content of summer organic milk is 
over 40% lower llian tint o f conventional milk is a concern 
from a public-health perspective.
Tlie UK adult reference nutrient intake for iodine is 
IfOpg/d*"'^* with no increment for pregnancy, a recommen. 
dation that is clearly outdated in die light o f current V7HO 
adviœ for pregnancy of 250pg''d*^*. Given that milk and 
dairy products are the primary source of iodine in the UK, 
those wfio switch to ceganic milk, with its lower iodine 
concentration, are likely to liave a reduced icxline intake. 
Tilts is of particular concern during pregnancy when a 
woman needs addititmal iodine for tliree reasons: (Î )  her pro­
duction of thvToid hormone increases by 50 ’?-» in order to liave 
adequate supplies for her own and her baby s needs; (2.) slie 
needs to compensate for increased renal dtnrance of irxline; 
and (3) she needs to provide iodine for the fetus to use 
after tlie onset of fetal thyroid fimction*'*. Consumption of 
organic miEs may reduce the cirtnoe o f a woman meetirç; 
the higher iodine ret|uremcnt of pregnancy. Based on txsr 
median mSk icxline values, a portion (2f)0g) o f conventional 
milk would provide approximately 50 pg compared witli 
only 29pg in a portion of organic m:&; iodine intalces 
would protiatily' be further compromised if oilier organic 
dairy’ products were consumed
Altlinugh onh’ a small proportion of liquid mBk sold in thé 
UK Is organic*"***, sales o f organic milk increased more limn 
50-fnld <5ver the 10-ycar period between 1997 and 2iTO7*"A 
and remained senng during tlie recent economic reces­
sion*” '^ . Increased advertising and promotion of organic 
milk is planned in the UK*"^ * and with a possible rise in 
organic raSk use, iliere is potential for exa cerf rati on tlie 
mild iodine deficiency descriliéd in llie UK, notably in .school­
girls*'®*, pregnant women*^’^ ®”^ ® and W’timeri of cliild bearing 
age******.
The lower iodine concentration in. organic milk cm  be 
explained by differing practice on organic and conventional 
farms. Organic farming regulations do not allow the routine 
use of vitamin and mineral preparations*'"'*^*. Regulations 
also .stipuhte tliat at least 69% o f the feed on organic farms 
must be fresh or conserved forage**'*, thus limiting the use 
of concentrates and relying on soE minerals, wliidi can be 
low in some areas. Due to these restrictions, deficiencies in 
some minerals, including itxisne, can occur in organically 
farmed livestnck*^^*. Nitrogen-fixing crops, such as clover, 
are important in organic farming and are used in place of arti­
ficial fertilisers*"'*. Wliite clover contains cyanogenic gluco- 
sides* '^* tliat ate thought to exiiibil goitrogenic properties*'* 
and. as suggested by Rasmussen ct rd.*' **, greater use o f goi­
trogenic feed could lower milk-iodine concentration through 
the inliihitson ofthesodsum-itxlide symportcr in die mammary 
gland of the cow. As iodoplior disinfectants and teat dips are 
peimitted in botii organic*'"* and conventional fanning**^*, it is 
unl&dy tliat the difference in iodine concentration can be 
explained by their use.
Our hypothe.sLs concerning regional differences in mslk- 
iodine concentration was only partially supported Although 
regional differences were fixmd wlien milk w as lirtiadîy 
grouped liy milk origin, no difference was found by area of 
purcliase. The latter fintiing may’ be explained by’ tlie 
supph’cliain logistics in tlie milk industry, where milk is 
bulked in the processir^ dairy and delivered to stores wiiliin 
the same supermarket diain in ndghlxiuring areas*"'*. Tlie 
inclusion of Scottish milk was unintentional ;tnd was revealed 
tlirough interpretation of the EU identification nrark*~*. Tlie 
finding tliat Scottish milk is higher in iodine than tliat from 
the \Ve.st Country is interesting in tliat. historiirally, goitre 
and cretinism were common in the West Country but tlieir 
incidence w:is lower in Scotland*^*. As tlie present study did 
not collect details cm farming niethfxls (e.g. soil and feed 
type), it is nc  ^possible to explain thedïïerence in iodine con­
centration between regions.
Tlie present -Study has a nuralier tif limitations: samples 
were only collected in the summer monllis, so  findings nuy  
not Ira represeniadve of the levels in winter milk. However, 
as conventionally reared cattle are less relmnt o n  mineral- 
supplemented feed during tlx: summer** '”* any difference 
observed between the sample grcxips in the summer is 
likely to Ixr matched. Or exceeded during tlie winter. Milk 
W'as largely purdrised from tlie south o f England, and wfiile 
tills could be considered a limitation, tlie results indicate that 
the region o f origin was a greater influence on iodine conc en ­
tration ilian area o f purchase. However, sample sizes for
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regional analysis were small and unerjua! and therefore 
regional differences shtxiM he interpreted cautiously. Furilser- 
niore, tlie present study used retail mük, which Is pooled from 
farms, tlius suhstantially masking regional dBïerences.
In conclusion, the fact tliat organic milk has a lower 
concentration of iodine tlxin conventional milk is a puhlsc- 
licaith concern. When individuals make the deci.sson to 
switch to organic produce they often start with milk**% believ­
ing this to be the lust choice. Individuals wlir> mrdte such 
a choice should be aware trial their iodine intake may be 
compromised, whicli may have implications for brain devel­
opment during pregnancy :ind infancy. Tlie autliors ree not 
.suggesting that all individuals should .switch to conventional 
milk, as there may be otlicr benefits to organic produce in 
terms of lower levels o f pesticide residues*^^*. Rallier, individ­
uals consuming organic milk (particuhely pregnant women) 
should lie aware o f alternative food sources o f iodine to 
ensure that ietjuremenr,s are met. Wliere these foods are not 
consumed, a nutritional supplement containing iodine 
should be ctKisidered (although kelp products are not rec- 
ommended as they may contain excessive levels of iodine**'*).
It would be pro dent for the organic diiry industry to take 
seriou.sly the deficit in îcxîèie content o f organic mEk that 
the jiresent study has revealed. Tlie restrfction.s imposed by 
organic farming metliods have nutritional implications both 
for organically raised animals***’ and for populations eating 
their produce. Hiough these restriaions may affect otlier 
trace mineral concentrations, the issue is likdy to lie most 
serious for iodine as a am sct jacnce o f milk and dairy pnxlucts 
being tlie principal source o f  iodine in the UK diet.
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Bath S, Steer C, Golding J, Emmett P & Rayman MP (2011) Maternal iodine status during 
pregnancy and the impact on cognitive outcomes in the offspring. Proc Nutr Soc 70 E386.
Proceedings o f  the Nutntion Sockly (2011), 70 (OCK6), IBS6 d»5:lOJOI7/SOb29fi65l t I0047IX
W nler Meeting, û -7 December 2011, 70ib Amivcrsary: Body weight reg ida lion -^ od , gut and brain signaHing
Maternal iodine status during pregnancy and the impact on cognitive 
outcomes in the offspring
s .  Balhh C. Steer, J. Golding*, P. Emmett* and M. P. Rayman*
^Utiiversiry o f  Surrey, Guildford, Surrey, GU2 7XH and "University of Bristol, Bristol, BS8 JTH
Iodine is acomponcniof ihc fiiyroid hormones wfêch urc cmeial fur brain and ncuroloajcal dcvclopmenE, partîcoîariy darir^ gestation and 
early life"'. lodiæ requirements ate therefoie two-thirds higher for women when pregnant than when nan-pregnant'"'. Iodine deficiency 
was common in the UK up to the I960s'^' and was cratScated, not by the usual practice of an iodiscd-salt programme, but through the 
adventitious mcrcase in milk-iodine concentration and increased milk intalœ'*'*. Thoteh the UK has therefore been assumed to be. iodine 
sufficient, a recent national study has revealed mild iodine deficiency in addcsccnt pris, giving cause for concern” '. Wtâlc randomised, 
contrullcd trials in regions of severe iodine deficiency have sliown that prenatal iodine deficiency causes dcvelopmcrffal defects in 
cognidon, there is less information on the effects in regions of mild iodine deficiency.
Our study investigated maternal ioÆnc status in I.OCK) women of the Avon Longitudinal Study of Parents and Children (ALSPAC) 
cohort who were recruited in the 19911s'*'. Iodine concentration (and creatinine lo adjust for urine volume) was measured in urine samples 
from pregnant women of median gestational age 13 weeks (IQR 10-16). Women were grouped as iodine-deficient or sufficient accor<£ng 
to WHO criteria'*'. The relation.shifK between maternal iodine status and child's IQ at age S (Wechsler Intelligence Scale for Children, 
WISC), rcaiSng ability at age 9 (Neale Analysis o f Reading Ability), and Key Stage 2 scores at age 11 were analysed Uflng kgistic 
rcgtesriun.
The group was mildly-to-moderatcly iodine deficient based on a median iodine concentration o f  91.8pg,fL (123 pg/g crcatimne)'^' and 
61% o f women were classed as iodine deficient when using (lie creatinine-adjusted data. The children o f  women deficient in ioÆne were 
more likely to have a total IQ score below the 25"" ccntile (unadjusted O R = 1.42,95% Cl 11)5-1.94). ThcTatde shows the risk of being 
in (Ire bottom quartilc of scores, after controlling for relevant confoundcrs (mother’s parcntiiç score, home score, family advctsiC>' during 
pregnancy, lîfe-cvcni score, dietary intake o f «-3 fatty acids and iron, ^nder, ethnicity, maternal age, smoking, alcdiol intake, parity, 
breastfccdng, partner at birth, parental education, housing status, crowding and use o f ifcn, fish oil and vitarnin/miiKral supplements).
ICognilivc test Nundtcr
Maternal iodine 
Odd R 'a
îtatiK: deheient «-s. sittfieieri 
95% Cl p \ -
IQ Total saoœ « 0 U S 3.09-229 0015
Reading AcenrWy ' ,746 1.83 1.22-2.74 0003
CanjiEhenaon 746 U 0.93-2.02 0.1 {
KeyStJSc2 English 754 123 0,83-1.82 030
Matte: 758 1.60 i.m-2.41 0.02
■ : Sciioee ■ 759 136 093-1.% 0.11
Although these results cannot prove causality, they arc .suggestive o f the importance of achieving adequate iodine .status during 
pregnancy and highli^it the possibility drat iodine deficiency can pose a risk to the dcvclopirg infant, even in a country considered to be 
iodine replete. A limkation of this study is the estimation of iodine in a single spot-urinc sample which may not rdlect maternal diet for 
the entire pregnancy. Wc |dan further study in this cohort with both a larger sample size and repeated iodine measures throughout 
gestation.
S. DaiLi gratsfuKy acfcnoRtedges DzDsmdauddp fuaiiag by the Waerloo Pouadatlm and Wa«sen Internaliotial.
1. Zimhrertnanx» MB (2f)09ji f c e t o c r 30,  376-40H.
2. AnierssM AL de Beaoia B, Delaiiee F, es a l (2007) Public Hcatik Nutr 1Û, 1606-1611.
3. PliaEp.sDf (ig97)ifpcdemfVif r<immimto-/feffi'f)r5L39]-393.
4. Vsaafetparap MT, Larams JIL Snyilr PP, ci al (2011) Lasscct 377,2007-2012.
5. Golding J, DîtsilwÉy M & lanes R (2(X)1) Paedsasr Perusist E^udemio! IS, 74-S7.
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OCE4,E119.
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Does fiirni-nianagenient system affect milk-iodine concentration? 
Comparison study of organic and conventional milk
s . Bath, S. Button and M. P. Rayman
Ufiiversity o f  Surrey, Chàldford, Surrey G U 2 7XH, UK
liHÎnc is rcquirrd l*w udcquaic thj-roid hotmonc pn-ductitsi. which is essentia! fur brain development, particularlj’ in the first tmicster 
of ptegnaney* Milk is the pincipal source of knline in OK diets, contributing tp to 42% of adult intake^'', and while small studies ki 
Europe^ *^*' have shown organic mük to have a lower iodine ciKicersralion than conveniioml milk, no such studj.' has been conducted m 
Britain. In view of the increasing popularity o f organic milk in the UK, wc aimed to compare the iodine concentration of retail organic 
and cimventiona! mi&_
Ninety two samples of organic and cighiy samples of conventional milk (semi-skimmed) were purchased fr»*n retail outlets in sixteen 
areas of the UK (Soudiem England. Wales and Northern Ireland) tkiring June. July and August 2JM)9. The nnlk sampks were analysed for 
iodine concentration using inductively coupled plasma MS.
Tlie iodine concentratim of the organic milk samples was significantly lower than that o f the conventional milk samples (P<0.001). 
The median value of organic milk ( 144.5 ng'g) was 42.1% lower than dial of conventional milk (249.5 ng/g).
Organic
Milk Type
The difference ki iodine content observed between the two milk types is likely explained by the restrictions on nfineral supplementation 
in organic lamving'^^'. The lower iodine content of organic milk has important public-health implications, particularly in view of 
emerging evidence of iodine deficKncy in UK population sub-groups, in d u in g  pregnant women*^*. Individuals who chtrowt organic milk 
should be aware that their iodine intake may be compromised and shrruld ensure adequate iodine intake from alternative sources.
S. lîailt g ratefu iy  ackriow W ggs PhD studetiJslttp funding by Tire W aerlot) Foundatks» artd Wassen Inlemational.
1. Zttiîoiensïanti MB |20(W> Emh/cr R e \ 3tL 376-408.
2. Henderson U living K. Gregory J ei aL (2W 31 Londotc HMSO.
3. DaM L OpsaM JA M ehrer HM f t  isi. (2t)t).3) B r J  V ior 9«. 679-685.
4. Rasmus sen IJJ. Lai sen LH & Ovesen L (2tKK)l Eur J  Cliis Nutr  54, 57-6(1
5. Eurt^jvean Uiiimii (2(M)7i J  Eur Uuum  5U, LI 89.
6  Lumpean Union (20(!tSs J  Eur Unkm  51, L25(l 
7. Lazarus HI 4  Srnvth TP 12008) Lemce, 372. KKN.
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Proc Nutr Soc 70 OCE4, E117
Praceedm^ o f  à e  Nmritsm Society (2011 ), 70 (OCM), EI 17 doi: 10.1017/50)29665111001656
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Iodised salt availability in the United Kingdom
S- Bath. S. BuUon and M. P. Rayman
Vnhtrsirs o f Surrey, GuUdford, Surrey GU2 7XH, UK
iodine deficiency has been demonstrated in the UK, particularly in pregnant womcn"\ WHO recommend iodised salt IbrctKrecting iotfinc 
deficiency in a population and to ensure an adequate iodine intake-" .^ Eumpc has a lower usage of iodised salt than other regions 
worldwide^’’. A study in Cardiff showed tliat only two of the thir^'-six salt samples had iodine concentrations suitable for the prevention 
of dcficicncj'*-*. The current study idmed to assess iodised salt availability in supermarkets in a number of areas in the UK.
Dunng June, July and August 3)09, iodised salt availability was surveyed in five supermarket chains in cadi of the fourteen areas 
(largely identified as munties) of Southern England, in Wales (Cardiff) and two supermarket chains in Northern Ireland (Co Antrim). The 
cost o f iodised salt was compared witli that of standard table salt. Weighted ioÆsed salt availafâlity per stpermarkct chain was calculated 
by multiplying the market sharc^ '^ * by the percentage availability in each chain and a total weighted availability figure was calculated ly  
summitig the figures for all the five chains.
Iodised salt was available in thirty-two o f the seventy-seven supermarkets (41 jS^); when talking market share into account, weighted 
availability was lower at !9—%>, Ccrcbos (IVcmicr Foods Group l4d,) was the only iodised sidt brand on sale and has a 0.6% volume 
sharc^ '** of the table salt market. Iodised salt costs between 123 and 14Spcncc/kg and standard table salt cost 23 pencc/kg.
S n p e m u r k c t
c h i n
M a r k e t
s h a re
P a c e n t i ç c  o f  i f o i c s  
s e t t i n g  io d is e d  s a l t  ( R )
W e ig h te d  
à v a i la h iÛ ty  (  S ' )
A 3 1 .0 0 0
B 1 7 .2 0 0
C 1 5 .9 3 7 . 5 5 .9 6
D 1 1 .4 8 6 .7 9 .8 8
:.H 3 .9 8 6 .7 3 .3 8
T o t a l 7 9 .4 4 1 .6 1 9 .2
After accounting for market share, fewer than 20% of supermarket shoppers will be exposed to iodised salt. Where iodised salt was 
available, it was up to six times more expensive and the prenfium price may dissuade consumers from purchasing iodised salt. Ccrcbos 
iodised salt has a low-vdumc share of the table salt market, teflecting poor availability.
Historic reports of goitre in the UK-prompted recommendations in the 1940s by the Medical Research Council that salt should be 
iodi.scd'*'*‘. However, tins recommendation was not followed and it was the adventitious increase in the iodine ctxitcnt of irnlk that led tt> 
the eradication of goitre in the UK^ **. It is therefore not surprising that ioÆsed salt has a low profile.
Current availability of iodised salt is low in die UK and is unlikely to be contributing to tlic iodine status of the (population. UK iodine 
intakes arc dependent entirely on food choice and good sources, such as dairy products and fish, may not be consumed sufficiently by all. 
In view of the importance of ioÆnc for neurological development during pregnancy and infancy/'*, the iodine status of die UK should be 
routinely monitored.
S. Uadi gratefully acknowlsdges PhD studaiistup funding by the Waterloo Foundation and Wassen International.
1. laszarus JH &. Srnvth PP i l i m t  inrnvt 372. S88.
2. WHO & I.TN1ŒF (2007) Geneva: WHO.
3. TNS Worldpanel (2009) wwwJasgfobtd-ComAiewsAiews DCT2«0A36-7C742BE922640S32CE142FA.aspx
4. Synpliony IRI (2010) 52 w/e 4  S^ptetnlper 10.
5. Kelly F  & Snedden W  (I960) Geneva: WHO.
& P iah p s  DI (1997)7 EpMemio! Omsmsmity Health SÇ 391-393,
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Bath S, Wright J, Taylor A, Walter A & Rayman MP (2010) Iodine deficiency in pregnant 
women living in the South-East of the UK Proc Nutr Soc 69 OCE6, E483
PriH-eedings o f  {he Nutiitim Sm-iety (2010), #  E4S3 dai: lO 1017/S(Ï)296651
Sumner Steeling. 2S June }  July 2010^ Nmriihn and healsh: cell to conimmmi
Iodine deficiency in pregnant women living in the South-East of the UK
s. Bath*, J. Wright', A. Taylor*, A. Walter* and M. P. Rayman*
^University of Surrey'. Guildford, Surrey GU2 7XH, UK attd 'Royal Surrey County Hospital. Guildford, Surrey, 
GU2 7XH, UK
Maternal iotfinc dclicicncy during pregnancy leads to an ïnadci|mle |rt>diietkwi o f Itiyroid hormone which, ta^ause it is requited for fetal 
brain dcvelopmeitt, can restdt in reduced IQ, reduced psyehomotor development and ADHD’ 1^ The requiremert for iodine is increased 
from ISOpgj'd in aduks to 250pg/d for pregnant womcn^"l Concerns have been voiced that women in the UK are unable to meet this 
additicml requirement and are Sierefrye at risk o f iodine deficiency during pregnancy*'  ^I
A pilot survey o f fOO pregnant women at 12 weeks gestation was therefore ccmducied at the Royal Surrey County Hospital, Cuildfcrd. 
Participants completed a general questionnaire giving details o f nutritional supplemerts, roedicatitti, age, parity imd catit^ habits 
(e.g. vegetarianism) and an FFQ designed to capture the consumptiœ of foods rich in iodine. Participants fjrorided a spot-urine sarrple; 
itrdine concentration in the urine was determined using inductively coupled pdasma MS and creatinine was measured to conrect for trinary 
volume excreted.
Both median urinary iodme concentration (85jig,(1) (see Fig.) and iodinefcreatinine ratio (I22.9pg,d) indicated that the group was 
dcltcient in iodine according to die WHO criteria'*’. Using the estimated iodine excretion in 24 h (based on adjusted iodine/creatinine 
ratio), only 18% of the individuals had intakes diat satisited the WHO recommendations for pregnancykkinary iodine concentration 
was signilicantly higher in women taking an iodine ermtaimng supplement (n 42) than in those who did not take such a su|^lemcnt 
(PeO.tNH ) (sec Fig, ) btinang it closer to the optimal value for pregnancy. Ninety-six percent of the women rarely or never ccmsumed 
iodi/ed sak.
Adeqaate rsrge tor pcriTaScn media? cdine oc'rcsnlrascn r peegnancf' '
t a r a  s i a p i a r e r r  u s e s N et ss îfie  safp&menl ibsie
This pilot survey conhrms earlier UK work tfiat showed an insuflicient intake d  iodine in pregnant women^ "*’. The grotp is classSicd as 
mild to moderately iodine deficient, which is likely to have implications for the developir^ fetus. Our lindmgs give cause for concern and 
challenge the beliefs held by many that iodine intake in tfic UK is sufficiertf. Pregnant women should be given advice about dietary
sources of iodine and those who habitually have low intAes of iodine-rich hvods should ensure that iodine is preset* in an antenatal
supplement Further studies are needed in different UK regions to confirm these findinp  ^ in other pregnant women.
S B graiefuMy aclatow kdges PliO aaA aitd t^ i faadtag by ilw W aak v o  1-ouadatka» and W assai Ijjtmiatiotial.
1. VertMtgliio I’. L« Presti VP, Moîeti M rf at. Attetitîoo: jfcfick and hy^ jetactiv ift Æsordets in tlte offspring of niolliers e.vposed to müd-moderate
iorfioe deficiency: a }vsssibie novel iodine deficiency discrdsr ki devetr^d countties. J Clin EnJiH-nnol Mchd> 8*#.
2. Andeisson M. de Beitoisi B. Delaiige I e! aL (2tX)7) B evartfctt and control o f W in e  deficiency in  (Megitant and lactatiiig women and in  chitdien less 
than 2-years-oId: coadiusiioos mtd reccrsEtiendaltotts o f  the Tedutical Cons al tM ion. Pubthr Heatck Xuir IW. 1W>6 1611.
3. Laratus JH & S m yth  IT  (24)08) Iodine defieieticy in  tlie UK and ketaiid. Imtscci 372. SSS.
4. Kibtrige MS. Ilatclàson S. Owen CJ vl at. t21M)4) Ptevalettce of maternal Æetary kvline insufficiency in the mwlheast of linghtid. implicatitsns ft* Ilte
teias. Arch fha  Child Feta! Neimatal Ed 89. F436-I439.
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APPENDIX 2: STUDY DOCUMENTATION
• Royal Surrey Study Questionnaires
For fe^stigstor «se only: Partidpaaî mnnber.,
Participnnt Questionnnii e: Assessment of iodine status In pi'egnancj*
Thcnûyaitfor ap'eeing to take part m this project. Please idte time to complete this sltort 
gestionnaire.
First nameSurname..............................................................
DateofBirih......................................................
Contact telephone number............................................. .....................................................
Do you currently smoke? YES/HO
Are you cmiently taking any medication? YES/KO
If YES, please state below the name o f medication and the dose
Do you take nutritional supplements? (E.g. Vitamins and minerals) YES/HO 
If YES, please state name, brand and dose below
Do you eat dairy foods? (E.g. milk/cheese/yogurts) YES/NO
Do you eat fish? YES/NO
Are you a vegetarian? YES/NO
If YES, please list below the foods you exclude fiom your diet
A reyouax^gan?
Have you gfi en biith in the last 3 years? 
If yes, how long ago xvas the bii th?
Uiankyonforyoîtr time
Less than 1 year ago 
Less than 2 j-ears ago 
Less than 3 years ago
YES/NO
YES/NO
Partidpaat Q«esticamire, Vcr àoa 2.0,24^ June 2005
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Food Frequency Questionnaire
PLEASE PUT A TfCK (v' jON EVERY UNE
FOODS AND AMOUNTS AVERAGE NUMBER OF TIMES EATEN IN THE LAST YEAR
FISH & MEAT
{medium servmg)
Never Of less 
than
once/month
1-3 times 
per month
Oncea
week
2-4 times 
per week
5-6 times 
per week
Oncea
day
2-3 times 
per day
4-5 times 
per day
6+times 
per day
Fish Med in batter, as in tish and chips
Fish fingers, fish cakes
Ottser white fresh cr frozen, e.g. cod. 
haddock, plaice, sc(e, halibut
Oiy fish, fresh cf canned, e.g. mackerel, 
sarcfines, tuna, kippers, safinon., herring
Shellfish, e.g. pnewn®, crab, mussels
Fish roe, taraimasalata
fieef. roast, steak, mince, stew
Seelburgers
Fork; roast chops, steafcasserote
Lamb: roast chops, stew/casserole
Chicken or poultry e.g. turkey
Bacon
Ham
Corned beef. Spant lunceon meat
Sausages
Uver, liver pâté, liver sausage
FRUIT, VEGETABLES, NUTS
Never or less 
than
once/month
1-3 times 
pernxmlh
Oncea
week
2-4 times 
per week
5-6 tinies 
per week
Oncea
day
2-3 times 
per day
4-5 tines 
per day
6+ times 
per day
Broccoli, spring greens, kale
Brussels sprouts
Cabbage
Cauliflower
Tumipj'Swede
Spinach
Radishes
Sweet Potatoes
Seaweed e.g. sudti, lava tjread
Peaches
Strawberries
Pearsuts
Brazil nuts
MISCELLANEOUS
Never cf less 
than
oncefmonth
1-3 times 
per month
O ncea
week
2-4 times 
per week
5-6 times 
per week;
Oncea
day
2-3 limes 
per day
4-5 tines 
per day
6+ times 
per day
Eggs
iodized Salt
Beertager (hüf pint)
Water y a s s )
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Food Frequency Questionnaire
PLEASE PUT A TICK {✓ pN EVERY LINE
FOODS AND AMOUNTS AVERAGE NUMBER OF TIMES EATEN IN THE LAST YEAR
DAIRY PRODUCTS
Never or less 
than
once/month
1-3 times 
per month
Once a 
week
2-4 times 
per week
5-6 times 
per v/eek
Once a 
day
2-3 times 
per day
4-5 times 
per day
6+ times 
per day
Single or sour cream/creme fraîche 
(tablespoon)
Double or dotted cream 
(tablespoon)
Low fat yogurt fromage frais 
(125g carton)
Full fat or Greek yogurt (125g carton)
Dairy desserts (125g carton)
Cheese e.g. Cheddar, Brie, Edam 
(medium serving)
Cottage cheese, low-fat soft cheese 
(medium serving)
Butter (teaspoon)
SOY & SOYBEAN PRODUCTS
Never or less 
than
once/month
1-3 times 
per month
Once a 
week
2-4 times 
per week
5-6 times 
per week
Once a 
day
2-3 times 
per day
4-5 times 
per day
6+ times 
per day
Soy milk
Tofu or tempeh
Other soy/soybean products
PLEASE CHECK THAT YOU HAVE Put A TICK (/)O N  EVERY LINE
MILK
What type of milk did you most often use?
Select one only Full cream, silver | |
Semi-skimmed, red | |
Skimmed, blue | |
Channel Islands, gold | [
Soya I  I
Dried milk | [
How much milk did you drink each day, including, milk with tea, coffee, cereals etc?
None
% pint (140 mi) 
% pint (280 ml)
□
□
□
V* pint (425 ml)
I pint (570 ml) ) 
More than I pint
□
□
□
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Royal Surrey Ethics Committee letters
Ezza
National Research Ethics Service
Surrey Research Ethics Committee
Education Centre 
Royal Surrey County Hospital 
Egerton Road 
GUILDFORD 
Surrey 
GU2 7XX
Tel: 01483406898 
Fax:
21 April 2009
Dr John Wright 
Consultant Physician 
Dept Diabetes and Endocrinology 
Royal Surrey County Hospital 
Egerton Road,
Guildford 
GU2 5XX
Dear Dr Wright
Study title:
REG reference: 
Amendment number: 
Amendment date:
Assessment of iodine status in pregnancy
08/H1109/140
3.1
09 April 2009
The above amendment was reviewed at the meeting of the Sub-Committee of the REC held 
on 20 April 2009.
Ethical opinion
The memt>ers of the Committee present gave a favourable ethical opinion of the 
amendment on the basis described in the notice of amendment form and supporting 
documentation.
Approved documents
The documents reviewed and approved at the meeting were;
Document Version Date
Sample Diary/Patient Card 1 09 April 2009
Questionnaire 1 09 April 2009
Questionnaire 1 09 April 2009
Protocol 2 09 April 2009
Participant Information Sheet 2 09 April 2009
Participant Consent Form 09 April 2009
Instruction Sheet 1 09 May 2009
Notice of Substantial Amendment (non-CTIMPs) 3.1 09 April 2009
Thii Research Ethics Committee h an advisory committee to South East Coast Strategic Health Authority 
The NstiomI R&ieatch Ethics Service (NRES) represents the NRBS Directorate within 
the National Patient Safety Agency and Research Ethks Committees in England
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R&D approval
All investigators arid research oollaborators In thé NHS should notify the R&D office for 
Royal Surrey County Hospital of this amendment and check whether it affects R&D 
approval of the research.
Statement of compliance
The Committee Is constituted In accordance with the Governance Arrangernents for 
Research Ethics Committees (July 2001 ) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
08/H1109/140; Please quote this number on all correspondence
Yours sincerely
rs Jane
Committee Co ordinator
E-mail: ethics.committee@royalsurrey.nhs.uk
Copy to: Ms Aimee Cox 
Registry
University of Surrey
Guildford
GU2 7XH
Mr Imran Malik 
R&D Manager
Royal Surrey County Hospital
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^  UNIVERSITY OF
SURREY
Ethics Committee
01 June 2009
Dear Sarah
Assessment of iodine status in pregnancy EC/2009/39/FHMS -  Fast Track
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the submitted protocol and supporting 
documentation.
Date of confirmation of ethical opinion: 29 May 2009.
The final list of documents reviewed by the Committee is as follows:
1 Document ^ Date
! Detailed protocol 29 May 09
1 Participant information sheet 29 May 09
i Consent form 29 May 09
1 Questionnaire 29 May 09
1 Food diary instructions 29 May 09
: 24 hour urine collection instruction sheet 29 May 09
1 Confirmation of favourable ethical opinion from NHS Surrey REC 29 May 09
! Confirmation of favourable ethical opinion for amendment from NHS Surrey REC 29 May 09
This opinion is given on the understanding that you will comply with the University's Ethical 
Guidelines for Teaching and Research. If the project includes distribution of a survey or 
questionnaire to members of the University community, researchers are asked to include a 
statement advising that the project has been reviewed by the University's Ethics Committee,
The Committee should be notified of any amendments to the protocol, any adverse reactions 
suffered by research participants, and if the study is terminated earlier than expected with 
reasons. Please be advised tnat the Ethics Committee is able to audit research to ensure that 
researchers are abiding by the University requirements and guidelines.
You are asked to note that a further submission to the Ethics Committee will be required in the 
event that the study is not completed within five years of the above date.
Please inform me when the research has been completed.
Yours sincerely
Aimee Cox (Miss)
Secretary, University Ethics Committee 
Registry
cc: Professor T Desombre, Chairman, Ethics Committee
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SPRINT Vitamin and Mineral Questionnaire
O u s M E n r a w :  N a r r t i ’a f s J a a B  - F o d c  i M u t r c * ’ v t l a r l r *  a r a  M n t r a t  V « l m  ! . .  I  D M a r a  20C e
SPRINT Vitamin and Mineral Supplements Questionnaire
TRIAL NUMBER
Did you take any vitamins, minerals. mul#ritamlns.'minerals or otier fcod supplements (e.g. „  i— i
kelp) in the six months prior to conception? * '— '
Are you currently taking any vitamins, minerals, muiivitaroinai'mmerals orofijerfood 
supplements (e.g. kelp)? Yes □
MO □  
NO □
If ye* to either question, please complete tfie table below. If have taken more Wan live types of supplement, please put the 
most frequently consumed brands first
VHAHN AND MtNBtAL SUPPLEXÆMTS
AVERAGE FREQUENCY 0= USE
Tick one box per line to she»' often on a v e r ^  >s!u oonsiaried 
each supplement
Date
NAME AMD BRAND
Reaae îstfiJl namte, brand and sJrengSi 
(i.e. dcse perplUsapail*?
DOSE
riLmber cf pills 
capsules, or 
ttaapoors 
oorsurred each
NeverCf 
less frian 
one* a 
nvcnth
t-3 trres 
per monfi
Oncea
week
2-4tmes 
per wee*
5-Stimes
c«-w«e*
Oncea
day
2-3 tme* 
per day
Empierrent
corrmerced
{mrr.yy)
SLf-pJemefi 
Kcfçed (f 
appFsable) 
(trmyyl
THANK YOU FOR YOUR HELP
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Appendix 2: Study Documents 
ALSPAC: University of Surrey Ethics Committee Opinion
UNIVERSITY OF
m SURREY
Sarah Bath 
Biosciences 
FHMS
Ethics Committee
OS FëbruaryizOlO 
Dear Sarah
Investigation into cognitive and behaviour outcomes In the offspring as a result of 
maternal iodine status - EC 2010/02/FHMS
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for the 
above research bn tlie basis described in the submitted protocol and supporting 
documentation,
pate of confirmation of ethical opinion: 8 Februarj,' 2010.
The final list of documents reviewed by the Committee is as follmvs:
Document Date
Detailed protocol for the project 8 Feb 10
ALSPAC consent form - children of the nineties 8 Feb 10
Bristol and Western Health Authority letter confirming ethical approval dated 28 
Nov 1989
8 Feb 10
Southmead Health Authority confirmation of approval o f the sub-group dated 5 
April 1990.
8 Feb 210
Frenchay Health Authority 8 Feb 10
This opinion is given on the understanding that you will comply with the University's Ethical 
Guidelines for Teaching and Research. If the project Includes distribution o f a sur/ey or 
questionnaire to members of the University community, researchers are asked to  include a 
statement advising that the project has been reviewed by the University's Ethics Committee.
The Committee should be notified of any amendments to the protocol, any adverse reactions 
suffered by research participants, and if the study is terminated earlier than expected with 
reasons. Please be advised that the Ethics Committee is able to audit research to ensure that 
researchers are abiding by the University requirements and guidelines.
You are asked to note that a further submission to the Ethics Committee will be required in the 
event that the study is not completed within five years of the above date.
Please inform me when the research has been completed.
Yours sincerely
Glenn Moulton 
Secretary, University Ethics Cbmmittee 
Registry
cc: Professor S Williamsbri, Chairman, Ethics Committee
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Appendix 3: Iodine-containing medication list for ALSPAC
APPENDIX 3: IODINE-CONTAINING MEDICATION LIST 
FOR ALSPAC
Variable: Hypothyroidism (y/n)
Based on use of following medications:
■ Levothyroxine Sodium (T4)
■ Liothyronine Sodium (T3)
■ Thyroid hormones
Variable: Hyperthyroidism (y/n)
Based on use of the following medications:
■ Carbimazole
■ Propylthiouracil
■ Methimazole
Variable: Iodine containing medication (y/n)
Based on use of the following medications:
Levothyroxine Sodium (T4) 
Liothyronine Sodium (T3) 
Thyroid hormones 
Topical Iodine 
Povidone iodine 
Povidone-iodine pessaries 
Amiodarone 
Kelp
Potassium iodide
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Appendix 4: Supermarket locations and milk sample data
APPENDIX 4: EXAMPLE OF SUPERMARKET LOCATION 
AND MILK-SAMPLE DATA
The other 15 regions, and details on brands of milk are on the data CD
i
£o
Ü
t o
Q
OÜ
3U1
OO jg
3  1o(O
e
i lr
•oo
^  (S 
(B SZ
“ I
8
2•o•c<
o
%
V)
Ü
X<
£0
§
I
CÛ
il
I=>
I
6
a.
I
JZ «£>
ll
I
11m
t
g g
13 g
I I
CO
a
it
to
S
If
I
!
I
2
Ifer
ro
II
I
lU
| ig tu
i sO CQ 
8
IÎ
ei
I
J
1
f
to
to
I
to
g
if
§
I
j
Im  CO
"SN
gs!
I
271
Appendix 5: Additional statistics for ALSPAC
APPENDIX 5: ADDIITONAL STATISTICS FOR ALSPAC
Comparison of current study (n 951) cohort to remainder ALSPAC cohort
Confounder This study cohort 
(n = 951)
Remaining ALSPAC 
cohort (n = 13037)
p value
Gender (% male) 48.2 51.9 p<0.05
Birthweight (% >2500g) 96.9 94.4 p<0.001
Gestation (% Preterm) 4.6 6.2 NS
Ethnic Group (% white) 988 978 p<0.01
Smoking in pregnancy
Non-smoker (%) 76.7 65.9 p<0.001
Stopped smoking (%) 12.0 13.8
Still Smoking at 18 weeks (%) 11.3 208
Alcohol in pregnancy
Non-consumer (%) 5.7 8.4 p<0.05
Stopped consuming (%) 37.6 378
Still consuming at 18 weeks (%) 56.7 54.1
Mean iron intake in pregnancy 10.91 (3.28) 1081 (3.39) p<0.001
(SD)
Mean n3 intake in pregnancy 0.16(0.15) 0.15(0.15) p<0.05
(SD)
Fish oil in pregnancy (%) 3.2 2.0 p<0.05
Parity
None (%) 48.5 44.4 p<0.05
One (%) 32.6 358
Two or more (%) 18.9 20A 1
Breastfeeding (% yes) 87.2 768 ' p<0.001
Postnatal depression (%) 25.7 31.8 p<0.001
Maternal Education
Low (%) 188 31.0 p<0.001
Medium (%) 32.4 34.8
High (%) 498 34.2
Paternal Education
Low (%) 24.1 35.4 p<0.001
Medium (%) 21.9 21.2
High(%) ............ _ 54.0 43.4
Housing
Owned/mortgaged (%) 86.9 728 p<0.001
Other rented (%) 7.5 10.9
Council rented (%) 5.7 16.8
Crowding (% 1+ per son/room) 3.4 7.1 NS
Mean Maternal age (years) f 29.8 (4.6) 27.9 (5.0) p<0 001
(SD)
Mean Life event score (SD) 3.55 (2.47) 3.66 (2.62) NS
Mean Long Index during 0.99(1.42) 185(1.62) p<0.001
pregnancy (SD)
Mean mother’s parenting score 10.60(1.42) 10.41(1-57) p<0.001
(SDL......
Mean HOME score (SD) 8.22 (2.11) 8.01 (2.26) p<0.01
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Appendix 5 : Additional statistics for ALSPAC 
Model statistics for logistic regression analysis (Chapter 5)
Model one* Model two* Model three*
IQ ____________________________________________________  ______________ ________
Verbal f  (6 )36 .0  p<0.0001,F?  
=0.06
)T(25) 89.2 p<0.0001,R^
=0.15
XA28) 80 .8p< 0.0001 ,R :
=0.15
Performance % ^(6)^.îp<Ô .00Ô l,R^=0.04 X^  (25) 53.9 p<0.001,R^=0.09 X^(28) 45.1 p<0.05,R^=0.08
Total (6) 42.2 p<0.Ô00Î,R^
X^(25) 111.5p<0.0001,R^ ;p (28) lb s .2 p<b.00b l, R^
=0.07 =0.19 _______ = 0 8 8 ___________
Ivey stage i
Reading % (^6) 18.7 p<0.05,R^ =0.07 f  (25) 42.5 p<0.()5, R^=Ô.Î8 7 ^M Lrp<Ô .Ô5rR^H L^"'
Writing %^(6)31.7 p<Ô.ÔÔOi,R^ =0.11
f  (25) 58.3 p<0.0001,R^
=0.22
X^(28)6b.O p<b.obbl,R^
=0.25
Mathematics % (^6) 16.3 p<Ô.Ô5, R^=d.06 X^(25) 44.0 p<Ô.Ô5, R^=0.18 x  ^(28) 4 i 9  P<b.b5, ÏP  =b. 19
Key Stage 2
% ^ (6 )5 8 iT p ^ .0 0 0 1 ,^ '
=0.10
English X^(2^ÎÔÏ.Ô p<Ô.bÔ01,R^
=0.19
x^^8) ÎÔ6.9 p<b.bbdi,Fp
=0.21
Mathematics (6 )^ .1  p < ô .d ô o i ,^  
=0.10
x ^ (^ )9 3 .5  p<b.dbbi,R^
=0.18
x^(28) ibô.6 p<b.bdbi,R^
=0.20
Science " 7 ( 6 )  5 8 .7 ^ 0 .0 0 0 1 , R' =0.10
x^  (25) 96.0 p<d.bbbi,R^  
=0.18
x^(28) 97.7 p<b.bbbl,R^
=0.19
Key Stage 3
English X“(6) 64.3 p<0.000l, R' =0.13
5? (25) Î40.0 p<0.0001,R% 
=0.30
7 2 8 )  143.5 p^.Ô Ô bï,R^
=0.32
Mathematics %"(6)28.3 p<0.0001,R^=0.06
x^  (25) 61.6 p<0.0001,R^
=0.14
x ^ ^ 8 )6 1 .7  p<0.bbbl,R^
=0.15
Science X^(6) 12.6 p<0.05,R^=0.03 X^(25) 28.7 p=0.28,R" =0.07 X^(28) 33.7 p=0.21,"R^=b.b8
Reading
Words X ^ (6 )^ .6  p<0.0001,R^ X^(25) 64.7 p<0.0001,R^ X ^(28)60.9p<0.000Ï,R ^
read/minute =0.08 =0.13 =0.13
Accuracy %^(6)62.ïp<Ô.ddÔÎ,R^
=0.11
x^(25)9d.5p<b.bbbi,R^
=0.17
X^(28) 84.7p<b.bbbl,R ^
=0.17
Comprehension ;^(6) 74.3 p<0.0001, R^
=0.13
X' (25) 106.5 p<0.0001,R" 
=0.20
X^  (28) 97.7p<0.0001,R%  
=0.19
Reading score (6) 52.2 p<Ô.Ô0dl,R^=0.09
7 ^ )  77.6 p<0.0001, R^
=0.15
x ^ ^ 7 6 . 4  p<0.bbbi, R^
=0.15
Special Education Needs
School action or 
above
X^(6) 6.6 p=0.35,R^ =0.02 X" (25) 21.7 p=0.65,R" =0.07 X^  (28) 31.4 p=0.30,R ^=0.10
Suboptinial hearing
Right ear X \6 )  12.7 p=0.05,R^ =0.03 X^(25) 29.8 p=0.23,R^ =0.06 x \2 8 )  29.8 p=0.37,R^ =0.07
Left ear x \ 6 )  Ü .9  p=6.06,R^=0.02 X^  (25) 23.8 p=b.53,R^ =0.05 X^(28) 24.3 p=0.66, R^=0.05
Unilateral X^(6) 16.5 p=0.01, R  ^=0.03' %^(25) 27.6p=0.33,R ^ =0.05 X^(28) 27.6 p=0.49, ' ] ^ b .0 5
Bilateral X^(6)7.3p=Q.30,R^=0.02 " 7 ( 2 5 )  24.6 p=0.49, R^=0.06 X^  (28) 21.6 p=0.8b,R^=0.06
Mjld hearing imp
Right ear
airnient
Y ^ ) T 2 .7  pLo.05, R^=0.06" T ^ j  32. i p=b. 15, R  ^=0.18 X ^(28)38.7p=0.09, R^=0.22
Left ear X^(6)2.8p=b.83,R^=0.01 f  (25) 22.1 p=0.63, R^=0.11 ?  (28) 26.3 p=0.56, R^=0.13
Unilateral X \6 )5 .9  p = 0 .4 3 ,r 2=0.02 X" (25) 26.4 p=0.39,R^=0.11 X'(28) 34.8 p=0.18, R^=0.14
Bilateral x \ 6 )  4.7 p=0.56,R^ =0.04 X^(25) 23.3 p=0.56,R^=0.20 X^(28) 26.2 p=0.56,R^ =0.23
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Appendix 6: Food portion weights
APPENDIX 6: FOOD PORTIONS WEIGHTS
# Food portion weights used to analyse ALSPAC FFQ
Food category
Pies and pasties
Sausages and 
burgers
Meat
Poultry
Offal
White fish
Oily fish
Shellfish
Eggs
Cheese
Individual items Portion (g)
Chicken pie 120
Pork pie 140
Beef pastie 160
Pastie 155
Steak pie 150
Beef sausage (2) 80
Pork sausage (2) 80
Frankfurter 47
Beefburger 105
Beef 90
Lamb 90
Fork 90
Chicken ÎÔO
T Lirkey 100
Liver portion 7bT
Kidney, average 112
Whole heart 200
Pate on toast 40
Cod 120
Haddock 170
Plaice 150
Fish fingers 56
Coley 120
Red Mullet 75
Whiting 180
Red Snapper 200
Mackerel 145
Salmon canned 100
Sardines 50
Tuna 45
Trout, rainbow 155
Pilchards, canned 55
Herring 200
Kippers 130
Prawns 60
Cockles 25
Mussels 40
Scampi 170
Boiled (2) 100
Fried 60
Poached(2) 100
Quiche 140
Haid cheese 40
Soft cheese 40
Average portion (g)
145
78
90
100
106
134
110
74
100
40
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Appendix 6: Food portion weights
Food portion weights used to analyse ALSPAC FFQ (continued)
Food category 
Boiled/baked/
Oat cereals
Wholegrain
cereals
Other cereals
mashed potato
Pasta
Peas /sweetcorn/ 
broad beans
Cabbage/sprouts/ 
leafy greens
Root vegetables
Other green 
vegetables
Salad
Fresh fruit
Fruit juice
Pudding
Individual items
Baked 
Boiled 
Mashed 
Spaghetti 
Macaroni 
Pasta 
Pot Noodle 
Peas 
Sweetcorn 
Broad beans 
Cabbage 
Sprouts 
Spinach 
Swede 
Parsnips 
Runner beans 
Cauliflower 
Leeks 
Cucumber 
Lettuce 
Tomato 
Apple 
Banana 
Pear 
Orange 
Grapes 
Plum 
Tinned 
Pure 
Fruit pie 
Crumble 
Cheesecake 
Milk Pudding 
Mousse 
Trifle 
Read) Brek 
Porridge 
Alpen 
Crunchy Muesli 
Branflakes 
Fruit and Fibre 
All bran 
Shredded wheat 
Cornflakes 
Rice Crispies 
Frosties
Portion
160
175
175
230
230
300
70
85
120
95
90
90
65
Average portion (g) 
170
90
90
75
23
30
85
100
100
170
160
100
55
160
160
110
170
120
200
74
170
180
50
60
30
30
40
45
30
30
30
245
92 
92 
63
85
46
114
160
141
113
36
30
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Appendix 6: Food portion weights
Food portion weights used to analyse ALSPAC FFQ (continued)
Food category Individual items Portion (g) Average portion (g)
Cakes or buns
Biscuits
Chocolate bars
Pulses
Nuts
Chocolate
Sweets
Fruit cake 
Teacake 
Iced bun 
Jam doughnut 
Sponge with cream 
Flapjack 
Cream biscuits 
Cereal 
Fruit biscuits 
Club 
Choc shortbread 
Jam filled 
Digestive 
Mars 
Twix 
Bounty 
Crème Egg 
Snickers 
Galaxy 
Lentils 
Beans 
Chickpeas 
Kidney beans 
Peanuts 
Cashew 
Bournville Chocolate 
Milk Chocolate bar 
Fruit pastilles 
liquorice allsorts 
mint chews 
Trebor mints 
Soft fruits 
Tic tacs
60
60
65
75
60
60
.12..
9
10 
24 
11 
12
13____
56
57
39 
61
47 
120 
120 
90 
70 
50 
50 
50 
50
40 
56 
39
48 
45 
12
63
13
54
100
50
50
40
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Appendix 6: Food portion weights 
Portion weights used for analysis of Royal Surrey Study FFQ
Food category Individual items
Fish fingers
White fish
Oily fish
Shellfish
Beef
Fork
Lamb
Poultry
Corned beef
Sausages
Liver
Broccoli 
Cheese 
Cottage cheese
Portion (g) Average portion (g)
Fish fingers 100 80F ishcake 60
Cod j 120
Haddock | 120
Plaice 1 130 137
Halibut 145
Sole 170
Mackerel 160
Sardines 100
Tuna
Kippers
96
130
122
Salmon 100
Herring 120
Prawns 60
Crab 130 77
Mussels 40
Ruaü: 90
Mince
Steak
140
144
129
Stew 140
Roast
Chop
90
120
105
Roast 90 80
Chop 70
Chicken 114 107
Turkey 100
Corned Beef 100
Spam 60 67
Luncheon Meat 40
Beef sausage (2) 80 80
Pork sausage (2) | 80
Liver | 70
Liver pate 
lice of grilled liver i
80
40
63
Broccoli 85 90Kale 95
Cheddar i 40 40
Edam I 40
Cottage cheese | 50 40
Soft cheese ! 30
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Appendix 7: Iodine values for Iodine Fact Sheet
APPENDIX 7: IODINE VALUES FOR FOOD FACT SHEET
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Appendix 7: Iodine values for Iodine Fact Sheet
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CD Appendix
CD APPENDIX
The CD affixed to the back cover of this thesis contains all SPSS output for the analysis 
reported. In addition, raw data from laboratory analysis is provided.
PLEASE APPLY TO THE LIBRARY IF CD APPENDIX IS REQUIRED
CZ..TX H.O-T -rue-
•a.'S
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